<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29518464</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8646</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Genomics</Title><ISOAbbreviation>Genomics</ISOAbbreviation></Journal><ArticleTitle>Whole genome sequence analysis of Geitlerinema sp. FC II unveils competitive edge of the strain in marine cultivation system for biofuel production.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0888-7543(18)30136-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygeno.2018.03.004</ELocationID><Abstract><AbstractText>A filamentous cyanobacteria, Geitlerinema sp. FC II, was isolated from marine algae culture pond at Reliance Industries Limited (RIL), India. The 6.7 Mb draft genome of FC II encodes for 6697 protein coding genes. Analysis of the whole genome sequence revealed presence of nif gene cluster, supporting its capability to fix atmospheric nitrogen. FC II genome contains two variants of sulfide:quinone oxidoreductases (SQR), which is a crucial elector donor in cyanobacterial metabolic processes. FC II is characterized by the presence of multiple CRISPR- Cas (Clustered Regularly Interspaced Short Palindrome Repeats - CRISPR associated proteins) clusters, multiple variants of genes encoding photosystem reaction centres, biosynthetic gene clusters of alkane, polyketides and non-ribosomal peptides. Presence of these pathways will help FC II in gaining an ecological advantage over other strains for biomass production in large scale cultivation system. Hence, FC II may be used for production of biofuel and other industrially important metabolites.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batchu</LastName><ForeName>Navish Kumar</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khater</LastName><ForeName>Shradha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patil</LastName><ForeName>Sonal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagle</LastName><ForeName>Vinod</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Gautam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhadra</LastName><ForeName>Bhaskar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapre</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dasgupta</LastName><ForeName>Santanu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Reliance Technology Group, Reliance Industries Limited, Navi Mumbai 400701, India. Electronic address: santanu.dasgupta@ril.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genomics</MedlineTA><NlmUniqueID>8800135</NlmUniqueID><ISSNLinking>0888-7543</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Algae to oil</Keyword><Keyword MajorTopicYN="N">Biofuel</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas – locus</Keyword><Keyword MajorTopicYN="N">Geitlerinema sp. FC II</Keyword><Keyword MajorTopicYN="N">Photosynthesis</Keyword><Keyword MajorTopicYN="N">Reliance Industries Limited</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29518464</ArticleId><ArticleId IdType="pii">S0888-7543(18)30136-8</ArticleId><ArticleId IdType="doi">10.1016/j.ygeno.2018.03.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29518409</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8638</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J. Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>AbiEi binds cooperatively to the Type IV abiE toxin-antitoxin operator via a positively-charged surface and causes DNA bending and negative autoregulation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0022-2836(18)30107-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmb.2018.02.022</ELocationID><Abstract><AbstractText>Bacteria resist phage infection using multiple strategies, including CRISPR-Cas and abortive infection (Abi) systems. Abi systems provide population-level protection from phage predation, via "altruistic" cell suicide. It has recently been shown that some Abi systems function via a toxin-antitoxin (TA) mechanism, such as the widespread AbiE family. The Streptococcus agalactiae AbiE system consists of a bicistronic operon encoding the AbiEi antitoxin and AbiEii toxin, which function as a Type IV TA system. Here we examine the AbiEi antitoxin, which belongs to a large family of transcriptional regulators with a conserved N-terminal winged-helix-turn-helix (wHTH) domain. This wHTH is essential for transcriptional repression of the abiE operon. The function of the AbiEi C-terminal domain (CTD) is poorly characterised, but it contributes to transcriptional repression and is sufficient for toxin neutralization. We demonstrate that a conserved charged surface on one face of the CTD assists sequence-specific DNA binding and negative autoregulation, without influencing antitoxicity. Furthermore, AbiEi binds cooperatively to two inverted repeats within the abiE promoter and bends the DNA by 72°. These findings demonstrate the mechanism of DNA binding by the widespread family of AbiEi antitoxins and transcriptional regulators can contribute to negative autoregulation.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hampton</LastName><ForeName>Hannah G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Simon A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagerlund</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Anne I M</ForeName><Initials>AIM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dy</LastName><ForeName>Ron L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blower</LastName><ForeName>Tim R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineran</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, PO, Box 56, Dunedin 9054, New Zealand. Electronic address: peter.fineran@otago.ac.nz.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AbiE</Keyword><Keyword MajorTopicYN="N">COG5340</Keyword><Keyword MajorTopicYN="N">abortive infection system</Keyword><Keyword MajorTopicYN="N">phage resistance</Keyword><Keyword MajorTopicYN="N">toxin-antitoxin system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29518409</ArticleId><ArticleId IdType="pii">S0022-2836(18)30107-4</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2018.02.022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29518315</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2161-5063</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>ACS synthetic biology</Title><ISOAbbreviation>ACS Synth Biol</ISOAbbreviation></Journal><ArticleTitle>Non-transgenic marker-free gene disruption by an episomal CRISPR system in the oleaginous microalga, Nannochloropsis oceanica CCMP1779.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acssynbio.7b00362</ELocationID><Abstract><AbstractText>Utilization of microalgae has been hampered by limited tools for creating loss-of-function mutants. Furthermore, modified strains for deployment into the field must be free of antibiotic resistance genes and face fewer regulatory hurdles if they are transgene free. The oleaginous microalga, Nannochloropsis oceanica CCMP1779, is an emerging model for microalga lipid metabolism. We present a one-vector episomal CRISPR/Cas9 system for N. oceanica that enables the generation of marker-free mutant lines. The CEN/ARS6 region from Saccharomyces cerevisiae was included in the vector to facilitate its maintenance as circular extrachromosal DNA. The vector utilizes a bidirectional promoter to produce both Cas9 and a ribozyme flanked sgRNA. This system efficiently generates targeted mutations, and allows the loss of episomal DNA after the removal of selection pressure, resulting in marker-free non-transgenic engineered lines. To test this system we disrupted the nitrate reductase gene (NR) and subsequently removed the CRISPR episome to generate non-transgenic marker-free nitrate reductase knockout lines (NR-KO).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poliner</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Takeuchi</LastName><ForeName>Tomomi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zhi-Yan</ForeName><Initials>ZY</Initials></Author><Author ValidYN="Y"><LastName>Benning</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Farre</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Synth Biol</MedlineTA><NlmUniqueID>101575075</NlmUniqueID><ISSNLinking>2161-5063</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29518315</ArticleId><ArticleId IdType="doi">10.1021/acssynbio.7b00362</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29518156</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 -mediated gene knockout of Anopheles gambiae FREP1 suppresses malaria parasite infection.</ArticleTitle><Pagination><MedlinePgn>e1006898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1006898</ELocationID><Abstract><AbstractText>Plasmodium relies on numerous agonists during its journey through the mosquito vector, and these agonists represent potent targets for transmission-blocking by either inhibiting or interfering with them pre- or post-transcriptionally. The recently developed CRISPR/Cas9-based genome editing tools for Anopheles mosquitoes provide new and promising opportunities for the study of agonist function and for developing malaria control strategies through gene deletion to achieve complete agonist inactivation. Here we have established a modified CRISPR/Cas9 gene editing procedure for the malaria vector Anopheles gambiae, and studied the effect of inactivating the fibrinogen-related protein 1 (FREP1) gene on the mosquito's susceptibility to Plasmodium and on mosquito fitness. FREP1 knockout mutants developed into adult mosquitoes that showed profound suppression of infection with both human and rodent malaria parasites at the oocyst and sporozoite stages. FREP1 inactivation, however, resulted in fitness costs including a significantly lower blood-feeding propensity, fecundity and egg hatching rate, a retarded pupation time, and reduced longevity after a blood meal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yuemei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simões</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marois</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4147-3747</Identifier><AffiliationInfo><Affiliation>Inserm, CNRS, Université de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulos</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6755-8111</Identifier><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29518156</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1006898</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-17-02447</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29518119</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.</ArticleTitle><Pagination><MedlinePgn>e0193560</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193560</ELocationID><Abstract><AbstractText>Human arylamine N-acetyltransferase 1 (NAT1) has been associated with cancer cell growth and invasion, but the underlying molecular mechanisms remain unknown. NAT1 is located on the short arm of chromosome 8 (8p21), a region that is commonly deleted in colon cancer. Previously, it was reported that HT-29 colon cancer cells, which have a large deletion at 8p21-22, show marked morphological changes, increased E-cadherin expression and altered cell-cell contact inhibition following down-regulation of NAT1 with shRNA. By contrast, no effects on growth were observed in HeLa cells. In the present study, cellular changes following knockout of NAT1 with CRISPR/Cas9 in HT-29 and HeLa cells were compared in the presence and absence of glucose. Cell growth decreased in both cell-lines during glucose starvation, but it was enhanced in HT-29 cells following NAT1 deletion. This was due to an increase in ROS production that induced cell apoptosis. Both ROS production and cell death were prevented by the glutathione precursor N-acetylcysteine. NAT1 knockout also resulted in a loss of the gain-of-function p53 protein in HT-29 cells. When p53 expression was inhibited with siRNA in parental HT-29 cells, ROS production and apoptosis increased to levels seen in the NAT1 knockout cells. The loss of p53 may explain the decreased colony formation and increased contact inhibition previously reported following NAT1 down-regulation in these cells. In conclusion, NAT1 is important in maintaining intracellular ROS, especially during glucose starvation, by stabilizing gain-of-function p53 in HT-29 cells. These results suggest that NAT1 may be a novel target to decrease intracellular gain-of -function p53.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>LiLi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minchin</LastName><ForeName>Rodney F</ForeName><Initials>RF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3178-4835</Identifier><AffiliationInfo><Affiliation>Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butcher</LastName><ForeName>Neville J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29518119</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193560</ArticleId><ArticleId IdType="pii">PONE-D-17-44931</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29517395</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-8584</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>RNA biology</Title><ISOAbbreviation>RNA Biol</ISOAbbreviation></Journal><ArticleTitle>Biochemical analysis of the Cas6-1 RNA endonuclease associated with the subtype I-D CRISPR-Cas system in Synechocystis sp. PCC 6803.</ArticleTitle><Pagination><MedlinePgn>1-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15476286.2018.1447742</ELocationID><Abstract><AbstractText>Specialized RNA endonucleases are critical for efficient activity of the CRISPR-Cas defense mechanisms against invading DNA or RNA. Cas6-type enzymes are the RNA endonucleases in many type I and type III CRISPR-Cas systems. These enzymes are diverse and critical residues involved in the recognition and cleavage of RNA substrates are not universally conserved. Cas6 endonucleases associated with the CRISPR-Cas subtypes I-A, I-B, I-C, I-E and I-F, as well as III-B have been studied from four archaea and three bacteria thus far. However, until now information about subtype I-D specific Cas6 endonucleases has remained scarce. Here, we report the biochemical analysis of Cas6-1, which is specific for the crRNA maturation from the subtype I-D CRISPR-Cas system of Synechocystis sp. PCC 6803. Assays of turnover kinetics suggest a single turnover mechanism for Cas6-1. The mutation of conserved amino acids R29A, H32A-S33A and H51A revealed these as essential, whereas the parallel mutation of R175A-R176A led to a pronounced and the K155A mutation to a slight reduction in enzymatic activity. In contrast, the mutations R67A, R81A and K231A left the enzymatic activity unchanged. These results are in accordance with the predominant role of histidine residues in the active site and of positively charged residues in RNA binding. Nevertheless, the protein-RNA interaction site seems to differ from other known systems, since imidazole could not restore the mutated histidine site.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jesser</LastName><ForeName>Rabea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>a Genetics and Experimental Bioinformatics , Faculty of Biology, University of Freiburg , Schänzlestr. 1, D-79104 Freiburg , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behler</LastName><ForeName>Juliane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>a Genetics and Experimental Bioinformatics , Faculty of Biology, University of Freiburg , Schänzlestr. 1, D-79104 Freiburg , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benda</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>b Department of Structural Cell Biology , Max-Planck-Institute of Biochemistry, Am Klopferspitz 18 , D-82152 Martinsried , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reimann</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>a Genetics and Experimental Bioinformatics , Faculty of Biology, University of Freiburg , Schänzlestr. 1, D-79104 Freiburg , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Wolfgang R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>a Genetics and Experimental Bioinformatics , Faculty of Biology, University of Freiburg , Schänzlestr. 1, D-79104 Freiburg , Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Freiburg Institute for Advanced Studies, University of Freiburg , Albertstr. 19, D-79104 Freiburg , Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>RNA Biol</MedlineTA><NlmUniqueID>101235328</NlmUniqueID><ISSNLinking>1547-6286</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas6</Keyword><Keyword MajorTopicYN="N">RNA endonuclease</Keyword><Keyword MajorTopicYN="N">RNA maturation</Keyword><Keyword MajorTopicYN="N">cyanobacteria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29517395</ArticleId><ArticleId IdType="doi">10.1080/15476286.2018.1447742</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29517035</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>555</Volume><Issue>7695</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>A CRISPR edit for heart disease.</ArticleTitle><Pagination><MedlinePgn>S23-S25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-018-02482-4</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>King</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29517035</ArticleId><ArticleId IdType="pii">d41586-018-02482-4</ArticleId><ArticleId IdType="doi">10.1038/d41586-018-02482-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29517026</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>555</Volume><Issue>7695</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>How CRISPR is transforming drug discovery.</ArticleTitle><Pagination><MedlinePgn>S10-S11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-018-02477-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29517026</ArticleId><ArticleId IdType="pii">d41586-018-02477-1</ArticleId><ArticleId IdType="doi">10.1038/d41586-018-02477-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29516520</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0765</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of periodontal research</Title><ISOAbbreviation>J. Periodont. Res.</ISOAbbreviation></Journal><ArticleTitle>25-Hydroxyvitamin D<sub>3</sub>-enhanced PTPN2 positively regulates periodontal inflammation through the JAK/STAT pathway in human oral keratinocytes and a mouse model of type 2 diabetes mellitus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/jre.12535</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Periodontitis is an increasingly prevalent complication of diabetes mellitus (known as diabetes mellitus-associated periodontitis), and 25-hydroxyvitamin D<sub>3</sub>(25VD<sub>3</sub>) was recently found to be a critical regulator of innate immunity in this disease, but the underlying mechanisms remain poorly understood. T-cell protein tyrosine phosphatase non-receptor type 2 (PTPN2) is a potential downstream protein of the 25VD<sub>3</sub>/vitamin D receptor pathway. The aim of this study was to investigate the regulation of PTPN2 in periodontal inflammation in diabetes mellitus-associated periodontitis.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Porphyromonas gingivalis-infected db/db mice were treated with 25VD<sub>3</sub>. Their fasting blood glucose and body weight were monitored every other week, and the levels of alveolar bone loss and serum inflammatory cytokines (tumor necrosis factor-α, interferon-γ and interleukin-6) were determined at the time of killing. The effect of PTPN2 on human OKF6-TERT2 oral keratinocytes was examined through the knockout of PTPN2 using the CRISPR/Cas9 knockout plasmid. The expression levels of the PTPN2, vitamin D receptor and JAK1/STAT3 signaling proteins in the gingival epithelium and OKF6-TERT2 cells were determined through western blot and immunohistochemical analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After 25VD<sub>3</sub>treatment, db/db mice exhibited alleviated serum inflammatory cytokines and alveolar bone loss, and 25VD<sub>3</sub>-enhanced PTPN2 expression decreased the expression of the JAK1/STAT3 signaling proteins in the gingival epithelium. Analyses of human oral keratinocytes showed that 25VD<sub>3</sub>increased the expression of PTPN2, which dephosphorylates protein substrates in the JAK1/STAT3 signaling pathway.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PTPN2 contributed to a decrease in periodontal inflammation in type 2 diabetes mellitus via dephosphorylate protein substrates in the JAK1/STAT3 signaling pathway after 25VD<sub>3</sub>treatment in human oral keratinocytes and a mouse model of type 2 diabetes mellitus. A thorough understanding of PTPN2 and its involvement in inhibiting inflammation might provide alternative therapeutic approaches for the pathogenesis and treatment of diabetes mellitus-associated periodontitis.</AbstractText><CopyrightInformation>© 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Dental Research, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aprecio</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Dental Research, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center for Dental Research, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Dental Research, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Periodontology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Q</ForeName><Initials>Q</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1588-9047</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Periodontal Res</MedlineTA><NlmUniqueID>0055107</NlmUniqueID><ISSNLinking>0022-3484</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">JAK</Keyword><Keyword MajorTopicYN="N">STAT</Keyword><Keyword MajorTopicYN="N">PTPN2</Keyword><Keyword MajorTopicYN="N">Vitamin D3</Keyword><Keyword MajorTopicYN="N">diabetes mellitus-associated periodontitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29516520</ArticleId><ArticleId IdType="doi">10.1111/jre.12535</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29516417</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0305</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Molecular biotechnology</Title><ISOAbbreviation>Mol. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Genome Editing in Stem Cells for Disease Therapeutics.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12033-018-0072-9</ELocationID><Abstract><AbstractText>Programmable nucleases including zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindrome repeats (CRISPR)/CRISPR-associated protein have tremendous potential biological and therapeutic applications as novel genome editing tools. These nucleases enable precise modification of the gene of interest by disruption, insertion, or correction. The application of genome editing technology to pluripotent stem cells or hematopoietic stem cells has the potential to remarkably advance the contribution of this technology to life sciences. Specifically, disease models can be generated and effective therapeutics can be developed with great efficiency and speed. Here we review the characteristics and mechanisms of each programmable nuclease. In addition, we review the applications of these nucleases to stem cells for disease therapies and summarize key studies of interest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Minjung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Food Biotechnology, College of Medical and Life Science, Silla University, Busan, South Korea. songmj@silla.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4038-1085</Identifier><AffiliationInfo><Affiliation>Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea. suri28@hanyang.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Hanyang University, Seoul, South Korea. suri28@hanyang.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017R1D1A1A02018480</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant><Grant><GrantID>2015R1C1A1A01054482</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Biotechnol</MedlineTA><NlmUniqueID>9423533</NlmUniqueID><ISSNLinking>1073-6085</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clustered regularly interspaced short palindrome repeat associated system</Keyword><Keyword MajorTopicYN="N">Hematopoietic stem cells</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">Transcription activator-like effector nucleases</Keyword><Keyword MajorTopicYN="N">Zinc finger nucleases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29516417</ArticleId><ArticleId IdType="doi">10.1007/s12033-018-0072-9</ArticleId><ArticleId IdType="pii">10.1007/s12033-018-0072-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29516116</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0724-6145</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2018</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Advances in biochemical engineering/biotechnology</Title><ISOAbbreviation>Adv. Biochem. Eng. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>TILLING: The Next Generation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/10_2017_54</ELocationID><Abstract><AbstractText>Gene space: the final frontier in plant functional genomics. These are the voyages of TILLING, the reverse-genetics strategy that sought to boldly go where no-one had gone before by combining high-density chemical mutagenesis with high-throughput mutation discovery. Its 18-year mission has been to explore new technologies such as next generation sequencing and to seek out new strategies like in silico databases of catalogued EMS-induced mutations from entire mutant plant populations. This chapter is a clip show highlighting key milestones in the development of TILLING. Use of different technologies for the discovery of induced mutations, establishment of TILLING in different plant species, what has been learned about the effect of chemical mutagens on the plant genome, development of exome capture sequencing in wheat, and a look to the future of reverse-genetics with targeted genome editing are discussed. Graphical Abstract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Till</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Plant Breeding and Genetics Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, IAEA Laboratories Seibersdorf, International Atomic Energy Agency, Vienna International Centre, Vienna, Austria. b.till@iaea.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Sneha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Plant Breeding and Genetics Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, IAEA Laboratories Seibersdorf, International Atomic Energy Agency, Vienna International Centre, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankowicz-Cieslak</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Plant Breeding and Genetics Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, IAEA Laboratories Seibersdorf, International Atomic Energy Agency, Vienna International Centre, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Adv Biochem Eng Biotechnol</MedlineTA><NlmUniqueID>8307733</NlmUniqueID><ISSNLinking>0724-6145</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">Chemical mutagenesis</Keyword><Keyword MajorTopicYN="N">EMS</Keyword><Keyword MajorTopicYN="N">In silico TILLING</Keyword><Keyword MajorTopicYN="N">Next generation sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29516116</ArticleId><ArticleId IdType="doi">10.1007/10_2017_54</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29515542</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Analysis of CRISPR-Cas System in<i>Streptococcus thermophilus</i>and Its Application.</ArticleTitle><Pagination><MedlinePgn>257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2018.00257</ELocationID><Abstract><AbstractText>CRISPR-Cas (Clustered regularly interspaced short palindromic repeats-CRISPR associated proteins) loci, which provide a specific immunity against exogenous elements, are hypervariable among distinct prokaryotes. Based on previous researches, this review focuses on concluding systematical genome editing protocols in<i>Streptococcus thermophilus.</i>Firstly, its protocols and optimized conditions in gene editing are introduced. What's more, classification and diversity analyses of<i>S. thermophilus</i>CRISPR-Cas benefit the further understanding of evolution relationship among<i>Streptococcus.</i>Ability of its foreign segment integration and spacer source analyses also indicate a new direction of phage resistance. Above all, all of these point out its potential to be regarded as another model system other than type II CRISPR-Cas in<i>Streptococcus pyogenes</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Mengyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Food Science and Engineering, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yanhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Food Science and Engineering, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, Heilongjiang Academy of Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas</Keyword><Keyword MajorTopicYN="N">Streptococcus thermophilus</Keyword><Keyword MajorTopicYN="N">diversity</Keyword><Keyword MajorTopicYN="N">gene editing</Keyword><Keyword MajorTopicYN="N">model system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29515542</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2018.00257</ArticleId><ArticleId IdType="pmc">PMC5826314</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29515357</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-4548</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in neuroscience</Title><ISOAbbreviation>Front Neurosci</ISOAbbreviation></Journal><ArticleTitle>Epitranscriptomics: A New Regulatory Mechanism of Brain Development and Function.</ArticleTitle><Pagination><MedlinePgn>85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnins.2018.00085</ELocationID><Abstract><AbstractText>Epigenetic modifications of DNA and chromatin are long known to control stem cell differentiation and organ function but the role of similar modifications at the level or regulatory RNAs is just beginning to emerge. Over 160 RNA modifications have been identified but their abundance, distribution and functional significance are not known. The few available maps of RNA modifications indicated their dynamic regulation during somatic stem cell differentiation, brain development and function in adulthood suggesting a hitherto unsuspected layer of regulation both at the level of RNA metabolism and post-transcriptional control of gene expression. The advent of programmable, RNA-specific CRISPR-Cas editing platforms together with the identification of RNA modifying enzymes now offers the opportunity to investigate the functional role of these elusive epitranscriptome changes. Here, we discuss recent insights in studying the most abundant modifications in functional mRNAs and lncRNAs, N6-methyladenosine and 5-(hydroxy-)methylcytosine, and their role in regulating somatic stem cell differentiation with particular attention to neural stem cells during mammalian corticogenesis. An outlook on novel CRISPR-Cas based systems that allow stem cell reprogramming by epitranscriptome-editing will also be discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noack</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>DFG-Research Center and Cluster of Excellence for Regenerative Therapies, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calegari</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>DFG-Research Center and Cluster of Excellence for Regenerative Therapies, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurosci</MedlineTA><NlmUniqueID>101478481</NlmUniqueID><ISSNLinking>1662-453X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-hydroxymethylcytosine</Keyword><Keyword MajorTopicYN="N">5-methylcytosine</Keyword><Keyword MajorTopicYN="N">N6-methyladenosine</Keyword><Keyword MajorTopicYN="N">RNA-epigenetics</Keyword><Keyword MajorTopicYN="N">brain development</Keyword><Keyword MajorTopicYN="N">epitranscriptome-editing</Keyword><Keyword MajorTopicYN="N">epitranscriptomics</Keyword><Keyword MajorTopicYN="N">neural stem cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29515357</ArticleId><ArticleId IdType="doi">10.3389/fnins.2018.00085</ArticleId><ArticleId IdType="pmc">PMC5826231</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29515313</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0971-5894</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Physiology and molecular biology of plants : an international journal of functional plant biology</Title><ISOAbbreviation>Physiol Mol Biol Plants</ISOAbbreviation></Journal><ArticleTitle>Insights into maize genome editing via CRISPR/Cas9.</ArticleTitle><Pagination><MedlinePgn>175-183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12298-017-0502-3</ELocationID><Abstract><AbstractText>Maize is an important crop for billions of people as food, feed, and industrial raw material. It is a prime driver of the global agricultural economy as well as the livelihoods of millions of farmers. Genetic interventions, such as breeding, hybridization and transgenesis have led to increased productivity of this crop in the last 100 years. The technique of genome editing is the latest advancement in genetics. Genome editing can be used for targeted deletions, additions, and corrections in the genome, all aimed at genetic enhancement of crops. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated protein 9 (CRISPR/Cas9) system is a recent genome editing technique that is considered simple, precise, robust and the most revolutionary. This review summarizes the current state of the art and predicts future directions in the use of the CRISPR/Cas9 tool in maize crop improvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Agarwal</LastName><ForeName>Astha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Indian Council of Agricultural Research- Indian Institute of Maize Research, Pusa Campus, New Delhi, 110012 India.</Affiliation><Identifier Source="ISNI">0000 0001 0643 7375</Identifier><Identifier Source="GRID">grid.418105.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yadava</LastName><ForeName>Pranjal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8735-0163</Identifier><AffiliationInfo><Affiliation>1Indian Council of Agricultural Research- Indian Institute of Maize Research, Pusa Campus, New Delhi, 110012 India.</Affiliation><Identifier Source="ISNI">0000 0001 0643 7375</Identifier><Identifier Source="GRID">grid.418105.9</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Department of Biology, Stanford University, 385 Serra Mall, Stanford, CA 94305 USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Krishan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1Indian Council of Agricultural Research- Indian Institute of Maize Research, Pusa Campus, New Delhi, 110012 India.</Affiliation><Identifier Source="ISNI">0000 0001 0643 7375</Identifier><Identifier Source="GRID">grid.418105.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Ishwar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>1Indian Council of Agricultural Research- Indian Institute of Maize Research, Pusa Campus, New Delhi, 110012 India.</Affiliation><Identifier Source="ISNI">0000 0001 0643 7375</Identifier><Identifier Source="GRID">grid.418105.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaul</LastName><ForeName>Tanushri</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>3International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067 India.</Affiliation><Identifier Source="ISNI">0000 0004 0498 7682</Identifier><Identifier Source="GRID">grid.425195.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattanayak</LastName><ForeName>Arunava</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>4Indian Council of Agricultural Research- Vivekananda Parvatiya Krishi Anusandhan Sansthan, Almora, Uttarakhand 263601 India.</Affiliation><Identifier Source="ISNI">0000 0004 1755 9396</Identifier><Identifier Source="GRID">grid.473812.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Pawan Kumar</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>5National Agricultural Science Fund, Indian Council of Agricultural Research, Krishi Anusandhan Bhavan I, Pusa, New Delhi, 110012 India.</Affiliation><Identifier Source="ISNI">0000 0001 0643 7375</Identifier><Identifier Source="GRID">grid.418105.9</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Physiol Mol Biol Plants</MedlineTA><NlmUniqueID>101304333</NlmUniqueID><ISSNLinking>0974-0430</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Gene editing</Keyword><Keyword MajorTopicYN="N">Genome modification</Keyword><Keyword MajorTopicYN="N">Maize</Keyword></KeywordList><CoiStatement>Compliance with ethical standardsThe authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29515313</ArticleId><ArticleId IdType="doi">10.1007/s12298-017-0502-3</ArticleId><ArticleId IdType="pii">502</ArticleId><ArticleId IdType="pmc">PMC5834987</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29515088</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2095-8137</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Zoological research</Title><ISOAbbreviation>Zool Res</ISOAbbreviation></Journal><ArticleTitle><i>In vivo</i>
genome editing thrives with diversified CRISPR technologies.</ArticleTitle><Pagination><MedlinePgn>58-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24272/j.issn.2095-8137.2017.012</ELocationID><Abstract><AbstractText>Prokaryotic type II adaptive immune systems have been developed into the versatile CRISPR technology, which has been widely applied in site-specific genome editing and has revolutionized biomedical research due to its superior efficiency and flexibility. Recent studies have greatly diversified CRISPR technologies by coupling it with various DNA repair mechanisms and targeting strategies. These new advances have significantly expanded the generation of genetically modified animal models, either by including species in which targeted genetic modification could not be achieved previously, or through introducing complex genetic modifications that take multiple steps and cost years to achieve using traditional methods. Herein, we review the recent developments and applications of CRISPR-based technology in generating various animal models, and discuss the everlasting impact of this new progress on biomedical research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Avery Sum-Yu</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Hei-Yin</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Samuel Yung-Kin</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Dittman Lai-Shun</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory for Regenerative Medicine in Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Guangdong 510530, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SBS Core Laboratory, CUHK Shenzhen Research Institute, Shenzhen Guangdong 518057, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zool Res</MedlineTA><NlmUniqueID>101697192</NlmUniqueID><ISSNLinking>2095-8137</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal models</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29515088</ArticleId><ArticleId IdType="doi">10.24272/j.issn.2095-8137.2017.012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29512652</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/nature26155</ELocationID><Abstract><AbstractText>A key limitation to the use of CRISPR-Cas9 proteins for genome editing and other applications is the requirement that a protospacer adjacent motif (PAM) be present at the target site. For the most commonly used Cas9 from Streptococcus pyogenes (SpCas9), the required PAM sequence is NGG. No natural or engineered Cas9 variants shown to function efficiently in mammalian cells offer a PAM less restrictive than NGG. Here we used phage-assisted continuous evolution (PACE) to evolve an expanded PAM SpCas9 variant (xCas9) that can recognize a broad range of PAM sequences including NG, GAA, and GAT. The PAM compatibility of xCas9 is the broadest reported to date among Cas9s active in mammalian cells, and supports applications in human cells including targeted transcriptional activation, nuclease-mediated gene disruption, and both cytidine and adenine base editing. Remarkably, despite its broadened PAM compatibility, xCas9 has much greater DNA specificity than SpCas9, with substantially lower genome-wide off-target activity at all NGG target sites tested, as well as minimal off-target activity when targeting genomic sites with non-NGG PAMs. These findings expand the DNA targeting scope of CRISPR systems and establish that there is no necessary trade-off between Cas9 editing efficiency, PAM compatibility, and DNA specificity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Johnny H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geurts</LastName><ForeName>Maarten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Weixin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeina</LastName><ForeName>Christina M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rees</LastName><ForeName>Holly A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29512652</ArticleId><ArticleId IdType="pii">nature26155</ArticleId><ArticleId IdType="doi">10.1038/nature26155</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29512112</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1934-8533</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Current protocols in microbiology</Title><ISOAbbreviation>Curr Protoc Microbiol</ISOAbbreviation></Journal><ArticleTitle>Molecular Genetic Manipulation of Sarcocystis neurona.</ArticleTitle><Pagination><MedlinePgn>20D.2.1-20D.2.14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cpmc.48</ELocationID><Abstract><AbstractText>Sarcocystis neurona is a member of the important phylum Apicomplexa and the primary cause of equine protozoal myeloencephalitis (EPM). Moreover, S. neurona is the best-studied species in the genus Sarcocystis, one of the most successful parasite taxa, as virtually all vertebrate animals may be infected by at least one species. Consequently, scientific investigation of S. neurona will aid in the control of EPM and neurologic disease in sea mammals, while also improving our understanding of a prominent branch on the apicomplexan phylogenetic tree. These protocols describe methods that expand the capabilities to study this prominent member of the Apicomplexa. © 2018 by John Wiley &amp; Sons, Inc.</AbstractText><CopyrightInformation>Copyright © 2018 John Wiley &amp; Sons, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>Daniel K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Veterinary Science, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeargan</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Veterinary Science, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Landon</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Veterinary Science, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dangoudoubiyam</LastName><ForeName>Sriveny</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Veterinary Science, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Protoc Microbiol</MedlineTA><NlmUniqueID>101257113</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apicomplexa</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Sarcocystis neurona</Keyword><Keyword MajorTopicYN="N">transfection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29512112</ArticleId><ArticleId IdType="doi">10.1002/cpmc.48</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29512106</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1938-8969</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Current protocols in stem cell biology</Title><ISOAbbreviation>Curr Protoc Stem Cell Biol</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.</ArticleTitle><Pagination><MedlinePgn>5B.7.1-5B.7.22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cpsc.46</ELocationID><Abstract><AbstractText>Human induced pluripotent stem cells (hiPSCs) are the ideal cell source for autologous cell replacement. However, for patients with Mendelian diseases, genetic correction of the original disease-causing mutation is likely required prior to cellular differentiation and transplantation. The emergence of the CRISPR-Cas9 system has revolutionized the field of genome editing. By introducing inexpensive reagents that are relatively straightforward to design and validate, it is now possible to correct genetic variants or insert desired sequences at any location within the genome. CRISPR-based genome editing of patient-specific iPSCs shows great promise for future autologous cell replacement therapies. One caveat, however, is that hiPSCs are notoriously difficult to transfect, and optimized experimental design considerations are often necessary. This unit describes design strategies and methods for efficient CRISPR-based genome editing of patient- specific iPSCs. Additionally, it details a flexible approach that utilizes positive selection to generate clones with a desired genomic modification, Cre-lox recombination to remove the integrated selection cassette, and negative selection to eliminate residual hiPSCs with intact selection cassettes. © 2018 by John Wiley &amp; Sons, Inc.</AbstractText><CopyrightInformation>Copyright © 2018 John Wiley &amp; Sons, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giacalone</LastName><ForeName>Joseph C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Tasneem P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burnight</LastName><ForeName>Erin R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fingert</LastName><ForeName>John F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullins</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Edwin M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tucker</LastName><ForeName>Budd A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Protoc Stem Cell Biol</MedlineTA><NlmUniqueID>101470226</NlmUniqueID><ISSNLinking>1938-8969</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">autologous cell replacement</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">hiPSC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29512106</ArticleId><ArticleId IdType="doi">10.1002/cpsc.46</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29511439</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1943-8141</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>American journal of translational research</Title><ISOAbbreviation>Am J Transl Res</ISOAbbreviation></Journal><ArticleTitle>Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway.</ArticleTitle><Pagination><MedlinePgn>455-464</MedlinePgn></Pagination><Abstract><AbstractText>The present study investigated the radiosensitizing effect of placenta specific 8 (PLAC8) in nasopharyngeal carcinoma (NPC) cells. A PLAC8-knockout CNE2 cell line was constructed using the CRISPR/Cas9 system. The CCK-8 assay demonstrated knockout of PLAC8 significantly reduced cell proliferation and cell survival after irradiation compared to both control cells and non-irradiated PLAC8-knockout cells. The clonogenic assay showed knockout of PLAC8 enhanced the radiosensitivity of NPC cells. Flow cytometry revealed knockout of PLAC8 increased apoptosis and G2/M phase arrest after irradiation. Western blotting demonstrated knockout of PLAC8 was associated with increased levels of γHA2X, a higher BAX:BCL-2 ratio, and increased levels of phosphorylated-Akt and phosphorylated-GSK-3β. Overall, this study indicates PLAC8 contributes to radioresistance in NPC by inhibiting the PI3K/AKT/GSK3β pathway.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Ze-Zhang</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mao-Ling</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yong-Fa</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Meng-Yuan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts, Institute of TechnologyCambridge 02139, Massachusetts (MA), USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shi-Ming</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University238 Jie-Fang Road, Wuhan 430060, Hubei, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Transl Res</MedlineTA><NlmUniqueID>101493030</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">PI3K/Akt/GSK3β pathway</Keyword><Keyword MajorTopicYN="N">knockout</Keyword><Keyword MajorTopicYN="N">nasopharyngeal carcinoma</Keyword><Keyword MajorTopicYN="N">placenta specific 8</Keyword><Keyword MajorTopicYN="N">radiosensitivity</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29511439</ArticleId><ArticleId IdType="pmc">PMC5835810</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29511313</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5500</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Cancer gene therapy</Title><ISOAbbreviation>Cancer Gene Ther.</ISOAbbreviation></Journal><ArticleTitle>Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41417-018-0010-9</ELocationID><Abstract><AbstractText>Basal-like breast cancer (BLBC) is a malignant carcinoma with aggressive motility and rapid growth. Accounting for 15% of breast cancers, BLBC often exhibits a poor prognosis and tends to metastasize to the brain and lungs. Because most BLBC display a triple-negative phenotype (ER-, PR-, and HER2-), conventional cytotoxic chemotherapy remains the only treatment option despite poor success and high rate of relapse. The overexpression of the forkhead-box transcription factor C1 (FOXC1) was recently identified as a biomarker of BLBC. Increased expression of FOXC1 was linked to excessive mobility and growth of BLBC cell lines, suggesting FOXC1 as a therapeutic target. In this study, siRNA-mediated knockdown of FOXC1 was confirmed to decrease the proliferation rate, migration, and invasion in a model BLBC-like cell line (4T1). 4T1 and 4T1-∆FOXC1 cells lacking FOXC1 expression (generated by CRISPR/Cas9) were used to evaluate the effects of FOXC1 expression in an orthotopic murine model of BLBC. No statistically significant difference in tumor volume was observed between 4T1 and 4T1-∆FOXC1 tumors. Furthermore, tumors metastasized to the liver and lungs to a similar degree regardless of FOXC1 expression. These data suggest that, despite positive results in vitro, FOXC1 may not be a promising therapeutic target for BLBC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mott</LastName><ForeName>Landon</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chemical and Materials Engineering, University of Kentucky, Lexington, KY, 40506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, 40536, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pack</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0410-0423</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Materials Engineering, University of Kentucky, Lexington, KY, 40506, USA. dan.pack@uky.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, 40536, USA. dan.pack@uky.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cancer Gene Ther</MedlineTA><NlmUniqueID>9432230</NlmUniqueID><ISSNLinking>0929-1903</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29511313</ArticleId><ArticleId IdType="doi">10.1038/s41417-018-0010-9</ArticleId><ArticleId IdType="pii">10.1038/s41417-018-0010-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29511190</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>ARMMs as a versatile platform for intracellular delivery of macromolecules.</ArticleTitle><Pagination><MedlinePgn>960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-018-03390-x</ELocationID><Abstract><AbstractText>Majority of disease-modifying therapeutic targets are restricted to the intracellular space and are therefore not druggable using existing biologic modalities. The ability to efficiently deliver macromolecules inside target cells or tissues would greatly expand the current landscape of therapeutic targets for future generations of biologic drugs, but remains challenging. Here we report the use of extracellular vesicles, known as arrestin domain containing protein 1 [ARRDC1]-mediated microvesicles (ARMMs), for packaging and intracellular delivery of a myriad of macromolecules, including the tumor suppressor p53 protein, RNAs, and the genome-editing CRISPR-Cas9/guide RNA complex. We demonstrate selective recruitment of these macromolecules into ARMMs. When delivered intracellularly via ARMMs, these macromolecules are biologically active in recipient cells. P53 delivered via ARMMs induces DNA damage-dependent apoptosis in multiple tissues in mice. Together, our results provide proof-of-principle demonstration that ARMMs represent a highly versatile platform for packaging and intracellular delivery of therapeutic macromolecules.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health, and Genetics &amp; Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jiujiu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health, and Genetics &amp; Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition and Health Sciences, University of Nebraska Lincoln, Lincoln, NE, 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadungure</LastName><ForeName>Tatenda</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyene</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health, and Genetics &amp; Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health, and Genetics &amp; Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. qlu@hsph.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29511190</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-03390-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-018-03390-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29511025</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2160-1836</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>G3 (Bethesda, Md.)</Title><ISOAbbreviation>G3 (Bethesda)</ISOAbbreviation></Journal><ArticleTitle>High-Resolution Analysis of the Efficiency, Heritability, and Editing Outcomes of CRISPR/Cas9-Induced Modifications of<i>NCED4</i>in Lettuce (<i>Lactuca sativa</i>).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">g3.300396.2017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1534/g3.117.300396</ELocationID><Abstract><AbstractText>CRISPR/Cas9 is a transformative tool for making targeted genetic alterations. In plants, high mutation efficiencies have been reported in primary transformants. However, many of the mutations analyzed were somatic and therefore not heritable. To provide more insights into the efficiency of creating stable homozygous mutants using CRISPR/Cas9, we targeted<i>LsNCED4</i>(<i>9-cis-epoxycarotenoid dioxygenase4)</i>, a gene conditioning thermoinhibition of seed germination in lettuce. Three constructs, each capable of expressing Cas9 and a single gRNA targeting different sites in<i>LsNCED4</i>, were stably transformed into lettuce (Lactuca sativa) cvs. Salinas and Cobham Green. Analysis of 47 primary transformants (T<sub>1</sub>) and 368 T<sub>2</sub>plants by deep amplicon sequencing revealed that 57% of T<sub>1</sub>plants contained events at the target site: 28% of plants had germline mutations in one allele indicative of an early editing event (mono-allelic), 8% of plants had germline mutations in both alleles indicative of two early editing events (bi-allelic), and the remaining 21% of plants had multiple low frequency mutations indicative of late events (chimeric plants). Editing efficiency was similar in both genotypes, while the different gRNAs varied in efficiency. Amplicon sequencing of 20 T<sub>1</sub>and more than 100 T<sub>2</sub>plants for each of the three gRNAs showed that repair outcomes were not random, but reproducible and characteristic for each gRNA. Knockouts of<i>NCED4</i>resulted in large increases in the maximum temperature for seed germination, with seeds of both cultivars capable of germinating &gt;70% at 37°C. Knockouts of<i>NCED4</i>provide a whole-plant selectable phenotype that has minimal pleiotropic consequences. Targeting<i>NCED4</i>in a co-editing strategy could therefore be used to enrich for germline-edited events simply by germinating seeds at high temperature.</AbstractText><CopyrightInformation>Copyright © 2018, G3: Genes, Genomes, Genetics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bertier</LastName><ForeName>Lien D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>University of California - Davis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ron</LastName><ForeName>Mily</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of California - Davis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Heiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of California - Davis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradford</LastName><ForeName>Kent J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>University of California - Davis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michelmore</LastName><ForeName>Richard W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>University of California - Davis rwmichelmore@ucdavis.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>G3 (Bethesda)</MedlineTA><NlmUniqueID>101566598</NlmUniqueID><ISSNLinking>2160-1836</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">NHEJ</Keyword><Keyword MajorTopicYN="N">amplicon sequencing</Keyword><Keyword MajorTopicYN="N">germination</Keyword><Keyword MajorTopicYN="N">lettuce</Keyword><Keyword MajorTopicYN="N">targeted mutagenesis</Keyword><Keyword MajorTopicYN="N">thermotolerance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29511025</ArticleId><ArticleId IdType="pii">g3.117.300396</ArticleId><ArticleId IdType="doi">10.1534/g3.117.300396</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29510160</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6216</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Mechanisms of ageing and development</Title><ISOAbbreviation>Mech. Ageing Dev.</ISOAbbreviation></Journal><ArticleTitle>Tropomyosin 2 heterozygous knockout in mice using CRISPR-Cas9 system displays the inhibition of injury-induced epithelial-mesenchymal transition, and lens opacity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0047-6374(17)30287-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mad.2018.03.001</ELocationID><Abstract><AbstractText>The process of epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) after cataract surgery contributes to tissue fibrosis, wound healing and lens regeneration via a mechanism not yet fully understood. Here, we show that tropomyosin 2 (Tpm2) plays a critical role in wound healing and lens aging. Posterior capsular opacification (PCO) after lens extraction surgery was accompanied by elevated expression of Tpm2. Tpm2 heterozygous knockout mice, generated via the clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) system showed promoted progression of cataract with age. Further, injury-induced EMT of the mouse lens epithelium, as evaluated histologically and by the expression patterns of Tpm1 and Tpm2, was attenuated in the absence of Tpm2. In conclusion, Tpm2 may be important in maintaining lens physiology and morphology. However, Tpm2 is involved in the progression of EMT during the wound healing process of mouse LECs, suggesting that inhibition of Tpm2 may suppress PCO.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Teppei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Shinsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishigaki</LastName><ForeName>Yasuhito</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiyokawa</LastName><ForeName>Etsuko</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Oncogenic Pathology, Kanazawa Medical University, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikawa</LastName><ForeName>Masahito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Dhirendra P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Eri</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan. Electronic address: kuboe@kanazawa-med.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Mech Ageing Dev</MedlineTA><NlmUniqueID>0347227</NlmUniqueID><ISSNLinking>0047-6374</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epithelial-mesenchymal transition</Keyword><Keyword MajorTopicYN="N">Lens</Keyword><Keyword MajorTopicYN="N">Posterior capsular opacification</Keyword><Keyword MajorTopicYN="N">Tropomyosin</Keyword><Keyword MajorTopicYN="N">cataract</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29510160</ArticleId><ArticleId IdType="pii">S0047-6374(17)30287-7</ArticleId><ArticleId IdType="doi">10.1016/j.mad.2018.03.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29509734</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>EPO revokes Broad's CRISPR patent.</ArticleTitle><Pagination><MedlinePgn>209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nbt0318-209b</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Mar 7;35(3):184</RefSource><PMID Version="1">28267722</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29509734</ArticleId><ArticleId IdType="pii">nbt0318-209b</ArticleId><ArticleId IdType="doi">10.1038/nbt0318-209b</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29509733</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Preprint wipes millions off CRISPR companies' stocks.</ArticleTitle><Pagination><MedlinePgn>211</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nbt0318-211</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Schaper</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29509733</ArticleId><ArticleId IdType="pii">nbt0318-211</ArticleId><ArticleId IdType="doi">10.1038/nbt0318-211</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29509719</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-7737</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Biology</Title><ISOAbbreviation>Biology (Basel)</ISOAbbreviation></Journal><ArticleTitle>Gene Editing of Microalgae: Scientific Progress and Regulatory Challenges in Europe.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biology7010021</ELocationID><Abstract><AbstractText>It is abundantly clear that the development of gene editing technologies, represents a potentially powerful force for good with regard to human and animal health and addressing the challenges we continue to face in a growing global population. This now includes the development of approaches to modify microalgal strains for potential improvements in productivity, robustness, harvestability, processability, nutritional composition, and application. The rapid emergence and ongoing developments in this area demand a timely review and revision of the current definitions and regulations around genetically modified organisms (GMOs), particularly within Europe. Current practices within the EU provide exemptions from the GMO directives for organisms, including crop plants and micro-organisms that are produced through chemical or UV/radiation mutagenesis. However, organisms generated through gene editing, including microalgae, where only genetic changes in native genes are made, remain currently under the GMO umbrella; they are, as such, excluded from practical and commercial opportunities in the EU. In this review, we will review the advances that are being made in the area of gene editing in microalgae and the impact of regulation on commercial advances in this area with consideration to the current regulatory framework as it relates to GMOs including GM microalgae in Europe.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spicer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Algenuity, Eden Laboratory, Bedfordshire MK43 9ND, UK. aps@algenuity.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Attila</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1044-6327</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Plant Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK. amolnar@exceed.ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biology (Basel)</MedlineTA><NlmUniqueID>101587988</NlmUniqueID><ISSNLinking>2079-7737</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cpf1</Keyword><Keyword MajorTopicYN="N">DSB</Keyword><Keyword MajorTopicYN="N">GMM</Keyword><Keyword MajorTopicYN="N">GMO</Keyword><Keyword MajorTopicYN="N">NPBT</Keyword><Keyword MajorTopicYN="N">SDN</Keyword><Keyword MajorTopicYN="N">gene editing</Keyword><Keyword MajorTopicYN="N">transgenic</Keyword></KeywordList><CoiStatement>The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29509719</ArticleId><ArticleId IdType="pii">biology7010021</ArticleId><ArticleId IdType="doi">10.3390/biology7010021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29509546</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation></Journal><ArticleTitle>A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI97992</ELocationID><ELocationID EIdType="pii" ValidYN="Y">97992</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Poly(ADP-ribose) polymerase (PARP) inhibitors are effective in a broad population of ovarian cancer patients, however resistance caused by low enzyme expression of the drug target, poly(ADP-ribose) polymerase 1 (PARP-1), remains to be clinically evaluated in this context. We hypothesize that PARP-1 expression is variable in ovarian cancer and can be quantified in primary and metastatic disease using a novel positron emitting tomography (PET) imaging agent.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used a translational approach to describe the significance of PET imaging of PARP-1 in ovarian cancer. First, we produced PARP1 KO ovarian cancer cell lines using CRISPR/Cas9 gene editing to test loss of PARP-1 as a resistance mechanism to all clinically used PARP inhibitors. Next, we performed pre-clinical microPET imaging studies using ovarian cancer patient derived xenografts in mouse models. Finally, in a phase 1 PET imaging clinical trial we explored PET imaging as a regional marker of PARP-1 expression in primary and metastatic disease through correlative tissue histology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found deletion of PARP1 causes resistance to all PARP inhibitors in vitro and microPET imaging provides proof of concept as an approach to quantify PARP-1 in vivo. Clinically, we observed a spectrum of standard uptake values (SUVs) for PARP-1 in tumors ranging from 2-12. In addition, we found a positive correlation between PET SUVs and fluorescent immunohistochemistry for PARP-1 (r2: 0.60).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This work confirms the translational potential of a PARP-1 PET imaging agent and supports future clinical trials to test PARP-1 expression as a method to stratify patients for PARP inhibitor therapy. Clinicaltrials.gov: NCT02637934.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makvandi</LastName><ForeName>Mehran</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pantel</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Schubert</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Kuiying</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chia-Ju</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyoung</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chi-Chang</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Winters</LastName><ForeName>Harrison</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Doot</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Farwell</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Pryma</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Roger A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Mankoff</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Simpkins</LastName><ForeName>Fiona</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Mach</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lilie L</ForeName><Initials>LL</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02637934</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnostic imaging</Keyword><Keyword MajorTopicYN="N">Molecular biology</Keyword><Keyword MajorTopicYN="N">Oncology</Keyword><Keyword MajorTopicYN="N">Pharmacology</Keyword><Keyword MajorTopicYN="N">Therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29509546</ArticleId><ArticleId IdType="pii">97992</ArticleId><ArticleId IdType="doi">10.1172/JCI97992</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29509513</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.</ArticleTitle><Pagination><MedlinePgn>fj201701129R</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201701129R</ELocationID><Abstract><AbstractText>Several groups have used CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) for DNA virus editing. In most cases, one single-guide RNA (sgRNA) is used, which produces inconsistencies in gene editing. In this study, we used a swine herpesvirus, pseudorabies virus, as a model to systematically explore the application of CRISPR/Cas9 in DNA virus editing. In our current report, we demonstrated that cotransfection of 2 sgRNAs and a viral genome resulted in significantly better knockout efficiency than the transfection-infection-based approach. This method could result in 100% knockout of ≤3500 bp of viral nonessential large fragments. Furthermore, knockin efficiency was significantly improved by using 2 sgRNAs and was also correlated with the number of background viruses. We also demonstrated that the background viruses were all 2-sgRNA-mediated knockout mutants. Finally, this study demonstrated that the efficacy of gene knockin is determined by the replicative kinetics of background viruses. We propose that CRISPR/Cas9 coupled with 2 sgRNAs creates a powerful tool for DNA virus editing and offers great potential for future applications.-Tang, Y.-D., Guo, J.-C., Wang, T.-Y., Zhao, K., Liu, J.-T., Gao, J.-C., Tian, Z.-J., An, T.-Q., Cai, X.-H. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yan-Dong</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jin-Chao</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tong-Yun</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Kuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ji-Ting</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jia-Cong</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Zhi-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Tong-Qing</ForeName><Initials>TQ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Xue-Hui</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA virus</Keyword><Keyword MajorTopicYN="N">herpesvirus</Keyword><Keyword MajorTopicYN="N">knockin</Keyword><Keyword MajorTopicYN="N">knockout</Keyword><Keyword MajorTopicYN="N">recombination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29509513</ArticleId><ArticleId IdType="doi">10.1096/fj.201701129R</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29507709</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.</ArticleTitle><Pagination><MedlinePgn>9540-9554</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23476</ELocationID><Abstract><AbstractText>Glioblastoma (GBM) is the most invasive and devastating primary brain tumor with a median overall survival rate about 18 months with aggressive multimodality therapy. Its unique characteristics of heterogeneity, invasion, clonal populations maintaining stem cell-like cells and recurrence, have limited responses to a variety of therapeutic approaches, and have made GBM the most difficult brain cancer to treat. A great effort and progress has been made to reveal promising molecular mechanisms to target therapeutically. Especially with the emerging of new technologies, the mechanisms underlying the pathology of GBM are becoming more clear. The purpose of this review is to summarize the current knowledge of molecular mechanisms of GBM and highlight the novel strategies and concepts for the treatment of GBM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sughrue</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2009 May;10 (5):459-66</RefSource><PMID Version="1">19269895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2017 Jul 1;28(7):1448-1456</RefSource><PMID Version="1">28407030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med. 2015 Dec 08;13:293</RefSource><PMID Version="1">26646075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2010 Apr 13;17 (4):362-75</RefSource><PMID Version="1">20385361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2004 Feb;4(2):143-53</RefSource><PMID Version="1">14732866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Med. 2016 Aug;5(8):1917-46</RefSource><PMID Version="1">27282910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Mol Neurosci. 2016 Apr 28;9:30</RefSource><PMID Version="1">27199655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2016 Sep;18(9):1219-29</RefSource><PMID Version="1">26917237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurooncol. 2012 Apr;107(2):343-9</RefSource><PMID Version="1">22048878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Jan 28;286(4):2375-81</RefSource><PMID Version="1">21115489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Aug 23;488(7412):522-6</RefSource><PMID Version="1">22854781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Virol. 2016;5(1):1-7</RefSource><PMID Version="1">28203321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Sep 15;65(18):8250-5</RefSource><PMID Version="1">16166301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2017 Jul 15;77(14 ):3894-3907</RefSource><PMID Version="1">28566332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2010 Oct;28(10):1057-68</RefSource><PMID Version="1">20944598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2017 Mar 28;7:45</RefSource><PMID Version="1">28401060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosurg. 2011 Sep;115(3):505-11</RefSource><PMID Version="1">21663411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurooncol. 2015 Sep;124(3):365-72</RefSource><PMID Version="1">26108658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Jun;1859(6):805-11</RefSource><PMID Version="1">26968235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Jul 5;7(27):41005-41016</RefSource><PMID Version="1">27191499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Jul 25;134(2):215-30</RefSource><PMID Version="1">18662538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Feb 02;7:10593</RefSource><PMID Version="1">26830441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Aug 9;7(32):52541-52552</RefSource><PMID Version="1">27250031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2015 Jul 15;21(14):3307-17</RefSource><PMID Version="1">25609060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2016 Jul 1;1642:59-69</RefSource><PMID Version="1">27016056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jun 11;6:7391</RefSource><PMID Version="1">26067104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2016 Aug 30;109 (1):</RefSource><PMID Version="1">27576906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 May 3;7(18):25769-82</RefSource><PMID Version="1">27013589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 May 29;348(6238):1036-9</RefSource><PMID Version="1">25977370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Neurosci. 2013 Jul;20(7):1014-8</RefSource><PMID Version="1">23693024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancers (Basel). 2013 Sep 03;5(3):1120-39</RefSource><PMID Version="1">24202337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Jun 10;26(17):2839-45</RefSource><PMID Version="1">18539962</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 15;8(8):e73267</RefSource><PMID Version="1">24039668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2006 May;7(5):392-401</RefSource><PMID Version="1">16648043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2017 May 15;121-122:130-137</RefSource><PMID Version="1">28288827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Oct 10;155(2):462-77</RefSource><PMID Version="1">24120142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Treat Options Neurol. 2017 Mar;19(3):11</RefSource><PMID Version="1">28349351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2016 Oct 15;129(20):3685-3693</RefSource><PMID Version="1">27672021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Virol. 2011 Sep;6(9):1045-1058</RefSource><PMID Version="1">21984883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 2013;986:171-87</RefSource><PMID Version="1">22879069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2015 Feb 18;7(275):275ra22</RefSource><PMID Version="1">25696001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 May 31;7(22):33440-50</RefSource><PMID Version="1">26967052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2004;20:781-810</RefSource><PMID Version="1">15473860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):551-3</RefSource><PMID Version="1">24681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2015 Jul;185(7):1820-33</RefSource><PMID Version="1">25976245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol Res. 2017;2017:5813951</RefSource><PMID Version="1">28512646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Aug 23;7(34):55924-55938</RefSource><PMID Version="1">27409839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2013 Aug;34(4):1991-2002</RefSource><PMID Version="1">23625692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Surg. 2016 Mar 02;3:11</RefSource><PMID Version="1">26973839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2016 Nov;18(11):1508-1518</RefSource><PMID Version="1">27194146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2013 Nov 22;14:818</RefSource><PMID Version="1">24261984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Aug 30;7(35):56958-56975</RefSource><PMID Version="1">27486972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Tumor Pathol. 2016 Jul;33(3):161-8</RefSource><PMID Version="1">27295313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroreport. 2010 Nov 17;21(16):1018-22</RefSource><PMID Version="1">20827226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Oct 15;67(20):9809-16</RefSource><PMID Version="1">17942911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Oct 23;455(7216):1061-8</RefSource><PMID Version="1">18772890</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Jun 1;276(22):18863-70</RefSource><PMID Version="1">11279179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Feb;123(2):855-65</RefSource><PMID Version="1">23298836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Oct;45(10):1141-9</RefSource><PMID Version="1">23917401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Artif Cells Nanomed Biotechnol. 2016 Sep;44(6):1365-73</RefSource><PMID Version="1">26046399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Sep 7;337(6099):1231-5</RefSource><PMID Version="1">22837387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2016 Apr 10;227:23-37</RefSource><PMID Version="1">26892752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6</RefSource><PMID Version="1">23530248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Mar 15;71(6):2392-402</RefSource><PMID Version="1">21406405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2016 Jul;48(7):768-76</RefSource><PMID Version="1">27270107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2013 Feb 15;85(4):478-85</RefSource><PMID Version="1">23159669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Feb 19;360(8):765-73</RefSource><PMID Version="1">19228619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancers (Basel). 2011 Aug 10;3(3):3242-78</RefSource><PMID Version="1">24212955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2015 Jan 28;356(2 Pt A):289-300</RefSource><PMID Version="1">25069036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2016 May;14 (5):458-69</RefSource><PMID Version="1">26869289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 29;6:28668</RefSource><PMID Version="1">27354287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Rev Cell Mol Biol. 2017;333:269-323</RefSource><PMID Version="1">28729027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Magn Reson Med Sci. 2016;15(2):165-77</RefSource><PMID Version="1">26726012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cancer. 2016 Jun;2(6):313-324</RefSource><PMID Version="1">28603775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Aug;24(8):1388-94</RefSource><PMID Version="1">27203441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 May 7;95(9):652-60</RefSource><PMID Version="1">12734316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 2016 Feb;96(2):137-50</RefSource><PMID Version="1">26641068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Mar 10;352(10 ):997-1003</RefSource><PMID Version="1">15758010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Neurosci. 2010 Nov;17(11):1381-5</RefSource><PMID Version="1">20727764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cancer Res. 2015 Feb 15;5(3):945-55</RefSource><PMID Version="1">26045979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Virol. 2015 Aug;13:81-5</RefSource><PMID Version="1">26083317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cancer Res. 2011;1(2):155-167</RefSource><PMID Version="1">21796274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Jul 5;7(27):41505-41526</RefSource><PMID Version="1">27166258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2009 Apr;11(2):102-8</RefSource><PMID Version="1">18676359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2015 Mar;17 Suppl 2:ii24-ii36</RefSource><PMID Version="1">25746089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2017 Mar 1;123(5):734-750</RefSource><PMID Version="1">27875627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2016 Oct 15;118:1-8</RefSource><PMID Version="1">27106078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Jun 8;149(6):1192-205</RefSource><PMID Version="1">22682243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Resist Updat. 2015 Mar;19:1-12</RefSource><PMID Version="1">25791797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2010 Jan 19;17(1):98-110</RefSource><PMID Version="1">20129251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Discov Med. 2015 Jul-Aug;20(108):7-15</RefSource><PMID Version="1">26321082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 May 14;9(5):e97407</RefSource><PMID Version="1">24827739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2016 Jan;19(1):10-9</RefSource><PMID Version="1">26713744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Mar 10;352(10 ):987-96</RefSource><PMID Version="1">15758009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2015 Aug;17(8):1051-63</RefSource><PMID Version="1">25934816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Aug 4;63(3):526-38</RefSource><PMID Version="1">27453044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurooncol. 2016 May;127(3):427-34</RefSource><PMID Version="1">26900075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2016 Jul;23 (7):557-9</RefSource><PMID Version="1">27029608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer J. 2012 Jan-Feb;18(1):69-81</RefSource><PMID Version="1">22290260</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9 genome editing</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">glioblastoma</Keyword><Keyword MajorTopicYN="N">immunotherapy</Keyword><Keyword MajorTopicYN="N">molecular mechanisms</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507709</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23476</ArticleId><ArticleId IdType="pii">23476</ArticleId><ArticleId IdType="pmc">PMC5823664</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29507701</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.</ArticleTitle><Pagination><MedlinePgn>9442-9455</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.24253</ELocationID><Abstract><AbstractText>The introduction of second-generation tyrosine kinase inhibitors (TKIs) targeting the protein-tyrosine kinase (PTK) BCR-ABL1 has improved treatment response in chronic myeloid leukemia (CML). However, in some patients response still remains suboptimal. Protein-tyrosine phosphatases (PTPs) are natural counter-actors of PTK activity and can affect TKI sensitivity, but the impact of PTPs on treatment response to second-generation TKIs is unknown. We assessed the mRNA expression level of 38 PTPs in 66 newly diagnosed CML patients and analyzed the potential relation with treatment outcome after 9 months of nilotinib medication. A significantly positive association with response was observed for higher PTPN13, PTPRA, PTPRC (also known as CD45), PTPRG, and PTPRM expression. Selected PTPs were then subjected to a functional analysis in CML cell line models using PTP gene knockout by CRISPR/Cas9 technology or PTP overexpression. These analyses revealed PTPRG positively and PTPRC negatively modulating nilotinib response. Consistently, PTPRG negatively and PTPRC positively affected BCR-ABL1 dependent transformation. We identified BCR-ABL1 signaling events, which were affected by modulating PTP levels or nilotinib treatment in the same direction. In conclusion, the PTP status of CML cells is important for the response to second generation TKIs and may help in optimizing therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drube</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut für Molekulare Zellbiologie, CMB, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfirrmann</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians Universität, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Benadict Vincent</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>Institut für Molekulare Zellbiologie, CMB, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drube</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut für Immunologie, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut für Molekulare Zellbiologie, CMB, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kresinsky</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut für Molekulare Zellbiologie, CMB, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halfter</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians Universität, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorio</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabisch</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochhaus</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böhmer</LastName><ForeName>Frank-D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Institut für Molekulare Zellbiologie, CMB, Universitätsklinikum Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Nov;11(11):1029-35</RefSource><PMID Version="1">20965785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2025-31</RefSource><PMID Version="1">16609011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2012 Oct;26(10):2172-5</RefSource><PMID Version="1">22504141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Sep 29;118(13):3634-44</RefSource><PMID Version="1">21821701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Jan;1832(1):275-84</RefSource><PMID Version="1">23124138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Nov 1;70(21):8896-906</RefSource><PMID Version="1">20959494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2008 Jan;22(1):96-102</RefSource><PMID Version="1">17943168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Apr;6(4):307-20</RefSource><PMID Version="1">16557282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Sep 1;135(5):1101-9</RefSource><PMID Version="1">24496747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 May 10;119(19):4476-9</RefSource><PMID Version="1">22438252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2012;106:253-306</RefSource><PMID Version="1">22340721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 1993;11 Suppl 1:39-43</RefSource><PMID Version="1">8251914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2014 Mar;28(3):702-5</RefSource><PMID Version="1">24192813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunology. 2012 Sep;137(1):1-19</RefSource><PMID Version="1">22862552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 May;7(5):345-56</RefSource><PMID Version="1">17457302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2016 May;57(5):1182-8</RefSource><PMID Version="1">26373709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2017 Mar 9;376(10 ):917-927</RefSource><PMID Version="1">28273028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Jan 18;409(6818):349-54</RefSource><PMID Version="1">11201744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Hematol. 2010 Oct;47(4):335-43</RefSource><PMID Version="1">20875550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 1999 Nov;13(11):1825-32</RefSource><PMID Version="1">10557058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2016 Feb 16;44(2):303-15</RefSource><PMID Version="1">26885857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Oct 4;7(40):64785-64797</RefSource><PMID Version="1">27579617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2011 Jan;11(1):35-49</RefSource><PMID Version="1">21179176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2017 May;31(5):1108-1116</RefSource><PMID Version="1">27890936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acc Chem Res. 2017 Jan 17;50(1):122-129</RefSource><PMID Version="1">27977138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Signal. 2010 Aug 31;3(137):rs1</RefSource><PMID Version="1">20807954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2013 Jan;280(2):708-30</RefSource><PMID Version="1">22938156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol. 2012 Feb;39(1):58-66</RefSource><PMID Version="1">22289492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2006 Jun;20(6):1047-54</RefSource><PMID Version="1">16598311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Commun Signal. 2012 Jul 11;10(1):19</RefSource><PMID Version="1">22784513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2004 Nov;32(11):1057-63</RefSource><PMID Version="1">15539083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2008 Oct 15;112(8):3330-8</RefSource><PMID Version="1">18684859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2017 Jul;31(7):1525-1531</RefSource><PMID Version="1">28218239</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD45</Keyword><Keyword MajorTopicYN="N">PTPRC</Keyword><Keyword MajorTopicYN="N">PTPRG</Keyword><Keyword MajorTopicYN="N">chronic myeloid leukemia</Keyword><Keyword MajorTopicYN="N">protein-tyrosine phosphatases</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST A.H. receives research support from Novartis, BMS, Pfizer, Incyte, and MSD. No potential conflict of interest is reported by the other authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507701</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.24253</ArticleId><ArticleId IdType="pii">24253</ArticleId><ArticleId IdType="pmc">PMC5823647</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29507619</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1838-7640</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Theranostics</Title><ISOAbbreviation>Theranostics</ISOAbbreviation></Journal><ArticleTitle>GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.</ArticleTitle><Pagination><MedlinePgn>1270-1285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/thno.22536</ELocationID><Abstract><AbstractText>Intraperitoneal metastasis is a common occurrence and is usually involved in the poor prognosis of ovarian cancer. Its specific metastatic pattern implies that certain indispensable microenvironmental factors secreted in the peritoneal cavity can direct metastatic ovarian cancer cells to permissive niches for secondary lesion formation. However, the underlying molecular mechanisms are ill defined. Herein, we report that GRO-α and IL-8 are predominately upregulated in culture media derived from either normal or cancerous omenta and are associated with increased ovarian cancer aggressiveness.<b>Methods:</b>OCM was established from culture medium of fresh human omental tissues. Primary and metastatic ovarian cancer cell lines were generated from human tumor tissues and verified by specific antibodies. The functional roles of GRO-α, IL-8, and their specific receptor CXCR2 were examined by neutralizing antibodies, shRNA gene knockdown, CRISPR/Cas9 gene knockout and pharmaceutical CXCR2 inhibitor SB225002. The oncogenic properties of ovarian cancer cells were examined by<i>in vitro</i>and<i>in vivo</i>mouse models.<b>Results:</b>Both GRO-α and IL-8 can activate TAK1/NFκB signaling via the CXCR2 receptor. Intriguingly, TAK1/NFκB signaling activity was higher in metastatic ovarian cancer cells; this higher activity makes them more susceptible to OCM-induced tumor aggressiveness. Treatment of ovarian cancer cells with GRO-α and IL-8 neutralizing antibodies or ablation of CXCR2 by shRNA gene knockdown, CRISPR/Cas9 gene knockout, or CXCR2 inhibitor SB225002 treatment significantly attenuated TAK1/NFκB signaling and decreased<i>in vitro</i>and<i>in vivo</i>oncogenic and metastatic potential, suggesting CXCR2 plays a key role in the GRO-α and IL-8-governed metastatic spreading of ovarian cancer cells in the intraperitoneal cavity.<b>Conclusion:</b>This study highlights the significance of GRO-α and IL-8 as the key chemokines in the peritoneal tumor microenvironment and suggests the utility of targeting their receptor CXCR2 as a potential target-based therapy for peritoneal metastases of ovarian cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>Mingo Ming-Ho</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hermit Wai-Man</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Patty Chun-Hui</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Thomas Ho-Yin</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngu</LastName><ForeName>Siew-Fei</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Karen Kar-Loen</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Dakang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medical Laboratory Science, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngan</LastName><ForeName>Hextan Yuen-Sheung</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>David Wai</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Theranostics</MedlineTA><NlmUniqueID>101552395</NlmUniqueID><ISSNLinking>1838-7640</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2009 Jun;46(3):382-91</RefSource><PMID Version="1">19401270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2013 Nov;19(11):1423-37</RefSource><PMID Version="1">24202395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2017 Nov;153(5):1378-1391.e6</RefSource><PMID Version="1">28734833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Feb 1;18(3):771-82</RefSource><PMID Version="1">22167410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2015 Sep 10;337(1):16-27</RefSource><PMID Version="1">26209607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prostate. 1999 Oct 1;41(2):78-88</RefSource><PMID Version="1">10477904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Mar 1;66(5):2740-8</RefSource><PMID Version="1">16510595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Aug 7;27(34):4712-23</RefSource><PMID Version="1">18408758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2014 Feb;232(3):283-8</RefSource><PMID Version="1">24254977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2000 Jul 20;19(31):3477-86</RefSource><PMID Version="1">10918606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Oct 14;147(2):275-92</RefSource><PMID Version="1">22000009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 20;8(12):e83789</RefSource><PMID Version="1">24376747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Metastasis Rev. 2007 Dec;26(3-4):453-67</RefSource><PMID Version="1">17828470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2011 Oct 30;17(11):1498-503</RefSource><PMID Version="1">22037646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Pathol. 2014 Oct;67(10):921-2</RefSource><PMID Version="1">25049276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2016 Jun 13;29(6):832-845</RefSource><PMID Version="1">27265504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16472-7</RefSource><PMID Version="1">17060621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2007 Apr 15;13(8):2385-91</RefSource><PMID Version="1">17438097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Oct;1831(10):1533-41</RefSource><PMID Version="1">23500888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 Nov 1;14(21):6735-41</RefSource><PMID Version="1">18980965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2006 Nov;7(11):925-34</RefSource><PMID Version="1">17081918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterol Res Pract. 2012;2012:541842</RefSource><PMID Version="1">22888339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surgery. 2014 Apr;155(4):640-9</RefSource><PMID Version="1">24582495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2014 Sep 15;5(17):7549-62</RefSource><PMID Version="1">25277189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genomics Proteomics. 2016 11-12;13(6):407-423</RefSource><PMID Version="1">27807064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2013 Jul;13(7):497-510</RefSource><PMID Version="1">23760024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine Growth Factor Rev. 2006 Jun;17(3):189-201</RefSource><PMID Version="1">16513409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Biol Med (Maywood). 2014 May;239(5):509-18</RefSource><PMID Version="1">24625439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Apr 25;8(17 ):28442-28454</RefSource><PMID Version="1">28415702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2005 Oct;5(10):749-59</RefSource><PMID Version="1">16175180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Jan 31;289(5):2687-700</RefSource><PMID Version="1">24337575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2006 Aug;102(2):244-51</RefSource><PMID Version="1">16434085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1999 Sep;74(3):400-7</RefSource><PMID Version="1">10479500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2010 Sep 1;9(17):3515-33</RefSource><PMID Version="1">20855962</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Mar 25;280(12):11395-403</RefSource><PMID Version="1">15647289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2012 Jan;33(1):20-9</RefSource><PMID Version="1">22021907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2015 Aug 28;365(1):11-22</RefSource><PMID Version="1">25963887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2001 Jul 12;20(31):4188-97</RefSource><PMID Version="1">11464285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2008 Feb 1;409(3):635-49</RefSource><PMID Version="1">18177271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2014 Nov 28;354(2):245-53</RefSource><PMID Version="1">25150782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2008 Nov 19;100(22):1630-42</RefSource><PMID Version="1">19001604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2012 Jan 1;130(1):20-8</RefSource><PMID Version="1">21503873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 02;8(12):e81859</RefSource><PMID Version="1">24312594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2010 Aug 1;16(15):3875-86</RefSource><PMID Version="1">20505188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2015 Oct;22(11):3695-700</RefSource><PMID Version="1">25691282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Sep 23;431(7007):461-6</RefSource><PMID Version="1">15329734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2007 Aug;6(8):1302-12</RefSource><PMID Version="1">17712227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2013 Jul;58(1):205-17</RefSource><PMID Version="1">23401231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cancer Res. 2012;2(5):566-80</RefSource><PMID Version="1">22957308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2012 May 22;106(11):1833-41</RefSource><PMID Version="1">22617157</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CXCR2</Keyword><Keyword MajorTopicYN="N">GRO-α</Keyword><Keyword MajorTopicYN="N">IL-8</Keyword><Keyword MajorTopicYN="N">NFκB signaling</Keyword><Keyword MajorTopicYN="N">chemokines</Keyword><Keyword MajorTopicYN="N">ovarian cancer</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507619</ArticleId><ArticleId IdType="doi">10.7150/thno.22536</ArticleId><ArticleId IdType="pii">thnov08p1270</ArticleId><ArticleId IdType="pmc">PMC5835935</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507424</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1718</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat. Genet.</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41588-018-0070-7</ELocationID><Abstract><AbstractText>Hexanucleotide-repeat expansions in the C9ORF72 gene are the most common cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD). The nucleotide-repeat expansions are translated into dipeptide-repeat (DPR) proteins, which are aggregation prone and may contribute to neurodegeneration. We used the CRISPR-Cas9 system to perform genome-wide gene-knockout screens for suppressors and enhancers of C9ORF72 DPR toxicity in human cells. We validated hits by performing secondary CRISPR-Cas9 screens in primary mouse neurons. We uncovered potent modifiers of DPR toxicity whose gene products function in nucleocytoplasmic transport, the endoplasmic reticulum (ER), proteasome, RNA-processing pathways, and chromatin modification. One modifier, TMX2, modulated the ER-stress signature elicited by C9ORF72 DPRs in neurons and improved survival of human induced motor neurons from patients with C9ORF72 ALS. Together, our results demonstrate the promise of CRISPR-Cas9 screens in defining mechanisms of neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4557-8343</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haney</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7381-4054</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgens</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovičić</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couthouis</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2378-4595</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ousey</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4886-0053</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8980-8940</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bieri</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0737-231X</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>C Kimberly</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yingxiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hertz</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessier-Lavigne</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichida</LastName><ForeName>Justin K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassik</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. bassik@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gitler</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8603-1526</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. agitler@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS097263</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507424</ArticleId><ArticleId IdType="doi">10.1038/s41588-018-0070-7</ArticleId><ArticleId IdType="pii">10.1038/s41588-018-0070-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507396</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-7838</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Cell research</Title><ISOAbbreviation>Cell Res.</ISOAbbreviation></Journal><ArticleTitle>A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41422-018-0020-z</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Haojie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liqin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>Bastiaan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Guangzhi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieftink</LastName><ForeName>Cor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beijersbergen</LastName><ForeName>Roderick L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Wenxin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China. wxqin@sjtu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernards</LastName><ForeName>René</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8677-3423</Identifier><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. r.bernards@nki.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Res</MedlineTA><NlmUniqueID>9425763</NlmUniqueID><ISSNLinking>1001-0602</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507396</ArticleId><ArticleId IdType="doi">10.1038/s41422-018-0020-z</ArticleId><ArticleId IdType="pii">10.1038/s41422-018-0020-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29507363</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Microbead-based spoligotyping of Mycobacterium tuberculosis from Ziehl-Neelsen-stained microscopy preparations in Ethiopia.</ArticleTitle><Pagination><MedlinePgn>3987</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-22071-9</ELocationID><Abstract><AbstractText>The worldwide dissemination of Mycobacterium tuberculosis strains has led to the study of their genetic diversity. One of the most used genotyping methods is spoligotyping, based on the detection of spacers in the clustered regularly interspaced short palindromic repeats (CRISPR) locus. This study assessed the performance of a microbead-based spoligotyping assay using samples extracted from Ziehl-Neelsen-stained smear-microscopy preparations and described the genetic diversity of Mycobacterium tuberculosis among new TB patients in Southern Nations, Nationalities and Peoples' Region (SNNPR) in Ethiopia. Among the 91 samples analysed, 59 (64.8%) generated spoligotyping patterns. Fifty (84.7%) samples were classified into 12 clusters (mostly Lineage 4 or 3) comprising 2-11 samples and nine had unique spoligotyping patterns. Among the 59 spoligotyping patterns, 25 belonged to the T1 sublineage, 11 to the T3-ETH, 5 to the URAL, 4 to the H3 and 14 to other L4 sublineages. There was a remarkable variation in genetic distribution in SNNPR compared to other regions of the country. Microbead-based spoligotyping is an easy-to-perform, high-throughput assay that can generate genotyping information using material obtained from smear microscopy preparations. The method provides an opportunity to obtain data of the M. tuberculosis genetic epidemiology in settings with limited laboratory resources.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Molina-Moya</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agonafir</LastName><ForeName>Mulualem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ethiopian Health and Nutrition Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSTM, Reach Ethiopia, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Natural Sciences, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dacombe</LastName><ForeName>Russell</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomgnimbou</LastName><ForeName>Michel K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Institut de Biologie Intégrative de la Cellule (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay. Gif-sur-Yvette, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre Muraz, Bobo-Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinasse</LastName><ForeName>Lizania</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut de Biologie Intégrative de la Cellule (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay. Gif-sur-Yvette, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes-Fernandes</LastName><ForeName>Meissiner</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datiko</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>REACH ETHIOPIA, Box 303, Hawassa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuevas</LastName><ForeName>Luis E</ForeName><Initials>LE</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6581-0587</Identifier><AffiliationInfo><Affiliation>Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sola</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut de Biologie Intégrative de la Cellule (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay. Gif-sur-Yvette, Orsay, France. christophe.sola@i2bc.paris-saclay.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507363</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-22071-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-22071-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507349</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2058-5276</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature microbiology</Title><ISOAbbreviation>Nat Microbiol</ISOAbbreviation></Journal><ArticleTitle>Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41564-018-0120-z</ELocationID><Abstract><AbstractText>Viruses employ a range of strategies to counteract the prokaryotic adaptive immune system, clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas), including mutational escape and physical blocking of enzymatic function using anti-CRISPR proteins (Acrs). Acrs have been found in many bacteriophages but so far not in archaeal viruses, despite the near ubiquity of CRISPR-Cas systems in archaea. Here, we report the functional and structural characterization of two archaeal Acrs from the lytic rudiviruses, SIRV2 and SIRV3. We show that a 4 kb deletion in the SIRV2 genome dramatically reduces infectivity in Sulfolobus islandicus LAL14/1 that carries functional CRISPR-Cas subtypes I-A, I-D and III-B. Subsequent insertion of a single gene from SIRV3, gp02 (AcrID1), which is conserved in the deleted fragment, successfully restored infectivity. We demonstrate that AcrID1 protein inhibits the CRISPR-Cas subtype I-D system by interacting directly with Cas10d protein, which is required for the interference stage. Sequence and structural analysis of AcrID1 show that it belongs to a conserved family of compact, dimeric αβ-sandwich proteins characterized by extreme pH and temperature stability and a tendency to form protein fibres. We identify about 50 homologues of AcrID1 in four archaeal viral families demonstrating the broad distribution of this group of anti-CRISPR proteins.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Danish Archaea Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhoobalan-Chitty</LastName><ForeName>Yuvaraj</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8104-7657</Identifier><AffiliationInfo><Affiliation>Danish Archaea Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van</LastName><ForeName>Lan B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Centre for Bacterial Stress Response and Persistence, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kjeldsen</LastName><ForeName>Anders L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Danish Archaea Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedola</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Danish Archaea Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makarova</LastName><ForeName>Kira S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koonin</LastName><ForeName>Eugene V</ForeName><Initials>EV</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3943-8299</Identifier><AffiliationInfo><Affiliation>National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodersen</LastName><ForeName>Ditlev E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5413-4667</Identifier><AffiliationInfo><Affiliation>Centre for Bacterial Stress Response and Persistence, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xu</ForeName><Initials>X</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3926-7514</Identifier><AffiliationInfo><Affiliation>Danish Archaea Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark. peng@bio.ku.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Microbiol</MedlineTA><NlmUniqueID>101674869</NlmUniqueID><ISSNLinking>2058-5276</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507349</ArticleId><ArticleId IdType="doi">10.1038/s41564-018-0120-z</ArticleId><ArticleId IdType="pii">10.1038/s41564-018-0120-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29507327</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Generation and characterization of a hypothyroidism rat model with truncated thyroid stimulating hormone receptor.</ArticleTitle><Pagination><MedlinePgn>4004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-22405-7</ELocationID><Abstract><AbstractText>Thyroid stimulating hormone receptor (TSHR), a G-protein-coupled receptor, is important for thyroid development and growth. In several cases, frameshift and/or nonsense mutations in TSHR were found in the patients with congenital hypothyroidism (CH), however they have not been functionally studied in an animal model. In the present work, we generated a unique Tshr<sup>Df/Df</sup>rat model that recapitulates the phenotypes in TSHR Y444X patient by CRISPR/Cas genome editing technology. In this rat model, TSHR is truncated at the second transmembrane domain, leading to CH phenotypes as what was observed in the patients, including dwarf, thyroid aplasia, infertility, TSH resistant as well as low serum thyroid hormone levels. The phenotypes can be reversed, at least partially, by levothyroxine (L-T4) treatment after weaning. The thyroid development is severely impaired in the Tshr<sup>Df/Df</sup>rats due to the suppression of the thyroid specific genes, i.e., thyroperoxidase (Tpo), thyroglobulin (Tg) and sodium iodide symporter (Nis), at both mRNA and protein levels. In conclusion, the Tshr<sup>Df/Df</sup>rat serves as a brand new genetic model to study CH in human, and will greatly help to shed light into the development of terminal organs that are sensitive to thyroid hormones.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, 200065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Junhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, 200065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, 200065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shanghai Pulmonary Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wanwan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Shanghai Pulmonary Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shuyang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Pulmonary Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Guoping</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5235-6410</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xianmin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Pulmonary Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200433, China. xianminzhu@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, 200065, China. xuezg@tongji.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wensheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China. zhouwesh@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507327</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-22405-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-22405-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29507284</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Microhomology-assisted scarless genome editing in human iPSCs.</ArticleTitle><Pagination><MedlinePgn>939</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-018-03044-y</ELocationID><Abstract><AbstractText>Gene-edited induced pluripotent stem cells (iPSCs) provide relevant isogenic human disease models in patient-specific or healthy genetic backgrounds. Towards this end, gene targeting using antibiotic selection along with engineered point mutations remains a reliable method to enrich edited cells. Nevertheless, integrated selection markers obstruct scarless transgene-free gene editing. Here, we present a method for scarless selection marker excision using engineered microhomology-mediated end joining (MMEJ). By overlapping the homology arms of standard donor vectors, short tandem microhomologies are generated flanking the selection marker. Unique CRISPR-Cas9 protospacer sequences nested between the selection marker and engineered microhomologies are cleaved after gene targeting, engaging MMEJ and scarless excision. Moreover, when point mutations are positioned unilaterally within engineered microhomologies, both mutant and normal isogenic clones are derived simultaneously. The utility and fidelity of our method is demonstrated in human iPSCs by editing the X-linked HPRT1 locus and biallelic modification of the autosomal APRT locus, eliciting disease-relevant metabolic phenotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Shin-Il</ForeName><Initials>SI</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1742-3718</Identifier><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kagawa</LastName><ForeName>Harunobu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Michiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirohata</LastName><ForeName>Ryoko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>Ayano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, 997-0052, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohishi</LastName><ForeName>Maki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, 997-0052, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuma</LastName><ForeName>Tetsushi</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0396-1563</Identifier><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, 739-8526, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soga</LastName><ForeName>Tomoyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, 997-0052, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, 739-8526, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woltjen</LastName><ForeName>Knut</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2293-1183</Identifier><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan. woltjen@cira.kyoto-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hakubi Center for Advanced Research, Kyoto University, Kyoto, 606-8501, Japan. woltjen@cira.kyoto-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Nov 20;5:5560</RefSource><PMID Version="1">25410609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Oct 12;478(7369):391-4</RefSource><PMID Version="1">21993621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2016 May 5;18(5):573-86</RefSource><PMID Version="1">27152442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2013 Mar;23(3):539-46</RefSource><PMID Version="1">23152450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1982 Mar;69(3):706-15</RefSource><PMID Version="1">7061709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1987 Feb 11;15(3):971-85</RefSource><PMID Version="1">3029712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2007 Jul;176(3):1403-15</RefSource><PMID Version="1">17483423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1981 Oct 25;256(20):10306-12</RefSource><PMID Version="1">7287714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Jul;11(7):705-6</RefSource><PMID Version="1">24972169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2008;3(10):1550-8</RefSource><PMID Version="1">18802436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 May 5;533(7601):125-9</RefSource><PMID Version="1">27120160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 May;8(5):409-12</RefSource><PMID Version="1">21460823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2012 May;30(5):460-5</RefSource><PMID Version="1">22484455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jul;39(12):e82</RefSource><PMID Version="1">21493687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1992 Mar;201(2):331-5</RefSource><PMID Version="1">1632522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chem. 2000 Mar 15;72(6):1236-41</RefSource><PMID Version="1">10740865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Jun 16;281(24):16768-76</RefSource><PMID Version="1">16608839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Apr 9;458(7239):766-70</RefSource><PMID Version="1">19252478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(11):e1003026</RefSource><PMID Version="1">23144625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2016 May 15;101:43-55</RefSource><PMID Version="1">26707206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jan;18(1):93-101</RefSource><PMID Version="1">9418857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2005 Jun;6(6):507-12</RefSource><PMID Version="1">15931173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Aug;38(15):e152</RefSource><PMID Version="1">20530528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1998 Nov 6;282(5391):1145-7</RefSource><PMID Version="1">9804556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1985 Oct;5(10):2662-8</RefSource><PMID Version="1">3837181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Growth Differ. 2014 Jan;56(1):2-13</RefSource><PMID Version="1">24387662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Sep 1;12(9):1385-90</RefSource><PMID Version="1">26299960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9591-6</RefSource><PMID Version="1">24927590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Jun 6;12(6):656-68</RefSource><PMID Version="1">23746975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):184-191</RefSource><PMID Version="1">26780180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013 Nov 29;3:3379</RefSource><PMID Version="1">24287550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Oct 19;550(7676):407-410</RefSource><PMID Version="1">28931002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2010 Jun;24(6):1714-24</RefSource><PMID Version="1">20110269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Jul 20;67(2):348-354.e4</RefSource><PMID Version="1">28732207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chem. 2009 Aug 1;81(15):6165-74</RefSource><PMID Version="1">19522513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Mar;26(3):313-5</RefSource><PMID Version="1">18278034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2014 May;15(5):321-34</RefSource><PMID Version="1">24690881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2005 Feb;25(3):896-906</RefSource><PMID Version="1">15657419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genesis. 2000 Sep;28(1):31-5</RefSource><PMID Version="1">11020714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2010 Mar;5(3):418-28</RefSource><PMID Version="1">20203661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 1988 May;42(5):726-34</RefSource><PMID Version="1">3358423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Feb 9;6(2):200-12</RefSource><PMID Version="1">26777058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1357:111-31</RefSource><PMID Version="1">26025620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):9049-61</RefSource><PMID Version="1">23907390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1984 Jan 10;259(1):27-30</RefSource><PMID Version="1">6706936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1985 Sep 19-25;317(6034):230-4</RefSource><PMID Version="1">2995814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Sep 13;7(3):496-507</RefSource><PMID Version="1">27594587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Mar;39(4):1372-80</RefSource><PMID Version="1">20965968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Nov 30;131(5):861-72</RefSource><PMID Version="1">18035408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1987 Nov 6;51(3):503-12</RefSource><PMID Version="1">2822260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 1990 Oct;85(5):500-4</RefSource><PMID Version="1">2227934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2008 Nov;24(11):529-38</RefSource><PMID Version="1">18809224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2013 Apr;18(4):315-26</RefSource><PMID Version="1">23388034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 May 7;110(19):7720-5</RefSource><PMID Version="1">23610439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16357-61</RefSource><PMID Version="1">16258059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2006;75:567-605</RefSource><PMID Version="1">16756503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2010 Aug;15(8):875-85</RefSource><PMID Version="1">20604805</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507284</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-03044-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-018-03044-y</ArticleId><ArticleId IdType="pmc">PMC5838097</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507191</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>dCas9-targeted locus-specific protein isolation method identifies histone gene regulators.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">201718844</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1718844115</ELocationID><Abstract><AbstractText>Eukaryotic gene regulation is a complex process, often coordinated by the action of tens to hundreds of proteins. Although previous biochemical studies have identified many components of the basal machinery and various ancillary factors involved in gene regulation, numerous gene-specific regulators remain undiscovered. To comprehensively survey the proteome directing gene expression at a specific genomic locus of interest, we developed an in vitro nuclease-deficient Cas9 (dCas9)-targeted chromatin-based purification strategy, called "CLASP" (Cas9 locus-associated proteome), to identify and functionally test associated gene-regulatory factors. Our CLASP method, coupled to mass spectrometry and functional screens, can be efficiently adapted for isolating associated regulatory factors in an unbiased manner targeting multiple genomic loci across different cell types. Here, we applied our method to isolate the<i>Drosophila melanogaster</i>histone cluster in S2 cells to identify several factors including Vig and Vig2, two proteins that bind and regulate core histone<i>H2A</i>and<i>H3</i>mRNA via interaction with their 3' UTRs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Chiahao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inouye</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Michaella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stowers Institute for Medical Research, Kansas City, MO 64110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florens</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9310-6650</Identifier><AffiliationInfo><Affiliation>Stowers Institute for Medical Research, Kansas City, MO 64110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Washburn</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Stowers Institute for Medical Research, Kansas City, MO 64110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjian</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720; jmlim@berkeley.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of California, Berkeley, CA 94720.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">histone regulation</Keyword><Keyword MajorTopicYN="N">reverse ChIP</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507191</ArticleId><ArticleId IdType="pii">1718844115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1718844115</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507186</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5549</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Molecular and cellular biology</Title><ISOAbbreviation>Mol. Cell. Biol.</ISOAbbreviation></Journal><ArticleTitle>Increased O-GlcNAcylation of SNAP29 drives arsenic-induced autophagic dysfunction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">MCB.00595-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/MCB.00595-17</ELocationID><Abstract><AbstractText>Environmental exposure to arsenic is linked to adverse health effects including cancer and diabetes. Pleiotropic cellular effects are observed with arsenic exposure. Previously, we demonstrated that arsenic dysregulated the autophagy pathway at low, environmentally relevant concentrations. Here, we show that arsenic blocks autophagy by preventing autophagosome-lysosome fusion. Specifically, arsenic disrupts formation of the STX17-SNAP29-VAMP8 SNARE complex, where SNAP29 mediates vesicle fusion through bridging STX17-containing autophagosomes to VAMP8-bearing lysosomes. Mechanistically, arsenic inhibits SNARE complex formation, at least in part, by enhancing O-GlcNAcylation of SNAP29. Transfection of O-GlcNAcylation defective, but not wild type, SNAP29 into CRISPR-mediated<i>SNAP29</i>knockout cells abolishes arsenic-mediated autophagy inhibition. These findings reveal a mechanism by which low-levels of arsenic perturb proteostasis through inhibition of SNARE complex formation, providing a possible therapeutic target for disease intervention in the more than 200 million people exposed to unsafe levels of arsenic.</AbstractText><CopyrightInformation>Copyright © 2018 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dodson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrose</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojo de la Vega</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholanians</LastName><ForeName>Aram B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Pak Kin</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA, 16802.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Donna D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA, 85721 dzhang@pharmacy.arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Cancer Center, University of Arizona, Tucson, AZ, USA, 85724.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell Biol</MedlineTA><NlmUniqueID>8109087</NlmUniqueID><ISSNLinking>0270-7306</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507186</ArticleId><ArticleId IdType="pii">MCB.00595-17</ArticleId><ArticleId IdType="doi">10.1128/MCB.00595-17</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29507093</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA117.000347</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA117.000347</ELocationID><Abstract><AbstractText>Hereditary tyrosinemia type I (HTI) is a metabolic genetic disorder caused by mutation of fumarylacetoacetate hydrolase (FAH). Because of the accumulation of toxic metabolites, HTI causes severe liver cirrhosis, liver failure andeven hepatocellular carcinoma. HTI is an ideal model for gene therapy, and several strategies have been shown to ameliorate HTI symptoms in animal models. Although CRISPR/Cas9 mediated genome editing is able to correct the Fahmutation in mouse models, wild-type Cas9 induces numerous undesired mutations that have raised safety concerns for clinical applications. To develop a new method for gene correction with high-fidelity, we generated a Fahmutant rat model to investigate whether Cas9 nickase (Cas9n)- mediated genome editing can efficiently correct the Fah. First, we confirmed that Cas9n rarely induces indels in both on-target and off-target sites in cell lines. Using wild-type Cas9 as a positive control, we delivered Cas9n and the repair donor template/single guide (sg)RNA through adenoviral vectors into HTI rats. Analysesof the initial genome editing efficiency indicated that only wild-type Cas9 but not Cas9n causes indels at the on-target site in the liver tissue. After receiving either Cas9n or wild-type Cas9-mediated gene correction therapy, HTI rats gained weight steadily and survived. Fah-expressing hepatocytes occupied over 95% of the liver tissue 9 months after the treatment. Moreover, CRISPR/Cas9 mediated gene therapy prevented the progression of liver cirrhosis, a phenotype that could not be recapitulated in the HTI mouse model.These results strongly suggest that Cas9n-mediated genome editing is a valuableand safegene therapy strategy for this genetic disease.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Yanjiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Nana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shengfei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yajing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingsong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Shuming</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Honghiu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bioray Laboratories Inc., China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University；Bioray Laboratories Inc, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ludi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academic of Sciences, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>Lijian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Qiurong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; University of Chinese Academy of Sciences, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Hongquan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingyao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Institute of Biosciences and Technology, Department of Molecular and Cellular Medicine, Texas A&amp;M University Health Science Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dali</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">Cas9 nickase</Keyword><Keyword MajorTopicYN="N">fibrosis</Keyword><Keyword MajorTopicYN="N">gene editing</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">genetic disease</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">hereditary tyrosinemia</Keyword><Keyword MajorTopicYN="N">liver</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29507093</ArticleId><ArticleId IdType="pii">RA117.000347</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA117.000347</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29505588</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Development of a multiple-gene-loading method by combining multi-integration system-equipped mouse artificial chromosome vector and CRISPR-Cas9.</ArticleTitle><Pagination><MedlinePgn>e0193642</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193642</ELocationID><Abstract><AbstractText>Mouse artificial chromosome (MAC) vectors have several advantages as gene delivery vectors, such as stable and independent maintenance in host cells without integration, transferability from donor cells to recipient cells via microcell-mediated chromosome transfer (MMCT), and the potential for loading a megabase-sized DNA fragment. Previously, a MAC containing a multi-integrase platform (MI-MAC) was developed to facilitate the transfer of multiple genes into desired cells. Although the MI system can theoretically hold five gene-loading vectors (GLVs), there are a limited number of drugs available for the selection of multiple-GLV integration. To overcome this issue, we attempted to knock out and reuse drug resistance genes (DRGs) using the CRISPR-Cas9 system. In this study, we developed new methods for multiple-GLV integration. As a proof of concept, we introduced five GLVs in the MI-MAC by these methods, in which each GLV contained a gene encoding a fluorescent or luminescent protein (EGFP, mCherry, BFP, Eluc, and Cluc). Genes of interest (GOI) on the MI-MAC were expressed stably and functionally without silencing in the host cells. Furthermore, the MI-MAC carrying five GLVs was transferred to other cells by MMCT, and the resultant recipient cells exhibited all five fluorescence/luminescence signals. Thus, the MI-MAC was successfully used as a multiple-GLV integration vector using the CRISPR-Cas9 system. The MI-MAC employing these methods may resolve bottlenecks in developing multiple-gene humanized models, multiple-gene monitoring models, disease models, reprogramming, and inducible gene expression systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Honma</LastName><ForeName>Kazuhisa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tottori Industrial Promotion Organization, Tottori, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uno</LastName><ForeName>Narumi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshimura</LastName><ForeName>Mitsuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohbayashi</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Laboratory Animal Science, Research Center for Bioscience and Technology, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazuki</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4818-4710</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29505588</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193642</ArticleId><ArticleId IdType="pii">PONE-D-17-34442</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29505302</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J.</ISOAbbreviation></Journal><ArticleTitle>AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.</ArticleTitle><Pagination><MedlinePgn>fj201701078R</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201701078R</ELocationID><Abstract><AbstractText>Prostate cancer (PCa) represents one of the most common solid neoplasms, and metastasis is the second leading cause of death in adult males. Anoikis is a programmed cell death that is induced upon cell detachment from the extracellular matrix (ECM), which behaves as a critical protective mechanism for anchorage-independent cell growth and metastasis formation. However, in the absence of ECM attachment, shift of metabolic pattern and tolerance to anoikis facilitate the survival of aggressive cancer cells in the circulatory system as well as their metastasis to distant sites. Few molecular targets in PCa have thus far been reported to prevent anoikis resistance, metabolic reprogramming, and metastasis simultaneously. In the present study, elevated migration, invasion, pyruvate production, lactate generation, ATP level, and impaired detachment-induced apoptosis were found in anoikis-resistant PCa cells, and genome microarray analysis demonstrated that the cell migration-inducing protein (CEMIP) was a potential molecular target for the regulation of the aforementioned malignant behaviors. Additional investigation revealed that the AMPK/glycogen synthase kinase 3β (GSK3β)/β-catenin cascade-triggered CEMIP overexpression in anoikis-resistant PCa cells might be implicated in local progression, metabolic shift, and cellular migration and invasion, whereas knockout of CEMIP by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 in anoikis-resistant PCa cells reversed the described bioeffects by reducing expressions of matrix metalloproteinase 2 (MMP2), VEGF, pyruvate dehydrogenase kinase isoform 4 (PDK4), and lactate dehydrogenase A. In addition, inhibition of glycolysis by CEMIP-mediated PDK4 down-regulation impaired the migration and invasion of anoikis-resistant PCa cells by attenuating MMP2 and VEGF expressions. Our findings establish that AMPK/GSK3β/β-catenin cascade-triggered CEMIP overexpression might promote migration and invasion in anoikis-resistant PCa cells by enhancing PDK4-associated metabolic reprogramming, which may provide a novel, promising therapeutic target for the treatment of advanced PCa.-Zhang, P., Song, Y., Sun, Y., Li, X., Chen, L., Yang, L., Xing, Y. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yarong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yadong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuechao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lifeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Likun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">KIAA1199</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">metastasis</Keyword><Keyword MajorTopicYN="N">prostatic carcinoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29505302</ArticleId><ArticleId IdType="doi">10.1096/fj.201701078R</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29503867</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.</ArticleTitle><Pagination><MedlinePgn>eaao5508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.aao5508</ELocationID><Abstract><AbstractText>Cancer genomics consortia have charted the landscapes of numerous human cancers. Whereas some mutations were found in classical oncogenes and tumor suppressors, others have not yet been functionally studied in vivo. To date, a comprehensive assessment of how these genes influence oncogenesis is lacking. We performed direct high-throughput in vivo mapping of functional variants in an autochthonous mouse model of cancer. Using adeno-associated viruses (AAVs) carrying a single-guide RNA (sgRNA) library targeting putative tumor suppressor genes significantly mutated in human cancers, we directly pool-mutagenized the livers of Cre-inducible CRISPR (clustered regularly interspaced short palindromic repeats)-associated protein 9 (Cas9) mice. All mice that received the AAV-mTSG library developed liver cancer and died within 4 months. We used molecular inversion probe sequencing of the sgRNA target sites to chart the mutational landscape of these tumors, revealing the functional consequence of multiple variants in driving liver tumorigenesis in immunocompetent mice. AAV-mediated autochthonous CRISPR screens provide a powerful means for mapping a provisional functional cancer genome atlas of tumor suppressors in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guangchuan</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5315-1599</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Ryan D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-1872-6307</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MD-PhD Program, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Lupeng</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3901-6598</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzman</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0001-6084-772X</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunobiology Program, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xiaoyun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MD-PhD Program, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0178-7995</Identifier><AffiliationInfo><Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, 75 Ames Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, MIT, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharp</LastName><ForeName>Phillip A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-1465-1691</Identifier><AffiliationInfo><Affiliation>Koch Institute for Integrative Cancer Research, MIT, 77 Massachusetts Avenue, Cambridge, MA 02139-4307, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, MIT, Cambridge, MA 02139-4307, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platt</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-2914-7052</Identifier><AffiliationInfo><Affiliation>Department of Biosystems Science and Engineering, ETH Zürich, Mattenstrasse 26, 4058 Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Basel, Petersplatz 1, 4003 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Sidi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3819-5005</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Institute, Yale University School of Medicine, 850 West Campus Drive, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunobiology Program, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological and Biomedical Sciences Program, Yale University School of Medicine, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comprehensive Cancer Center, Yale University School of Medicine, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem Cell Center, Yale University School of Medicine, West Haven, CT 06516, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2013 Nov;19(11):1423-37</RefSource><PMID Version="1">24202395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2003 Jun;21(6):673-8</RefSource><PMID Version="1">12730666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Mar 28;153(1):17-37</RefSource><PMID Version="1">23540688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Apr 9;458(7239):719-24</RefSource><PMID Version="1">19360079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Dec 21;338(6114):1619-22</RefSource><PMID Version="1">23160955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Oct 17;502(7471):333-339</RefSource><PMID Version="1">24132290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Sep;32(9):941-6</RefSource><PMID Version="1">24952903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Sep 12;501(7466):185-90</RefSource><PMID Version="1">23945586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 Sep;7(9):645-58</RefSource><PMID Version="1">17687385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Mar 27;323(5922):1747-50</RefSource><PMID Version="1">19251594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Aug 14;158(4):929-944</RefSource><PMID Version="1">25109877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2012 Mar;22(3):568-76</RefSource><PMID Version="1">22300766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2008 Jun;16(6):1073-80</RefSource><PMID Version="1">18414476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jan 23;505(7484):495-501</RefSource><PMID Version="1">24390350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50</RefSource><PMID Version="1">20952405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Nov 7;155(4):948-62</RefSource><PMID Version="1">24183448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):551-3</RefSource><PMID Version="1">24681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Aug 15;25(16):2078-9</RefSource><PMID Version="1">19505943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1081-2</RefSource><PMID Version="1">24037244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Apr;35(4):371-376</RefSource><PMID Version="1">28191901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2017 Oct;20(10 ):1329-1341</RefSource><PMID Version="1">28805815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2011 Mar 15;25(6):534-55</RefSource><PMID Version="1">21406553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Oct;45(10):1134-40</RefSource><PMID Version="1">24071852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Oct 16;514(7522):380-4</RefSource><PMID Version="1">25119044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Jun 1;70(11):4287-91</RefSource><PMID Version="1">20501857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2007 Apr 17;17(8):728-33</RefSource><PMID Version="1">17398096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Apr 17;109 (16):5934-41</RefSource><PMID Version="1">22421440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jul 11;499(7457):214-218</RefSource><PMID Version="1">23770567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2017 Apr;152(5):1161-1173.e1</RefSource><PMID Version="1">27956228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2010 Jul;10(7):470-80</RefSource><PMID Version="1">20574449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Mar 12;160(6):1246-60</RefSource><PMID Version="1">25748654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13982-7</RefSource><PMID Version="1">26508638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Jul 1;70(13):5305-15</RefSource><PMID Version="1">20530665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):423-7</RefSource><PMID Version="1">25337876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2012 May;2(5):401-4</RefSource><PMID Version="1">22588877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2012 May;142(5):1229-1239.e3</RefSource><PMID Version="1">22342966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Oct;45(10):1113-20</RefSource><PMID Version="1">24071849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2015 Jul 15;29(14):1576-85</RefSource><PMID Version="1">26178787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 29;517(7536):583-8</RefSource><PMID Version="1">25494202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Mar 29;339(6127):1546-58</RefSource><PMID Version="1">23539594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2007 Jun;132(7):2557-76</RefSource><PMID Version="1">17570226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource><PMID Version="1">19451168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):428-31</RefSource><PMID Version="1">25337879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Oct;45(10):1127-33</RefSource><PMID Version="1">24071851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 9;159(2):440-55</RefSource><PMID Version="1">25263330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Jul 6;150(1):12-27</RefSource><PMID Version="1">22770212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Nov 28;135(5):852-64</RefSource><PMID Version="1">19012953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Sep;38(16):e164</RefSource><PMID Version="1">20601685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2004 Aug;10 (8):789-99</RefSource><PMID Version="1">15286780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29503867</ArticleId><ArticleId IdType="doi">10.1126/sciadv.aao5508</ArticleId><ArticleId IdType="pii">aao5508</ArticleId><ArticleId IdType="pmc">PMC5829971</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29503817</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-634X</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in cell and developmental biology</Title><ISOAbbreviation>Front Cell Dev Biol</ISOAbbreviation></Journal><ArticleTitle>Cystathionine β-Synthase Is Necessary for Axis Development<i>in Vivo</i>.</ArticleTitle><Pagination><MedlinePgn>14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcell.2018.00014</ELocationID><Abstract><AbstractText>The cystathionine ß-synthase (CBS) is a critical enzyme in the transsulfuration pathway and is responsible for the synthesis of cystathionine from serine and homocysteine. Cystathionine is a precursor to amino acid cysteine. CBS is also responsible for generation of hydrogen sulfide (H<sub>2</sub>S) from cysteine. Mutation in<i>CBS</i>enzyme causes homocysteine levels to rise, and gives rise to a condition called hyperhomocysteinuria. To date, numerous mouse knockout models for CBS enzyme has been generated, which show panoply of defects, reflecting the importance of this enzyme in development. In zebrafish, we and others have identified two orthologs of<i>cbs</i>, which we call<i>cbsa</i>and<i>cbsb</i>. Previous gene knockdown studies in zebrafish have reported a function for<i>cbsb</i>ortholog in maintaining ion homeostasis in developing embryos. However, its role in maintaining H<sub>2</sub>S homeostasis in embryos is unknown. Here, we have performed RNA analysis in whole zebrafish embryos that showed a wide expression pattern for<i>cbsa</i>and<i>cbsb</i>primarily along the embryonic axis of the developing embryo. Loss-of-function analysis using a combination of approaches which include splice morpholinos and CRISPR/Cas9 genomic engineering show evidence that<i>cbsb</i>ortholog is responsible for anterior-posterior axis development, and<i>cbsa</i>function is redundant.<i>Cbsb</i>loss of function fish embryos show shortened and bent axis, along with less H<sub>2</sub>S and more homocysteine, effects resulting from loss of Cbsb. Using a chemical biology approach, we rescued the axis defects with betaine, a compound known to reduce homocysteine levels in plasma, and GYY4137, a long term H<sub>2</sub>S donor. These results collectively argue that cells along the axis of a developing embryo are sensitive to changes in homocysteine and H<sub>2</sub>S levels, pathways that are controlled by Cbsb, and thus is essential for development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prabhudesai</LastName><ForeName>Shubhangi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koceja</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Anindya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eisa-Beygi</LastName><ForeName>Shahram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatrics Radiology, Developmental Vascular Biology Program, Children's Research Institute, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leigh</LastName><ForeName>Noah R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Milwaukee Health Department, City of Milwaukee, Milwaukee, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharya</LastName><ForeName>Resham</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Priyabrata</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramchandran</LastName><ForeName>Ramani</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Radiology, Developmental Vascular Biology Program, Children's Research Institute, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Dev Biol</MedlineTA><NlmUniqueID>101630250</NlmUniqueID><ISSNLinking>2296-634X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1585-9</RefSource><PMID Version="1">7878023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 May 3;102(18):6373-8</RefSource><PMID Version="1">15849270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2015 Jul 1;309(1):C60-9</RefSource><PMID Version="1">25948733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Pathol. 2007 Oct;83(2):249-53</RefSource><PMID Version="1">17543941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Handb Exp Pharmacol. 2015;230:3-25</RefSource><PMID Version="1">26162827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Drug Targets. 2016;17 (13):1455-70</RefSource><PMID Version="1">26931358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2014 Jul 15;592(14 ):3075-88</RefSource><PMID Version="1">24756639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2001 Jun 8;88(11):1203-9</RefSource><PMID Version="1">11397788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Miner Electrolyte Metab. 1999 Jul-Dec;25(4-6):269-78</RefSource><PMID Version="1">10681651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yeast. 2000 Dec;17(4):302-306</RefSource><PMID Version="1">11119307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 28;9(1):e86930</RefSource><PMID Version="1">24489806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pflugers Arch. 2015 Apr;467(4):651-64</RefSource><PMID Version="1">24939700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Respir Physiol Neurobiol. 2012 Nov 15;184(2):117-29</RefSource><PMID Version="1">22546339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 May-Jun;7(5-6):813-22</RefSource><PMID Version="1">15890029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Dev Biol. 2012 Apr 05;12:12</RefSource><PMID Version="1">22480165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2015 Jan 12;32(1):97-108</RefSource><PMID Version="1">25533206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 1999;13(5):362-75</RefSource><PMID Version="1">10338090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2015 May;14(5):329-45</RefSource><PMID Version="1">25849904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Feb;11(2):122-3</RefSource><PMID Version="1">24481216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anat Rec A Discov Mol Cell Evol Biol. 2005 Jan;282(1):1-7</RefSource><PMID Version="1">15622513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H970-5</RefSource><PMID Version="1">10993757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet. 2002 Feb 15;108(1):57-63</RefSource><PMID Version="1">11857551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2014;1211:53-67</RefSource><PMID Version="1">25218376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9</RefSource><PMID Version="1">23918387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Jul;25(7):1030-42</RefSource><PMID Version="1">26048245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R39-46</RefSource><PMID Version="1">15016621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Physiol B. 2016 Feb;186(2):145-59</RefSource><PMID Version="1">26660653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2000 Dec;10(12):1890-902</RefSource><PMID Version="1">11116085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 Dec;140(24):4982-7</RefSource><PMID Version="1">24257628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Metab. 2010 Oct-Nov;101(2-3):153-62</RefSource><PMID Version="1">20638879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2007 Apr 15;304(2):735-44</RefSource><PMID Version="1">17306248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4460-70</RefSource><PMID Version="1">19357353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anat Rec A Discov Mol Cell Evol Biol. 2004 Oct;280(2):1072-6</RefSource><PMID Version="1">15386278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2007 Jan;46(1):151-9</RefSource><PMID Version="1">17030070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21972-7</RefSource><PMID Version="1">19955410</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">homcystinuria</Keyword><Keyword MajorTopicYN="N">hydrogen sulfide</Keyword><Keyword MajorTopicYN="N">methionine</Keyword><Keyword MajorTopicYN="N">morpholino</Keyword><Keyword MajorTopicYN="N">small molecules</Keyword><Keyword MajorTopicYN="N">zebrafish</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29503817</ArticleId><ArticleId IdType="doi">10.3389/fcell.2018.00014</ArticleId><ArticleId IdType="pmc">PMC5820354</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29503634</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Excision of Nucleopolyhedrovirus Form Transgenic Silkworm Using the CRISPR/Cas9 System.</ArticleTitle><Pagination><MedlinePgn>209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2018.00209</ELocationID><Abstract><AbstractText>The CRISPR/Cas9-mediated genome engineering has been shown to efficiently suppress infection by disrupting genes of the pathogen. We recently constructed transgenic lines expressing CRISPR/Cas9 and the double sgRNA target<i>Bombyx mori</i>nucleopolyhedrovirus (BmNPV)<i>immediate early-1</i>(<i>ie-1</i>) gene in the silkworm, respectively, and obtained four transgenic hybrid lines by G1 generation hybridization: Cas9(-)/sgRNA(-), Cas9(+)/sgRNA(-), Cas9(-)/sgRNA(+), and Cas9(+)/sgRNA(+). We demonstrated that the Cas9(+)/sgRNA(+) transgenic lines effectively edited the target site of the BmNPV genome, and large fragment deletion was observed after BmNPV infection. Further antiviral analysis of the Cas9(+)/sgRNA(+) transgenic lines shows that the median lethal dose (LD50) is 1,000-fold higher than the normal lines after inoculation with occlusion bodies. The analysis of economic characters and off-target efficiency of Cas9(+)/sgRNA(+) transgenic hybrid line showed no significant difference compared with the normal lines. Our findings indicate that CRISPR/Cas9-mediated genome engineering more effectively targets the BmNPV genomes and could be utilized as an insect antiviral treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Zhanqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Feifan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xinbo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Biotechnology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yaming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Minhui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2017 Feb;49(2):193-203</RefSource><PMID Version="1">27992415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioengineered. 2017 May 4;8(3):274-279</RefSource><PMID Version="1">28581909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2017 Mar 29;91(8):</RefSource><PMID Version="1">28122981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antiviral Res. 2014 Apr;104:143-52</RefSource><PMID Version="1">24486953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol. 2015 Feb;45(2-3):141-8</RefSource><PMID Version="1">25444863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 15;9(9):e105986</RefSource><PMID Version="1">25221982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Dec 14;10(12):e0144930</RefSource><PMID Version="1">26660313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol Methods. 2002 Feb;100(1-2):141-7</RefSource><PMID Version="1">11742661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):328-33</RefSource><PMID Version="1">26829318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Virol. 2004 Oct;149(10):1931-40</RefSource><PMID Version="1">15669105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Insect Biochem Mol Biol. 2014 May;48:1-7</RefSource><PMID Version="1">24561307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jan 17;493(7432):429-32</RefSource><PMID Version="1">23242138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Apr 1;31(7):1120-3</RefSource><PMID Version="1">25414360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2015 Nov 02;16(11):26077-86</RefSource><PMID Version="1">26540039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 10;7:46187</RefSource><PMID Version="1">28393927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virus Res. 2014 May 12;184:62-70</RefSource><PMID Version="1">24583368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2017 Jun;15(6):351-364</RefSource><PMID Version="1">28420884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2014 Dec;41(12):8247-54</RefSource><PMID Version="1">25200437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yi Chuan. 2015 May;37(5):412-8</RefSource><PMID Version="1">25998428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(8):e41838</RefSource><PMID Version="1">22870254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2014 Jan;21(1):81-8</RefSource><PMID Version="1">24173242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antiviral Res. 2016 Jun;130:50-7</RefSource><PMID Version="1">26979473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 May 16;545(7654):277-278</RefSource><PMID Version="1">28516945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Aug;24(7):1258-66</RefSource><PMID Version="1">27203444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2017 Feb 23;13(2):e1006206</RefSource><PMID Version="1">28231264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yi Chuan. 2016 Jan;38(1):9-16</RefSource><PMID Version="1">26787519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2016 May 15;30(8):1163-74</RefSource><PMID Version="1">26990633</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BmNPV</Keyword><Keyword MajorTopicYN="N">Bombyx mori</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">antiviral therapy</Keyword><Keyword MajorTopicYN="N">transgenic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29503634</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2018.00209</ArticleId><ArticleId IdType="pmc">PMC5820291</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29503187</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Insm1 Induces Neural Progenitor Delamination in Developing Neocortex via Downregulation of the Adherens Junction Belt-Specific Protein Plekha7.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(18)30077-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2018.01.052</ELocationID><Abstract><AbstractText>Delamination of neural progenitor cells (NPCs) from the ventricular surface is a crucial prerequisite to form the subventricular zone, the germinal layer linked to the expansion of the mammalian neocortex in development and evolution. Here, we dissect the molecular mechanism by which the transcription factor Insm1 promotes the generation of basal progenitors (BPs). Insm1 protein is most highly expressed in newborn BPs in mouse and human developing neocortex. Forced Insm1 expression in embryonic mouse neocortex causes NPC delamination, converting apical to basal radial glia. Insm1 represses the expression of the apical adherens junction belt-specific protein Plekha7. CRISPR/Cas9-mediated disruption of Plekha7 expression suffices to cause NPC delamination. Plekha7 overexpression impedes the intrinsic and counteracts the Insm1-induced, NPC delamination. Our findings uncover a novel molecular mechanism underlying NPC delamination in which a BP-genic transcription factor specifically targets the integrity of the apical adherens junction belt, rather than adherens junction components as such.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tavano</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taverna</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalebic</LastName><ForeName>Nereo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haffner</LastName><ForeName>Christiane</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namba</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deep Sequencing Group SFB 655, DFG Research Center for Regenerative Therapies and Biotechnology Center, Technische Universität Dresden, Fetscherstrasse 105, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilsch-Bräuninger</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paridaen</LastName><ForeName>Judith T M L</ForeName><Initials>JTML</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany. Electronic address: j.t.m.l.paridaen@umcg.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huttner</LastName><ForeName>Wieland B</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany. Electronic address: huttner@mpi-cbg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AJ belt disassembly</Keyword><Keyword MajorTopicYN="N">Insm1</Keyword><Keyword MajorTopicYN="N">NPC delamination</Keyword><Keyword MajorTopicYN="N">Plekha7</Keyword><Keyword MajorTopicYN="N">basal progenitors</Keyword><Keyword MajorTopicYN="N">basal radial glia</Keyword><Keyword MajorTopicYN="N">subventricular zone</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29503187</ArticleId><ArticleId IdType="pii">S0896-6273(18)30077-1</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2018.01.052</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29502955</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3686</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cancer cell</Title><ISOAbbreviation>Cancer Cell</ISOAbbreviation></Journal><ArticleTitle>The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1535-6108(18)30018-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccell.2018.01.018</ELocationID><Abstract><AbstractText>Synovial sarcoma is an aggressive cancer invariably associated with a chromosomal translocation involving genes encoding the SWI-SNF complex component SS18 and an SSX (SSX1 or SSX2) transcriptional repressor. Using functional genomics, we identify KDM2B, a histone demethylase and component of a non-canonical polycomb repressive complex 1 (PRC1.1), as selectively required for sustaining synovial sarcoma cell transformation. SS18-SSX1 physically interacts with PRC1.1 and co-associates with SWI/SNF and KDM2B complexes on unmethylated CpG islands. Via KDM2B, SS18-SSX1 binds and aberrantly activates expression of developmentally regulated genes otherwise targets of polycomb-mediated repression, which is restored upon KDM2B depletion, leading to irreversible mesenchymal differentiation. Thus, SS18-SSX1 deregulates developmental programs to drive transformation by hijacking a transcriptional repressive complex to aberrantly activate gene expression.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banito</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laporte</LastName><ForeName>Aimée N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Research Institute and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roe</LastName><ForeName>Jae-Seok</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Vega</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chun-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dancsok</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Research Institute and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatzi</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chi-Chao</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tschaharganeh</LastName><ForeName>Darjus F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandwani</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasdemir</LastName><ForeName>Nilgun</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Kevin B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Orthopedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capecchi</LastName><ForeName>Mario R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakoc</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladanyi</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Torsten O</ForeName><Initials>TO</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Research Institute and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Scott W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, New York, NY 10065, USA. Electronic address: lowes@mskcc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Cell</MedlineTA><NlmUniqueID>101130617</NlmUniqueID><ISSNLinking>1535-6108</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9-mediated endogenous protein tagging</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">SWI/SNF</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">non-canonical polycomb repressive complex</Keyword><Keyword MajorTopicYN="N">oncogenic gene fusion</Keyword><Keyword MajorTopicYN="N">sarcoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29502955</ArticleId><ArticleId IdType="pii">S1535-6108(18)30018-7</ArticleId><ArticleId IdType="doi">10.1016/j.ccell.2018.01.018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29502803</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Aminopeptidase-N-independent entry of porcine epidemic diarrhea virus into Vero or porcine small intestine epithelial cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0042-6822(18)30062-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2018.02.019</ELocationID><Abstract><AbstractText>A monkey cell line Vero (ATCC CCL-81) is commonly used for porcine epidemic diarrhea virus (PEDV) propagation in vitro. However, it is still controversial whether the porcine aminopeptidase N (pAPN) counterpart on Vero cells (Vero-APN) confers PEDV entry. We found that endogenous expression of Vero-APN was undetectable in the mRNA and the protein levels in Vero cells. We cloned the partial Vero-APN gene (3340-bp) containing exons 1 to 9 from cellular DNA and subsequently generated two APN-knockout Vero cell lines by CRISPR/Cas9 approach. PEDV infection of two APN-knockout Vero cells had the same efficiency as the Vero cells with or without neuraminidase treatment. A Vero cells stably expressing pAPN did not increase PEDV production. SiRNA-knockdown of pAPN in porcine jejunum epithelial cells had no effects on PEDV infection. The results suggest that there exists an additional cellular receptor on Vero or porcine jejunal cells independent of APN for PEDV entry.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Chun-Miao</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Virology of Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Virology of Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiyong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Virology of Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yao-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Virology of Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China. Electronic address: yhuang@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminopeptidase N (APN)</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">IPEC-J2 cells</Keyword><Keyword MajorTopicYN="N">Porcine epidemic diarrhea virus (PEDV)</Keyword><Keyword MajorTopicYN="N">Receptor</Keyword><Keyword MajorTopicYN="N">Vero cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29502803</ArticleId><ArticleId IdType="pii">S0042-6822(18)30062-X</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2018.02.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29500989</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0429</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Current opinion in biotechnology</Title><ISOAbbreviation>Curr. Opin. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>CRISPR-based methods for high-throughput annotation of regulatory DNA.</ArticleTitle><Pagination><MedlinePgn>32-41</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0958-1669(17)30270-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.copbio.2018.02.004</ELocationID><Abstract><AbstractText>Developments in CRISPR/Cas9-based technologies provide a new paradigm in functional screening of the genome. Conventional screening methods have focused on high-throughput perturbations of the protein-coding genome with technologies such as RNAi. However, equivalent methods for perturbing the non-coding genome have not existed until recently. CRISPR-based screening of genomic DNA has enabled the study of both genes and non-coding gene regulatory elements. Here we review recent progress in assigning function to the non-coding genome using CRISPR-based genomic and epigenomic screens, and discuss the prospects of these technologies to transforming our understanding of genome structure and regulation.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Tyler S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC 27708, United States; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Joshua B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC 27708, United States; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gersbach</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC 27708, United States; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, United States; Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, United States. Electronic address: charles.gersbach@duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM008555</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 OD008586</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA036865</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG007900</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R41 GM119914</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR066527</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Biotechnol</MedlineTA><NlmUniqueID>9100492</NlmUniqueID><ISSNLinking>0958-1669</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29500989</ArticleId><ArticleId IdType="pii">S0958-1669(17)30270-7</ArticleId><ArticleId IdType="doi">10.1016/j.copbio.2018.02.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29500194</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>An Efficient Platform for Generating Somatic Point Mutations with Germline Transmission in the Zebrafish by CRISPR/Cas9-mediated Gene Editing.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA117.001080</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA117.001080</ELocationID><Abstract><AbstractText>Homology-directed recombination (HDR)-mediated genome editing is a powerful approach for both basic functional study and disease modeling. Although some studies have reported HDR-mediated precise editing in non-rodent models, the efficiency of establishing pure mutant animal lines that carry specific amino acid substitutions remains low. Furthermore, because the efficiency of nonhomologous end joining (NHEJ)-induced insertion and deletion (indel) mutations is normally much higher than that of HDR-induced point mutations, it is often difficult to identify the latter in the background of indel mutations. Using zebrafish as the model organism and Y box binding protein 1 (Ybx1/<i>ybx1</i>) as the model molecule, we have established an efficient platform for precise CRISPR/Cas9-mediated gene editing in somatic cells, yielding an efficiency of up to 74% embryos. Moreover, we established a procedure for screening germline transmission of point mutations out of indel mutations even when germline transmission efficiency was low (&lt;2%). To further improve germline transmission of HDR-induced point mutations, we optimized several key factors that may affect HDR efficiency, including the type of DNA donor, suppression of NHEJ, stimulation of HDR pathways, and use of Cas9 protein instead of mRNA. The optimized combination of these factors significantly increased the efficiency of germline transmission of point mutation up to 25%. In summary, we have developed an efficient procedure for creating point mutations and differentiating mutant individuals from those carrying knockouts of the entire genes.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Macau, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">gene knockout</Keyword><Keyword MajorTopicYN="N">homologous recombination</Keyword><Keyword MajorTopicYN="N">site-directed mutagenesis</Keyword><Keyword MajorTopicYN="N">zebrafish</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29500194</ArticleId><ArticleId IdType="pii">RA117.001080</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA117.001080</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29500128</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(18)30069-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2018.02.015</ELocationID><Abstract><AbstractText>α1-antitrypsin (AAT) is a circulating serine protease inhibitor secreted from the liver and important in preventing proteolytic neutrophil elastase associated tissue damage, primarily in lungs. In humans, AAT is encoded by the SERPINA1 (hSERPINA1) gene in which a point mutation (commonly referred to as PiZ) causes aggregation of the miss-folded protein in hepatocytes resulting in subsequent liver damage. In an attempt to rescue the pathologic liver phenotype of a mouse model of human AAT deficiency (AATD), we used adenovirus to deliver Cas9 and a guide-RNA (gRNA) molecule targeting hSERPINA1. Our single dose therapeutic gene editing approach completely reverted the phenotype associated with the PiZ mutation, including circulating transaminase and human AAT (hAAT) protein levels, liver fibrosis and protein aggregation. Furthermore, liver histology was significantly improved regarding inflammation and overall morphology in hSERPINA1 gene edited PiZ mice. Genomic analysis confirmed significant disruption to the hSERPINA1 transgene resulting in a reduction of hAAT protein levels and quantitative mRNA analysis showed a reduction in fibrosis and hepatocyte proliferation as a result of editing. Our findings indicate that therapeutic gene editing in hepatocytes is possible in an AATD mouse model.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bjursell</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porritt</LastName><ForeName>Michelle J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ericson</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taheri-Ghahfarokhi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clausen</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnusson</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Admyre</LastName><ForeName>Therese</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitsch</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayr</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aasehaug</LastName><ForeName>Leif</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeliger</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maresca</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohlooly-Y</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: mohammad.bohlooly@astrazeneca.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9 gene editing</Keyword><Keyword MajorTopicYN="N">Liver fibrosis</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">α1-antitrypsin deficiency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29500128</ArticleId><ArticleId IdType="pii">S2352-3964(18)30069-0</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2018.02.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29499947</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2162-2531</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>Molecular therapy. Nucleic acids</Title><ISOAbbreviation>Mol Ther Nucleic Acids</ISOAbbreviation></Journal><ArticleTitle>Delineation of the Exact Transcription Termination Signal for Type 3 Polymerase III.</ArticleTitle><Pagination><MedlinePgn>36-44</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2162-2531(17)30290-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.omtn.2017.11.006</ELocationID><Abstract><AbstractText>Type 3 Pol III promoters such as U6 are widely used for expression of small RNAs, including short hairpin RNA for RNAi applications and guide RNA in CRISPR genome-editing platforms. RNA polymerase III uses a T-stretch as termination signal, but the exact properties have not been thoroughly investigated. Here, we systematically measured the in vivo termination efficiency and the actual site of termination for different T-stretch signals in three commonly used human Pol III promoters (U6, 7SK, and H1). Both the termination efficiency and the actual termination site depend on the T-stretch signal. The T4 signal acts as minimal terminator, but full termination efficiency is reached only with a T-stretch of ≥6. The termination site within the T-stretch is quite heterogeneous, and consequently small RNAs have a variable U-tail of 1-6 nucleotides. We further report that such variable U-tails can have a significant negative effect on the functionality of the crRNA effector of the CRISPR-AsCpf1 system. We next improved these crRNAs by insertion of the HDV ribozyme to avoid U-tails. This study provides detailed design guidelines for small RNA expression cassettes based on Pol III.</AbstractText><CopyrightInformation>Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Zongliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera-Carrillo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berkhout</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: b.berkhout@amc.uva.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther Nucleic Acids</MedlineTA><NlmUniqueID>101581621</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Sep 1;31(17):5033-8</RefSource><PMID Version="1">12930953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Apr;11(4):399-402</RefSource><PMID Version="1">24584192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2000 Feb 25;287(5457):1493-7</RefSource><PMID Version="1">10688799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2002 May;20(5):500-5</RefSource><PMID Version="1">11981565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2002 Oct 15;16(20):2593-620</RefSource><PMID Version="1">12381659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1981 Apr;24(1):261-70</RefSource><PMID Version="1">6263489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2005 May;11(5):674-82</RefSource><PMID Version="1">15811921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5515-20</RefSource><PMID Version="1">11960009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6047-52</RefSource><PMID Version="1">11972060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2015 Sep 15;4:e252</RefSource><PMID Version="1">26372022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Jun 18;58(6):1124-32</RefSource><PMID Version="1">25959395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2002 May;20(5):497-500</RefSource><PMID Version="1">11981564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Integr Plant Biol. 2014 Apr;56(4):343-9</RefSource><PMID Version="1">24373158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2003 Jun;4(6):457-67</RefSource><PMID Version="1">12778125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechniques. 2003 Jul;35(1):90-4, 97-8</RefSource><PMID Version="1">12866410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1994 Jan 28;235(4):1173-92</RefSource><PMID Version="1">8308883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Mar 17;45(5):e28</RefSource><PMID Version="1">27799472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):318-30</RefSource><PMID Version="1">23099421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Apr 20;45(7):4036-4050</RefSource><PMID Version="1">27928054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 May 20;280(20):19551-62</RefSource><PMID Version="1">15788403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2014 Jun;15(6):423-37</RefSource><PMID Version="1">24776770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(11):e1003028</RefSource><PMID Version="1">23166507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transcription. 2017;8(5):275-287</RefSource><PMID Version="1">28598252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Oct 2;273(40):26110-6</RefSource><PMID Version="1">9748291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Apr 19;296(5567):550-3</RefSource><PMID Version="1">11910072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2014 May 06;3:e161</RefSource><PMID Version="1">24803291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2016 Jul 1;103:157-66</RefSource><PMID Version="1">27083402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2002 May;20(5):505-8</RefSource><PMID Version="1">11981566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wiley Interdiscip Rev RNA. 2011 May-Jun;2(3):362-75</RefSource><PMID Version="1">21572561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2006 Jan 06;3:2</RefSource><PMID Version="1">16398936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1986 Dec 9;14 (23 ):9243-60</RefSource><PMID Version="1">2948154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 Nov;16(11):6468-76</RefSource><PMID Version="1">8887675</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pol III termination</Keyword><Keyword MajorTopicYN="N">T-stretch termination signal</Keyword><Keyword MajorTopicYN="N">small RNA</Keyword><Keyword MajorTopicYN="N">termination efficiency</Keyword><Keyword MajorTopicYN="N">termination site</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499947</ArticleId><ArticleId IdType="pii">S2162-2531(17)30290-1</ArticleId><ArticleId IdType="doi">10.1016/j.omtn.2017.11.006</ArticleId><ArticleId IdType="pmc">PMC5725217</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29499925</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2162-2531</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>Molecular therapy. Nucleic acids</Title><ISOAbbreviation>Mol Ther Nucleic Acids</ISOAbbreviation></Journal><ArticleTitle>High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2162-2531(17)30285-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.omtn.2017.11.001</ELocationID><Abstract><AbstractText>The CRISPR/Cas9 prokaryotic adaptive immune system and its swift repurposing for genome editing enables modification of any prespecified genomic sequence with unprecedented accuracy and efficiency, including targeted gene repair. We used the CRISPR/Cas9 system for targeted repair of patient-specific point mutations in the Cytochrome b-245 heavy chain gene (CYBB), whose inactivation causes chronic granulomatous disease (XCGD)-a life-threatening immunodeficiency disorder characterized by the inability of neutrophils and macrophages to produce microbicidal reactive oxygen species (ROS). We show that frameshift mutations can be effectively repaired in hematopoietic cells by non-integrating lentiviral vectors carrying RNA-guided Cas9 endonucleases (RGNs). Because about 25% of most inherited blood disorders are caused by frameshift mutations, our results suggest that up to a quarter of all patients suffering from monogenic blood disorders could benefit from gene therapy employing personalized, donor template-free RGNs.</AbstractText><CopyrightInformation>Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sürün</LastName><ForeName>Duran</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany; LOEWE Center for Cell and Gene Therapy, Goethe University Medical School, 60590 Frankfurt am Main, Germany. Electronic address: d.sueruen@med.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwäble</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>LOEWE Center for Cell and Gene Therapy, Goethe University Medical School, 60590 Frankfurt am Main, Germany; Institute for Transfusion Medicine und Immunohematology, Goethe University Medical School, 60528 Frankfurt am, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasovic</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehling</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany; LOEWE Center for Cell and Gene Therapy, Goethe University Medical School, 60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurrle</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Melchner</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany; LOEWE Center for Cell and Gene Therapy, Goethe University Medical School, 60590 Frankfurt am Main, Germany. Electronic address: melchner@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnütgen</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany; LOEWE Center for Cell and Gene Therapy, Goethe University Medical School, 60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther Nucleic Acids</MedlineTA><NlmUniqueID>101581621</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Sep;24(9):1526-33</RefSource><PMID Version="1">25096406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2008 Oct 20;15(10):1116-24</RefSource><PMID Version="1">18940671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2013 Sep;21(9):1718-26</RefSource><PMID Version="1">23732986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2014 May;111(5):1048-53</RefSource><PMID Version="1">23928856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9832-6</RefSource><PMID Version="1">8234321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jun 2;435(7042):646-51</RefSource><PMID Version="1">15806097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Jul 3;15(1):37-50</RefSource><PMID Version="1">24813857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2017 Jan 11;9(372):null</RefSource><PMID Version="1">28077679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Apr 23;125(17):2597-604</RefSource><PMID Version="1">25733580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2013 Sep;21(9):1705-17</RefSource><PMID Version="1">23857176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Methods Clin Dev. 2014 Aug 27;1:14037</RefSource><PMID Version="1">26015977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Apr 7;270(14):8194-200</RefSource><PMID Version="1">7713925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2011 Nov;29(11):1717-26</RefSource><PMID Version="1">21898685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Allergy Clin Immunol. 2011 Jun;127(6):1344-50</RefSource><PMID Version="1">21440291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Rev Allergy Immunol. 2010 Feb;38(1):3-10</RefSource><PMID Version="1">19504359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2015 Apr;26(4):210-9</RefSource><PMID Version="1">25860576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1987 Aug;70(2):372-8</RefSource><PMID Version="1">3475136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2011 May;12(5):301-15</RefSource><PMID Version="1">21445084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2015 Oct;43(10):838-848.e3</RefSource><PMID Version="1">26101162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2007 Feb;28(2):206</RefSource><PMID Version="1">17221864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 Oct 1;7(10):1765-71</RefSource><PMID Version="1">18675941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e46962</RefSource><PMID Version="1">23118864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(11):e3647</RefSource><PMID Version="1">18985154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Dec 15;104(13):4010-9</RefSource><PMID Version="1">15284122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2007 Jul;4(7):555-7</RefSource><PMID Version="1">17572680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Jun 15;474(7351):337-42</RefSource><PMID Version="1">21677750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Nov 29;288(48):34671-9</RefSource><PMID Version="1">24155235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Jan 20;117(3):798-807</RefSource><PMID Version="1">21041718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Immunol. 2003 Oct;15(5):578-84</RefSource><PMID Version="1">14499268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1997 Mar 15;89(6):1968-77</RefSource><PMID Version="1">9058718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jun 12;510(7504):235-240</RefSource><PMID Version="1">24870228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Apr 10;7(1):293-305</RefSource><PMID Version="1">24685129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2011 Jan;19(1):28-35</RefSource><PMID Version="1">21045810</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CGD</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">NHEJ</Keyword><Keyword MajorTopicYN="N">chronic granulomatous disease</Keyword><Keyword MajorTopicYN="N">hematopoietic cells</Keyword><Keyword MajorTopicYN="N">in situ gene correction</Keyword><Keyword MajorTopicYN="N">non-homologous end joining</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499925</ArticleId><ArticleId IdType="pii">S2162-2531(17)30285-8</ArticleId><ArticleId IdType="doi">10.1016/j.omtn.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC5723376</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29499836</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2084</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</Title><ISOAbbreviation>Drug Resist. Updat.</ISOAbbreviation></Journal><ArticleTitle>New tools for old drugs: Functional genetic screens to optimize current chemotherapy.</ArticleTitle><Pagination><MedlinePgn>30-46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1368-7646(18)30001-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drup.2018.01.001</ELocationID><Abstract><AbstractText>Despite substantial advances in the treatment of various cancers, many patients still receive anti-cancer therapies that hardly eradicate tumor cells but inflict considerable side effects. To provide the best treatment regimen for an individual patient, a major goal in molecular oncology is to identify predictive markers for a personalized therapeutic strategy. Regarding novel targeted anti-cancer therapies, there are usually good markers available. Unfortunately, however, targeted therapies alone often result in rather short remissions and little cytotoxic effect on the cancer cells. Therefore, classical chemotherapy with frequent long remissions, cures, and a clear effect on cancer cell eradication remains a corner stone in current anti-cancer therapy. Reliable biomarkers which predict the response of tumors to classical chemotherapy are rare, in contrast to the situation for targeted therapy. For the bulk of cytotoxic therapeutic agents, including DNA-damaging drugs, drugs targeting microtubules or antimetabolites, there are still no reliable biomarkers used in the clinic to predict tumor response. To make progress in this direction, meticulous studies of classical chemotherapeutic drug action and resistance mechanisms are required. For this purpose, novel functional screening technologies have emerged as successful technologies to study chemotherapeutic drug response in a variety of models. They allow a systematic analysis of genetic contributions to a drug-responsive or -sensitive phenotype and facilitate a better understanding of the mode of action of these drugs. These functional genomic approaches are not only useful for the development of novel targeted anti-cancer drugs but may also guide the use of classical chemotherapeutic drugs by deciphering novel mechanisms influencing a tumor's drug response. Moreover, due to the advances of 3D organoid cultures from patient tumors and in vivo screens in mice, these genetic screens can be applied using conditions that are more representative of the clinical setting. Patient-derived 3D organoid lines furthermore allow the characterization of the "essentialome", the specific set of genes required for survival of these cells, of an individual tumor, which could be monitored over the course of treatment and help understanding how drug resistance evolves in clinical tumors. Thus, we expect that these functional screens will enable the discovery of novel cancer-specific vulnerabilities, and through clinical validation, move the field of predictive biomarkers forward. This review focuses on novel advanced techniques to decipher the interplay between genetic alterations and drug response.</AbstractText><CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerhards</LastName><ForeName>Nora M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rottenberg</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: sven.rottenberg@vetsuisse.unibe.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Drug Resist Updat</MedlineTA><NlmUniqueID>9815369</NlmUniqueID><ISSNLinking>1368-7646</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D organoids</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Chemotherapy</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">Functional genetic screens</Keyword><Keyword MajorTopicYN="N">Gene essentiality</Keyword><Keyword MajorTopicYN="N">Haploid cells</Keyword><Keyword MajorTopicYN="N">Insertional mutagenesis</Keyword><Keyword MajorTopicYN="N">Predictive markers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499836</ArticleId><ArticleId IdType="pii">S1368-7646(18)30001-3</ArticleId><ArticleId IdType="doi">10.1016/j.drup.2018.01.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29499499</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-7753</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Stem cell research</Title><ISOAbbreviation>Stem Cell Res</ISOAbbreviation></Journal><ArticleTitle>Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>161-164</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1873-5061(18)30060-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scr.2018.02.015</ELocationID><Abstract><AbstractText>Mutations in RAB39B are a known cause of X-linked early onset Parkinson's disease. Isogenic human embryonic stem cell lines carrying two independent deletions of RAB39B were generated using CRISPR/Cas9 genome editing tool. The deletions were confirmed by PCR and direct sequence analysis in two edited stem cell lines. Both cell lines showed pluripotency and displayed a normal karyotype. Further, they were able to form embryoid bodies in vitro, and express markers indicative of differentiation to the three germ layers.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yujing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Gabrielle R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozaoglu</LastName><ForeName>Kiymet</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elefanty</LastName><ForeName>Andrew G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia; Blood Cell Development and Disease Laboratory, Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Victoria, 3052, Australia; Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanley</LastName><ForeName>Edouard G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia; Stem Cell Technology Laboratory, Murdoch Children's Research Institute, The Royal Children's Hospital, , Melbourne, Victoria, 3052, Australia; Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dottori</LastName><ForeName>Mirella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Neural Engineering, The University of Melbourne, Carlton, VIC, 3010, Australia; Illawarra Health and Medical Research Institute, Centre for Molecular and Medical Bioscience, University of Wollongong, Wollongong, New South Wales, 2500, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lockhart</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, 3052, Australia. Electronic address: paul.lockhart@mcri.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cell Res</MedlineTA><NlmUniqueID>101316957</NlmUniqueID><ISSNLinking>1873-5061</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499499</ArticleId><ArticleId IdType="pii">S1873-5061(18)30060-6</ArticleId><ArticleId IdType="doi">10.1016/j.scr.2018.02.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29499194</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2104</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Biochemical and biophysical research communications</Title><ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation></Journal><ArticleTitle>HDAC8 regulates neural differentiation through embryoid body formation in P19 cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0006-291X(18)30441-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2018.02.195</ELocationID><Abstract><AbstractText>Histone acetylation and deacetylation correlate with diverse biological phenomena through gene transcription. Histone deacetylases (HDACs) regulate deacetylation of histones and other proteins. However, as a member of the HDAC family, HDAC8 function during neurodevelopment is currently unknown. Therefore, we investigated HDAC8 function during neurodevelopment by examining embryoid body (EB) formation in P19 cells. HDAC8-selective inhibitor (NCC-149) (HDAC8i)-treated cells showed smaller EBs than non-treated cells, as well as reduced expression levels of the neuronal marker, NeuN. Additionally, HDAC8i treatment led to inhibition of cellular proliferation by G2/M phase accumulation and downregulated cyclin A2 and cyclin B1 gene expression. Furthermore, two independent HDAC8 knockout cell lines were established by CRISPR-Cas9, which resulted in smaller EBs, similar to HDAC8i-treated cells. These results suggest that HDAC8 regulates neural differentiation by exerting control of EB formation.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Syouichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morii</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makanga</LastName><ForeName>Juliet O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Sakyo-ku, Kyoto 606-0823, Japan; CREST, Japan Science and Technology Agency (JST), Kawaguchi, Saitama 332-0012, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Drug Discovery Science, Nagoya City University, Mizuho-ku, Nagoya 467-8603, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inazu</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan. Electronic address: tinazu@fc.ritsumei.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Cell cycle</Keyword><Keyword MajorTopicYN="N">HDAC8</Keyword><Keyword MajorTopicYN="N">HDAC8-Selective inhibitor</Keyword><Keyword MajorTopicYN="N">NCC-149</Keyword><Keyword MajorTopicYN="N">Neurodevelopment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499194</ArticleId><ArticleId IdType="pii">S0006-291X(18)30441-8</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2018.02.195</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29499139</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4164</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol. Cell</ISOAbbreviation></Journal><ArticleTitle>CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.</ArticleTitle><Pagination><MedlinePgn>893-905.e7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1097-2765(18)30091-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2018.01.032</ELocationID><Abstract><AbstractText>Cas9 nucleases naturally utilize CRISPR RNAs (crRNAs) to silence foreign double-stranded DNA. While recent work has shown that some Cas9 nucleases can also target RNA, RNA recognition has required nuclease modifications or accessory factors. Here, we show that the Campylobacter jejuni Cas9 (CjCas9) can bind and cleave complementary endogenous mRNAs in a crRNA-dependent manner. Approximately 100 transcripts co-immunoprecipitated with CjCas9 and generally can be subdivided through their base-pairing potential to the four crRNAs. A subset of these RNAs was cleaved around or within the predicted binding site. Mutational analyses revealed that RNA binding was crRNA and tracrRNA dependent and that target RNA cleavage required the CjCas9 HNH domain. We further observed that RNA cleavage was PAM independent, improved with greater complementarity between the crRNA and the RNA target, and was programmable in vitro. These findings suggest that C. jejuni Cas9 is a promiscuous nuclease that can coordinately target both DNA and RNA.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dugar</LastName><ForeName>Gaurav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leenay</LastName><ForeName>Ryan T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eisenbart</LastName><ForeName>Sara K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischler</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aul</LastName><ForeName>Belinda U</ForeName><Initials>BU</Initials><AffiliationInfo><Affiliation>Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beisel</LastName><ForeName>Chase L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA; Helmholtz Institute for RNA-based Infection Research (HIRI), Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany. Electronic address: cbeisel@ncsu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Cynthia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany. Electronic address: cynthia.sharma@uni-wuerzburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Campylobacter jejuni</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">RIP-seq</Keyword><Keyword MajorTopicYN="N">RNA binding proteins</Keyword><Keyword MajorTopicYN="N">RNA cleavage</Keyword><Keyword MajorTopicYN="N">crRNA</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">non-coding RNA</Keyword><Keyword MajorTopicYN="N">post-transcriptional regulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29499139</ArticleId><ArticleId IdType="pii">S1097-2765(18)30091-1</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2018.01.032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29498931</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-4315</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Biological chemistry</Title><ISOAbbreviation>Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Functional characterization of the mouse Serpina1 paralog DOM-7.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1515/hsz-2018-0154</ELocationID><ELocationID EIdType="pii" ValidYN="Y">/j/bchm.just-accepted/hsz-2018-0154/hsz-2018-0154.xml</ELocationID><Abstract><AbstractText>The generation of authentic mouse-models for human α1-antitrypsin-deficiency is difficult due to the high complexity of the mouse Serpina1 gene locus. Depending on the exact mouse strain, three to five paralogs are expressed, with different proteinase inhibitory properties. With nowadays CRISPR-technology, genome editing of complex genomic loci is feasible and could be employed for generation of α1-antitrypsin-deficiency mouse-models. In preparation of a CRISPR/Cas9-based genome-engineering approach we identified cDNA clones with a functional CDS for the Serpina1-paralog DOM-7. Here, we show that DOM-7 functionally inhibits Elane and chymotrypsin, and therefore needs to be considered when aiming at the generation of α1-antitrypsin-deficiency models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jülicher</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wähner</LastName><ForeName>Annabell</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haase</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>4The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbour</LastName><ForeName>Karen W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>5Department of Biological Sciences, and Center for Colon Cancer Research, University of South Carolina, Columbia, SC 29208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Franklin G</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>5Department of Biological Sciences, and Center for Colon Cancer Research, University of South Carolina, Columbia, SC 29208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiehlmann</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>6Core Unit 'Next Generation Sequencing', Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>6Core Unit 'Next Generation Sequencing', Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuster-Gossler</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>7Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stitz</LastName><ForeName>Jörn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>2University of Applied Sciences, Cologne Faculty of Applied Natural Sciences, Campus Leverkusen, D-51368 Leverkusen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggenschwiler</LastName><ForeName>Reto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biol Chem</MedlineTA><NlmUniqueID>9700112</NlmUniqueID><ISSNLinking>1431-6730</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antitrypsin deficiency / chymotrypsin / DOM-7 / neutrophil elastase / Serpina</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29498931</ArticleId><ArticleId IdType="doi">10.1515/hsz-2018-0154</ArticleId><ArticleId IdType="pii">/j/bchm.just-accepted/hsz-2018-0154/hsz-2018-0154.xml</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29497452</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1745-1981</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Drugs in context</Title><ISOAbbreviation>Drugs Context</ISOAbbreviation></Journal><ArticleTitle>The latest evidence for possible HIV-1 curative strategies.</ArticleTitle><Pagination><MedlinePgn>212522</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7573/dic.212522</ELocationID><Abstract><AbstractText>Human immunodeficiency virus type 1 (HIV-1) infection remains a major health issue worldwide. In developed countries, antiretroviral therapy has extended its reach from treatment of people living with HIV-1 to post-exposure prophylaxis, treatment as prevention, and, more recently, pre-exposure prophylaxis. These healthcare strategies offer the epidemiological tools to curve the epidemic in rich settings and will be concomitantly implemented in developing countries. One of the remaining challenges is to identify an efficacious curative strategy. This review manuscript will focus on some of the current curative strategies aiming at providing a sterilizing or functional cure to HIV-1-positive individuals. These include the following: early treatment initiation in post-treatment controllers as a long-term HIV-1 remission strategy, latency reversal, gene editing with or without stem cell transplantation, and antibodies against either the viral envelope protein or the host integrin α4β7.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Hanh Thi</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesplède</LastName><ForeName>Thibault</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Experimental Medicine, Faculty of Medicine, McGill University, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Jewish General Hospital, McGill University, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Drugs Context</MedlineTA><NlmUniqueID>101262187</NlmUniqueID><ISSNLinking>1740-4398</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Trends Immunol. 2012 Nov;33(11):554-62</RefSource><PMID Version="1">22867874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2000 Mar;181(3):933-8</RefSource><PMID Version="1">10720515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013;9(5):e1003347</RefSource><PMID Version="1">23671416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):317-25</RefSource><PMID Version="1">22918156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Viruses. 2010 Feb;2(2):574-600</RefSource><PMID Version="1">21994649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Jan 25;16(2):227-33</RefSource><PMID Version="1">11807307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Nov 14;503(7475):224-8</RefSource><PMID Version="1">24172905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2009 Sep;330(3):864-75</RefSource><PMID Version="1">19509315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Mar 6;370(10):901-10</RefSource><PMID Version="1">24597865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2018 Feb;18(2):91-104</RefSource><PMID Version="1">28990586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet HIV. 2014 Oct;1(1):e13-21</RefSource><PMID Version="1">26423811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2010 Feb;84(3):1302-13</RefSource><PMID Version="1">19906907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):230-2</RefSource><PMID Version="1">23360966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr HIV/AIDS Rep. 2016 Feb;13(1):31-7</RefSource><PMID Version="1">26841901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2017 Feb 6;14 (1):9</RefSource><PMID Version="1">28166799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2749-54</RefSource><PMID Version="1">10688894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Jan;6(1):38-51</RefSource><PMID Version="1">16397526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Aug 13;329(5993):856-61</RefSource><PMID Version="1">20616233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Aug 27;373(9):795-807</RefSource><PMID Version="1">26192873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2009 Mar;4(2):96-103</RefSource><PMID Version="1">19339947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2007 Nov;8(11):1246-54</RefSource><PMID Version="1">17906628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2014 Jan 2;123(1):61-9</RefSource><PMID Version="1">24162716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jun 23;43(11):5560-71</RefSource><PMID Version="1">25964300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2011 Jan 13;7(1):e1001251</RefSource><PMID Version="1">21249232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2010 Aug;28(8):839-47</RefSource><PMID Version="1">20601939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Microbiol. 2016 May;62(5):375-82</RefSource><PMID Version="1">27031127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jul 25;487(7408):482-5</RefSource><PMID Version="1">22837004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 May 28;285(22):16538-45</RefSource><PMID Version="1">20335163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2018 Jan;29(1):51-67</RefSource><PMID Version="1">28599597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2000 Feb;6(2):207-10</RefSource><PMID Version="1">10655111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2013 Nov 7;369(19):1828-35</RefSource><PMID Version="1">24152233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2017 Oct;23 (10 ):945-961</RefSource><PMID Version="1">28890135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Nov 9;287(46):38427-32</RefSource><PMID Version="1">23019344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2013 Aug;5(8):1180-95</RefSource><PMID Version="1">23828858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2007 Mar 15;195(6):833-6</RefSource><PMID Version="1">17299713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2009 Jun 02;6:52</RefSource><PMID Version="1">19486542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Oct 18;16(15):2019-25</RefSource><PMID Version="1">12370500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Sep 08;7:12731</RefSource><PMID Version="1">27605062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Jun 6;121(23):4635-46</RefSource><PMID Version="1">23589670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11461-6</RefSource><PMID Version="1">25049410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Jul 30;11(7):e1005066</RefSource><PMID Version="1">26225771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Apr 19;15(3):481-489</RefSource><PMID Version="1">27068471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Feb 12;360(7):692-8</RefSource><PMID Version="1">19213682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20877-82</RefSource><PMID Version="1">19933330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2011 May-Jun;17(5-6):466-72</RefSource><PMID Version="1">21424110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Viruses. 2014 Aug 27;6(9):3377-85</RefSource><PMID Version="1">25166745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Dec 6;16(18):2385-90</RefSource><PMID Version="1">12461411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2014 Sep 2;161(5):319-27</RefSource><PMID Version="1">25047577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2004 Nov;54(5):915-20</RefSource><PMID Version="1">15456731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Jul;26(7):808-16</RefSource><PMID Version="1">18587387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Oct 6;358(6359):85-90</RefSource><PMID Version="1">28931639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Int Assoc Physicians AIDS Care (Chic). 2009 Jan-Feb;8(1):21-2</RefSource><PMID Version="1">19171916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virus Erad. 2015 Jan 01;1(1):13-6</RefSource><PMID Version="1">27482391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Jun 30;4(6):e6093</RefSource><PMID Version="1">19564922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Jul 13;337(6091):183-6</RefSource><PMID Version="1">22798606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Dec 18;371(25):2437-8</RefSource><PMID Version="1">25517721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2008 Mar;9(3):301-9</RefSource><PMID Version="1">18264102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Nov 6;15(5):643-52</RefSource><PMID Version="1">25517468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Jun 19;22(10):1125-9</RefSource><PMID Version="1">18525257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2007;13(33):3378-93</RefSource><PMID Version="1">18045192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2017 Jun 5;14 (1):36</RefSource><PMID Version="1">28583191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Dec;20(12):1397-400</RefSource><PMID Version="1">25419708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2007 Oct;81(20):11016-31</RefSource><PMID Version="1">17686878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Feb 19;372(8):786-8</RefSource><PMID Version="1">25693029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2012 Aug;69(15):2583-92</RefSource><PMID Version="1">22322557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Sep 28;276(39):36734-41</RefSource><PMID Version="1">11473107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Dec;89(24):12501-12</RefSource><PMID Version="1">26446600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Nov 13;5:16445</RefSource><PMID Version="1">26563568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jul 22;5:12442</RefSource><PMID Version="1">26199173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Oct 14;354(6309):197-202</RefSource><PMID Version="1">27738167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virus Erad. 2016 Jul 01;2(3):183-6</RefSource><PMID Version="1">27482460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:2510</RefSource><PMID Version="1">23974631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Jun 29;316(5833):1912-5</RefSource><PMID Version="1">17600219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2001 Nov 15;98(10):3006-15</RefSource><PMID Version="1">11698284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan 7;41(1):277-87</RefSource><PMID Version="1">23087374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2017 Oct 13;91(21):</RefSource><PMID Version="1">28835492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2016 Jan 07;12(1):e1005349</RefSource><PMID Version="1">26741490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Sep;41(16):7771-82</RefSource><PMID Version="1">23804764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Dec 18;371(25):2438</RefSource><PMID Version="1">25517720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2012 Jul 31;26(12):1473-82</RefSource><PMID Version="1">22555163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1990 Jul 1;172(1):151-8</RefSource><PMID Version="1">2193094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Oct 9;326(5950):285-9</RefSource><PMID Version="1">19729618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013 Mar;9(3):e1003211</RefSource><PMID Version="1">23516360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2015 Aug 1;195(3):755-61</RefSource><PMID Version="1">26188068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Mar 17;10(3):e0120047</RefSource><PMID Version="1">25781496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 24;10(7):e0132430</RefSource><PMID Version="1">26208341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 May 23;121(21):4321-9</RefSource><PMID Version="1">23589672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2017 Jul;33(7):658-667</RefSource><PMID Version="1">28335609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2016 May 27;13(1):37</RefSource><PMID Version="1">27230886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2002 Dec 19;20 Suppl 4:A61-5</RefSource><PMID Version="1">12477430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1994 Nov 11;266(5187):1024-7</RefSource><PMID Version="1">7973652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2012 May 2;4(132):132ra53</RefSource><PMID Version="1">22553251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2011 Dec;226(12):3385-91</RefSource><PMID Version="1">21344388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet HIV. 2016 Jan;3(1):e49-54</RefSource><PMID Version="1">26762993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2016 Jul 15;197(2):407-17</RefSource><PMID Version="1">27382129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2015 Aug;23 (8):1358-1367</RefSource><PMID Version="1">26050990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2005 Jun;11(6):615-22</RefSource><PMID Version="1">15880120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e27864</RefSource><PMID Version="1">22174752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2015 Feb 20;29(4):504-6</RefSource><PMID Version="1">25628259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1999 May;73(5):4009-18</RefSource><PMID Version="1">10196297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Sep 8;118(10):2763-73</RefSource><PMID Version="1">21693759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr HIV/AIDS Rep. 2012 Mar;9(1):81-90</RefSource><PMID Version="1">22198819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Jan 15;186(2):1044-59</RefSource><PMID Version="1">21149598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2012 Mar 23;36(3):491-501</RefSource><PMID Version="1">22406268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Int AIDS Soc. 2015 Dec 04;18:20824</RefSource><PMID Version="1">26642452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Feb 25;115(8):1534-44</RefSource><PMID Version="1">20018916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2000 Jul;6(7):736-7</RefSource><PMID Version="1">10888912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gene Med. 2010 Mar;12(3):255-65</RefSource><PMID Version="1">20186995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2015 Feb 27;12:22</RefSource><PMID Version="1">25808449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2010 Aug 10;7(8):null</RefSource><PMID Version="1">20711481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2013 Oct 24;10:119</RefSource><PMID Version="1">24156240</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2016 May 15;30(8):1163-74</RefSource><PMID Version="1">26990633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Mol Med. 2009 Feb 11;11:e6</RefSource><PMID Version="1">19208267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2003 Feb;2(2):151-63</RefSource><PMID Version="1">12589032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2016 Apr 14;90(9):4441-53</RefSource><PMID Version="1">26889036</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">HIV-1 infection</Keyword><Keyword MajorTopicYN="N">HIV-1 latency</Keyword><Keyword MajorTopicYN="N">HIV-1 persistence</Keyword><Keyword MajorTopicYN="N">antiretroviral</Keyword><Keyword MajorTopicYN="N">antiretroviral treatment intensification</Keyword><Keyword MajorTopicYN="N">broadly neutralizing antibodies</Keyword><Keyword MajorTopicYN="N">dolutegravir</Keyword><Keyword MajorTopicYN="N">shock and kill</Keyword></KeywordList><CoiStatement>Disclosure and potential conflicts of interest: The authors have nothing to disclose. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors are available for download at: http://www.drugsincontext.com/wp-content/uploads/2018/01/dic.212522-COI.pdf</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29497452</ArticleId><ArticleId IdType="doi">10.7573/dic.212522</ArticleId><ArticleId IdType="pii">dic-7-212522</ArticleId><ArticleId IdType="pmc">PMC5824924</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29497118</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.</ArticleTitle><Pagination><MedlinePgn>3883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-22177-0</ELocationID><Abstract><AbstractText>The bacterial CRISPR-Cas system provides adaptive immunity against invading phages. Cas9, an RNA-guided endonuclease, specifically cleaves target DNA substrates and constitutes a well-established platform for genome editing. Recently, anti-CRISPR (Acr) proteins that inhibit Cas9 have been discovered, promising a useful off-switch for Cas9 to avoid undesirable off-target effects. Here, we report the solution structure and dynamics of Listeria monocytogenes AcrIIA4 that inhibits Streptococcus pyogenes Cas9 (SpyCas9). AcrIIA4 forms a compact monomeric αβββαα fold comprising three antiparallel β strands flanked by three α-helices and a short 3<sub>10</sub>-helix. AcrIIA4 exhibits distinct backbone dynamics in fast and slow timescales at loop regions that form interaction surfaces for SpyCas9. In particular, the β1-β2 loop that binds to the RuvC domain of SpyCas9 is highly mobile, and the β1-β2 and α2-α3 loops that bind to the RuvC and C-terminal domains of SpyCas9, respectively, undergoes conformational exchanges in microsecond-to-millisecond time scales. AcrIIA4 binds to apo-SpyCas9 with K<sub>D</sub>~4.8 μM, which compares to K<sub>D</sub>~0.6 nM for AcrIIA4 binding to sgRNA-bound SpyCas9. Since the binary complex between AcrIIA4 and SpyCas9 does not compete with the target DNA binding, it can effectively disable the Cas9 nuclease activity by forming a tight ternary complex in the presence of sgRNA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Iktae</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Migyeong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ka</LastName><ForeName>Donghyun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Mookyoung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Nak-Kyoon</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Advanced Analysis Center, Korea Institute of Science and Technology, Seoul, 02792, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Euiyoung</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Jeong-Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, South Korea. jysuh@snu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biomedical Sciences, Shinshu University, Minamiminowa, Nagano, 399-4598, Japan. jysuh@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Apr 8;332(6026):234-8</RefSource><PMID Version="1">21474759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol NMR. 1995 Nov;6(3):277-93</RefSource><PMID Version="1">8520220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1987 Aug 5;196(3):611-39</RefSource><PMID Version="1">2445992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1986 Oct;5(10):2729-35</RefSource><PMID Version="1">16453716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 May 21;58(4):568-74</RefSource><PMID Version="1">26000842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2017 Jul 12;3(7):e1701620</RefSource><PMID Version="1">28706995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jan 17;493(7432):429-32</RefSource><PMID Version="1">23242138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5958-63</RefSource><PMID Version="1">15831591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2013 Oct;11(10):675-87</RefSource><PMID Version="1">23979432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol NMR. 1994 Sep;4(5):727-34</RefSource><PMID Version="1">7919956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Magn Reson. 2011 Dec;213(2):357-63</RefSource><PMID Version="1">22152355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Feb 25;280(8):7088-99</RefSource><PMID Version="1">15591056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Jun 15;546(7658):436-439</RefSource><PMID Version="1">28448066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol NMR. 1994 Sep;4(5):603-14</RefSource><PMID Version="1">22911360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jan 12;168(1-2):150-158.e10</RefSource><PMID Version="1">28041849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Mar 23;169(1):47-57.e11</RefSource><PMID Version="1">28340349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Jun 26;348(6242):1477-81</RefSource><PMID Version="1">26113724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol NMR. 2009 Aug;44(4):213-23</RefSource><PMID Version="1">19548092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Magn Reson B. 1995 Jan;106(1):92-6</RefSource><PMID Version="1">7850178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Magn Reson. 1998 Mar;131(1):159-62</RefSource><PMID Version="1">9533920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Dec 15;167(7):1829-1838.e9</RefSource><PMID Version="1">27984730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Magn Reson B. 1994 Jul;104(3):266-75</RefSource><PMID Version="1">8069484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Jul 6;67(1):117-127.e5</RefSource><PMID Version="1">28602637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Jul 16;305(5682):386-9</RefSource><PMID Version="1">15256668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2017 Jun;37:67-78</RefSource><PMID Version="1">28605718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Magn Reson. 2001 Apr;149(2):239-44</RefSource><PMID Version="1">11318623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol NMR. 1996 Oct;8(3):273-84</RefSource><PMID Version="1">8953218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Eng. 1988 Apr;2(1):27-38</RefSource><PMID Version="1">2855369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Microbiol. 2015;69:209-28</RefSource><PMID Version="1">26209264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Q Rev Biophys. 2016;49:e6</RefSource><PMID Version="1">27088887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 14;164(1-2):29-44</RefSource><PMID Version="1">26771484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2001;339:127-74</RefSource><PMID Version="1">11462810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Mar 14;343(6176):1247997</RefSource><PMID Version="1">24505130</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29497118</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-22177-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-22177-0</ArticleId><ArticleId IdType="pmc">PMC5832863</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29496966</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-4586</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Molecular biology of the cell</Title><ISOAbbreviation>Mol. Biol. Cell</ISOAbbreviation></Journal><ArticleTitle>C3G dynamically associates with nuclear speckles and regulates mRNA splicing.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">mbc.E17-07-0442</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1091/mbc.E17-07-0442</ELocationID><Abstract><AbstractText>C3G (RapGEF1), essential for mammalian embryonic development, is ubiquitously expressed and undergoes regulated nucleo-cytoplasmic exchange. Here we show that C3G localizes to SC35 positive nuclear speckles, and regulates splicing activity. Reversible association of C3G with speckles was seen upon inhibition of transcription and splicing. C3G shows partial colocalization with SC35, and is recruited to a chromatin and RNase sensitive fraction of speckles. Its presence in speckles is dependent on intact cellular actin cytoskeleton, and is lost upon expression of the kinase, Clk1. Rap1, a substrate of C3G, is also present in nuclear speckles and inactivation of Rap signalling by expression of GFP-Rap1GAP, alters speckle morphology and number. Enhanced association of C3G with speckles is seen upon GSK3β inhibition, or differentiation of C2C12 cells to myotubes. CRISPR/Cas9 mediated knockdown of C3G resulted in altered splicing activity of an artificial gene as well as endogenous CD44. C3G knockout clones of C2C12 as well as MDA-MB-231 showed reduced protein levels of several splicing factors compared to control cells. Our results identify C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing activity.</AbstractText><CopyrightInformation>© 2018 by The American Society for Cell Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shakyawar</LastName><ForeName>Dhruv Kumar</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad - 500 007, INDIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muralikrishna</LastName><ForeName>Bhattiprolu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad - 500 007, INDIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radha</LastName><ForeName>Vegesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad - 500 007, INDIA vradha@ccmb.res.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Biol Cell</MedlineTA><NlmUniqueID>9201390</NlmUniqueID><ISSNLinking>1059-1524</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29496966</ArticleId><ArticleId IdType="pii">mbc.E17-07-0442</ArticleId><ArticleId IdType="doi">10.1091/mbc.E17-07-0442</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29496706</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5336</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Applied and environmental microbiology</Title><ISOAbbreviation>Appl. Environ. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Erratum for Song et al., "CRISPR-Cas9<sup>D10A</sup>Nickase-Assisted Genome Editing in Lactobacillus casei".</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00146-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/AEM.00146-18</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Medical Instrument and Food Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Medical Instrument and Food Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ai</LastName><ForeName>Lianzhong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Medical Instrument and Food Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu National Synergetic Innovation Center for Advanced Materials, SICAM, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Research and Development Center of Industrial Biotechnology, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Appl Environ Microbiol</MedlineTA><NlmUniqueID>7605801</NlmUniqueID><ISSNLinking>0099-2240</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Appl Environ Microbiol. 2017 Oct 31;83(22):</RefSource><PMID Version="1">28864652</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29496706</ArticleId><ArticleId IdType="pii">84/6/e00146-18</ArticleId><ArticleId IdType="doi">10.1128/AEM.00146-18</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29496558</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0038</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Gene</Title><ISOAbbreviation>Gene</ISOAbbreviation></Journal><ArticleTitle>Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0378-1119(18)30214-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gene.2018.02.066</ELocationID><Abstract><AbstractText>Molecular diagnostics is of critical importance to public health worldwide. It facilitates not only detection and characterization of diseases, but also monitors drug responses, assists in the identification of genetic modifiers and disease susceptibility. Based upon DNA variation, a wide range of molecular-based tests are available to assess/diagnose diseases. The CRISPR-Cas9 system has recently emerged as a versatile tool for biological and medical research. In this system, a single guide RNA (sgRNA) directs the endonuclease Cas9 to a targeted DNA sequence for site-specific manipulation. As designing CRISPR-guided nucleases can be done easily and relatively fast, the CRISPR/Cas9 system has evolved as widely used DNA editing tool. This technique led to a large number of gene editing studies in variety of organisms. CRISPR/Cas9-mediated diagnosis and therapy has picked up pace due to specificity and accuracy of CRISPR. The aim is not only to identify specific pathogens, especially virus but also to repair disease-causing alleles by changing the DNA sequence at the exact location on the chromosome. At present, PCR-based molecular diagnostic testing predominates; however, alternative technologies aimed at reducing genome complexity without PCR are anticipated to gain momentum in the coming years. Furthermore, development of integrated chip devices should allow point-of-care testing and facilitate genetic readouts from single cells and molecules. Together with molecular based therapy CRISPR based diagnostic testing will be a revolution in modern health care settings. In this review, we emphasize on current developing diagnostic techniques based upon CRISPR Cas approach along with short insights on its therapeutic usage.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uppada</LastName><ForeName>Vanita</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Animal Biology, University of Hyderabad, Hyderabad 500046, Telangana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gokara</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Hyderabad, Hyderabad 500046, Telangana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasineni</LastName><ForeName>Girish Kumar</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Sandor Life Sciences Pvt. Ltd., Banjara Hills, Hyderabad 500 034, Telangana, India. Electronic address: girishkumar@sandor.co.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Gene</MedlineTA><NlmUniqueID>7706761</NlmUniqueID><ISSNLinking>0378-1119</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">Diagnostic tools</Keyword><Keyword MajorTopicYN="N">Therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29496558</ArticleId><ArticleId IdType="pii">S0378-1119(18)30214-2</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2018.02.066</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29494622</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>AHR2 required for normal behavioral responses and proper development of the skeletal and reproductive systems in zebrafish.</ArticleTitle><Pagination><MedlinePgn>e0193484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193484</ELocationID><Abstract><AbstractText>The aryl hydrocarbon receptor (AHR) is a conserved ligand-activated transcription factor required for proper vertebrate development and homeostasis. The inappropriate activation of AHR by ubiquitous pollutants can lead to adverse effects on wildlife and human health. The zebrafish is a powerful model system that provides a vertebrate data stream that anchors hypothesis at the genetic and cellular levels to observations at the morphological and behavioral level, in a high-throughput format. In order to investigate the endogenous functions of AHR, we generated an AHR2 (homolog of human AHR)-null zebrafish line (ahr2osu1) using the clustered, regulatory interspaced, short palindromic repeats (CRISPR)-Cas9 precision genome editing method. In zebrafish, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) mediated toxicity requires AHR2. The AHR2-null line was resistant to TCDD-induced toxicity, indicating the line can be used to investigate the biological and toxicological functions of AHR2. The AHR2-null zebrafish exhibited decreased survival and fecundity compared to the wild type line. At 36 weeks, histological evaluations of the AHR2-null ovaries revealed a reduction of mature follicles when compared to wild type ovaries, suggesting AHR2 regulates follicle growth in zebrafish. AHR2-null adults had malformed cranial skeletal bones and severely damaged fins. Our data suggests AHR2 regulates some aspect(s) of neuromuscular and/or sensory system development, with impaired behavioral responses observed in larval and adult AHR2-null zebrafish. This study increases our understanding of the endogenous functions of AHR, which may help foster a better understanding of the target organs and molecular mechanisms involved in AHR-mediated toxicities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Gloria R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Environmental &amp; Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bugel</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Environmental &amp; Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Environmental &amp; Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spagnoli</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanguay</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6190-3682</Identifier><AffiliationInfo><Affiliation>Department of Environmental &amp; Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29494622</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193484</ArticleId><ArticleId IdType="pii">PONE-D-17-43764</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29494564</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2073-4425</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Translational Advances of Hydrofection by Hydrodynamic Injection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes9030136</ELocationID><Abstract><AbstractText>Hydrodynamic gene delivery has proven to be a safe and efficient procedure for gene transfer, able to mediate, in murine model, therapeutic levels of proteins encoded by the transfected gene. In different disease models and targeting distinct organs, it has been demonstrated to revert the pathologic symptoms and signs. The therapeutic potential of hydrofection led different groups to work on the clinical translation of the procedure. In order to prevent the hemodynamic side effects derived from the rapid injection of a large volume, the conditions had to be moderated to make them compatible with its use in mid-size animal models such as rat, hamster and rabbit and large animals as dog, pig and primates. Despite the different approaches performed to adapt the conditions of gene delivery, the results obtained in any of these mid-size and large animals have been poorer than those obtained in murine model. Among these different strategies to reduce the volume employed, the most effective one has been to exclude the vasculature of the target organ and inject the solution directly. This procedure has permitted, by catheterization and surgical procedures in large animals, achieving protein expression levels in tissue close to those achieved in gold standard models. These promising results and the possibility of employing these strategies to transfer gene constructs able to edit genes, such as CRISPR, have renewed the clinical interest of this procedure of gene transfer. In order to translate the hydrodynamic gene delivery to human use, it is demanding the standardization of the procedure conditions and the molecular parameters of evaluation in order to be able to compare the results and establish a homogeneous manner of expressing the data obtained, as 'classic' drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sendra</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3176-9763</Identifier><AffiliationInfo><Affiliation>Pharmacology Department, Faculty of Medicine, Universidad Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. luis.sendra@uv.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacogenetics Unit, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, 46026 Valencia, Spain. luis.sendra@uv.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>María José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Faculty of Medicine, Universidad Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. maria.jose.herrero@uv.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacogenetics Unit, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, 46026 Valencia, Spain. maria.jose.herrero@uv.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aliño</LastName><ForeName>Salvador F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Faculty of Medicine, Universidad Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. alino@uv.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacogenetics Unit, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, 46026 Valencia, Spain. alino@uv.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology Unit, Área Clínica del Medicamento, Hospital La Fe, Av. Fernando Abril Martorell 106, 46026 Valencia, Spain. alino@uv.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">hydrodynamic</Keyword><Keyword MajorTopicYN="N">non-viral</Keyword><Keyword MajorTopicYN="N">translational</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29494564</ArticleId><ArticleId IdType="pii">genes9030136</ArticleId><ArticleId IdType="doi">10.3390/genes9030136</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29492697</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2048</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Planta</Title><ISOAbbreviation>Planta</ISOAbbreviation></Journal><ArticleTitle>Gene editing by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00425-018-2866-1</ELocationID><Abstract><AbstractText Label="MAIN CONCLUSION" NlmCategory="UNASSIGNED">The CRISPR/Cas9 technique was successfully used to edit the genome of the obligatory outcrossing plant species Medicago sativa L. (alfalfa). RNA-guided genome engineering using Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR)/Cas9 technology enables a variety of applications in plants. Successful application and validation of the CRISPR technique in a multiplex genome, such as that of M. sativa (alfalfa) will ultimately lead to major advances in the improvement of this crop. We used CRISPR/Cas9 technique to mutate squamosa promoter binding protein like 9 (SPL9) gene in alfalfa. Because of the complex features of the alfalfa genome, we first used droplet digital PCR (ddPCR) for high-throughput screening of large populations of CRISPR-modified plants. Based on the results of genome editing rates obtained from the ddPCR screening, plants with relatively high rates were subjected to further analysis by restriction enzyme digestion/PCR amplification analyses. PCR products encompassing the respective small guided RNA target locus were then sub-cloned and sequenced to verify genome editing. In summary, we successfully applied the CRISPR/Cas9 technique to edit the SPL9 gene in a multiplex genome, providing some insights into opportunities to apply this technology in future alfalfa breeding. The overall efficiency in the polyploid alfalfa genome was lower compared to other less-complex plant genomes. Further refinement of the CRISPR technology system will thus be required for more efficient genome editing in this plant.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ruimin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feyissa</LastName><ForeName>Biruk A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croft</LastName><ForeName>Mana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hannoufa</LastName><ForeName>Abdelali</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0064-620X</Identifier><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, London, ON, Canada. Abdelali.Hannoufa@agr.gc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Western Ontario, London, ON, Canada. Abdelali.Hannoufa@agr.gc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>J-000260</GrantID><Agency>Agriculture and Agri-Food Canada</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Planta</MedlineTA><NlmUniqueID>1250576</NlmUniqueID><ISSNLinking>0032-0935</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alfalfa</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Droplet digital PCR (ddPCR)</Keyword><Keyword MajorTopicYN="N">Gene editing</Keyword><Keyword MajorTopicYN="N">Multiplex mutagenesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29492697</ArticleId><ArticleId IdType="doi">10.1007/s00425-018-2866-1</ArticleId><ArticleId IdType="pii">10.1007/s00425-018-2866-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29491424</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages.</ArticleTitle><Pagination><MedlinePgn>3788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-21998-3</ELocationID><Abstract><AbstractText>The NLRC4 inflammasome recognizes bacterial flagellin and components of the type III secretion apparatus. NLRC4 stimulation leads to caspase-1 activation followed by a rapid lytic cell death known as pyroptosis. NLRC4 is linked to pathogen-free auto-inflammatory diseases, suggesting a role for NLRC4 in sterile inflammation. Here, we show that NLRC4 activates an alternative cell death program morphologically similar to apoptosis in caspase-1-deficient BMDMs. By performing an unbiased genome-wide CRISPR/Cas9 screen with subsequent validation studies in gene-targeted mice, we highlight a critical role for caspase-8 and ASC adaptor in an alternative apoptotic pathway downstream of NLRC4. Furthermore, caspase-1 catalytically dead knock-in (Casp1 C284A KI) BMDMs genetically segregate pyroptosis and apoptosis, and confirm that caspase-1 does not functionally compete with ASC for NLRC4 interactions. We show that NLRC4/caspase-8-mediated apoptotic cells eventually undergo plasma cell membrane damage in vitro, suggesting that this pathway can lead to secondary necrosis. Unexpectedly, we found that DFNA5/GSDME, a member of the pore-forming gasdermin family, is dispensable for the secondary necrosis that follows NLRC4-mediated apoptosis in macrophages. Together, our data confirm the existence of an alternative caspase-8 activation pathway diverging from the NLRC4 inflammasome in primary macrophages.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bettina L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirrashidi</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stowe</LastName><ForeName>Irma B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kummerfeld</LastName><ForeName>Sarah K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haley</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuellar</LastName><ForeName>Trinna L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reichelt</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Genentech Inc., South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayagaki</LastName><ForeName>Nobuhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech Inc., South San Francisco, California, USA. kayagaki.nobuhiko@gene.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907</RefSource><PMID Version="1">15520809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Oct;46(10):1140-6</RefSource><PMID Version="1">25217959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Mar 21;343 (6177):1357-60</RefSource><PMID Version="1">24557836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2010 Aug 30;207(9):1807-17</RefSource><PMID Version="1">20805564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 11;516(7530):246-9</RefSource><PMID Version="1">25274309</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2006 Jun;7(6):576-82</RefSource><PMID Version="1">16648852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 May 22;157(5):1013-22</RefSource><PMID Version="1">24855941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2010 Dec;11(12):1136-42</RefSource><PMID Version="1">21057511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Oct 25;490(7421):539-42</RefSource><PMID Version="1">22885697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jul 06;535(7610):153-8</RefSource><PMID Version="1">27383986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Nov 15;191(10 ):5239-46</RefSource><PMID Version="1">24123685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7858-63</RefSource><PMID Version="1">27339137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2006 Jun;7(6):569-75</RefSource><PMID Version="1">16648853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Jul 6;547(7661):99-103</RefSource><PMID Version="1">28459430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Dec 26;21(13):3846-3859</RefSource><PMID Version="1">29281832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2013 Mar 28;49(6):1034-48</RefSource><PMID Version="1">23434371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Jul 24;454(7203):428-35</RefSource><PMID Version="1">18650913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2017 Apr 18;46(4):649-659</RefSource><PMID Version="1">28410991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Mar 19;140(6):805-20</RefSource><PMID Version="1">20303872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 1999;15:269-90</RefSource><PMID Version="1">10611963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1997 Feb 7;88(3):355-65</RefSource><PMID Version="1">9039262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2007 Nov 15;179(10):6933-42</RefSource><PMID Version="1">17982084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 17;471(7338):368-72</RefSource><PMID Version="1">21368762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Aug 28;477(7366):592-5</RefSource><PMID Version="1">21874021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Oct 29;526(7575):666-71</RefSource><PMID Version="1">26375259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2001 Aug;21(16):5299-305</RefSource><PMID Version="1">11463813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2006 Apr;3(4):287-93</RefSource><PMID Version="1">16554834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2016 Aug 15;35(16):1766-78</RefSource><PMID Version="1">27418190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 1998 Mar;8(3):107-11</RefSource><PMID Version="1">9695819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2009 Feb;7(2):99-109</RefSource><PMID Version="1">19148178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2010 Dec 16;8(6):471-83</RefSource><PMID Version="1">21147462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 17;471(7338):363-7</RefSource><PMID Version="1">21368763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2010 Mar 15;427(1):91-104</RefSource><PMID Version="1">20085538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 1999 Nov;6(11):1117-24</RefSource><PMID Version="1">10578181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Jan 03;8:14128</RefSource><PMID Version="1">28045099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Transl Immunology. 2017 Jan 06;6(1):e124</RefSource><PMID Version="1">28197335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4050-5</RefSource><PMID Version="1">25775556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Dec 19;21(12 ):3427-3444</RefSource><PMID Version="1">29262324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Oct;46(10 ):1135-1139</RefSource><PMID Version="1">25217960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jul 7;535(7610):111-6</RefSource><PMID Version="1">27281216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Sep 13;341(6151):1246-9</RefSource><PMID Version="1">23887873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Jul 12;341(6142):172-5</RefSource><PMID Version="1">23765277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Dec 4;290(49):29217-30</RefSource><PMID Version="1">26468282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2017 May 1;214(5):1351-1370</RefSource><PMID Version="1">28404595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2017 Aug 3;13(8):e1006502</RefSource><PMID Version="1">28771586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Oct 23;350(6259):404-9</RefSource><PMID Version="1">26449474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Apoptosis. 2008 Apr;13(4):463-82</RefSource><PMID Version="1">18322800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Oct 29;526(7575):660-5</RefSource><PMID Version="1">26375003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Chem Biol. 2017 Apr 20;24(4):507-514.e4</RefSource><PMID Version="1">28392147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Oct 16;479(7371):117-21</RefSource><PMID Version="1">22002608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2001 Mar;9(3):113-4</RefSource><PMID Version="1">11303500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Sep 14;477(7366):596-600</RefSource><PMID Version="1">21918512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2008 Oct;9(10):1171-8</RefSource><PMID Version="1">18724372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Immunol. 2014 Feb;26:147-56</RefSource><PMID Version="1">24556412</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29491424</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-21998-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-21998-3</ArticleId><ArticleId IdType="pmc">PMC5830643</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29491135</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1549-5477</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3-4</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Genes &amp; development</Title><ISOAbbreviation>Genes Dev.</ISOAbbreviation></Journal><ArticleTitle>Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation.</ArticleTitle><Pagination><MedlinePgn>202-223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1101/gad.310367.117</ELocationID><Abstract><AbstractText>Enhancers are important genomic regulatory elements directing cell type-specific transcription. They assume a key role during development and disease, and their identification and functional characterization have long been the focus of scientific interest. The advent of next-generation sequencing and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based genome editing has revolutionized the means by which we study enhancer biology. In this review, we cover recent developments in the prediction of enhancers based on chromatin characteristics and their identification by functional reporter assays and endogenous DNA perturbations. We discuss that the two latter approaches provide different and complementary insights, especially in assessing enhancer sufficiency and necessity for transcription activation. Furthermore, we discuss recent insights into mechanistic aspects of enhancer function, including findings about cofactor requirements and the role of post-translational histone modifications such as monomethylation of histone H3 Lys4 (H3K4me1). Finally, we survey how these approaches advance our understanding of transcription regulation with respect to promoter specificity and transcriptional bursting and provide an outlook covering open questions and promising developments.</AbstractText><CopyrightInformation>© 2018 Catarino and Stark; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catarino</LastName><ForeName>Rui R</ForeName><Initials>RR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0400-7843</Identifier><AffiliationInfo><Affiliation>Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genes Dev</MedlineTA><NlmUniqueID>8711660</NlmUniqueID><ISSNLinking>0890-9369</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enhancer prediction</Keyword><Keyword MajorTopicYN="N">enhancers</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">genetic screens</Keyword><Keyword MajorTopicYN="N">reporter assays</Keyword><Keyword MajorTopicYN="N">transcription regulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29491135</ArticleId><ArticleId IdType="pii">32/3-4/202</ArticleId><ArticleId IdType="doi">10.1101/gad.310367.117</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29490999</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-8561</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical chemistry</Title><ISOAbbreviation>Clin. Chem.</ISOAbbreviation></Journal><ArticleTitle>Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.</ArticleTitle><Pagination><MedlinePgn>489-491</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1373/clinchem.2017.278317</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baylis</LastName><ForeName>Françoise</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Novel Tech Ethics, Dalhousie University, Halifax, Canada. francoise.baylis@dal.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Chem</MedlineTA><NlmUniqueID>9421549</NlmUniqueID><ISSNLinking>0009-9147</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29490999</ArticleId><ArticleId IdType="pii">clinchem.2017.278317</ArticleId><ArticleId IdType="doi">10.1373/clinchem.2017.278317</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29490686</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1474-760X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Genome biology</Title><ISOAbbreviation>Genome Biol.</ISOAbbreviation></Journal><ArticleTitle>Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology.</ArticleTitle><Pagination><MedlinePgn>27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13059-018-1409-1</ELocationID><Abstract><AbstractText>The generation of genetically modified alleles in mice using conventional transgenesis technologies is a long and inefficient process. A new study shows that the in situ delivery of CRISPR/Cas9 reagents into pregnant mice results in a high efficiency of editing, and enables the rapid generation of both simple and complex alleles.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burgio</LastName><ForeName>Gaetan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia. Gaetan.burgio@anu.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genome Biol</MedlineTA><NlmUniqueID>100960660</NlmUniqueID><ISSNLinking>1474-7596</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 May 17;18(1):92</RefSource><PMID Version="1">28511701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2018 Feb 26;19(1):25</RefSource><PMID Version="1">29482575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1987 Nov 6;51(3):503-12</RefSource><PMID Version="1">2822260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1370-9</RefSource><PMID Version="1">23992847</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29490686</ArticleId><ArticleId IdType="doi">10.1186/s13059-018-1409-1</ArticleId><ArticleId IdType="pii">10.1186/s13059-018-1409-1</ArticleId><ArticleId IdType="pmc">PMC5831610</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29490266</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Nap1l1 Controls Embryonic Neural Progenitor Cell Proliferation and Differentiation in the Developing Brain.</ArticleTitle><Pagination><MedlinePgn>2279-2293</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(18)30187-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2018.02.019</ELocationID><Abstract><AbstractText>The precise function and role of nucleosome assembly protein 1-like 1 (Nap1l1) in brain development are unclear. Here, we find that Nap1l1 knockdown decreases neural progenitor cell (NPC) proliferation and induces premature neuronal differentiation during cortical development. A similar deficiency in embryonic neurogenesis was observed in Nap1l1 knockout (KO) mice, which were generated using the CRISPR-Cas9 system. RNA sequencing (RNA-seq) analysis indicates that Ras-associated domain family member 10 (RassF10) may be the downstream target of Nap1l1. Furthermore, we found that Nap1l1 regulates RassF10 expression by promoting SETD1A-mediated H3K4 trimethylation at the RassF10 promoter. Nap1l1 KO defects may be rescued by RassF10 overexpression, suggesting that Nap1l1 controls NPC differentiation through RassF10. Our findings reveal an essential role for the Nap1l1 histone chaperone in cortical neurogenesis during early embryonic brain development.</AbstractText><CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China; Sino-Danish College at University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duo</LastName><ForeName>Shuguang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: jifen@ioz.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: jwjiao@ioz.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H3K4me3</Keyword><Keyword MajorTopicYN="N">Nap1l1</Keyword><Keyword MajorTopicYN="N">RassF10</Keyword><Keyword MajorTopicYN="N">cortex development</Keyword><Keyword MajorTopicYN="N">gain of function</Keyword><Keyword MajorTopicYN="N">histone chaperone</Keyword><Keyword MajorTopicYN="N">loss of function</Keyword><Keyword MajorTopicYN="N">neural differentiation and proliferation</Keyword><Keyword MajorTopicYN="N">neural progenitor cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29490266</ArticleId><ArticleId IdType="pii">S2211-1247(18)30187-6</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.02.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29490262</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.</ArticleTitle><Pagination><MedlinePgn>2227-2235</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(18)30182-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2018.02.014</ELocationID><Abstract><AbstractText>The development of clinically viable delivery methods presents one of the greatest challenges in the therapeutic application of CRISPR/Cas9 mediated genome editing. Here, we report the development of a lipid nanoparticle (LNP)-mediated delivery system that, with a single administration, enabled significant editing of the mouse transthyretin (Ttr) gene in the liver, with a &gt;97% reduction in serum protein levels that persisted for at least 12 months. These results were achieved with an LNP delivery system that was biodegradable and well tolerated. The LNP delivery system was combined with a sgRNA having a chemical modification pattern that was important for high levels of in vivo activity. The formulation was similarly effective in a rat model. Our work demonstrates that this LNP system can deliver CRISPR/Cas9 components to achieve clinically relevant levels of in vivo genome editing with a concomitant reduction of TTR serum protein, highlighting the potential of this system as an effective genome editing platform.</AbstractText><CopyrightInformation>Copyright © 2018 Intellia Therapeutics, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Finn</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Amy Rhoden</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Mihir C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youniss</LastName><ForeName>Madeleine R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Heteren</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dirstine</LastName><ForeName>Tanner</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciullo</LastName><ForeName>Corey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lescarbeau</LastName><ForeName>Reynald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitzer</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ruchi R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Aalok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Growe</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pink</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohde</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Kristy M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomon</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>William F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dombrowski</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strapps</LastName><ForeName>Walter R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrissey</LastName><ForeName>David V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Intellia Therapeutics, Cambridge, MA 02139, USA. Electronic address: davidm@intelliatx.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">LNP</Keyword><Keyword MajorTopicYN="N">TTR</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">lipid nanoparticle</Keyword><Keyword MajorTopicYN="N">liver delivery</Keyword><Keyword MajorTopicYN="N">sgRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29490262</ArticleId><ArticleId IdType="pii">S2211-1247(18)30182-7</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.02.014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29489336</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2161-5063</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>ACS synthetic biology</Title><ISOAbbreviation>ACS Synth Biol</ISOAbbreviation></Journal><ArticleTitle>Rewiring Calcium Signaling for Precise Transcriptional Reprogramming.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acssynbio.7b00467</ELocationID><Abstract><AbstractText>Tools capable of modulating gene expression in living organisms are very useful for interrogating the gene regulatory network and controlling biological processes. The catalytically inactive CRISPR/Cas9 (dCas9), when fused with repressive or activating effectors, functions as a versatile platform to reprogram gene transcription at targeted genomic loci. However, without temporal control, the application of these reprogramming tools will likely cause off-target effects and lack strict reversibility. To overcome this limitation, we report herein the development of a chemical or light-inducible transcriptional reprogramming device that combines photoswitchable genetically encoded calcium actuators with dCas9 to control gene expression. By fusing an engineered Ca<sup>2+</sup>-responsive NFAT fragment with dCas9 and transcriptional coactivators, we harness the power of light to achieve photoinducible transcriptional reprogramming in mammalian cells. This synthetic system (designated CaRROT) can also be used to document calcium-dependent activity in mammals after exposure to ligands or chemicals that would elicit calcium response inside cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Nhung Thi</ForeName><Initials>NT</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Lian</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Martinez-Moczygemba</LastName><ForeName>Margarita</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yun</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yubin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7962-0517</Identifier></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM112003</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Synth Biol</MedlineTA><NlmUniqueID>101575075</NlmUniqueID><ISSNLinking>2161-5063</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">NFAT</Keyword><Keyword MajorTopicYN="N">calcium signaling</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">optogenetics</Keyword><Keyword MajorTopicYN="N">transcriptional reprogramming</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29489336</ArticleId><ArticleId IdType="doi">10.1021/acssynbio.7b00467</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29489018</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3350</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Hepatology (Baltimore, Md.)</Title><ISOAbbreviation>Hepatology</ISOAbbreviation></Journal><ArticleTitle>Use of the CRISPR/Cas9-Based Epigenetic Gene Activation System in Vivo: a New Potential Therapeutic Modality.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.29860</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Samar H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8470-8337</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Gastroenterology &amp; Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology &amp; Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Keith D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 DK111397</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK110024</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hepatology</MedlineTA><NlmUniqueID>8302946</NlmUniqueID><ISSNLinking>0270-9139</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">epigenetic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29489018</ArticleId><ArticleId IdType="doi">10.1002/hep.29860</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29488867</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-2080</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Microbiology (Reading, England)</Title><ISOAbbreviation>Microbiology (Reading, Engl.)</ISOAbbreviation></Journal><ArticleTitle>Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1099/mic.0.000635</ELocationID><Abstract><AbstractText>Given the widespread use and application of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas gene editing system across many fields, a major focus has been the development, engineering and discovery of molecular means to precisely control and regulate the enzymatic function of the Cas9 nuclease. To date, a variety of Cas9 variants and fusion assemblies have been proposed to provide temporally inducible and spatially controlled editing functions. The discovery of a new class of 'anti-CRISPR' proteins, evolved from bacteriophage in response to the prokaryotic nuclease-based immune system, provides a new platform for control over genomic editing. One Cas9-based application of interest to the field of population control is that of the 'gene drive'. Here, we demonstrate use of the AcrIIA2 and AcrIIA4 proteins to inhibit active gene drive systems in budding yeast. Furthermore, an unbiased mutational scan reveals that titration of Cas9 inhibition may be possible by modification of the anti-CRISPR primary sequence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basgall</LastName><ForeName>Erianna M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetting</LastName><ForeName>Samantha C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goeckel</LastName><ForeName>Megan E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giersch</LastName><ForeName>Rachael M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>2​Department of Biology, 116 Ackert Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roggenkamp</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrock</LastName><ForeName>Madison N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halloran</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finnigan</LastName><ForeName>Gregory C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>1​Department of Biochemistry and Molecular Biophysics, 141 Chalmers Hall, Kansas State University, Manhattan, KS 66506, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microbiology</MedlineTA><NlmUniqueID>9430468</NlmUniqueID><ISSNLinking>1350-0872</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29488867</ArticleId><ArticleId IdType="doi">10.1099/mic.0.000635</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29487145</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1943-2631</ISSN><JournalIssue CitedMedium="Internet"><Volume>208</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Genetics</Title><ISOAbbreviation>Genetics</ISOAbbreviation></Journal><ArticleTitle>RNA Interference (RNAi) Screening in<i>Drosophila</i>.</ArticleTitle><Pagination><MedlinePgn>853-874</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1534/genetics.117.300077</ELocationID><Abstract><AbstractText>In the last decade, RNA interference (RNAi), a cellular mechanism that uses RNA-guided degradation of messenger RNA transcripts, has had an important impact on identifying and characterizing gene function. First discovered in<i>Caenorhabditis elegans</i>, RNAi can be used to silence the expression of genes through introduction of exogenous double-stranded RNA into cells. In<i>Drosophila</i>, RNAi has been applied in cultured cells or<i>in vivo</i>to perturb the function of single genes or to systematically probe gene function on a genome-wide scale. In this review, we will describe the use of RNAi to study gene function in<i>Drosophila</i>with a particular focus on high-throughput screening methods applied in cultured cells. We will discuss available reagent libraries and cell lines, methodological approaches for cell-based assays, and computational methods for the analysis of high-throughput screens. Furthermore, we will review the generation and use of genome-scale RNAi libraries for tissue-specific knockdown analysis<i>in vivo</i>and discuss the differences and similarities with the use of genome-engineering methods such as CRISPR/Cas9 for functional analysis.</AbstractText><CopyrightInformation>Copyright © 2018 Heigwer et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heigwer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8230-1485</Identifier><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center, and Department of Cell and Molecular Biology, Heidelberg University, Medical Faculty Mannheim, D-69120, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Port</LastName><ForeName>Fillip</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5157-4835</Identifier><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center, and Department of Cell and Molecular Biology, Heidelberg University, Medical Faculty Mannheim, D-69120, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutros</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9458-817X</Identifier><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center, and Department of Cell and Molecular Biology, Heidelberg University, Medical Faculty Mannheim, D-69120, Germany m.boutros@dkfz.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genetics</MedlineTA><NlmUniqueID>0374636</NlmUniqueID><ISSNLinking>0016-6731</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">FlyBook</Keyword><Keyword MajorTopicYN="N">RNAi</Keyword><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">functional genomics</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">high-throughput screening</Keyword><Keyword MajorTopicYN="N">image-based screening</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29487145</ArticleId><ArticleId IdType="pii">genetics.117.300077</ArticleId><ArticleId IdType="doi">10.1534/genetics.117.300077</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29486366</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1567-7257</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title><ISOAbbreviation>Infect. Genet. Evol.</ISOAbbreviation></Journal><ArticleTitle>Mini-review on CRISPR-Cas9 and its potential applications to help controlling neglected tropical diseases caused by Trypanosomatidae.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1567-1348(18)30075-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2018.02.030</ELocationID><Abstract><AbstractText>The CRISPR-Cas system, which was originally identified as a prokaryotic defense mechanism, is increasingly being used for the functional study of genes. This technology, which is simple, inexpensive and efficient, has aroused a lot of enthusiasm in the scientific community since its discovery, and every month many publications emanate from very different communities reporting on the use of CRISPR-Cas9. Currently, there are no vaccines to control neglected tropical diseases (NTDs) caused by Trypanosomatidae, particularly Human African Trypanosomiasis (HAT) and Animal African Trypanosomoses (AAT), and treatments are cumbersome and sometimes not effective enough. CRISPR-Cas9 has the potential to functionally analyze new target molecules that could be used for therapeutic and vaccine purposes. In this review, after briefly describing CRIPSR-Cas9 history and how it works, different applications on diseases, especially on parasitic diseases, are reviewed. We then focus the review on the use of CRISPR-Cas9 editing on Trypanosomatidae parasites, the causative agents of NTDs, which are still a terrible burden for human populations in tropical regions, and their vectors.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Minet</LastName><ForeName>Cécile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CIRAD, UMR INTERTRYP, F-34398 Montpellier, France; INTERTRYP, Univ Montpellier, CIRAD, IRD, Montpellier, France. Electronic address: cecile.minet@cirad.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thevenon</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CIRAD, UMR INTERTRYP, F-34398 Montpellier, France; INTERTRYP, Univ Montpellier, CIRAD, IRD, Montpellier, France. Electronic address: sophie.thevenon@cirad.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chantal</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>CIRAD, UMR INTERTRYP, F-34398 Montpellier, France; INTERTRYP, Univ Montpellier, CIRAD, IRD, Montpellier, France. Electronic address: isabelle.chantal@cirad.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solano</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRD, UMR INTERTRYP IRD, CIRAD, University of Montpellier, F-34398 Montpellier, France. Electronic address: philippe.solano@ird.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berthier</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CIRAD, UMR INTERTRYP, F-34398 Montpellier, France; INTERTRYP, Univ Montpellier, CIRAD, IRD, Montpellier, France. Electronic address: david.berthier@cirad.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Infect Genet Evol</MedlineTA><NlmUniqueID>101084138</NlmUniqueID><ISSNLinking>1567-1348</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Neglected tropical diseases</Keyword><Keyword MajorTopicYN="N">Parasites</Keyword><Keyword MajorTopicYN="N">Trypanosomatidae</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29486366</ArticleId><ArticleId IdType="pii">S1567-1348(18)30075-3</ArticleId><ArticleId IdType="doi">10.1016/j.meegid.2018.02.030</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29486239</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9130</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Methods (San Diego, Calif.)</Title><ISOAbbreviation>Methods</ISOAbbreviation></Journal><ArticleTitle>A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1046-2023(17)30339-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymeth.2018.02.016</ELocationID><Abstract><AbstractText>The RNA-guided nucleases derived from the CRISPR-Cas systems in bacteria and archaea have found numerous applications in biotechnology, including genome editing, imaging, and gene regulation. However, the discovery of novel Cas nucleases has outpaced their characterization and subsequent exploitation. A key step in characterizing Cas nucleases is determining which protospacer-adjacent motif (PAM) sequences they recognize. Here, we report advances to an in vitro method based on an E. coli cell-free transcription-translation system (TXTL) to rapidly elucidate PAMs recognized by Cas nucleases. The method obviates the need for cloning Cas nucleases or gRNAs, does not require the purification of protein or RNA, and can be performed in less than a day. To advance our previously published method, we incorporated an internal GFP cleavage control to assess the extent of library cleavage as well as Sanger sequencing of the cleaved library to assess PAM depletion prior to next-generation sequencing. We also detail the methods needed to construct all relevant DNA constructs, and how to troubleshoot the assay. We finally demonstrate the technique by determining PAM sequences recognized by the Neisseria meningitidis Cas9, revealing subtle sequence requirements of this highly specific PAM. The overall method offers a rapid means to identify PAMs recognized by diverse CRISPR nucleases, with the potential to greatly accelerate our ability to characterize and harness novel CRISPR nucleases across their many uses.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Colin S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Physics and Astronomy, University of Minnesota, Minneapolis, MN, 55455, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noireaux</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Physics and Astronomy, University of Minnesota, Minneapolis, MN, 55455, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beisel</LastName><ForeName>Chase L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, United States; Helmholtz Institute for RNA-based Infection Research (HIRI), Josef-Schneider-Str. 2 / D15, D-97080 Würzburg, Germany. Electronic address: cbeisel@ncsu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods</MedlineTA><NlmUniqueID>9426302</NlmUniqueID><ISSNLinking>1046-2023</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cas12a</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">PAM</Keyword><Keyword MajorTopicYN="N">TXTL</Keyword><Keyword MajorTopicYN="N">crRNA</Keyword><Keyword MajorTopicYN="N">sgRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29486239</ArticleId><ArticleId IdType="pii">S1046-2023(17)30339-0</ArticleId><ArticleId IdType="doi">10.1016/j.ymeth.2018.02.016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29486117</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2161-5063</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>ACS synthetic biology</Title><ISOAbbreviation>ACS Synth Biol</ISOAbbreviation></Journal><ArticleTitle>Highly Effective and Low-Cost MicroRNA Detection with CRISPR-Cas9.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acssynbio.7b00446</ELocationID><Abstract><AbstractText>MicroRNAs have been reported as related to multiple diseases and have potential applications in diagnosis and therapeutics. However, detection of miRNAs remains improvable, given their complexity, high cost, and low sensitivity as of currently. In this study, we attempt to build a novel platform that detects miRNAs at low cost and high efficacy. This detection system contains isothermal amplification, detecting and reporting process based on rolling circle amplification, CRISPR-Cas9, and split-horseradish peroxidase techniques. It is able to detect trace amount of miRNAs from samples with mere single-base specificity. Moreover, we demonstrated that such scheme can effectively detect target miRNAs in clinical serum samples and significantly distinguish patients of non-small cell lung cancer from healthy volunteers by detecting the previously reported biomarker: circulating let-7a. As the first to use CRISPR-Cas9 in miRNA detection, this method is a promising approach capable of being applied in screening, diagnosing, and prognosticating of multiple diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xin-Yuan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lv-Yun</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chu-Shu</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jia-Xin</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oncology , The Second Xiangya Hospital of Central South University , Changsha , Hunan 410012 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiao-Min</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Si-Si</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>De-An</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory , Hospital of National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dong-Yi</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lingyun</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0420-4508</Identifier><AffiliationInfo><Affiliation>Department of Biology and Chemistry, College of Liberal Arts and Sciences , National University of Defense Technology , Changsha , Hunan 410073 , People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Synth Biol</MedlineTA><NlmUniqueID>101575075</NlmUniqueID><ISSNLinking>2161-5063</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-dCas9</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">miRNA detection</Keyword><Keyword MajorTopicYN="N">rolling circle amplification</Keyword><Keyword MajorTopicYN="N">split reporter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29486117</ArticleId><ArticleId IdType="doi">10.1021/acssynbio.7b00446</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29485996</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Characterization of knockin mice at the Rosa26, Tac1 and Plekhg1 loci generated by homologous recombination in oocytes.</ArticleTitle><Pagination><MedlinePgn>e0193129</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193129</ELocationID><Abstract><AbstractText>Design and engineering of complex knockin mice has revolutionized the in vivo manipulation of genetically defined cells. Recently development of the bacterial clustered regularly interspersed short palindromic repeats (CRISPR) associated protein 9 (Cas9) system for single site cleavage of mammalian genomes has opened the way for rapid generation of knockin mice by targeting homology directed repair to selected cleavage sites. We used this approach to generate new lines of mice that will be useful for a variety of aspects of neuroscience research. These lines have been bred to homozygosity and details of the expression and function of the transgenes are reported. Two lines target the Rosa26-locus and have been engineered to allow Cre-dependent expression of the avian tva receptor, and Cre-dependent expression of a cell surface targeted spaghetti-monster carrying many copies of the "ollas-tag". Another line expresses red fluorescent protein and tva in Tac1-positive neurons; the fourth line targets FlpO expression to Plekhg1 expressing neurons, providing a powerful approach to modify gene expression in thalamic excitatory neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Youmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>María José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>Lauren S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryba</LastName><ForeName>Nicholas J P</ForeName><Initials>NJP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2060-8393</Identifier><AffiliationInfo><Affiliation>National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickel</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29485996</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193129</ArticleId><ArticleId IdType="pii">PONE-D-17-36594</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29483943</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1757-4749</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Gut pathogens</Title><ISOAbbreviation>Gut Pathog</ISOAbbreviation></Journal><ArticleTitle>Complete genome sequence of<i>Lactobacillus rhamnosus</i>Pen, a probiotic component of a medicine used in prevention of antibiotic-associated diarrhoea in children.</ArticleTitle><Pagination><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13099-018-0235-z</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED"><i>Lactobacillus rhamnosus</i>
Pen is a human endogenous strain with well-documented health promoting properties that is used for production of probiotics. It has a long safety history of application, and its effectiveness in the prevention of antibiotic-associated diarrhoea has also been confirmed in clinical trials.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">Here we present the complete genome sequence of<i>L. rhamnosus</i>Pen, which consists of a circular 2,884,4966-bp chromosome with a GC content of 46.8%. Within 2907 open reading frames (ORFs), genes involved with probiotic properties were identified. A CRISPR locus, consisting of a 1092-nt region with 16 spacers, was also detected. Finally, an intact prophage of ~ 40.7 kb, 57 ORFs, GC content 44.8% was identified.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Genomic analysis confirmed the probiotic properties of<i>L. rhamnosus</i>Pen and may indicate new biotechnological applications of this industrially important strain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jarocki</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0714-4512</Identifier><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podleśny</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Process and Development Department, Grupa Azoty Zakłady Azotowe "Puławy" S.A, Al. Tysiąclecia Państwa Polskiego 13, 24-110 Puławy, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krawczyk</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3Genomed SA, Ponczowa 12, 02-971 Warsaw, Poland.</Affiliation><Identifier Source="GRID">grid.460352.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glibowska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawelec</LastName><ForeName>Jarosław</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>4Laboratory of Electron Microscopy, Department of Comparative Anatomy and Anthropology, Maria Curie-Skłodowska University, 19 Akademicka St., 20-033 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0004 1937 1303</Identifier><Identifier Source="GRID">grid.29328.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komoń-Janczara</LastName><ForeName>Elwira</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kholiavskyi</LastName><ForeName>Oleksandr</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dworniczak</LastName><ForeName>Michał</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Targoński</LastName><ForeName>Zdzisław</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 8 Skromna St., 20-704 Lublin, Poland.</Affiliation><Identifier Source="ISNI">0000 0000 8816 7059</Identifier><Identifier Source="GRID">grid.411201.7</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gut Pathog</MedlineTA><NlmUniqueID>101474263</NlmUniqueID><ISSNLinking>1757-4749</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Microbiol Res. 2017 Dec;205:88-98</RefSource><PMID Version="1">28942850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W54-7</RefSource><PMID Version="1">27174935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aliment Pharmacol Ther. 2008 Jul;28(1):154-61</RefSource><PMID Version="1">18410562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Biotechnol. 2010 Mar;20(3):558-62</RefSource><PMID Version="1">20372027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2007 Jun 18;8:209</RefSource><PMID Version="1">17577412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2010;1:147</RefSource><PMID Version="1">21266997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21</RefSource><PMID Version="1">27141966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 May 11;12 (5):e0176739</RefSource><PMID Version="1">28493885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2012 Nov;67(11):2640-4</RefSource><PMID Version="1">22782487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2013 Jul 18;4:202</RefSource><PMID Version="1">23882264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Biotechnol. 2013 Mar;23(3):357-63</RefSource><PMID Version="1">23462009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2011 Aug 08;12:402</RefSource><PMID Version="1">21824423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(8):e1003683</RefSource><PMID Version="1">23966868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol Evol. 2016 Jul 02;8(6):1889-905</RefSource><PMID Version="1">27358423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Microbiol. 2010;59(2):113-8</RefSource><PMID Version="1">20734756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 14;9(3):e90643</RefSource><PMID Version="1">24632842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D190-D199</RefSource><PMID Version="1">27899635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W52-7</RefSource><PMID Version="1">17537822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2009 Dec;191(24):7630-1</RefSource><PMID Version="1">19820099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(9):3100-8</RefSource><PMID Version="1">17452365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antonie Van Leeuwenhoek. 2014 Oct;106(4):751-62</RefSource><PMID Version="1">25090959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2015 Feb;197(3):410-9</RefSource><PMID Version="1">25404701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jan;39(Database issue):D225-9</RefSource><PMID Version="1">21109532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Announc. 2013 Aug 15;1(4):null</RefSource><PMID Version="1">23950137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17193-8</RefSource><PMID Version="1">19805152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 Feb 15;21(4):537-9</RefSource><PMID Version="1">15479716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Biol. 2012 May;19(5):455-77</RefSource><PMID Version="1">22506599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2008 Aug;74(15):4601-9</RefSource><PMID Version="1">18539811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Oct 08;8(10):e75073</RefSource><PMID Version="1">24116025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Benef Microbes. 2011 Dec 1;2(4):319-34</RefSource><PMID Version="1">22146691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W448-53</RefSource><PMID Version="1">23677608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Virol. 2006 May;151(5):947-65</RefSource><PMID Version="1">16328134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D286-93</RefSource><PMID Version="1">26582926</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR–Cas locus</Keyword><Keyword MajorTopicYN="N">Genome sequence</Keyword><Keyword MajorTopicYN="N">Lactobacillus rhamnosus Pen</Keyword><Keyword MajorTopicYN="N">Probiotics</Keyword><Keyword MajorTopicYN="N">Prophage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483943</ArticleId><ArticleId IdType="doi">10.1186/s13099-018-0235-z</ArticleId><ArticleId IdType="pii">235</ArticleId><ArticleId IdType="pmc">PMC5822663</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29483900</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Recent Developments of the Synthetic Biology Toolkit for<i>Clostridium</i>.</ArticleTitle><Pagination><MedlinePgn>154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2018.00154</ELocationID><Abstract><AbstractText>The<i>Clostridium</i>genus is a large, diverse group consisting of Gram-positive, spore-forming, obligate anaerobic firmicutes. Among this group are historically notorious pathogens as well as several industrially relevant species with the ability to produce chemical commodities, particularly biofuels, from renewable biomass. Additionally, other species are studied for their potential use as therapeutics. Although metabolic engineering and synthetic biology have been instrumental in improving product tolerance, titer, yields, and feed stock consumption capabilities in several organisms, low transformation efficiencies and lack of synthetic biology tools and genetic parts make metabolic engineering within the<i>Clostridium</i>genus difficult. Progress has recently been made to overcome challenges associated with engineering various<i>Clostridium</i>spp. For example, developments in CRISPR tools in multiple species and strains allow greater capability to produce edits with greater precision, faster, and with higher efficiencies. In this mini-review, we will highlight these recent advances and compare them to established methods for genetic engineering in<i>Clostridium</i>. In addition, we discuss the current state and development of<i>Clostridium</i>-based promoters (constitutive and inducible) and reporters. Future progress in this area will enable more rapid development of strain engineering, which would allow for the industrial exploitation of<i>Clostridium</i>for several applications including bioproduction of several commodity products.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Rochelle C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Nancy M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Interdisciplinary Bioinnovation PhD Program, Tulane University, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval</LastName><ForeName>Nicholas R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2015 Sep 09;6:950</RefSource><PMID Version="1">26441884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2011 Dec;77(23):8439-41</RefSource><PMID Version="1">21965407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2014 Dec;98(23):9777-94</RefSource><PMID Version="1">25280743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2015 Sep;99(18):7589-99</RefSource><PMID Version="1">25994254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 Sep 15;6(9):1672-1678</RefSource><PMID Version="1">28602076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1999 Jan;181(1):319-30</RefSource><PMID Version="1">9864345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 May 23;9:109</RefSource><PMID Version="1">27222664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 Jan 04;9:4</RefSource><PMID Version="1">26732067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2017 Jan;39:38-48</RefSource><PMID Version="1">27794465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 May 09;6:25666</RefSource><PMID Version="1">27157668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biosyst. 2015 May;11(5):1434-42</RefSource><PMID Version="1">25832359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Microbiol Biotechnol. 2000 Jan;2(1):53-7</RefSource><PMID Version="1">10937488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 May 19;44(9):4243-51</RefSource><PMID Version="1">27060147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Sep 11;7(1):11178</RefSource><PMID Version="1">28894250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 22;6:19452</RefSource><PMID Version="1">26797514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2002 Jul;184(13):3586-97</RefSource><PMID Version="1">12057953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2017 Sep 18;13(9):e1005731</RefSource><PMID Version="1">28922354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2017 Dec;35(8):1032-1039</RefSource><PMID Version="1">28939499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 Feb 02;9:23</RefSource><PMID Version="1">26839586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2013 Feb;195(3):629-36</RefSource><PMID Version="1">23204460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2004 Feb;70(2):798-803</RefSource><PMID Version="1">14766557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2000 Sep;37(5):1172-85</RefSource><PMID Version="1">10972834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 Aug 18;6(8):1584-1595</RefSource><PMID Version="1">28463494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Dec 16;5(12 ):1376-1382</RefSource><PMID Version="1">27333161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2009 Jul;78(1):79-85</RefSource><PMID Version="1">19445976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2011 Sep 30;12:479</RefSource><PMID Version="1">21962126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Jun 22;287(26):22295-304</RefSource><PMID Version="1">22573334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2001 Dec;19(12):1162-7</RefSource><PMID Version="1">11731786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioresour Technol. 2015 Aug;189:292-301</RefSource><PMID Version="1">25898092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2012 Nov;78(22):8112-21</RefSource><PMID Version="1">22983967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2001 Sep;67(9):4382-4</RefSource><PMID Version="1">11526053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2014 Nov 19;7(1):163</RefSource><PMID Version="1">25431621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2007 Sep;70(3):452-64</RefSource><PMID Version="1">17658189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Jul;81(13):4423-31</RefSource><PMID Version="1">25911483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2011 Jan;77(2):471-8</RefSource><PMID Version="1">21097603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Pathog. 1997 May;22(5):275-84</RefSource><PMID Version="1">9160297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anaerobe. 2017 Dec;48:203-205</RefSource><PMID Version="1">28899647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 2000 Jul 1;188(1):29-33</RefSource><PMID Version="1">10867230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2016 Jul 10;229:53-7</RefSource><PMID Version="1">27164255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 1996 Aug;142 ( Pt 8):2079-86</RefSource><PMID Version="1">8760920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1991 Nov;173(22):7136-41</RefSource><PMID Version="1">1657880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 May 19;6(5):849-861</RefSource><PMID Version="1">28146359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Nov 21;8(1):1647</RefSource><PMID Version="1">29162801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anaerobe. 2016 Oct;41:104-112</RefSource><PMID Version="1">27234263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2015 Dec 24;8:227</RefSource><PMID Version="1">26705421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2018 Jan 10;265:119-126</RefSource><PMID Version="1">29158189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 Oct;76(19):6591-9</RefSource><PMID Version="1">20693441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 Feb;76(4):1103-9</RefSource><PMID Version="1">20023081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Mar 15;31(6):1656-64</RefSource><PMID Version="1">12626707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2007 Apr;25(4):443-5</RefSource><PMID Version="1">17351616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 1989 Sep;22(2):169-74</RefSource><PMID Version="1">2560219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2003 Mar;185(6):1923-34</RefSource><PMID Version="1">12618456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2001 May;67(5):2004-10</RefSource><PMID Version="1">11319074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2017 May 1;83(10 ):</RefSource><PMID Version="1">28258147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 21;6:23463</RefSource><PMID Version="1">26996606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Sep 30;82(20):6109-6119</RefSource><PMID Version="1">27496775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2011 Oct;79(10):4061-7</RefSource><PMID Version="1">21788384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1995 May;16(3):535-51</RefSource><PMID Version="1">7565113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Sep 23;8(9):e73026</RefSource><PMID Version="1">24086268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2015 Dec 21;589(24 Pt B):3952-8</RefSource><PMID Version="1">26522134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19515-20</RefSource><PMID Version="1">19887636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 11;6:19044</RefSource><PMID Version="1">26750307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Biotechnol. 2016 Apr 28;26(4):725-9</RefSource><PMID Version="1">26767573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2014 Apr;80(8):2410-6</RefSource><PMID Version="1">24509933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2013 Apr 09;6(1):50</RefSource><PMID Version="1">23570573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2015 Mar 04;8:36</RefSource><PMID Version="1">25763107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2011 Jan 25;2(1):e00340-10</RefSource><PMID Version="1">21264064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2014 Jan 28;5(1):e00972-13</RefSource><PMID Version="1">24473130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2016 Oct 14;12 (10 ):e1005946</RefSource><PMID Version="1">27741317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Jul 14;4(7):e6232</RefSource><PMID Version="1">19597556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 2016 Apr;363(8):</RefSource><PMID Version="1">27001972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2012 Jan;14(1):59-67</RefSource><PMID Version="1">22056607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Mar;81(5):1652-60</RefSource><PMID Version="1">25527559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anaerobe. 2016 Aug;40:95-9</RefSource><PMID Version="1">27370902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2006 Jan;188(1):96-102</RefSource><PMID Version="1">16352825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Jul 15;5(7):721-32</RefSource><PMID Version="1">27115041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2014 Mar 10;173:65-7</RefSource><PMID Version="1">24384234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 Jul;76(13):4448-60</RefSource><PMID Version="1">20453132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Dec;32(12):1241-9</RefSource><PMID Version="1">25419741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 1995 Aug 15;131(1):99-105</RefSource><PMID Version="1">7557317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol J. 2016 Jul;11(7):961-72</RefSource><PMID Version="1">27213844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1995 Jan;15(2):191-202</RefSource><PMID Version="1">7746141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 2000 Nov 1;192(1):15-20</RefSource><PMID Version="1">11040422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2010 Jan;80(1):49-55</RefSource><PMID Version="1">19891996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Aug 19;353(6301):819-22</RefSource><PMID Version="1">27540174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 Oct 18;9:219</RefSource><PMID Version="1">27777621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2007 Nov;17(11):963-5</RefSource><PMID Version="1">17971808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2005 Nov;71(11):7542-7</RefSource><PMID Version="1">16269799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Microbiol Biotechnol. 2000 Jan;2(1):59-69</RefSource><PMID Version="1">10937489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2017 Oct;101(20):7427-7434</RefSource><PMID Version="1">28884354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2009 May;75(9):2638-42</RefSource><PMID Version="1">19270116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Dec 20;6:39076</RefSource><PMID Version="1">27996021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2015 Dec;119:37-43</RefSource><PMID Version="1">26427827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2017 Sep 07;8:1744</RefSource><PMID Version="1">28936208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Microbiol. 2005 Feb;54(Pt 2):137-41</RefSource><PMID Version="1">15673506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Aug 16;6:31518</RefSource><PMID Version="1">27527841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2016 Dec 12;12 (12 ):e1006070</RefSource><PMID Version="1">27942025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2015 Jan;99(2):1011-22</RefSource><PMID Version="1">25472438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Nov 24;6:37895</RefSource><PMID Version="1">27883076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2015 Apr 20;200:1-5</RefSource><PMID Version="1">25680931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Dec 16;5(12 ):1355-1361</RefSource><PMID Version="1">27276212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2017 Mar;40:124-137</RefSource><PMID Version="1">28119139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2016 Jan 4;216:25-30</RefSource><PMID Version="1">26386202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2016 Dec;113(12 ):2739-2743</RefSource><PMID Version="1">27240718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1999 Sep;65(9):3793-9</RefSource><PMID Version="1">10473377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2012 Jul;78(13):4683-90</RefSource><PMID Version="1">22522680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 2007 Sep;58(2):182-9</RefSource><PMID Version="1">17553563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2002 Feb;68(2):928-32</RefSource><PMID Version="1">11823238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Apr;40(8):e59</RefSource><PMID Version="1">22259038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 May 31;8(5):e64753</RefSource><PMID Version="1">23741385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anaerobe. 2015 Aug;34:86-93</RefSource><PMID Version="1">25937262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2001 May;155(5):716-23</RefSource><PMID Version="1">11302769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 11;5:11301</RefSource><PMID Version="1">26062452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2006 Sep;61(5):1335-51</RefSource><PMID Version="1">16925561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2016 Jul 20;230:40-3</RefSource><PMID Version="1">27188957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Aug 5;286(31):27483-93</RefSource><PMID Version="1">21659510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2017 Sep;140:5-11</RefSource><PMID Version="1">28610973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 Jul 21;6(7):1273-1282</RefSource><PMID Version="1">28375596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Biochem Biotechnol. 1996 Spring;57-58:213-21</RefSource><PMID Version="1">8669898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2003 Aug;69(8):4985-8</RefSource><PMID Version="1">12902297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e56051</RefSource><PMID Version="1">23405251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2016 Aug;34(8):652-664</RefSource><PMID Version="1">26996613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2011 Feb;77(4):1375-82</RefSource><PMID Version="1">21183644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Apr 02;10(4):e0122411</RefSource><PMID Version="1">25836262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2010 May;12(3):268-81</RefSource><PMID Version="1">20060060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Sep 30;7:12800</RefSource><PMID Version="1">27687501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2009 Jan 1;102(1):38-49</RefSource><PMID Version="1">18726959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Jan;35(1):48-55</RefSource><PMID Version="1">27941803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Apr 01;32(6):1973-81</RefSource><PMID Version="1">15060177</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">biotechnology of microorganisms</Keyword><Keyword MajorTopicYN="N">clostridium</Keyword><Keyword MajorTopicYN="N">metabolic engineering</Keyword><Keyword MajorTopicYN="N">synthetic biology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483900</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2018.00154</ArticleId><ArticleId IdType="pmc">PMC5816073</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29483708</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5551</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Leukemia</Title><ISOAbbreviation>Leukemia</ISOAbbreviation></Journal><ArticleTitle>An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41375-018-0065-5</ELocationID><Abstract><AbstractText>T cell malignancies represent a group of hematologic cancers with high rates of relapse and mortality in patients for whom no effective targeted therapies exist. The shared expression of target antigens between chimeric antigen receptor (CAR) T cells and malignant T cells has limited the development of CAR-T because of unintended CAR-T fratricide and an inability to harvest sufficient autologous T cells. Here, we describe a fratricide-resistant "off-the-shelf" CAR-T (or UCART7) that targets CD7+ T cell malignancies and, through CRISPR/Cas9 gene editing, lacks both CD7 and T cell receptor alpha chain (TRAC) expression. UCART7 demonstrates efficacy against human T cell acute lymphoblastic leukemia (T-ALL) cell lines and primary T-ALL in vitro and in vivo without the induction of xenogeneic GvHD. Fratricide-resistant, allo-tolerant "off-the-shelf" CAR-T represents a strategy for treatment of relapsed and refractory T-ALL and non-Hodgkin's T cell lymphoma without a requirement for autologous T cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. matthewcooper@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jaebok</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5590-087X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staser</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchey</LastName><ForeName>Julie K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devenport</LastName><ForeName>Jessica M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckardt</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rettig</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eissenberg</LastName><ForeName>Linda G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghobadi</LastName><ForeName>Armin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehrs</LastName><ForeName>Leah N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prior</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achilefu</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4266-6700</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fronick</LastName><ForeName>Catrina C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neal</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinstock</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0249-9007</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fulton</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiPersio</LastName><ForeName>John F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. jdipersi@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Leukemia</MedlineTA><NlmUniqueID>8704895</NlmUniqueID><ISSNLinking>0887-6924</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483708</ArticleId><ArticleId IdType="doi">10.1038/s41375-018-0065-5</ArticleId><ArticleId IdType="pii">10.1038/s41375-018-0065-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29483683</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2055-0278</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature plants</Title><ISOAbbreviation>Nat Plants</ISOAbbreviation></Journal><ArticleTitle>Precision genome engineering through adenine and cytosine base editing.</ArticleTitle><Pagination><MedlinePgn>148-151</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41477-018-0115-z</ELocationID><Abstract><AbstractText>Adenine base editors (ABEs), composed of an engineered deaminase and a catalytically impaired CRISPR-Cas9 variant, are powerful new tools for targeted base editing in cells and organisms. Together with cytosine base editors (CBEs), ABEs enable single-nucleotide conversions cleanly, efficiently and reversibly without double-stranded DNA cleavage, advancing genome editing in a new dimension.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Soo</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of Korea. jskim01@snu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Seoul National University, Seoul, Republic of Korea. jskim01@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Plants</MedlineTA><NlmUniqueID>101651677</NlmUniqueID><ISSNLinking>2055-0278</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483683</ArticleId><ArticleId IdType="doi">10.1038/s41477-018-0115-z</ArticleId><ArticleId IdType="pii">10.1038/s41477-018-0115-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29483633</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Targeted Mutation of NGN3 Gene Disrupts Pancreatic Endocrine Cell Development in Pigs.</ArticleTitle><Pagination><MedlinePgn>3582</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-22050-0</ELocationID><Abstract><AbstractText>The domestic pig is an attractive model for biomedical research because of similarities in anatomy and physiology to humans. However, key gaps remain in our understanding of the role of developmental genes in pig, limiting its full potential. In this publication, the role of NEUROGENIN 3 (NGN3), a transcription factor involved in endocrine pancreas development has been investigated by CRISPR/Cas9 gene ablation. Precomplexed Cas9 ribonucleoproteins targeting NGN3 were injected into in vivo derived porcine embryos, and transferred into surrogate females. On day 60 of pregnancy, nine fetuses were collected for genotypic and phenotypic analysis. One of the piglets was identified as an in-frame biallelic knockout (Δ2/Δ2), which showed a loss of putative NGN3-downstream target genes: NEUROD1 and PAX4, as well as insulin, glucagon, somatostatin and pancreatic polypeptide-Y. Fibroblasts from this fetus were used in somatic cell nuclear transfer to generate clonal animals to qualify the effect of mutation on embryonic lethality. Three live piglets were born, received colostrum and suckled normally, but experienced extreme weight loss over a 24 to 36-hour period requiring humane euthanasia. Expression of pancreatic endocrine hormones: insulin, glucagon, and somatostatin were lost. The data support a critical role of NGN3 in porcine endocrine pancreas development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sheets</LastName><ForeName>Timothy P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ki-Eun</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RenOVAte Biosciences Inc, Reisterstown, MD, 21136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chi-Hun</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swift</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donovan</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Telugu</LastName><ForeName>Bhanu P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA. btelugu@umd.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Bioscience and Biotechnology Laboratory, USDA, ARS, Beltsville, MD, 20705, USA. btelugu@umd.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RenOVAte Biosciences Inc, Reisterstown, MD, 21136, USA. btelugu@umd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Differentiation. 2008 Apr;76(4):381-91</RefSource><PMID Version="1">17924961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2016 May 26;17 (6):</RefSource><PMID Version="1">27240344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Jan 01;3:e01846</RefSource><PMID Version="1">24714494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transplant Proc. 2013 Jun;45(5):2019-24</RefSource><PMID Version="1">23769099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7999-8004</RefSource><PMID Version="1">10884429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 May 21;8(5):e63241</RefSource><PMID Version="1">23704897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 May;20(9):3292-307</RefSource><PMID Version="1">10757813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Surg. 2014 Mar 24;1:7</RefSource><PMID Version="1">25593932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1607-11</RefSource><PMID Version="1">10677506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2010 Mar 1;339(1):26-37</RefSource><PMID Version="1">20025861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2010 Jul 19;11:438</RefSource><PMID Version="1">20642822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2016 Jan;238(2):247-56</RefSource><PMID Version="1">26414877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Apr 22;464(7292):1149-54</RefSource><PMID Version="1">20364121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Dec 1;540(7631):51-59</RefSource><PMID Version="1">27905428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Dev Biol. 2009 Dec 10;9:65</RefSource><PMID Version="1">20003319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anat Histol Embryol. 2010 Apr;39(2):107-19</RefSource><PMID Version="1">20028378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2000 Aug;127(16):3533-42</RefSource><PMID Version="1">10903178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Biol. 2014 Dec 31;12:771</RefSource><PMID Version="1">25551289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Feb 11;463(7282):775-80</RefSource><PMID Version="1">20148032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jan 26;168(3):473-486.e15</RefSource><PMID Version="1">28129541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2008 Apr 1;316(1):74-86</RefSource><PMID Version="1">18294628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Res Clin Pract. 2013 Jul;101(1):1-9</RefSource><PMID Version="1">23380136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transpl Immunol. 2009 Jun;21(2):81-6</RefSource><PMID Version="1">19427901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2013 Oct;62(10):3514-22</RefSource><PMID Version="1">23630303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2012 Mar 15;442(3):539-50</RefSource><PMID Version="1">22150363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Nov 6;284(45):31236-48</RefSource><PMID Version="1">19759004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 1990 Apr;39(4):515-8</RefSource><PMID Version="1">2108071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Jan 25;132(2):197-207</RefSource><PMID Version="1">18243096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Jul;51(7):1169-80</RefSource><PMID Version="1">18491072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2002 Oct 28;159(2):303-12</RefSource><PMID Version="1">12403815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2011 Oct;141(4):1451-62, 1462.e1-6</RefSource><PMID Version="1">21763240</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatobiliary Pancreat Surg. 2009;16(2):101-12</RefSource><PMID Version="1">19110649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(5):e37055</RefSource><PMID Version="1">22606327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Islets. 2009 Nov-Dec;1(3):177-84</RefSource><PMID Version="1">21099270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(2):e1003278</RefSource><PMID Version="1">23408910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genesis. 2012 Aug;50(8):612-24</RefSource><PMID Version="1">22539496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Feb;51(2):285-97</RefSource><PMID Version="1">18094957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1999 Dec;19(12):8272-80</RefSource><PMID Version="1">10567552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2013 Jun;144(6):1170-9</RefSource><PMID Version="1">23622126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2013 Apr 1;376(1):1-12</RefSource><PMID Version="1">23370147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013 Oct 10;3:2847</RefSource><PMID Version="1">24108318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Transplant. 1997;2(3):63-8</RefSource><PMID Version="1">9869866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Sep 5;7(1):10487</RefSource><PMID Version="1">28874671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2004 Dec;36(12):1301-5</RefSource><PMID Version="1">15543146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2000 Feb;49(2):163-76</RefSource><PMID Version="1">10868931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Aug 19;10 (8):e0133862</RefSource><PMID Version="1">26288179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2005 Jul;233(3):946-53</RefSource><PMID Version="1">15906379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4557-62</RefSource><PMID Version="1">23431169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9715-20</RefSource><PMID Version="1">19487660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 Jun;140(12):2472-83</RefSource><PMID Version="1">23715541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2016 Aug 15;30(16):1852-65</RefSource><PMID Version="1">27585590</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483633</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-22050-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-22050-0</ArticleId><ArticleId IdType="pmc">PMC5827570</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29483625</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol. Psychiatry</ISOAbbreviation></Journal><ArticleTitle>New considerations for hiPSC-based models of neuropsychiatric disorders.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-018-0029-1</ELocationID><Abstract><AbstractText>The development of human-induced pluripotent stem cells (hiPSCs) has made possible patient-specific modeling across the spectrum of human disease. Here, we discuss recent advances in psychiatric genomics and post-mortem studies that provide critical insights concerning cell-type composition and sample size that should be considered when designing hiPSC-based studies of complex genetic disease. We review recent hiPSC-based models of SZ, in light of our new understanding of critical power limitations in the design of hiPSC-based studies of complex genetic disorders. Three possible solutions are a movement towards genetically stratified cohorts of rare variant patients, application of CRISPR technologies to engineer isogenic neural cells to study the impact of common variants, and integration of advanced genetics and hiPSC-based datasets in future studies. Overall, we emphasize that to advance the reproducibility and relevance of hiPSC-based studies, stem cell biologists must contemplate statistical and biological considerations that are already well accepted in the field of genetics. We conclude with a discussion of the hypothesis of biological convergence of disease-through molecular, cellular, circuit, and patient level phenotypes-and how this might emerge through hiPSC-based studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Gabriel E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrode</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaherty</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennand</LastName><ForeName>Kristen J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0993-5956</Identifier><AffiliationInfo><Affiliation>Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. kristen.brennand@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. kristen.brennand@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. kristen.brennand@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. kristen.brennand@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 MH112285</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101454</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH106056</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483625</ArticleId><ArticleId IdType="doi">10.1038/s41380-018-0029-1</ArticleId><ArticleId IdType="pii">10.1038/s41380-018-0029-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29483615</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5470</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Genes and immunity</Title><ISOAbbreviation>Genes Immun.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/cas9 mediated knockout of an intergenic variant rs6927172 identified IL-20RA as a new risk gene for multiple autoimmune diseases.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41435-018-0011-6</ELocationID><Abstract><AbstractText>Genetic variants near the tumor necrosis factor-α-induced protein 3 gene (TNFAIP3) at the chromosomal region 6q23 demonstrated significant associations with multiple autoimmune diseases. The signals of associations have been explained to the TNFAIP3 gene, the most likely causal gene. In this study, we employed CRISPR/cas9 genome-editing tool to generate cell lines with deletions including a candidate causal variant, rs6927172, at 140 kb upstream of the TNFAIP3 gene. Interestingly, we observed alterations of multiple genes including IL-20RA encoding a subunit of the receptor for interleukin 20. Using Electrophoretic mobility shift assay (EMSA), Western blotting, and chromatin conformation capture we characterized the molecular mechanism that the DNA element carrying the variant rs6927172 influences expression of IL-20RA and TNFAIP3 genes. Additionally, we developed a new use of the transcription activator-like effector (TALE) to study the role of the variant in regulating expressions of its target genes. In summary, we generated deletion knockouts that included the candidate causal variant rs6927172 in HEK293T cells provided new evidence and mechanism for IL-20RA gene as a risk factor for multiple autoimmune diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Institute of Epigenetic Medicine, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Basic Medicine, The Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sirui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Institute of Pediatrics, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Institute of Epigenetic Medicine, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Institute of Epigenetic Medicine, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xianjun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Institute of Epigenetic Medicine, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Center of Research, The Second Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Xueqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The College of Life Sciences, The Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Wanguo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kaiyu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jiaao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Burn Surgery, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Liankun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Basic Medicine, The Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shaofeng</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8314-7304</Identifier><AffiliationInfo><Affiliation>The Institute of Epigenetic Medicine, The First Hospital of Jilin University, Changchun, China. shaofengwang@jlu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Pediatrics, The First Hospital of Jilin University, Changchun, China. shaofengwang@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Immun</MedlineTA><NlmUniqueID>100953417</NlmUniqueID><ISSNLinking>1466-4879</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483615</ArticleId><ArticleId IdType="doi">10.1038/s41435-018-0011-6</ArticleId><ArticleId IdType="pii">10.1038/s41435-018-0011-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29483550</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Oligonucleotide conjugated multi-functional adeno-associated viruses.</ArticleTitle><Pagination><MedlinePgn>3589</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-21742-x</ELocationID><Abstract><AbstractText>Recombinant adeno-associated viruses (AAVs) are among the most commonly used vehicles for in vivo gene delivery. However, their tropism is limited, and additionally their efficacy can be negatively affected by prevalence of neutralizing antibodies in sera. Methodologies to systematically engineer AAV capsid properties would thus be of great relevance. In this regard, we develop here multi-functional AAVs by engineering precision tethering of oligonucleotides onto the AAV surface, and thereby enabling a spectrum of nucleic-acid programmable functionalities. Towards this, we engineered genetically encoded incorporation of unnatural amino acids (UAA) bearing bio-orthogonal chemical handles onto capsid proteins. Via these we enabled site-specific coupling of oligonucleotides onto the AAV capsid surface using facile click chemistry. The resulting oligo-AAVs could be sequence specifically labeled, and also patterned in 2D using DNA array substrates. Additionally, we utilized these oligo conjugations to engineer viral shielding by lipid-based cloaks that efficaciously protected the AAV particles from neutralizing serum. We confirmed these 'cloaked AAVs' retained full functionality via their ability to transduce a range of cell types, and also enable robust delivery of CRISPR-Cas9 effectors. Taken together, we anticipate this programmable oligo-AAV system will have broad utility in synthetic biology and AAV engineering applications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katrekar</LastName><ForeName>Dhruva</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Genghao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worlikar</LastName><ForeName>Atharv</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mali</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, CA, USA. pmali@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA222826</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009285</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 1996 Nov 10;7(17):2101-12</RefSource><PMID Version="1">8934224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2014 Aug;35(26):7598-609</RefSource><PMID Version="1">24917028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Mar 16;440(7082):297-302</RefSource><PMID Version="1">16541064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2009 Feb 1;199(3):381-90</RefSource><PMID Version="1">19133809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jun 23;43(11):e73</RefSource><PMID Version="1">25765642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 May;10(5):403-6</RefSource><PMID Version="1">23503053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2004 Nov 24;126(46):15046-7</RefSource><PMID Version="1">15547999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1983 Feb;45(2):555-64</RefSource><PMID Version="1">6300419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2005 Oct 5;92(1):24-34</RefSource><PMID Version="1">15937953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Aug 11;12(6):1056-68</RefSource><PMID Version="1">26235624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2012 Feb;20(2):443-55</RefSource><PMID Version="1">22068425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):548-58</RefSource><PMID Version="1">25195922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Feb;13(2):158-64</RefSource><PMID Version="1">26727110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2008 Jun;16(6):1073-80</RefSource><PMID Version="1">18414476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Oct 15;30(20):2968-70</RefSource><PMID Version="1">24990609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2003 Apr 15;101(8):2963-72</RefSource><PMID Version="1">12515715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 1999 Nov;59(3):406-11</RefSource><PMID Version="1">10502275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Sci. 1998 Feb;7(2):419-26</RefSource><PMID Version="1">9521119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Dec 22;365(25):2357-65</RefSource><PMID Version="1">22149959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2013 Jan;21(1):109-18</RefSource><PMID Version="1">22968478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2012 Jan;20(1):73-83</RefSource><PMID Version="1">21915102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10645-9</RefSource><PMID Version="1">27483453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1472-6</RefSource><PMID Version="1">23233389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e59142</RefSource><PMID Version="1">23527116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 2012 Aug 8;20(8):1310-20</RefSource><PMID Version="1">22727812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioconjug Chem. 2011 Apr 20;22(4):529-32</RefSource><PMID Version="1">21388193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 May 21;459(7245):414-8</RefSource><PMID Version="1">19458720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(2):e31970</RefSource><PMID Version="1">22384115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2014 Jul;15(7):445-51</RefSource><PMID Version="1">24840552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10405-10</RefSource><PMID Version="1">12136130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2012 May;97(5):1635-44</RefSource><PMID Version="1">22438229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jul 27;43(13):6450-8</RefSource><PMID Version="1">26082496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2010 Jun;21(6):704-12</RefSource><PMID Version="1">20095819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2001 Sep 20;12(14):1697-711</RefSource><PMID Version="1">11560765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Oct;13(10 ):868-74</RefSource><PMID Version="1">27595405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2006 Feb;24(2):198-204</RefSource><PMID Version="1">16429148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11803-8</RefSource><PMID Version="1">23818609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gene Med. 2006 Feb;8(2):155-62</RefSource><PMID Version="1">16285001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):204-9</RefSource><PMID Version="1">26829320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2006 Apr;17(4):440-7</RefSource><PMID Version="1">16610931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2009 Aug 12;131(31):11174-8</RefSource><PMID Version="1">19603808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2006 Mar;12(3):342-7</RefSource><PMID Version="1">16474400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2002 May;76(9):4559-66</RefSource><PMID Version="1">11932421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2014 Nov 5;136(44):15577-83</RefSource><PMID Version="1">25350841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(9):e24077</RefSource><PMID Version="1">21912664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Sep;74(18):8635-47</RefSource><PMID Version="1">10954565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(3):1412-28</RefSource><PMID Version="1">17406430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Nov 30;338(6111):1177-83</RefSource><PMID Version="1">23197527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2002 Jul 15;41(14):2596-9</RefSource><PMID Version="1">12203546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2303-4</RefSource><PMID Version="1">18802015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Aug 7;325(5941):725-30</RefSource><PMID Version="1">19661424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2008 Jun;82(12):5887-911</RefSource><PMID Version="1">18400866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1965 Aug 13;149(3685):754-6</RefSource><PMID Version="1">14325163</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483550</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-21742-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-21742-x</ArticleId><ArticleId IdType="pmc">PMC5827683</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29483258</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>OCT4/POU5F1 is required for NANOG expression in bovine blastocysts.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">201718833</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1718833115</ELocationID><Abstract><AbstractText>Mammalian preimplantation development involves two lineage specifications: first, the CDX2-expressing trophectoderm (TE) and a pluripotent inner cell mass (ICM) are separated during blastocyst formation. Second, the pluripotent epiblast (EPI; expressing NANOG) and the differentiated primitive endoderm (PrE; expressing GATA6) diverge within the ICM. Studies in mice revealed that OCT4/POU5F1 is at the center of a pluripotency regulatory network. To study the role of OCT4 in bovine preimplantation development, we generated<i>OCT4</i>knockout (KO) fibroblasts by CRISPR-Cas9 and produced embryos by somatic cell nuclear transfer (SCNT). SCNT embryos from nontransfected fibroblasts and embryos produced by in vitro fertilization served as controls. In<i>OCT4</i>KO morulae (day 5), ∼70% of the nuclei were OCT4 positive, indicating that maternal<i>OCT4</i>mRNA partially maintains OCT4 protein expression during early development. In contrast,<i>OCT4</i>KO blastocysts (day 7) lacked OCT4 protein entirely. CDX2 was detected only in TE cells; OCT4 is thus not required to suppress CDX2 in the ICM. Control blastocysts showed a typical salt-and-pepper distribution of NANOG- and GATA6-positive cells in the ICM. In contrast, NANOG was absent or very faint in the ICM of<i>OCT4</i>KO blastocysts, and no cells expressing exclusively NANOG were observed. This mimics findings in OCT4-deficient human blastocysts but is in sharp contrast to<i>Oct4</i>-null mouse blastocysts, where NANOG persists and PrE development fails. Our study supports bovine embryogenesis as a model for early human development and exemplifies a general strategy for studying the roles of specific genes in embryos of domestic species.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simmet</LastName><ForeName>Kilian</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2188-3108</Identifier><AffiliationInfo><Affiliation>Chair for Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakhartchenko</LastName><ForeName>Valeri</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Chair for Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philippou-Massier</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory for Functional Genome Analysis, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blum</LastName><ForeName>Helmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory for Functional Genome Analysis, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klymiuk</LastName><ForeName>Nikolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chair for Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Eckhard</ForeName><Initials>E</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0430-9510</Identifier><AffiliationInfo><Affiliation>Chair for Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany; ewolf@lmu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Functional Genome Analysis, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GATA6</Keyword><Keyword MajorTopicYN="N">NANOG</Keyword><Keyword MajorTopicYN="N">OCT4</Keyword><Keyword MajorTopicYN="N">bovine</Keyword><Keyword MajorTopicYN="N">embryo</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483258</ArticleId><ArticleId IdType="pii">1718833115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1718833115</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29483211</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-8514</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Molecular cancer therapeutics</Title><ISOAbbreviation>Mol. Cancer Ther.</ISOAbbreviation></Journal><ArticleTitle>Anti-tumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR Exon 20 Insertions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">molcanther.0758.2017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1158/1535-7163.MCT-17-0758</ELocationID><Abstract><AbstractText>EGFR exon 20 insertions (Ex20Ins) account for 4-10% of EGFR activating mutations in non-small cell lung cancer (NSCLC). EGFR Ex20Ins tumors are generally unresponsive to 1st and 2nd generation EGFR inhibitors, and current standard of care for NSCLC patients with EGFR Ex20Ins is conventional cytotoxic chemotherapy. Therefore, the development of an EGFR TKI that can more effectively target NSCLC with EGFR Ex20Ins mutations represents a major advance for this patient subset. Osimertinib is a third-generation EGFR TKI approved for the treatment of advanced NSCLC harboring EGFR T790M; however, the activity of osimertinib in EGFR Ex20Ins NSCLC has yet to be fully assessed. Using CRISPR-Cas 9 engineered cell lines carrying the most prevalent Ex20Ins mutations, namely Ex20Ins D770_N771InsSVD (22%) or Ex20Ins V769_D770InsASV (17%), and a series of patient-derived xenografts, we have characterised osimertinib and AZ5104 (a circulating metabolite of osimertinib) activities against NSCLC harboring Ex20Ins. We report that osimertinib and AZ5104 inhibit signalling pathways and cellular growth in Ex20Ins mutant cell lines in vitro and demonstrate sustained tumor growth inhibition of EGFR-mutant tumor xenograft harboring the most prevalent Ex20Ins in vivo. The anti-tumor activity of osimertinib and AZ5104 in NSCLC harboring EGFR Ex20Ins is further described herein using a series of patient derived xenograft models. Together these data support clinical testing of osimertinib in patients with EGFR Ex20Ins NSCLC.</AbstractText><CopyrightInformation>Copyright ©2018, American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Floc'h</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca nicolas.floch@astrazeneca.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riess</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>University of California Davis Comprehensive Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orme</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>IMED Discovery Science, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staniszewska</LastName><ForeName>Anna D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menard</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuomo</LastName><ForeName>Maria Emanuela</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>IMED Discovery Science, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>IMED Discovery Science, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlay</LastName><ForeName>M Raymond V</ForeName><Initials>MRV</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKerrecher</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Mingshan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jackson Laboratory West.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vang</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>University of California Davis Comprehensive Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Rebekah A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>University of California Davis Comprehensive Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keck</LastName><ForeName>James G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Jackson Laboratory West.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandara</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>University of California Davis Comprehensive Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>Philip C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>University of California Davis Comprehensive Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Darren Ae</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>IMED Oncology, AstraZeneca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cancer Ther</MedlineTA><NlmUniqueID>101132535</NlmUniqueID><ISSNLinking>1535-7163</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483211</ArticleId><ArticleId IdType="pii">1535-7163.MCT-17-0758</ArticleId><ArticleId IdType="doi">10.1158/1535-7163.MCT-17-0758</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29483174</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3.</ArticleTitle><Pagination><MedlinePgn>975-977</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.117.031335</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chadwick</LastName><ForeName>Alexandra C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evitt</LastName><ForeName>Niklaus H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Wenjian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musunuru</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. kiranmusunuru@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL118744</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL126875</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007170</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL007843</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Jan 13;117(2):470-9</RefSource><PMID Version="1">20959605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Endocrinol. 2017 Sep;13(9):503-504</RefSource><PMID Version="1">28707678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2014 Nov;55(11):2370-9</RefSource><PMID Version="1">25258384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1741-1747</RefSource><PMID Version="1">28751571</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANGPTL3 protein, human</Keyword><Keyword MajorTopicYN="N">clustered regularly interspaced short palindromic repeats</Keyword><Keyword MajorTopicYN="N">coronary disease</Keyword><Keyword MajorTopicYN="N">lipids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483174</ArticleId><ArticleId IdType="pii">CIRCULATIONAHA.117.031335</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031335</ArticleId><ArticleId IdType="pmc">PMC5830171</ArticleId><ArticleId IdType="mid">NIHMS936766</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29482624</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-6512</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Stem cell research &amp; therapy</Title><ISOAbbreviation>Stem Cell Res Ther</ISOAbbreviation></Journal><ArticleTitle>One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.</ArticleTitle><Pagination><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13287-018-0779-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Thalassemia is the most common genetic disease worldwide; those with severe disease require lifelong blood transfusion and iron chelation therapy. The definitive cure for thalassemia is allogeneic hematopoietic stem cell transplantation, which is limited due to lack of HLA-matched donors and the risk of post-transplant complications. Induced pluripotent stem cell (iPSC) technology offers prospects for autologous cell-based therapy which could avoid the immunological problems. We now report genetic correction of the beta hemoglobin (HBB) gene in iPSCs derived from a patient with a double heterozygote for hemoglobin E and β-thalassemia (HbE/β-thalassemia), the most common thalassemia syndrome in Thailand and Southeast Asia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used the CRISPR/Cas9 system to target the hemoglobin E mutation from one allele of the HBB gene by homology-directed repair with a single-stranded DNA oligonucleotide template. DNA sequences of the corrected iPSCs were validated by Sanger sequencing. The corrected clones were differentiated into hematopoietic progenitor and erythroid cells to confirm their multilineage differentiation potential and hemoglobin expression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hemoglobin E mutation of HbE/β-thalassemia iPSCs was seamlessly corrected by the CRISPR/Cas9 system. The corrected clones were differentiated into hematopoietic progenitor cells under feeder-free and OP9 coculture systems. These progenitor cells were further expanded in erythroid liquid culture system and developed into erythroid cells that expressed mature HBB gene and HBB protein.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study provides a strategy to correct hemoglobin E mutation in one step and these corrected iPSCs can be differentiated into hematopoietic stem cells to be used for autologous transplantation in patients with HbE/β-thalassemia in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wattanapanitch</LastName><ForeName>Methichit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damkham</LastName><ForeName>Nattaya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potirat</LastName><ForeName>Ponthip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trakarnsanga</LastName><ForeName>Kongtana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janan</LastName><ForeName>Montira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>U-Pratya</LastName><ForeName>Yaowalak</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheolamai</LastName><ForeName>Pakpoom</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cell Biology, Department of Pre-clinical Sciences, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klincumhom</LastName><ForeName>Nuttha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issaragrisil</LastName><ForeName>Surapol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. surapolsi@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. surapolsi@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RTA 488-0007</GrantID><Agency>Thailand Research Fund</Agency><Country/></Grant><Grant><GrantID>TRG5880200</GrantID><Agency>Thailand Research Fund</Agency><Country/></Grant><Grant><GrantID>CHE-RES-RG-49</GrantID><Agency>Commission on Higher Education (Thailand)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cell Res Ther</MedlineTA><NlmUniqueID>101527581</NlmUniqueID><ISSNLinking>1757-6512</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Sep;24(9):1526-33</RefSource><PMID Version="1">25096406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jul 14;9(7):e100874</RefSource><PMID Version="1">25019302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Transl Med. 2016 Jan;5(1):8-19</RefSource><PMID Version="1">26676643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2010 Feb;12(2):61-76</RefSource><PMID Version="1">20098328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jul 09;5:12065</RefSource><PMID Version="1">26156589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2014 May;99(5):811-20</RefSource><PMID Version="1">24790059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Rev. 2010 Jan;24(1):27-37</RefSource><PMID Version="1">19910091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Apr 4;12(4):393-4</RefSource><PMID Version="1">23561441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Jun 28;119(26):6296-306</RefSource><PMID Version="1">22490681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):833-8</RefSource><PMID Version="1">23907171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2014 Nov;99(11):1677-85</RefSource><PMID Version="1">25107887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):543-8</RefSource><PMID Version="1">25803306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2015 Jul;26(7):425-31</RefSource><PMID Version="1">26068112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):577-582</RefSource><PMID Version="1">24770324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2011 Oct;134:522-31</RefSource><PMID Version="1">22089616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 May 8;290(19):12079-89</RefSource><PMID Version="1">25795783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2015 May;33(5):1470-9</RefSource><PMID Version="1">25702619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Apr 23;125(17):2597-604</RefSource><PMID Version="1">25733580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2015 Aug 27;7:93</RefSource><PMID Version="1">26307031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Feb;21(2):121-31</RefSource><PMID Version="1">25654603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Sep 01;6:32463</RefSource><PMID Version="1">27581487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):569-76</RefSource><PMID Version="1">24770325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2013 Sep;31(9):1785-94</RefSource><PMID Version="1">23712774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Jul 18;122(3):376-85</RefSource><PMID Version="1">23723449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Jan;29(1):73-8</RefSource><PMID Version="1">21151124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):9049-61</RefSource><PMID Version="1">23907390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Nov 29;288(48):34671-9</RefSource><PMID Version="1">24155235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 10;9(9):e106952</RefSource><PMID Version="1">25207966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2012 Apr;22(4):637-48</RefSource><PMID Version="1">22310243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2015 May 1;24(9):1053-65</RefSource><PMID Version="1">25517294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Aug 5;291(32):16576-85</RefSource><PMID Version="1">27288406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2014;546:119-38</RefSource><PMID Version="1">25398338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hematology Am Soc Hematol Educ Program. 2007;:79-83</RefSource><PMID Version="1">18024613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Dec 12;122(25):4035-46</RefSource><PMID Version="1">24124087</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Genetic correction</Keyword><Keyword MajorTopicYN="N">Hematopoietic differentiation</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">Thalassemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29482624</ArticleId><ArticleId IdType="doi">10.1186/s13287-018-0779-3</ArticleId><ArticleId IdType="pii">10.1186/s13287-018-0779-3</ArticleId><ArticleId IdType="pmc">PMC5828150</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29482606</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-0500</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC research notes</Title><ISOAbbreviation>BMC Res Notes</ISOAbbreviation></Journal><ArticleTitle>enChIP systems using different CRISPR orthologues and epitope tags.</ArticleTitle><Pagination><MedlinePgn>154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13104-018-3262-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Previously, we developed the engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) technology, which isolates specific genomic regions while preserving their molecular interactions. In enChIP, the locus of interest is tagged with engineered DNA-binding molecules such as the clustered regularly interspaced short palindromic repeats (CRISPR) system, consisting of a catalytically inactive form of Cas9 (dCas9) and guide RNA, followed by affinity purification of the tagged locus to allow identification of associated molecules. In our previous studies, we used a 3xFLAG-tagged CRISPR system from Streptococcus pyogenes (S. pyogenes). In this study, to increase the flexibility of enChIP, we used the CRISPR system from Staphylococcus aureus (S. aureus) along with different epitope tags.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We generated a plasmid expressing S. aureus dCas9 (Sa-dCas9) fused to a nuclear localization signal (NLS) and a 3xFLAG-tag (Sa-dCas9-3xFLAG). The yields of enChIP using Sa-dCas9-3xFLAG were comparable to those using S. pyogenes dCas9 fused with an NLS and a 3xFLAG-tag (3xFLAG-Sp-dCas9). We also generated another enChIP system using Sp-dCas9 fused with an NLS and a 2xAM-tag (Sp-dCas9-2xAM). We obtained high enChIP yields using this system as well. Our findings indicate that these tools will increase the flexibility of enChIP analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Toshitsugu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuno</LastName><ForeName>Miyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Hodaka</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1296-4256</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. hodaka@hirosaki-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan. hodaka@hirosaki-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>15K06895</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>15H04329</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>15H01354</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Res Notes</MedlineTA><NlmUniqueID>101462768</NlmUniqueID><ISSNLinking>1756-0500</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1974 Apr;33(4):1027-33</RefSource><PMID Version="1">4132053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jul 22;9(7):e103084</RefSource><PMID Version="1">25051498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Sep 13;439(1):132-6</RefSource><PMID Version="1">23942116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2016 Apr;21(4):370-7</RefSource><PMID Version="1">26848818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2014 Sep 1;28(17):1859-72</RefSource><PMID Version="1">25184674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2017 Jun;22(6):506-520</RefSource><PMID Version="1">28474362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 2017 Oct 1;24(5):537-548</RefSource><PMID Version="1">28586432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1987 Jan;7(1):379-87</RefSource><PMID Version="1">3031469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Sep 30;333(6051):1843-6</RefSource><PMID Version="1">21960622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Apr 13;10(4):e0123387</RefSource><PMID Version="1">25874893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013 Nov 08;3:3171</RefSource><PMID Version="1">24201379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 14;164(1-2):29-44</RefSource><PMID Version="1">26771484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11331-6</RefSource><PMID Version="1">16076961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Dec;33(12):1293-1298</RefSource><PMID Version="1">26524662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jul 28;6:30485</RefSource><PMID Version="1">27465215</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">ChIP</Keyword><Keyword MajorTopicYN="N">Chromatin immunoprecipitation</Keyword><Keyword MajorTopicYN="N">Sa-dCas9</Keyword><Keyword MajorTopicYN="N">enChIP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29482606</ArticleId><ArticleId IdType="doi">10.1186/s13104-018-3262-4</ArticleId><ArticleId IdType="pii">10.1186/s13104-018-3262-4</ArticleId><ArticleId IdType="pmc">PMC5828479</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29482575</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1474-760X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Genome biology</Title><ISOAbbreviation>Genome Biol.</ISOAbbreviation></Journal><ArticleTitle>i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases.</ArticleTitle><Pagination><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13059-018-1400-x</ELocationID><Abstract><AbstractText>We present a robust method called improved-Genome editing via Oviductal Nucleic Acids Delivery (i-GONAD) that delivers CRISPR ribonucleoproteins to E0.7 embryos via in situ electroporation. The method generates mouse models containing single-base changes, kilobase-sized deletions, and knock-ins. The efficiency of i-GONAD is comparable to that of traditional microinjection methods, which rely on ex vivo handling of zygotes and require recipient animals for embryo transfer. In contrast, i-GONAD avoids these technically difficult steps, and it can be performed at any laboratory with simple equipment and technical expertise. Further, i-GONAD-treated females retain reproductive function, suggesting future use of the method for germline gene therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohtsuka</LastName><ForeName>Masato</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6952-4238</Identifier><AffiliationInfo><Affiliation>Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Isehara, Kanagawa, Japan. masato@is.icc.u-tokai.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Isehara, Kanagawa, Japan. masato@is.icc.u-tokai.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan. masato@is.icc.u-tokai.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miura</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Isehara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takabayashi</LastName><ForeName>Shuji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory Animal Facilities &amp; Services, Preeminent Medical Photonics Education &amp; Research Center, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuyama</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Molecular Genetics, Shigei Medical Research Institute, Minami-ku, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyano</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Molecular Genetics, Shigei Medical Research Institute, Minami-ku, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arifin</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Biochemistry, School of Engineering, Tokai University, Hiratsuka, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Shingo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Biomedical Engineering, National Defense Medical College Research Institute, Tokorozawa, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Kenta</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Bioproduction, Tokyo University of Agriculture, Abashiri, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurumurthy</LastName><ForeName>Channabasavaiah B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Developmental Neuroscience, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>16K18821</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>15K14371</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>16H05049</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>2014</GrantID><Agency>Tokai University School of Medicine Research Aid</Agency><Country/></Grant><Grant><GrantID>2016-2017</GrantID><Agency>Tokai University School of Medicine Project Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genome Biol</MedlineTA><NlmUniqueID>100960660</NlmUniqueID><ISSNLinking>1474-7596</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):807-8</RefSource><PMID Version="1">27272385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2010 Feb;133(Pt 2):482-95</RefSource><PMID Version="1">20123725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2015 Jun;200(2):423-30</RefSource><PMID Version="1">25819794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 22;5:11406</RefSource><PMID Version="1">26096991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2017 May 15;121-122:16-28</RefSource><PMID Version="1">28351759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod. 2010 Mar;25(3):605-12</RefSource><PMID Version="1">20085915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Hum Genet. 2016 Jan 01;88:Unit 15.8</RefSource><PMID Version="1">26724720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 May 17;18(1):92</RefSource><PMID Version="1">28511701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod Update. 2001 Jul-Aug;7(4):419-27</RefSource><PMID Version="1">11476355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015;2015:745043</RefSource><PMID Version="1">26137492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2018 Jan;13(1):195-215</RefSource><PMID Version="1">29266098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2016 Jan 05;5:e276</RefSource><PMID Version="1">26730813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3196-201</RefSource><PMID Version="1">14963232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 Jul;6(7):493-5</RefSource><PMID Version="1">19525957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Oct 01;4:6382</RefSource><PMID Version="1">25269785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Jul 8;291(28):14457-67</RefSource><PMID Version="1">27151215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Apr 29;16:87</RefSource><PMID Version="1">25924609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Aug 05;5:12799</RefSource><PMID Version="1">26242611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 11;5:11315</RefSource><PMID Version="1">26066060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2005 Oct;25(20):8854-63</RefSource><PMID Version="1">16199865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2016 Oct 1;418(1):1-9</RefSource><PMID Version="1">27474397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1990 Dec 25;18(24):7293-8</RefSource><PMID Version="1">2124349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2016 Sep;135(9):971-6</RefSource><PMID Version="1">27384229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mob DNA. 2016 May 06;7:9</RefSource><PMID Version="1">27158268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mamm Genome. 2011 Dec;22(11-12):693-702</RefSource><PMID Version="1">22002806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Nov 10;10(11):e0142755</RefSource><PMID Version="1">26556280</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Easi-CRISPR</Keyword><Keyword MajorTopicYN="N">GONAD</Keyword><Keyword MajorTopicYN="N">In vivo electroporation</Keyword><Keyword MajorTopicYN="N">Knock-in</Keyword><Keyword MajorTopicYN="N">Long ssDNA</Keyword><Keyword MajorTopicYN="N">Transgenic mouse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29482575</ArticleId><ArticleId IdType="doi">10.1186/s13059-018-1400-x</ArticleId><ArticleId IdType="pii">10.1186/s13059-018-1400-x</ArticleId><ArticleId IdType="pmc">PMC5828090</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29482072</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>808</Volume><PubDate><Year>2018</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>The roles of human MTH1, MTH2 and MTH3 proteins in maintaining genome stability under oxidative stress.</ArticleTitle><Pagination><MedlinePgn>10-19</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(17)30201-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2018.01.002</ELocationID><Abstract><AbstractText>The hydrolysis of nucleotides containing 8-oxo-7,8-dihydroguanine (8-oxoG) is important in the maintenance of genome stability. Human cells possess three types of proteins, MTH1 (NUDT1), MTH2 (NUDT15) and MTH3 (NUDT18), which have the potential to hydrolyze deoxyribonucleoside di- and triphosphates containing 8-oxoG to the monophosphate, the form of which is unusable for DNA synthesis. To elucidate the physiological roles of these enzymes, we constructed single knockout (KO) cell lines for each of the MTH1, MTH2 and MTH3 genes and MTH1 and MTH2-double KO cell lines from the human HeLa S3 line using CRISPR/Cas9. With the exception of MTH3-KO, all of the KO cell lines showed similar proliferation rates to the parental line, HeLa S3, indicating that the MTH1 and MTH2 functions are dispensable for cell growth. On the other hand, the MTH3-KO cells showed a significantly slower growth rate, suggesting that MTH3 has a definite role in cell growth in addition to the cleavage of 8-oxoG-containing deoxyribonucleotide. MTH1-KO, MTH2-KO and MTH1- MTH2-KO cells exhibited increased sensitivity to hydrogen peroxide, whereas MTH3-KO did not. MTH1-KO cells showed only a slight increase in mutant frequency in comparison to the parental HeLa S3 line. The overproduction of MTH1 and MTH2 suppressed the mutator phenotype of mutT-deficient E. coli cells, whereas the overproduction of MTH3 did not show such a suppressive effect. Our findings suggest that both MTH1 and MTH2 are involved in the maintaining genome stability in human cells against oxidative stress, while MTH3 may play some other role(s).</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashiguchi</LastName><ForeName>Kazunari</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Fukuoka Dental College, Fukuoka 814-0193, Japan; Frontier Research Center, Fukuoka Dental College, Fukuoka 814-0193, Japan. Electronic address: hashi@college.fdcnet.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Michio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekiguchi</LastName><ForeName>Mutsuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Frontier Research Center, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umezu</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Fukuoka Dental College, Fukuoka 814-0193, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-oxoguanine (8-oxoG)</Keyword><Keyword MajorTopicYN="N">Genomic instability</Keyword><Keyword MajorTopicYN="N">MutT homolog</Keyword><Keyword MajorTopicYN="N">Nucleoside/nucleotide metabolism</Keyword><Keyword MajorTopicYN="N">Nudix</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29482072</ArticleId><ArticleId IdType="pii">S0027-5107(17)30201-4</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2018.01.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29481711</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4644</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of cellular biochemistry</Title><ISOAbbreviation>J. Cell. Biochem.</ISOAbbreviation></Journal><ArticleTitle>Cover Image, Volume 119, Number 4, April 2018.</ArticleTitle><Pagination><MedlinePgn>i</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcb.26785</ELocationID><Abstract><AbstractText>Cover: The cover image, by Rajamani Rathinam et al, is based on the Original Research Article, CRISPR/Cas9-mediated knockout of Lim-domain only four retards organ of Corti cell growth, DOI: 10.1002/jcb.26529.</AbstractText><CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rathinam</LastName><ForeName>Rajamani</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosati</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamesdaniel</LastName><ForeName>Samson</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5269-9007</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cell Biochem</MedlineTA><NlmUniqueID>8205768</NlmUniqueID><ISSNLinking>0730-2312</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29481711</ArticleId><ArticleId IdType="doi">10.1002/jcb.26785</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29480524</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2443</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Genes to cells : devoted to molecular &amp; cellular mechanisms</Title><ISOAbbreviation>Genes Cells</ISOAbbreviation></Journal><ArticleTitle>Transgenic mouse lines expressing the 3xFLAG-dCas9 protein for enChIP analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/gtc.12573</ELocationID><Abstract><AbstractText>We developed the engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) technology to isolate specific genomic regions while retaining their molecular interactions. In enChIP, the locus of interest is tagged with an engineered DNA-binding molecule, such as a modified form of the clustered regularly interspaced short palindromic repeats (CRISPR) system containing a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). The locus is then affinity-purified to enable identification of associated molecules. In this study, we generated transgenic mice expressing 3xFLAG-tagged Streptococcus pyogenes dCas9 (3xFLAG-dCas9) and retrovirally transduced gRNA into primary CD4<sup>+</sup>T cells from these mice for enChIP. Using this approach, we achieved high yields of enChIP at the targeted genomic region. Our novel transgenic mouse lines provide a valuable tool for enChIP analysis in primary mouse cells.</AbstractText><CopyrightInformation>© 2018 The Authors. Genes to Cells published by Molecular Biology Society of Japan and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Toshitsugu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitaura</LastName><ForeName>Fusako</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oji</LastName><ForeName>Asami</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Genome Research, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanigawa</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuno</LastName><ForeName>Miyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikawa</LastName><ForeName>Masahito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Genome Research, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniuchi</LastName><ForeName>Ichiro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama City, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Hodaka</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1296-4256</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Cells</MedlineTA><NlmUniqueID>9607379</NlmUniqueID><ISSNLinking>1356-9597</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ChIP</Keyword><Keyword MajorTopicYN="N">chromatin immunoprecipitation</Keyword><Keyword MajorTopicYN="N">dCas9</Keyword><Keyword MajorTopicYN="N">enChIP</Keyword><Keyword MajorTopicYN="N">transgenic mouse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29480524</ArticleId><ArticleId IdType="doi">10.1111/gtc.12573</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29480475</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>1732</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>Knockdown of Human AMPK Using the CRISPR/Cas9 Genome-Editing System.</ArticleTitle><Pagination><MedlinePgn>171-194</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-7598-3_11</ELocationID><Abstract><AbstractText>AMP-activated protein kinase (AMPK) is a critical energy sensor, regulating signaling networks involved in pathology including metabolic diseases and cancer. This increasingly recognized role of AMPK has prompted tremendous research efforts to develop new pharmacological AMPK activators. To precisely study the role of AMPK, and the specificity and activity of AMPK activators in cellular models, genetic AMPK inactivating tools are required. We report here methods for genetic inactivation of AMPK α1/α2 catalytic subunits in human cell lines by the CRISPR/Cas9 technology, a recent breakthrough technique for genome editing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grenier</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sujobert</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie Biologique, Pierre-Bénite, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Claude Bernard Lyon-1, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1052, CNRS 5286, Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux, Université de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivier</LastName><ForeName>Séverine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guermouche</LastName><ForeName>Hélène</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mondésir</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosmider</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viollet</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>U1016, Department EMD, Institut Cochin, Inserm, Paris, France. benoit.viollet@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France. benoit.viollet@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes, Paris, France. benoit.viollet@inserm.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamburini</LastName><ForeName>Jérôme</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>U1016, Institut Cochin, Inserm, Paris, France. jerome.tamburini@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR8104, CNRS, Paris, France. jerome.tamburini@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Descartes,, Paris, France. jerome.tamburini@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France. jerome.tamburini@inserm.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AMPK</Keyword><Keyword MajorTopicYN="N">AMPKα1</Keyword><Keyword MajorTopicYN="N">AMPKα2</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">PRKAA1</Keyword><Keyword MajorTopicYN="N">PRKAA2, AML, Caco2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29480475</ArticleId><ArticleId IdType="doi">10.1007/978-1-4939-7598-3_11</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29480205</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-6400</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of Huntington's disease</Title><ISOAbbreviation>J Huntingtons Dis</ISOAbbreviation></Journal><ArticleTitle>Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.</ArticleTitle><Pagination><MedlinePgn>35-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JHD-170266</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Huntington disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. We previously discovered that mutant Huntingtin sensitizes type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1) to InsP3. This causes calcium leakage from the endoplasmic reticulum (ER) and a compensatory increase in neuronal store-operated calcium (nSOC) entry. We previously demonstrated that supranormal nSOC leads to synaptic loss in striatal medium spiny neurons (MSNs) in YAC128 HD mice.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to identify calcium channels supporting supranormal nSOC in HD MSNs and to validate these channels as potential therapeutic targets for HD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cortico-striatal cultures were established from wild type and YAC128 HD mice and the density of MSN spines was quantified. The expression of candidate nSOC components was suppressed by RNAi knockdown and by CRISPR/Cas9 knockout. TRPC1 knockout mice were crossed with YAC128 HD mice for evaluation of motor performance in a beamwalk assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">RNAi-mediated knockdown of TRPC1, TRPC6, Orai1, or Orai2, but not other TRPC isoforms or Orai3, rescued the density of YAC128 MSN spines. Knockdown of stromal interaction molecule 1 (STIM1), an ER calcium sensor and nSOC activator, also rescued YAC128 MSN spines. Knockdown of the same targets suppressed supranormal nSOC in YAC128 MSN spines. These channel subunits co-immunoprecipitated with STIM1 and STIM2 in synaptosomal lysates from mouse striata. Crossing YAC128 mice with TRPC1 knockout mice improved motor performance and rescued MSN spines in vitro and in vivo, indicating that inhibition of TRPC1 may serve as a neuroprotective strategy for HD treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">TRPC1 channels constitute a potential therapeutic target for treatment of HD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryskamp</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birnbaumer</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurobiology Laboratory, NIEHS, Research Triangle Park, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedical Research (BIOMED), Catholic University of Argentina, C1107AFF Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezprozvanny</LastName><ForeName>Ilya</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Huntingtons Dis</MedlineTA><NlmUniqueID>101589965</NlmUniqueID><ISSNLinking>1879-6397</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Huntingtin</Keyword><Keyword MajorTopicYN="N">STIM1</Keyword><Keyword MajorTopicYN="N">TRPC1</Keyword><Keyword MajorTopicYN="N">beamwalk</Keyword><Keyword MajorTopicYN="N">imaging</Keyword><Keyword MajorTopicYN="N">store-operated calcium entry</Keyword><Keyword MajorTopicYN="N">synaptic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29480205</ArticleId><ArticleId IdType="pii">JHD170266</ArticleId><ArticleId IdType="doi">10.3233/JHD-170266</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29480201</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation></Journal><ArticleTitle>Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice.</ArticleTitle><Pagination><MedlinePgn>571-578</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-171058</ELocationID><Abstract><AbstractText>Alzheimer's disease and other dementias present with tau pathology. Several mouse lines with knockout of the tau-encoding Mapt gene have been reported, yet findings often differed between lines and sites. Here, we report a new tau knockout strain (tauΔex1), generated by CRISPR/Cas9-mediated genome editing of intron -1/exon 1 of Mapt in C57Bl/6J mice. TauΔex1 mice had no overt phenotype, but, in line with previous models, they showed a significantly reduced susceptibility to excitotoxic seizures, with normal memory formation in young mice. This new in vivo resource will be made freely available to the research community.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Daniel C S</ForeName><Initials>DCS</Initials><AffiliationInfo><Affiliation>Dementia Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Transgenic Animal Unit, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Sherilyn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Transgenic Animal Unit, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ittner</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dementia Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertz</LastName><ForeName>Josefine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dementia Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Yazi D</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Motor Neuron Disease Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ittner</LastName><ForeName>Lars M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Dementia Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Transgenic Animal Unit, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delerue</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Transgenic Animal Unit, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C57Bl/6</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">gene knockout</Keyword><Keyword MajorTopicYN="N">mouse</Keyword><Keyword MajorTopicYN="N">tau</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29480201</ArticleId><ArticleId IdType="pii">JAD171058</ArticleId><ArticleId IdType="doi">10.3233/JAD-171058</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29479779</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1467-7652</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Plant biotechnology journal</Title><ISOAbbreviation>Plant Biotechnol. J.</ISOAbbreviation></Journal><ArticleTitle>Blocking Amino acid transporter OsAAP3 improves grain yield by promoting outgrowth buds and increasing tiller number in rice.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/pbi.12907</ELocationID><Abstract><AbstractText>Amino acid transporters (AATs) play indispensable roles in nutrient allocation during plant development. In this study, we demonstrated that inhibiting expression of the rice amino acid transporter OsAAP3 increased grain yield due to a formation of larger numbers of tillers as a result of increased bud outgrowth. Elevated expression of OsAAP3 in transgenic plants resulted in significantly higher amino acid concentrations of Lys, Arg, His, Asp, Ala, Gln, Gly, Thr and Tyr, and inhibited bud outgrowth and rice tillering. However, RNAi of OsAAP3 decreased significantly Arg, Lys, Asp, and Thr concentrations to a small extent, and thus promoted bud outgrowth, increased significantly tiller numbers and effective panicle numbers per plant, and further enhanced significantly grain yield and nitrogen use efficiency (NUE). The promoter sequences of OsAAP3 showed some divergence between Japonica and Indica rice, and expression of the gene was higher in Japonica, which produced fewer tillers than Indica. We generated knockout-lines of OsAAP3 on Japonica ZH11 and KY131 using CRISPR technology and found that grain yield could be increased significantly. These results suggest that manipulation of OsAAP3 expression could be used to increase grain yield in rice. This article is protected by copyright. All rights reserved.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Haipeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement, College of Plant Science and technology, Huazhong Agricultural University, Wuhan 430070, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement, College of Plant Science and technology, Huazhong Agricultural University, Wuhan 430070, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Weiting</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Zhongming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan 430415, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement, College of Plant Science and technology, Huazhong Agricultural University, Wuhan 430070, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Plant Biotechnol J</MedlineTA><NlmUniqueID>101201889</NlmUniqueID><ISSNLinking>1467-7644</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amino acid</Keyword><Keyword MajorTopicYN="N">grain yield</Keyword><Keyword MajorTopicYN="N">outgrowth bud</Keyword><Keyword MajorTopicYN="N">rice</Keyword><Keyword MajorTopicYN="N">tiller</Keyword><Keyword MajorTopicYN="N">transporter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29479779</ArticleId><ArticleId IdType="doi">10.1111/pbi.12907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29479076</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-1534</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Nature reviews. Microbiology</Title><ISOAbbreviation>Nat. Rev. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Viral infection: CRISPR-Cas enhances HGT by transduction.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrmicro.2018.28</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du Toit</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Microbiol</MedlineTA><NlmUniqueID>101190261</NlmUniqueID><ISSNLinking>1740-1526</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29479076</ArticleId><ArticleId IdType="pii">nrmicro.2018.28</ArticleId><ArticleId IdType="doi">10.1038/nrmicro.2018.28</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29478914</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3686</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Cancer cell</Title><ISOAbbreviation>Cancer Cell</ISOAbbreviation></Journal><ArticleTitle>Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1535-6108(18)30012-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccell.2018.01.012</ELocationID><Abstract><AbstractText>To identify novel targets for acute myeloid leukemia (AML) therapy, we performed genome-wide CRISPR-Cas9 screening using AML cell lines, followed by a second screen in vivo. Here, we show that the mRNA decapping enzyme scavenger (DCPS) gene is essential for AML cell survival. The DCPS enzyme interacted with components of pre-mRNA metabolic pathways, including spliceosomes, as revealed by mass spectrometry. RG3039, a DCPS inhibitor originally developed to treat spinal muscular atrophy, exhibited anti-leukemic activity via inducing pre-mRNA mis-splicing. Humans harboring germline biallelic DCPS loss-of-function mutations do not exhibit aberrant hematologic phenotypes, indicating that DCPS is dispensable for human hematopoiesis. Our findings shed light on a pre-mRNA metabolic pathway and identify DCPS as a target for AML therapy.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamauchi</LastName><ForeName>Takuji</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan; Department of Stem Cell Biology and Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuda</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canver</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiler</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H3 Biomedicine, Inc., Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semba</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shboul</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, A∗STAR, 8A Biomedical Grove, Singapore 138648, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Raqad</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, A∗STAR, 8A Biomedical Grove, Singapore 138648, Singapore; Al-Balqa Applied University, Faculty of Science, Al-Salt, Salt 19117, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Manami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoonenberg</LastName><ForeName>Vivien A C</ForeName><Initials>VAC</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cole</LastName><ForeName>Mitchel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macias-Trevino</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Qiuming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Michitaka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orkin</LastName><ForeName>Stuart H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reversade</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, A∗STAR, 8A Biomedical Grove, Singapore 138648, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonamici</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H3 Biomedicine, Inc., Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinello</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akashi</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka 812-8582, Japan. Electronic address: t_maeda@cancer.med.kyushu-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 DK093705</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 DK109232</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK049216</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL032262</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 HG008399</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 DK103359</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Cell</MedlineTA><NlmUniqueID>101130617</NlmUniqueID><ISSNLinking>1535-6108</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9 saturation mutagenesis</Keyword><Keyword MajorTopicYN="N">acute myeloid leukemia</Keyword><Keyword MajorTopicYN="N">decapping enzyme</Keyword><Keyword MajorTopicYN="N">drug repurposing</Keyword><Keyword MajorTopicYN="N">genome-wide CRISPR-Cas9 screening</Keyword><Keyword MajorTopicYN="N">mRNA decay</Keyword><Keyword MajorTopicYN="N">pre-mRNA metabolism</Keyword><Keyword MajorTopicYN="N">pre-mRNA splicing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29478914</ArticleId><ArticleId IdType="pii">S1535-6108(18)30012-6</ArticleId><ArticleId IdType="doi">10.1016/j.ccell.2018.01.012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29478674</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3096</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Trends in biotechnology</Title><ISOAbbreviation>Trends Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0167-7799(18)30048-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tibtech.2018.01.014</ELocationID><Abstract><AbstractText>With an increasing prevalence in the human population, cancer has become one of the most investigated fields of medicine. Among the potential targets for cancer therapy is the tumor suppressor gene TP53, which is found in a mutated state in approximately 50% of human cancers and is often associated with poor prognosis. We propose a novel, highly tumor-specific delivery system for TP53, based on the CRISPR/Cas9 genome editing technology. This system will restore the normal p53 phenotype in tumor cells by replacing the mutant TP53 gene with a functional copy, leading to sustained expression of p53 protein and tumor regression.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sergiu</LastName><ForeName>Chira</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania. Electronic address: sergiu.chira@umfcluj.ro.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diana</LastName><ForeName>Gulei</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>MedFuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>Hajitou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Phage Therapy Group, Division of Brain Sciences, Imperial College London, W12 0NN London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioana</LastName><ForeName>Berindan-Neagoe</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania; MedFuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania; Department of Functional Genomics and Experimental Pathology, Oncology Institute Prof. Dr. Ion Chiricuta, 400015 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Biotechnol</MedlineTA><NlmUniqueID>8310903</NlmUniqueID><ISSNLinking>0167-7799</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AAVP tumor-target vector</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">tumor regression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29478674</ArticleId><ArticleId IdType="pii">S0167-7799(18)30048-9</ArticleId><ArticleId IdType="doi">10.1016/j.tibtech.2018.01.014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29477855</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-7184</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Metabolic engineering</Title><ISOAbbreviation>Metab. Eng.</ISOAbbreviation></Journal><ArticleTitle>Directed combinatorial mutagenesis of Escherichia coli for complex phenotype engineering.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1096-7176(17)30284-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymben.2018.02.007</ELocationID><Abstract><AbstractText>Strain engineering for industrial production requires a targeted improvement of multiple complex traits, which range from pathway flux to tolerance to mixed sugar utilization. Here, we report the use of an iterative CRISPR EnAbled Trackable genome Engineering (iCREATE) method to engineer rapid glucose and xylose co-consumption and tolerance to hydrolysate inhibitors in E. coli. Deep mutagenesis libraries were rationally designed, constructed, and screened to target ~40,000 mutations across 30 genes. These libraries included global and high-level regulators that regulate global gene expression, transcription factors that play important roles in genome-level transcription, enzymes that function in the sugar transport system, NAD(P)H metabolism, and the aldehyde reduction system. Specific mutants that conferred increased growth in mixed sugars and hydrolysate tolerance conditions were isolated, confirmed, and evaluated for changes in genome-wide expression levels. We tested the strain with positive combinatorial mutations for 3-hydroxypropionic acid (3HP) production under high furfural and high acetate hydrolysate fermentation, which demonstrated a 7- and 8-fold increase in 3HP productivity relative to the parent strain, respectively.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rongming</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Renewable and Sustainable Energy Institute (RASEI), University of Colorado Boulder, Boulder, Colorado 80303, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Liya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Renewable and Sustainable Energy Institute (RASEI), University of Colorado Boulder, Boulder, Colorado 80303, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garst</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Renewable and Sustainable Energy Institute (RASEI), University of Colorado Boulder, Boulder, Colorado 80303, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Alaksh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Renewable and Sustainable Energy Institute (RASEI), University of Colorado Boulder, Boulder, Colorado 80303, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogué</LastName><ForeName>Violeta Sànchez I</ForeName><Initials>VSI</Initials><AffiliationInfo><Affiliation>National Bioenergy Center, National Renewable Energy Laboratory, Golden, Colorado 80401, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckham</LastName><ForeName>Gregg T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>National Bioenergy Center, National Renewable Energy Laboratory, Golden, Colorado 80401, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Ryan T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Renewable and Sustainable Energy Institute (RASEI), University of Colorado Boulder, Boulder, Colorado 80303, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Metab Eng</MedlineTA><NlmUniqueID>9815657</NlmUniqueID><ISSNLinking>1096-7176</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Combinatorial mutagenesis</Keyword><Keyword MajorTopicYN="N">Genome engineering</Keyword><Keyword MajorTopicYN="N">Iterative CRISPR EnAbled Trackable genome Engineering</Keyword><Keyword MajorTopicYN="N">Lignocellulosic biomass</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29477855</ArticleId><ArticleId IdType="pii">S1096-7176(17)30284-7</ArticleId><ArticleId IdType="doi">10.1016/j.ymben.2018.02.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29477498</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9947</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Fish &amp; shellfish immunology</Title><ISOAbbreviation>Fish Shellfish Immunol.</ISOAbbreviation></Journal><ArticleTitle>Efficient resistance to grass carp reovirus infection in JAM-A knockout cells using CRISPR/Cas9.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1050-4648(18)30101-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fsi.2018.02.039</ELocationID><Abstract><AbstractText>The hemorrhagic disease of grass carp (Ctenopharyngodon idellus) induced by grass carp reovirus (GCRV) leads to huge economic losses in China and currently, there are no effective methods available for prevention and treatment. The various GCRV genotypes may be one of the major obstacles in the pursuit of an effective antiviral treatment. In this study, we exploited CRISPR/Cas9 gene editing to specifically knockout the DNA sequence of the grass carp Junctional Adhesion Molecule-A (gcJAM-A) and evaluated in vitro resistance against various GCRV genotypes. Our results show that CRISPR/Cas9 effectively knocked out gcJAM-A and reduced GCRV infection for two different genotypes in permissive grass carp kidney cells (CIK), as evidenced by suppressed cytopathic effect (CPE) and GCRV progeny production in infected cells. In addition, with ectopic expression of gcJAM-A in cells, non-permissive cells derived from Chinese giant salamander (Andrias davidianus) muscle (GSM) could be highly infected by both GCRV-JX0901 and Hubei grass carp disease reovirus (HGDRV) strains that have different genotypes. Taken together, the results demonstrate that gcJAM-A is necessary for GCRV infection, implying a potential approach for viral control in aquaculture.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: jiema@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yuding</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: fanyd@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: zhouy@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenzhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: liuwenzhialisa@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: jn851027@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jieming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: zhangjm@yfi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Lingbing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Fish Disease, Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, Hubei, 430223, PR China. Electronic address: zlb@yfi.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Fish Shellfish Immunol</MedlineTA><NlmUniqueID>9505220</NlmUniqueID><ISSNLinking>1050-4648</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">GCRV</Keyword><Keyword MajorTopicYN="N">JAM-A</Keyword><Keyword MajorTopicYN="N">Knockout</Keyword><Keyword MajorTopicYN="N">Resistance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29477498</ArticleId><ArticleId IdType="pii">S1050-4648(18)30101-3</ArticleId><ArticleId IdType="doi">10.1016/j.fsi.2018.02.039</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29477495</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-0024</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title><ISOAbbreviation>Mol. Ther.</ISOAbbreviation></Journal><ArticleTitle>Gene Editing of Human Embryos with CRISPR/Cas9: Great Promise Coupled with Important Caveats.</ArticleTitle><Pagination><MedlinePgn>659-660</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1525-0016(18)30060-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymthe.2018.02.007</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schenkwein</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ylä-Herttuala</LastName><ForeName>Seppo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland; Heart Center and Gene Therapy Unit, Kuopio University Hospital, 70211 Kuopio, Finland. Electronic address: seppo.ylaherttuala@uef.fi.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther</MedlineTA><NlmUniqueID>100890581</NlmUniqueID><ISSNLinking>1525-0016</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29477495</ArticleId><ArticleId IdType="pii">S1525-0016(18)30060-1</ArticleId><ArticleId IdType="doi">10.1016/j.ymthe.2018.02.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29476918</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-9867</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecular plant</Title><ISOAbbreviation>Mol Plant</ISOAbbreviation></Journal><ArticleTitle>High-efficient A·T to G·C base editing by Cas9n-guided tRNA adenosine deaminase in rice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1674-2052(18)30058-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molp.2018.02.008</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuang</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China; Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingwen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China; College of Agronomy, Henan University of Science and Technology, Luoyang 471023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Honghui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA 50011, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xueping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China; State Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huanbin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China. Electronic address: hbzhou@ippcaas.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Plant</MedlineTA><NlmUniqueID>101465514</NlmUniqueID><ISSNLinking>1674-2052</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">TadA</Keyword><Keyword MajorTopicYN="N">base editing</Keyword><Keyword MajorTopicYN="N">rice (Oryza sativa L.)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29476918</ArticleId><ArticleId IdType="pii">S1674-2052(18)30058-3</ArticleId><ArticleId IdType="doi">10.1016/j.molp.2018.02.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29476306</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-5028</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Plant molecular biology</Title><ISOAbbreviation>Plant Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11103-018-0709-x</ELocationID><Abstract><AbstractText Label="KEY MESSAGE" NlmCategory="UNASSIGNED">We present novel observations of high-specificity SpCas9 variants, sgRNA expression strategies based on mutant sgRNA scaffold and tRNA processing system, and CRISPR/Cas9-mediated T-DNA integrations. Specificity of CRISPR/Cas9 tools has been a major concern along with the reports of their successful applications. We report unexpected observations of high frequency off-target mutagenesis induced by CRISPR/Cas9 in T1 Arabidopsis mutants although the sgRNA was predicted to have a high specificity score. We also present evidence that the off-target effects were further exacerbated in the T2 progeny. To prevent the off-target effects, we tested and optimized two strategies in Arabidopsis, including introduction of a mCherry cassette for a simple and reliable isolation of Cas9-free mutants and the use of highly specific mutant SpCas9 variants. Optimization of the mCherry vectors and subsequent validation found that fusion of tRNA with the mutant rather than the original sgRNA scaffold significantly improves editing efficiency. We then examined the editing efficiency of eight high-specificity SpCas9 variants in combination with the improved tRNA-sgRNA fusion strategy. Our results suggest that highly specific SpCas9 variants require a higher level of expression than their wild-type counterpart to maintain high editing efficiency. Additionally, we demonstrate that T-DNA can be inserted into the cleavage sites of CRISPR/Cas9 targets with high frequency. Altogether, our results suggest that in plants, continuous attention should be paid to off-target effects induced by CRISPR/Cas9 in current and subsequent generations, and that the tools optimized in this report will be useful in improving genome editing efficiency and specificity in plants and other organisms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Hui-Li</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhi-Ping</ForeName><Initials>ZP</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hai-Yan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xue-Chen</ForeName><Initials>XC</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qi-Jun</ForeName><Initials>QJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7827-8211</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Plant Physiology and Biochemistry, College of Biological Sciences, China Agricultural University, Beijing, 100193, China. qjchen@cau.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31670371</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Plant Mol Biol</MedlineTA><NlmUniqueID>9106343</NlmUniqueID><ISSNLinking>0167-4412</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Editing efficiency</Keyword><Keyword MajorTopicYN="N">Editing specificity</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">Off-target effects</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29476306</ArticleId><ArticleId IdType="doi">10.1007/s11103-018-0709-x</ArticleId><ArticleId IdType="pii">10.1007/s11103-018-0709-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29476007</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation></Journal><ArticleTitle>Characterization of Coding/Noncoding Variants for<i>SHROOM3</i>in Patients with CKD.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ASN.2017080856</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2017080856</ELocationID><Abstract><AbstractText><b>Background</b>
Interpreting genetic variants is one of the greatest challenges impeding analysis of rapidly increasing volumes of genomic data from patients. For example,<i>SHROOM3</i>is an associated risk gene for CKD, yet causative mechanism(s) of<i>SHROOM3</i>allele(s) are unknown.<b>Methods</b>We used our analytic pipeline that integrates genetic, computational, biochemical, CRISPR/Cas9 editing, molecular, and physiologic data to characterize coding and noncoding variants to study the human<i>SHROOM3</i>risk locus for CKD.<b>Results</b>We identified a novel<i>SHROOM3</i>transcriptional start site, which results in a shorter isoform lacking the PDZ domain and is regulated by a common noncoding sequence variant associated with CKD (rs17319721, allele frequency: 0.35). This variant disrupted allele binding to the transcription factor TCF7L2 in podocyte cell nuclear extracts and altered transcription levels of<i>SHROOM3</i>in cultured cells, potentially through the loss of repressive looping between rs17319721 and the novel start site. Although common variant mechanisms are of high utility, sequencing is beginning to identify rare variants involved in disease; therefore, we used our biophysical tools to analyze an average of 112,849 individual human genome sequences for rare SHROOM3 missense variants, revealing 35 high-effect variants. The high-effect alleles include a coding variant (P1244L) previously associated with CKD (<i>P</i>=0.01, odds ratio=7.95; 95% CI, 1.53 to 41.46) that we find to be present in East Asian individuals at an allele frequency of 0.0027. We determined that P1244L attenuates the interaction of<i>SHROOM3</i>with 14-3-3, suggesting alterations to the Hippo pathway, a known mediator of CKD.<b>Conclusions</b>These data demonstrate multiple new<i>SHROOM3</i>-dependent genetic/molecular mechanisms that likely affect CKD.</AbstractText><CopyrightInformation>Copyright © 2018 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prokop</LastName><ForeName>Jeremy W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama; jprokop54@gmail.com jlazar@hudsonalpha.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Nan Cher</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottmann</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhetri</LastName><ForeName>Surya B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, The University of Alabama in Huntsville, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florus</LastName><ForeName>Kacie L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Emily J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical and Physical Biology, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosonkina</LastName><ForeName>Nadiya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Link</LastName><ForeName>Brian A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology and Anatomy and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Barry I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppola</LastName><ForeName>Candice J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, The University of Alabama in Huntsville, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott-Roe</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiology, Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leysen</LastName><ForeName>Seppe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milroy</LastName><ForeName>Lech-Gustav</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Femke A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geurts</LastName><ForeName>Aron M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Physiology, Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauscher</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Gene Expression &amp; Regulation Program, Wistar Institute, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramaker</LastName><ForeName>Ryne</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flister</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Physiology, Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Howard J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendenhall</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, The University of Alabama in Huntsville, Huntsville, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazar</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>HudsonAlpha Institute for Biotechnology, Huntsville, Alabama; jprokop54@gmail.com jlazar@hudsonalpha.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">GWAS</Keyword><Keyword MajorTopicYN="N">Genomic Variants</Keyword><Keyword MajorTopicYN="N">Rare Variants</Keyword><Keyword MajorTopicYN="N">SHROOM3</Keyword><Keyword MajorTopicYN="N">TCF7L2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29476007</ArticleId><ArticleId IdType="pii">ASN.2017080856</ArticleId><ArticleId IdType="doi">10.1681/ASN.2017080856</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29474918</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>172</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.</ArticleTitle><Pagination><MedlinePgn>897-909.e21</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(18)30155-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2018.02.011</ELocationID><Abstract><AbstractText>X-linked Dystonia-Parkinsonism (XDP) is a Mendelian neurodegenerative disease that is endemic to the Philippines and is associated with a founder haplotype. We integrated multiple genome and transcriptome assembly technologies to narrow the causal mutation to the TAF1 locus, which included a SINE-VNTR-Alu (SVA) retrotransposition into intron 32 of the gene. Transcriptome analyses identified decreased expression of the canonical cTAF1 transcript among XDP probands, and de novo assembly across multiple pluripotent stem-cell-derived neuronal lineages discovered aberrant TAF1 transcription that involved alternative splicing and intron retention (IR) in proximity to the SVA that was anti-correlated with overall TAF1 expression. CRISPR/Cas9 excision of the SVA rescued this XDP-specific transcriptional signature and normalized TAF1 expression in probands. These data suggest an SVA-mediated aberrant transcriptional mechanism associated with XDP and may provide a roadmap for layered technologies and integrated assembly-based analyses for other unsolved Mendelian disorders.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aneichyk</LastName><ForeName>Tatsiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendriks</LastName><ForeName>William T</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Rachita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Dadi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaine</LastName><ForeName>Christine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Ryan L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domingo</LastName><ForeName>Aloysius</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Currall</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stortchevoi</LastName><ForeName>Alexei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Multhaupt-Buell</LastName><ForeName>Trisha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penney</LastName><ForeName>Ellen B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhakal</LastName><ForeName>Jyotsna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Harrison</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanscom</LastName><ForeName>Carrie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antolik</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dy</LastName><ForeName>Marisela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragavendran</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Underwood</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pacific Biosciences, Menlo Park, CA 94025, USA; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantsilieris</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munson</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichler</LastName><ForeName>Evan E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acuña</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go</LastName><ForeName>Criscely</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jose Reyes Memorial Medical Center, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamora</LastName><ForeName>R Dominic G</ForeName><Initials>RDG</Initials><AffiliationInfo><Affiliation>Philippine General Hospital, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosales</LastName><ForeName>Raymond L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>University of Santo Tomas Hospital, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>Deanna M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>10X Genomics, Pleasanton, CA 94566, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>10X Genomics, Pleasanton, CA 94566, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>10X Genomics, Pleasanton, CA 94566, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institut für Humangenetik, Justus-Liebig-Universität, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilhelmsen</LastName><ForeName>Kirk C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timmers</LastName><ForeName>H T Marc</ForeName><Initials>HTM</Initials><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK) partner site Freiburg and Department of Urology, University Medical Center, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapir</LastName><ForeName>Yechiam</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wainger</LastName><ForeName>Brian J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisenfeld</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>10X Genomics, Pleasanton, CA 94566, USA; Genome Sequencing and Analysis Program, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaffe</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>10X Genomics, Pleasanton, CA 94566, USA; Genome Sequencing and Analysis Program, Broad Institute, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Nutan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breakefield</LastName><ForeName>Xandra O</ForeName><Initials>XO</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozelius</LastName><ForeName>Laurie J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragg</LastName><ForeName>D Cristopher</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA. Electronic address: bragg@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talkowski</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142, USA; The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital, Charlestown, MA 02129, USA; Departments of Psychiatry and Pathology, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mtalkowski@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 NS087997</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 HG008900</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS102423</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR023440</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR020936</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD016372</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD012027</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 May;34(5):525-7</RefSource><PMID Version="1">27043002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2016 Apr;9(4):451-62</RefSource><PMID Version="1">26769797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 Mar 15;18(1):51</RefSource><PMID Version="1">28298237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21</RefSource><PMID Version="1">23359684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2012 Mar 04;9(4):357-9</RefSource><PMID Version="1">22388286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2011 Aug 04;12:323</RefSource><PMID Version="1">21816040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transcription. 2017 Mar 15;8(2):120-125</RefSource><PMID Version="1">28129043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mob Genet Elements. 2012 May 1;2(3):154-157</RefSource><PMID Version="1">23061024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurol. 2015 Jun;11(6):351-9</RefSource><PMID Version="1">25986506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2016 Dec;11(12 ):2529-2548</RefSource><PMID Version="1">27854363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Sep;46(9):944-50</RefSource><PMID Version="1">25086666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 Jul 2;97(1):170-6</RefSource><PMID Version="1">26094575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Apr 27;149(3):525-37</RefSource><PMID Version="1">22521361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Sep 1;30(17):2503-5</RefSource><PMID Version="1">24812344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Jan 17;451(7176):359-62</RefSource><PMID Version="1">18202663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2015 Apr 1;142(7):1375-86</RefSource><PMID Version="1">25804741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2013 Jan 1;29(1):15-21</RefSource><PMID Version="1">23104886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zygote. 2006 Aug;14(3):209-15</RefSource><PMID Version="1">16822332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neurosci. 2011;121 Suppl 1:3-11</RefSource><PMID Version="1">21047175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2014 Dec 1;28(23):2663-76</RefSource><PMID Version="1">25452276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Transl Med. 2013 Nov;2(11):862-70</RefSource><PMID Version="1">24113065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Aug 1;30(15):2114-20</RefSource><PMID Version="1">24695404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2013 Jun 5;78(5):785-98</RefSource><PMID Version="1">23764284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2014 Dec;243(12):1632-6</RefSource><PMID Version="1">25160973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2017 Jan;49(1):36-45</RefSource><PMID Version="1">27841880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10347-52</RefSource><PMID Version="1">12928496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Aug 15;25(16):2078-9</RefSource><PMID Version="1">19505943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 May 15;29(7):644-52</RefSource><PMID Version="1">21572440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2015 Oct;23 (10 ):1334-40</RefSource><PMID Version="1">25604858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mamm Genome. 2007 Nov;18(11):787-95</RefSource><PMID Version="1">17952504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2014 Nov 12;312(18):1870-9</RefSource><PMID Version="1">25326635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 Aug 6;97(2):199-215</RefSource><PMID Version="1">26166479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1096-8</RefSource><PMID Version="1">24056875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 Dec 3;97(6):922-32</RefSource><PMID Version="1">26637982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2015 Feb;31(2):67-76</RefSource><PMID Version="1">25637093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 2014 Mar;36(3):236-43</RefSource><PMID Version="1">24352796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2011 Jun 15;27(12):1691-2</RefSource><PMID Version="1">21493652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Nov;24(11):1774-86</RefSource><PMID Version="1">25258385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2008 Dec 29;9:559</RefSource><PMID Version="1">19114008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2008;9(2):208</RefSource><PMID Version="1">18304372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2017 Sep;136(9):1043-1057</RefSource><PMID Version="1">28391524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Aug 17;536(7616):285-91</RefSource><PMID Version="1">27535533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2007 Mar;80(3):393-406</RefSource><PMID Version="1">17273961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2011 May;43(5):491-8</RefSource><PMID Version="1">21478889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2008 Mar 1;24(5):719-20</RefSource><PMID Version="1">18024473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2017 May 1;10 (5):509-518</RefSource><PMID Version="1">28468937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2016 Mar 1;25(5):1008-18</RefSource><PMID Version="1">26740556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Dec;46(12):1350-5</RefSource><PMID Version="1">25326702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Mar 28;495(7442):516-9</RefSource><PMID Version="1">23503660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14840-5</RefSource><PMID Version="1">26578803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mob Genet Elements. 2014 Jan 1;4(1):e28084</RefSource><PMID Version="1">24616836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jun 15;31(12):2032-4</RefSource><PMID Version="1">25697820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2005 Nov 9;25(45):10372-5</RefSource><PMID Version="1">16280575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2017 May;27(5):757-767</RefSource><PMID Version="1">28381613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2016 Dec 21;92 (6):1238-1251</RefSource><PMID Version="1">27939583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2016 Jun 15;8(6):2471-89</RefSource><PMID Version="1">27398133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 Mar 6;18(1):36</RefSource><PMID Version="1">28260531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Oncol Res. 2017 Jan;23 (1):125-130</RefSource><PMID Version="1">27571988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource><PMID Version="1">19451168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4468-77</RefSource><PMID Version="1">25294932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Biochem Mol Biol. 2006 May-Jun;41(3):105-78</RefSource><PMID Version="1">16858867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Apr 9;279(15):15339-47</RefSource><PMID Version="1">14726532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2005 Jun;21(6):339-45</RefSource><PMID Version="1">15922833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):550</RefSource><PMID Version="1">25516281</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DYT3</Keyword><Keyword MajorTopicYN="N">Parkinson’s disease</Keyword><Keyword MajorTopicYN="N">SVA</Keyword><Keyword MajorTopicYN="N">TAF1</Keyword><Keyword MajorTopicYN="N">XDP</Keyword><Keyword MajorTopicYN="N">dystonia</Keyword><Keyword MajorTopicYN="N">genome assembly</Keyword><Keyword MajorTopicYN="N">intron retention</Keyword><Keyword MajorTopicYN="N">retrotransposon</Keyword><Keyword MajorTopicYN="N">transcriptome assembly</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29474918</ArticleId><ArticleId IdType="pii">S0092-8674(18)30155-7</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.02.011</ArticleId><ArticleId IdType="pmc">PMC5831509</ArticleId><ArticleId IdType="mid">NIHMS940130</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29474905</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>172</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response.</ArticleTitle><Pagination><MedlinePgn>1007-1021.e17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(18)30109-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2018.01.032</ELocationID><Abstract><AbstractText>MLL/SET methyltransferases catalyze methylation of histone 3 lysine 4 and play critical roles in development and cancer. We assessed MLL/SET proteins and found that SETD1A is required for survival of acute myeloid leukemia (AML) cells. Mutagenesis studies and CRISPR-Cas9 domain screening show the enzymatic SET domain is not necessary for AML cell survival but that a newly identified region termed the "FLOS" (functional location on SETD1A) domain is indispensable. FLOS disruption suppresses DNA damage response genes and induces p53-dependent apoptosis. The FLOS domain acts as a cyclin-K-binding site that is required for chromosomal recruitment of cyclin K and for DNA-repair-associated gene expression in S phase. These data identify a connection between the chromatin regulator SETD1A and the DNA damage response that is independent of histone methylation and suggests that targeting SETD1A and cyclin K complexes may represent a therapeutic opportunity for AML and, potentially, for other cancers.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoshii</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cifani</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zhaohui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chun-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cell and Developmental Biology Program, Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koche</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chun-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Scott W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cell and Developmental Biology Program, Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA; Howard Hughes Medical Institute, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kentsis</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Scott A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02210, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: scott_armstrong@dfci.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">SETD1A</Keyword><Keyword MajorTopicYN="N">cyclin K</Keyword><Keyword MajorTopicYN="N">histone methyltransferase</Keyword><Keyword MajorTopicYN="N">leukemia</Keyword><Keyword MajorTopicYN="N">transcription</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29474905</ArticleId><ArticleId IdType="pii">S0092-8674(18)30109-0</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.01.032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29474354</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet.</ISOAbbreviation></Journal><ArticleTitle>Bombyx mori histone methyltransferase BmAsh2 is essential for silkworm piRNA-mediated sex determination.</ArticleTitle><Pagination><MedlinePgn>e1007245</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1007245</ELocationID><Abstract><AbstractText>Sex determination is a hierarchically-regulated process with high diversity in different organisms including insects. The W chromosome-derived Fem piRNA has been identified as the primary sex determination factor in the lepidopteran insect, Bombyx mori, revealing a distinctive piRNA-mediated sex determination pathway. However, the comprehensive mechanism of silkworm sex determination is still poorly understood. We show here that the silkworm PIWI protein BmSiwi, but not BmAgo3, is essential for silkworm sex determination. CRISPR/Cas9-mediated depletion of BmSiwi results in developmental arrest in oogenesis and partial female sexual reversal, while BmAgo3 depletion only affects oogenesis. We identify three histone methyltransferases (HMTs) that are significantly down-regulated in BmSiwi mutant moths. Disruption one of these, BmAsh2, causes dysregulation of piRNAs and transposable elements (TEs), supporting a role for it in the piRNA signaling pathway. More importantly, we find that BmAsh2 mutagenesis results in oogenesis arrest and partial female-to-male sexual reversal as well as dysregulation of the sex determination genes, Bmdsx and BmMasc. Mutagenesis of other two HMTs, BmSETD2 and BmEggless, does not affect piRNA-mediated sex determination. Histological analysis and immunoprecipitation results support a functional interaction between the BmAsh2 and BmSiwi proteins. Our data provide the first evidence that the HMT, BmAsh2, plays key roles in silkworm piRNA-mediated sex determination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhiqian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Lang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Anthony A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Departments of Microbiology &amp; Molecular Genetics and Molecular Biology &amp; Biochemistry, University of California, Irvine, Irvine, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yongping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Anjiang</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29474354</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1007245</ArticleId><ArticleId IdType="pii">PGENETICS-D-17-01752</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29474063</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2161-5063</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>ACS synthetic biology</Title><ISOAbbreviation>ACS Synth Biol</ISOAbbreviation></Journal><ArticleTitle>Wicket: A Versatile Tool for the Integration and Optimization of Exogenous Pathways in Saccharomyces cerevisiae.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acssynbio.7b00391</ELocationID><Abstract><AbstractText>Yeast can be used as a microbial cell factory to produce valuable chemicals. However, introducing an exogenous pathway into particular or different chromosomal locations for stable expression is still a daunting task. To address this issue, we designed a DNA cassette called a "wicket", which can be integrated into the yeast genome at designated loci to accept exogenous DNA upon excision by a nuclease. Using this system, we demonstrated that, in strains with "wickets", we could achieve near 100% efficiency for integration of the β-carotene pathway with no need for selective markers. Furthermore, it allowed independent and simultaneous integration of different genes in a pathway, resulting in a large variety of strains with variable copy numbers of each gene. This system could be a useful tool to modulate the integration of multiple copies of genes within a metabolic pathway and to optimize the yield of the target products.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Sha</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4378-0479</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Industrial Biocatalysis (Ministry of Education) and Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University , Beijing 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Industrial Biocatalysis (Ministry of Education) and Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University , Beijing 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Junbiao</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5299-4700</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Industrial Biocatalysis (Ministry of Education) and Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University , Beijing 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Synthetic Genomics, Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences , Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Synth Biol</MedlineTA><NlmUniqueID>101575075</NlmUniqueID><ISSNLinking>2161-5063</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">Saccharomyces cerevisiae</Keyword><Keyword MajorTopicYN="N">cocktail integration</Keyword><Keyword MajorTopicYN="N">multicopy integration</Keyword><Keyword MajorTopicYN="N">pathway optimization</Keyword><Keyword MajorTopicYN="N">tandem duplication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29474063</ArticleId><ArticleId IdType="doi">10.1021/acssynbio.7b00391</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29473500</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-5631</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Current gene therapy</Title><ISOAbbreviation>Curr Gene Ther</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/1566523218666180221110627</ELocationID><Abstract><AbstractText>Genome editing mediated by clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) has recently been considered to be used as efficient, rapid and site-specific tools in the modification of endogenous genes in biomedically important cell types and whole organisms. It has become a predictable and precise method of choice for genome engineering by specifying a 20-nt targeting sequence within its guide RNA. First, this review aims to describe the biology of CRISPR system. Next, the applications of CRISPR-Cas9 in various ways, such as efficient generation of a wide variety of biomedically important cellular models as well as those of animals, modifying epigenomes, conducting genome-wide screens, gene therapy, labelling specific genomic loci in living cells, metabolic engineering of yeast and bacteria and endogenous gene expression regulation by an altered version of this system were reviewed.</AbstractText><CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashemi</LastName><ForeName>Atieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran. Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Gene Ther</MedlineTA><NlmUniqueID>101125446</NlmUniqueID><ISSNLinking>1566-5232</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Applications</Keyword><Keyword MajorTopicYN="N">Biology</Keyword><Keyword MajorTopicYN="N">Biomedicine</Keyword><Keyword MajorTopicYN="N">Biotechnology</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Genome Engineering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29473500</ArticleId><ArticleId IdType="pii">CGT-EPUB-88694</ArticleId><ArticleId IdType="doi">10.2174/1566523218666180221110627</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29473438</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2513</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Immunopharmacology and immunotoxicology</Title><ISOAbbreviation>Immunopharmacol Immunotoxicol</ISOAbbreviation></Journal><ArticleTitle>CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis.</ArticleTitle><Pagination><MedlinePgn>1-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08923973.2018.1437625</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Rheumatoid arthritis (RA), as one of the most disabling autoimmune diseases, is a common health problem that progressively reduces the life quality of patients. Although various biologics have been introduced for RA, attempts to establish an efficient long-term therapies failed due to the heterogeneity of this disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the last decade, immunomodulatory approaches such as T cell adoptive therapy have been developed for controlling autoimmunity. Regulatory T cells (Tregs), the major self-tolerance mediator, are crucial for down-regulation of aberrant immune stimulations. Hence, recruiting ex vivo Tregs emerged as a promising therapy for a variety of autoimmune diseases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The major bottleneck of the Treg adoptive therapy is maintaining the in vivo stability and plasticity of these fascinating cells. Recent progress in genome editing technology clustered regularly interspaced short palindromic repeats (CRISPR) in combination with CRISPR-associated (Cas) 9 system provided a new solution for this bottleneck.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present paper discusses RA pathogenesis and the potential application of new developments in CRISPR-mediated Treg genome editing in personalized therapy of RA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Safari</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>a Department of Medical Biotechnology, Faculty of Advanced Medical Sciences , Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Student Research Committee , Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Medical Biotechnology , Shiraz University of Medical Sciences , Shiraz , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farajnia</LastName><ForeName>Safar</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6087-9147</Identifier><AffiliationInfo><Affiliation>d Biotechnology Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arya</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>e Drug Applied Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarredar</LastName><ForeName>Habib</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>f Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrolahi</LastName><ForeName>Ava</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>g Molecular Medicine Department, Faculty of Advanced Medical Sciences , Tabriz University of Medical Sciences , Tabriz , Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunopharmacol Immunotoxicol</MedlineTA><NlmUniqueID>8800150</NlmUniqueID><ISSNLinking>0892-3973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adoptive transfer</Keyword><Keyword MajorTopicYN="N">CRISPR–Cas systems</Keyword><Keyword MajorTopicYN="N">arthritis rheumatoid</Keyword><Keyword MajorTopicYN="N">epigenomics</Keyword><Keyword MajorTopicYN="N">regulatory T cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29473438</ArticleId><ArticleId IdType="doi">10.1080/08923973.2018.1437625</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29473342</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2045-7634</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Cancer medicine</Title><ISOAbbreviation>Cancer Med</ISOAbbreviation></Journal><ArticleTitle>Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.1323</ELocationID><Abstract><AbstractText>Cytosine arabinoside (Ara-C) is one of the key drugs for the treatment of acute myeloid leukemia. It is also used for consolidation therapy of acute lymphoblastic leukemia (ALL). Ara-C is a deoxyadenosine analog and is phosphorylated to form cytosine arabinoside triphosphate (Ara-CTP) as an active form. In the first step of the metabolic pathway, Ara-C is phosphorylated to Ara-CMP by deoxycytidine kinase (DCK). However, the current cumulative evidence in the association of the Ara-C sensitivity in ALL appears inconclusive. We analyzed various cell lines for the possible involvement of DCK in the sensitivities of B-cell precursor ALL (BCP-ALL) to Ara-C. Higher DCK expression was associated with higher Ara-C sensitivity. DCK knockout by genome editing with a CRISPR-Cas9 system in an Ara-C-sensitive-ALL cell line induced marked resistance to Ara-C, but not to vincristine and daunorubicin, indicating the involvement of DCK expression in the Ara-C sensitivity of BCP-ALL. DCK gene silencing due to the hypermethylation of a CpG island and reduced DCK activity due to a nonsynonymous variant allele were not associated with Ara-C sensitivity. Clofarabine is a second-generation deoxyadenosine analog rationally synthesized to improve stability and reduce toxicity. The IC50 of clofarabine in 79 BCP-ALL cell lines was approximately 20 times lower than that of Ara-C. In contrast to Ara-C, although the knockout of DCK induced marked resistance to clofarabine, sensitivity to clofarabine was only marginally associated with DCK gene expression level, suggesting a possible efficacy of clofarabine for BCP-ALL that shows relative Ara-C resistance due to low DCK expression.</AbstractText><CopyrightInformation>© 2018 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Meixian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inukai</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4783-2184</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyake</LastName><ForeName>Kunio</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Yoichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Kitasato University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kagami</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Masako</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hematology/Oncology and Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minegishi</LastName><ForeName>Masayoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Japanese Red Cross Fukushima Blood Center, Fukushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwamoto</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugihara</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somazu</LastName><ForeName>Shinpei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinohara</LastName><ForeName>Tamao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshiro</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akahane</LastName><ForeName>Koshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goi</LastName><ForeName>Kumiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugita</LastName><ForeName>Kanji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Med</MedlineTA><NlmUniqueID>101595310</NlmUniqueID><ISSNLinking>2045-7634</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute lymphoblastic leukemia</Keyword><Keyword MajorTopicYN="N">clofarabine</Keyword><Keyword MajorTopicYN="N">cytosine arabinoside</Keyword><Keyword MajorTopicYN="N">deoxycytidine kinase</Keyword><Keyword MajorTopicYN="N">drug resistance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29473342</ArticleId><ArticleId IdType="doi">10.1002/cam4.1323</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29472945</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>An Update on Phosphodiesterase Mutations Underlying Genetic Etiology of Hearing Loss and Retinitis Pigmentosa.</ArticleTitle><Pagination><MedlinePgn>9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2018.00009</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mittal</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bencie</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrish</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittal</LastName><ForeName>Jeenu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xue Zhong</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2009 Apr;17(4):474-82</RefSource><PMID Version="1">18854872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hear Res. 2015 Sep;327:102-8</RefSource><PMID Version="1">25987504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2015 Dec 15;359(1-2):266-74</RefSource><PMID Version="1">26671126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>3 Biotech. 2017 Aug;7(4):251</RefSource><PMID Version="1">28721681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2015 Jun 17;35(24):9225-35</RefSource><PMID Version="1">26085644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2017 May;74(10 ):1883-1893</RefSource><PMID Version="1">28039524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2017 Oct 31;:null</RefSource><PMID Version="1">29097191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Iran J Otorhinolaryngol. 2016 May;28(86):189-95</RefSource><PMID Version="1">27429947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hum Genet. 2017 Nov;81(6):258-266</RefSource><PMID Version="1">28786104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Neurobiol. 2017;17 :285-304</RefSource><PMID Version="1">28956337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Formos Med Assoc. 2015 May;114(5):422-9</RefSource><PMID Version="1">24485247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2007 Feb;6(2):149-61</RefSource><PMID Version="1">17239802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Otol Neurotol. 2013 Dec;34(9):1586-9</RefSource><PMID Version="1">24232060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Evol Biol. 2016 Jun 13;16(1):124</RefSource><PMID Version="1">27296292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Otolaryngol. 2017 Jan;137(1):8-15</RefSource><PMID Version="1">27685753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 1998 Mar;17(3):332-5</RefSource><PMID Version="1">9543643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Ophthalmol. 2017 Apr 18;10 (4):646-651</RefSource><PMID Version="1">28503441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2017 Oct;38:76-84</RefSource><PMID Version="1">28668721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Mar 14;8:14716</RefSource><PMID Version="1">28291770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 1995;5(3):228-34</RefSource><PMID Version="1">7599633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Auris Nasus Larynx. 2017 Dec;44(6):678-684</RefSource><PMID Version="1">28159388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2403-9</RefSource><PMID Version="1">26521189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2017 Sep;37:74-80</RefSource><PMID Version="1">28583373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Atherosclerosis. 2015 Feb;238(2):344-9</RefSource><PMID Version="1">25555266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biotechnol. 2010 Jan;44(1):66-70</RefSource><PMID Version="1">19707892</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">hearing loss</Keyword><Keyword MajorTopicYN="N">phosphodiesterase</Keyword><Keyword MajorTopicYN="N">retinitis pigmentosa</Keyword><Keyword MajorTopicYN="N">usher syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29472945</ArticleId><ArticleId IdType="doi">10.3389/fgene.2018.00009</ArticleId><ArticleId IdType="pmc">PMC5809491</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29472540</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Exploiting genetic variation to uncover rules of transcription factor binding and chromatin accessibility.</ArticleTitle><Pagination><MedlinePgn>782</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-018-03082-6</ELocationID><Abstract><AbstractText>Single-nucleotide variants that underlie phenotypic variation can affect chromatin occupancy of transcription factors (TFs). To delineate determinants of in vivo TF binding and chromatin accessibility, we introduce an approach that compares ChIP-seq and DNase-seq data sets from genetically divergent murine erythroid cell lines. The impact of discriminatory single-nucleotide variants on TF ChIP signal enables definition at single base resolution of in vivo binding characteristics of nuclear factors GATA1, TAL1, and CTCF. We further develop a facile complementary approach to more deeply test the requirements of critical nucleotide positions for TF binding by combining CRISPR-Cas9-mediated mutagenesis with ChIP and targeted deep sequencing. Finally, we extend our analytical pipeline to identify nearby contextual DNA elements that modulate chromatin binding by these three TFs, and to define sequences that impact kb-scale chromatin accessibility. Combined, our approaches reveal insights into the genetic basis of TF occupancy and their interplay with chromatin features.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behera</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Perry</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Face</LastName><ForeName>Carolyne J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamagami</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sankaranarayanan</LastName><ForeName>Laavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Cheryl A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Penn State University, University Park, PA, 16802, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardine</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Penn State University, University Park, PA, 16802, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardison</LastName><ForeName>Ross C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4084-7516</Identifier><AffiliationInfo><Affiliation>Penn State University, University Park, PA, 16802, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Junwei</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8427-6316</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blobel</LastName><ForeName>Gerd A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. blobel@email.chop.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 DK108469</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 DK106766</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 DK058044</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK007780</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2009 Dec;19(12):2172-84</RefSource><PMID Version="1">19887574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Oct 1;526(7571):68-74</RefSource><PMID Version="1">26432245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Jul;13(7):4011-22</RefSource><PMID Version="1">8321208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2015 Oct 26;36(1):157-72</RefSource><PMID Version="1">26503782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2010 Mar;20(3):381-92</RefSource><PMID Version="1">20075146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Nov 15;104(10):3136-47</RefSource><PMID Version="1">15297311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Nov;28(21):6681-94</RefSource><PMID Version="1">18779319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Jul;13(7):3999-4010</RefSource><PMID Version="1">8321207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Feb;25(2):213-25</RefSource><PMID Version="1">25373146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 May 30;121(22):4575-85</RefSource><PMID Version="1">23610375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2016 Jan 11;36(1):9-23</RefSource><PMID Version="1">26766440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Apr 25;3(4):1093-104</RefSource><PMID Version="1">23562153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4103-8</RefSource><PMID Version="1">24591581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1995 Jan 3;14(1):106-16</RefSource><PMID Version="1">7828582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e41374</RefSource><PMID Version="1">22829947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2012 Sep;22(9):1680-8</RefSource><PMID Version="1">22955980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Oct 27;118(17):e139-48</RefSource><PMID Version="1">21900194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jun;33(6):661-7</RefSource><PMID Version="1">25961408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Sep 14;477(7364):289-94</RefSource><PMID Version="1">21921910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2015 Oct 15;24(R1):R111-9</RefSource><PMID Version="1">26157023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2007 Aug 3;27(3):380-92</RefSource><PMID Version="1">17679089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):476-81</RefSource><PMID Version="1">14695898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Data. 2016 Jun 07;3:160025</RefSource><PMID Version="1">27271295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Apr 30;125(18):2825-34</RefSource><PMID Version="1">25696920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 May;15(5):2437-47</RefSource><PMID Version="1">7739528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Sep 6;489(7414):57-74</RefSource><PMID Version="1">22955616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2010 Mar 16;18(3):359-70</RefSource><PMID Version="1">20230745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Apr 21;165(3):730-41</RefSource><PMID Version="1">27087447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 May 28;38(4):576-89</RefSource><PMID Version="1">20513432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Nov 28;503(7477):487-92</RefSource><PMID Version="1">24121437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Feb;13(2):1093-103</RefSource><PMID Version="1">8423777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2000 Jun;16(6):276-7</RefSource><PMID Version="1">10827456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2011 Mar;21(3):447-55</RefSource><PMID Version="1">21106904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Aug 17;150(4):725-37</RefSource><PMID Version="1">22901805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Nov 20;515(7527):355-64</RefSource><PMID Version="1">25409824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1974 Jul;71(7):2668-70</RefSource><PMID Version="1">4527790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Feb;32(2):171-178</RefSource><PMID Version="1">24441470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brief Funct Genomic Proteomic. 2009 Jul;8(4):310-6</RefSource><PMID Version="1">19641089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3181-5</RefSource><PMID Version="1">8159721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jan 04;481(7381):389-93</RefSource><PMID Version="1">22217937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9585-9</RefSource><PMID Version="1">7568177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Apr 20;43(7):e47</RefSource><PMID Version="1">25605792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Mar 15;26(6):841-2</RefSource><PMID Version="1">20110278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):980-5</RefSource><PMID Version="1">14715908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2011 Oct;21(10):1659-71</RefSource><PMID Version="1">21795386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):13513-24</RefSource><PMID Version="1">25428352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2011 May;43(5):491-8</RefSource><PMID Version="1">21478889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(2):774-89</RefSource><PMID Version="1">24121688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 Dec 18;10(12):e1004890</RefSource><PMID Version="1">25521328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Dec;24(12):1945-62</RefSource><PMID Version="1">25319994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Nov 25;36(4):682-95</RefSource><PMID Version="1">19941827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2012 Aug 24;47(4):608-21</RefSource><PMID Version="1">22771118</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014;42(17):10943-59</RefSource><PMID Version="1">25183525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Nov 19;527(7578):384-8</RefSource><PMID Version="1">26550823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biostatistics. 2004 Oct;5(4):557-72</RefSource><PMID Version="1">15475419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2015 Mar;1849(3):282-9</RefSource><PMID Version="1">25528728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Jul 2;162(1):33-44</RefSource><PMID Version="1">26140591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2016 Jan 11;17 Suppl 1:4</RefSource><PMID Version="1">26818008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Apr 19;119(16):3724-33</RefSource><PMID Version="1">22383799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2012 Sep;13(9):613-26</RefSource><PMID Version="1">22868264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 Mar 5;113(10):2191-201</RefSource><PMID Version="1">19011221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Nov;37(21):7024-38</RefSource><PMID Version="1">19767611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Dec 15;26(24):5684-91</RefSource><PMID Version="1">9838000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Sep 11;158(6):1431-1443</RefSource><PMID Version="1">25215497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 May 30;3(5):1678-1689</RefSource><PMID Version="1">23707059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Nov 25;36(4):667-81</RefSource><PMID Version="1">19941826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2011 Nov 1;27(21):2957-63</RefSource><PMID Version="1">21903629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource><PMID Version="1">19451168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jun 2;165(6):1530-1545</RefSource><PMID Version="1">27259154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Nov 8;342(6159):744-7</RefSource><PMID Version="1">24136355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2011 Nov 1;25(21):2227-41</RefSource><PMID Version="1">22056668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2014 May;15(5):335-46</RefSource><PMID Version="1">24739678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 May 5;473(7345):43-9</RefSource><PMID Version="1">21441907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1997 Mar;17(3):1642-51</RefSource><PMID Version="1">9032291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2015 Dec;47(12):1393-401</RefSource><PMID Version="1">26502339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Dec 4;159(6):1327-40</RefSource><PMID Version="1">25480297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2011 Apr 1;27(7):1017-8</RefSource><PMID Version="1">21330290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Jun 15;129(6):1111-23</RefSource><PMID Version="1">17574024</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29472540</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-03082-6</ArticleId><ArticleId IdType="pii">10.1038/s41467-018-03082-6</ArticleId><ArticleId IdType="pmc">PMC5823854</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29472270</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-5469</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Genome research</Title><ISOAbbreviation>Genome Res.</ISOAbbreviation></Journal><ArticleTitle>CRISPR RNAs trigger innate immune responses in human cells.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1101/gr.231936.117</ELocationID><Abstract><AbstractText>Here, we report that CRISPR guide RNAs (gRNAs) with a 5'-triphosphate group (5'-ppp gRNAs) produced via in vitro transcription trigger RNA-sensing innate immune responses in human and murine cells, leading to cytotoxicity. 5'-ppp gRNAs in the cytosol are recognized by DDX58, which in turn activates type I interferon responses, causing up to ∼80% cell death. We show that the triphosphate group can be removed by a phosphatase in vitro and that the resulting 5'-hydroxyl gRNAs in complex with Cas9 or Cpf1 avoid innate immune responses and can achieve targeted mutagenesis at a frequency of 95% in primary human CD4<sup>+</sup>T cells. These results are in line with previous findings that chemically synthesized sgRNAs with a 5'-hydroxyl group are much more efficient than in vitro-transcribed (IVT) sgRNAs in human and other mammalian cells. The phosphatase treatment of IVT sgRNAs is a cost-effective method for making highly active sgRNAs, avoiding innate immune responses in human cells.</AbstractText><CopyrightInformation>© 2018 Kim et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sojung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Taeyoung</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul 08826, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Science, University of Science &amp; Technology, Daejeon 34113, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jee</LastName><ForeName>Hyeon-Gun</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Center for Chronic Diseases, Research Institute, National Medical Center, Seoul 04564, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Hee-Yeon</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul 08826, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Gyeorae</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul 08826, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Science, University of Science &amp; Technology, Daejeon 34113, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Dong-Gyun</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Center for Chronic Diseases, Research Institute, National Medical Center, Seoul 04564, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyoung Shik</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Research Center for Infectious Diseases, Research Institute, National Medical Center, Seoul 04564, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Soo</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Genome Engineering, Institute for Basic Science, Seoul 08826, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Science, University of Science &amp; Technology, Daejeon 34113, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Seoul National University, Seoul 08826, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genome Res</MedlineTA><NlmUniqueID>9518021</NlmUniqueID><ISSNLinking>1088-9051</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29472270</ArticleId><ArticleId IdType="pii">gr.231936.117</ArticleId><ArticleId IdType="doi">10.1101/gr.231936.117</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29472249</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-327X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Diabetes</Title><ISOAbbreviation>Diabetes</ISOAbbreviation></Journal><ArticleTitle>Improved Murine-MHC-Deficient HLA-Transgenic NOD-Mouse Models for Type 1 Diabetes Therapy Development.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">db171467</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2337/db17-1467</ELocationID><Abstract><AbstractText>Improved mouse models for type 1 diabetes (T1D) therapy development are needed. T1D susceptibility is restored to normally resistant NOD.β2m<sup>-/-</sup>mice transgenically expressing human disease associated HLA-A*02:01 or HLA-B*39:06 class I molecules in place of their murine counterparts. T1D is dependent on pathogenic CD8<sup>+</sup>T-cell responses mediated by these human class I variants. NOD.β2m<sup>-/-</sup>-A2.1 mice were previously used to identify β-cell autoantigens presented by this human class I variant to pathogenic CD8<sup>+</sup>T-cells, and for testing therapies to attenuate such effectors. However, NOD.β2m<sup>-/-</sup>mice also lack non-classical MHC I family members, including FcRn required for antigen presentation, and maintenance of serum IgG and albumin, precluding therapies dependent on these molecules. Hence, we utilized CRISPR/Cas9 to directly ablate the NOD H2-K<sup>d</sup>and H2-D<sup>b</sup>classical class I variants either individually or in tandem (cMHCI<sup>-/-</sup>). Ablation of the H2-A<sup>g7</sup>class II variant in the latter stock created NOD mice totally lacking in classical murine MHC expression (cMHCI/II<sup>-/-</sup>). NOD-cMHCI<sup>-/-</sup>mice retained non-classical MHC I molecule expression and FcRn activity. Transgenic expression of HLA-A2 or B39 restored pathogenic CD8<sup>+</sup>T-cell development and T1D susceptibility to NOD-cMHCI<sup>-/-</sup>mice. These next generation HLA-humanized NOD models may provide improved platforms for T1D therapy development.</AbstractText><CopyrightInformation>© 2018 by the American Diabetes Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Racine</LastName><ForeName>Jeremy J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratiu</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christianson</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowell</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helm</LastName><ForeName>Kelsay</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allocco</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maser</LastName><ForeName>Richard S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Guang</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Medical College of Wisconsin, Milwaukee, Wisconsin USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutz</LastName><ForeName>Cathleen M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roopenian</LastName><ForeName>Derry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schloss</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Albert Einstein College of Medicine, Bronx NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiLorenzo</LastName><ForeName>Teresa P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Albert Einstein College of Medicine, Bronx NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serreze</LastName><ForeName>David V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, Maine USA dave.serreze@jax.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 DK103368</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK064315</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AI119225</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK094327</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 DK020541</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007288</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA013330</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes</MedlineTA><NlmUniqueID>0372763</NlmUniqueID><ISSNLinking>0012-1797</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29472249</ArticleId><ArticleId IdType="pii">db17-1467</ArticleId><ArticleId IdType="doi">10.2337/db17-1467</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29471431</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0929</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Toxicological sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol. Sci.</ISOAbbreviation></Journal><ArticleTitle>Making Waves: New Developments in Toxicology with the Zebrafish.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/toxsci/kfy044</ELocationID><Abstract><AbstractText>The laboratory zebrafish (Danio rerio) is now an accepted model in toxicologic research. The zebrafish model fills a niche between in vitro models and mammalian biomedical models. The developmental characteristics of the small fish are strategically being used by scientists to study topics ranging from high-throughput toxicity screens to toxicity in multi- and transgenerational studies. High-throughput technology has increased the utility of zebrafish embryonic toxicity assays in screening of chemicals and drugs for toxicity or effect. Additionally, advances in behavioral characterization and experimental methodology allow for observation of recognizable phenotypic changes after xenobiotic exposure. Future directions in zebrafish research are predicted to take advantage of CRISPR-Cas9 genome editing methods in creating models of disease and interrogating mechanisms of action with fluorescent reporters or tagged proteins. Zebrafish can also model developmental origins of health and disease and multi- and transgenerational toxicity. The zebrafish has many advantages as a toxicologic model and new methodologies and areas of study continue to expand the usefulness and application of the zebrafish.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horzmann</LastName><ForeName>Katharine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Purdue University, West Lafayette, Indiana, 47907.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Purdue University, West Lafayette, Indiana, 47907.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29471431</ArticleId><ArticleId IdType="pii">4870163</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfy044</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29471289</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5586</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neoplasia (New York, N.Y.)</Title><ISOAbbreviation>Neoplasia</ISOAbbreviation></Journal><ArticleTitle>Single Nucleotide Polymorphism Facilitated Down-Regulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities.</ArticleTitle><Pagination><MedlinePgn>289-294</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1476-5586(17)30454-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neo.2018.01.003</ELocationID><Abstract><AbstractText>The biological underpinnings for racial disparities in colorectal cancer (CRC) incidence remain to be elucidated. We have previously reported that the cohesin SA-1 down-regulation is an early event in colon carcinogenesis which is dramatically accentuated in African-Americans. In order to investigate the mechanism, we evaluated single nucleotide polymorphisms (SNPs) for association with SA-1-related outcomes followed by gene editing of candidate SNP. We observed that rs34149860 SNP was significantly associated with a lower colonic mucosal SA-1 expression and evaluation of public databases showed striking racial discordance. Given that the predicted SNP would alter miR-29b binding site, we used CRISPR knock-in in CRC cells and demonstrated that the SNP but not wild-type had profound alterations in SA-1 expression with miR-29b inhibitor. This is the first demonstration of high-order chromatin regulators as a modulator of racial differences, risk alteration with SNPs and finally specific modulation by microRNAs.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Somenath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherva</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Biomedical Genetics, Boston University Medical Center, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De La Cruz</LastName><ForeName>Mart</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backman</LastName><ForeName>Vadim</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Sanjib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA. Electronic address: sanjib@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Hemant K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Section of Gastroenterology, Boston University Medical Center, Boston, MA 02118, USA. Electronic address: hkroy@bu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neoplasia</MedlineTA><NlmUniqueID>100886622</NlmUniqueID><ISSNLinking>1476-5586</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29471289</ArticleId><ArticleId IdType="pii">S1476-5586(17)30454-2</ArticleId><ArticleId IdType="doi">10.1016/j.neo.2018.01.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29471259</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Current opinion in genetics &amp; development</Title><ISOAbbreviation>Curr. Opin. Genet. Dev.</ISOAbbreviation></Journal><ArticleTitle>Functional genomics and assays of regulatory activity detect mechanisms at loci for lipid traits and coronary artery disease.</ArticleTitle><Pagination><MedlinePgn>52-59</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0959-437X(18)30005-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gde.2018.02.004</ELocationID><Abstract><AbstractText>Many genome-wide association studies (GWAS) have identified signals located in non-coding regions, and an increasing number of functional genomics annotations of regulatory elements and assays of regulatory activity have been used to investigate mechanisms. Genome-wide datasets that characterize chromatin structure help detect potential regulatory elements. Assays to experimentally assess candidate variants include transcriptional reporter assays, and recently, massively parallel reporter assays (MPRAs). Additionally, the effect of candidate regulatory elements and variants on gene expression and function can be evaluated using genomic editing with the CRISPR-Cas9 technology. We highlight some recent studies that employed these strategies to identify variant effects and elucidate molecular and/or biological mechanisms at GWAS loci for lipid traits and coronary artery disease.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Tamara S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohlke</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, United States. Electronic address: mohlke@med.unc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK072193</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK093757</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL069768</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK105561</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Genet Dev</MedlineTA><NlmUniqueID>9111375</NlmUniqueID><ISSNLinking>0959-437X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29471259</ArticleId><ArticleId IdType="pii">S0959-437X(18)30005-4</ArticleId><ArticleId IdType="doi">10.1016/j.gde.2018.02.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29471215</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6882</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Current opinion in neurobiology</Title><ISOAbbreviation>Curr. Opin. Neurobiol.</ISOAbbreviation></Journal><ArticleTitle>Genetic approaches to access cell types in mammalian nervous systems.</ArticleTitle><Pagination><MedlinePgn>109-118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0959-4388(17)30189-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.conb.2018.02.003</ELocationID><Abstract><AbstractText>Understanding brain circuit organization and function requires systematic dissection of its cellular components. With vast cell number and diversity, mammalian nervous systems present a daunting challenge for achieving specific and comprehensive cell type access-prerequisite to circuit analysis. Genetic approaches in the mouse have relied on germline engineering to access marker-defined cell populations. Combinatorial strategies that engage marker intersection, anatomy and projection pattern (e.g. antero-grade and retro-grade viral vectors), and developmental lineage substantially increase the specificity of cell type targeting. While increasing number of mouse cell types are becoming experimentally accessible, comprehensive coverage requires larger coordinated efforts with strategic infrastructural and fiscal planning. CRISPR-based genome editing may enable cell type access in other species, but issues of time, cost and ethics remain, especially for primates. Novel approaches that bypass the germline, such as somatic cell engineering and cell surface-based gene delivery, may reduce the barrier of genetic access to mammalian cell types.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: hem@fudan.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Z Josh</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA. Electronic address: huangj@cshl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Neurobiol</MedlineTA><NlmUniqueID>9111376</NlmUniqueID><ISSNLinking>0959-4388</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29471215</ArticleId><ArticleId IdType="pii">S0959-4388(17)30189-7</ArticleId><ArticleId IdType="doi">10.1016/j.conb.2018.02.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29471209</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0429</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Current opinion in biotechnology</Title><ISOAbbreviation>Curr. Opin. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Genetic engineering of host organisms for pharmaceutical synthesis.</ArticleTitle><Pagination><MedlinePgn>191-200</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0958-1669(17)30238-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.copbio.2018.02.001</ELocationID><Abstract><AbstractText>Pharmaceutical production hosts may be derived from almost any organism, from Chinese Hamster Ovary (CHO) cell lines to isolated actinomycetes. Each host can be improved, historically only through adaptive evolution. Recently, the maturation of organism engineering has expanded the available models, methods, and tools for altering host phenotypes. New tools like CRISPR-associated endonucleases promise to enable precise cellular reprogramming and to access previously intractable hosts. In this review, we discuss the most recent advances in engineering several types of pharmaceutical production hosts. These include model organisms, potential platform hosts with advantageous metabolism or physiology, specialized producers capable of unique biosynthesis, and CHO, the most widely used recombinant protein production host. To realize improved engineered hosts, an increasing number of approaches involving DNA sequencing and synthesis, host rewriting technologies, computational methods, and organism engineering strategies must be used. Integrative workflows that enable application of the right combination of methods to the right production host could enable economical production solutions for emerging human health treatments.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Joseph H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, Worcester Polytechnic Institute, 100 Institute Road, Worcester, MA 01609, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, Worcester Polytechnic Institute, 100 Institute Road, Worcester, MA 01609, United States. Electronic address: ericyoung7@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Biotechnol</MedlineTA><NlmUniqueID>9100492</NlmUniqueID><ISSNLinking>0958-1669</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29471209</ArticleId><ArticleId IdType="pii">S0958-1669(17)30238-0</ArticleId><ArticleId IdType="doi">10.1016/j.copbio.2018.02.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29469899</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Commentary: Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage.</ArticleTitle><Pagination><MedlinePgn>21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2018.00021</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsoukas</LastName><ForeName>Ianis G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Faculty of Health and Human Sciences, School of Sport and Biomedical Sciences. University of Bolton, Bolton, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nature. 2017 Nov 23;551(7681):464-471</RefSource><PMID Version="1">29160308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Sep 16;353(6305):</RefSource><PMID Version="1">27492474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jun 2;435(7042):646-51</RefSource><PMID Version="1">15806097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Apr 7;45(6):3369-3377</RefSource><PMID Version="1">28132026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2009 May;11(5):307-13</RefSource><PMID Version="1">19444013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2016 Feb;14(2):67-76</RefSource><PMID Version="1">26751509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Dec 11;326(5959):1501</RefSource><PMID Version="1">19933106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2012 Jul 18;13(8):565-75</RefSource><PMID Version="1">22805709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Oct;25(10):1442-55</RefSource><PMID Version="1">26430154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Jan 4;283(1):1-5</RefSource><PMID Version="1">17999957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2010 Oct;186(2):757-61</RefSource><PMID Version="1">20660643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2011 Sep 14;12(9):228</RefSource><PMID Version="1">21920049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Feb;29(2):143-8</RefSource><PMID Version="1">21179091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2017 Jun;16(6):387-399</RefSource><PMID Version="1">28337020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Feb;21(2):121-31</RefSource><PMID Version="1">25654603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2007 Jul;25(7):778-85</RefSource><PMID Version="1">17603475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Apr 28;8:15024</RefSource><PMID Version="1">28452355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2014 Sep 15;23(R1):R40-6</RefSource><PMID Version="1">24651067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Nov 23;551(7681):464-471</RefSource><PMID Version="1">29160308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2011 Sep 27;12(11):745-55</RefSource><PMID Version="1">21946919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12 ):null</RefSource><PMID Version="1">27908936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Sep 2;309(5740):1534-9</RefSource><PMID Version="1">16141067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2017 Aug 30;3(8):eaao4774</RefSource><PMID Version="1">28875174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Sep 08;34(9):933-941</RefSource><PMID Version="1">27606440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Dec 11;326(5959):1509-12</RefSource><PMID Version="1">19933107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2016 Sep;22(9):987-90</RefSource><PMID Version="1">27525524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2016 Jan;32(1):16-28</RefSource><PMID Version="1">26608778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2006 May 23;45(20):6407-16</RefSource><PMID Version="1">16700551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2016 Jul;41(7):578-594</RefSource><PMID Version="1">27283515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(22):e149</RefSource><PMID Version="1">17130168</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas-9</Keyword><Keyword MajorTopicYN="N">base editing</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">targeted gene repair</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29469899</ArticleId><ArticleId IdType="doi">10.3389/fgene.2018.00021</ArticleId><ArticleId IdType="pmc">PMC5808320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29469110</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>554</Volume><Issue>7693</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>CRISPR hack transform﻿s cells into data recorders.</ArticleTitle><Pagination><MedlinePgn>414-415</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-018-02068-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ledford</LastName><ForeName>Heidi</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29469110</ArticleId><ArticleId IdType="pii">d41586-018-02068-0</ArticleId><ArticleId IdType="doi">10.1038/d41586-018-02068-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29468553</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>1726</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-Mediated Knockout of Rb1 in Xenopus tropicalis.</ArticleTitle><Pagination><MedlinePgn>177-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-7565-5_16</ELocationID><Abstract><AbstractText>At this time, no molecular targeted therapies exist for treatment of retinoblastoma. This can be, in part, attributed to the lack of animal models that allow for both rapid identification of novel therapeutic targets and hypothesis driven drug testing. Within this scope, we have recently reported the first genuine genetic nonmammalian retinoblastoma cancer model within the aquatic model organism Xenopus tropicalis (Naert et al., Sci Rep 6: 35263, 2016). Here we describe the methods to generate rb1 mosaic mutant Xenopus tropicalis by employing the CRISPR/Cas9 technology. In depth, we discuss short guide RNA (sgRNA) design parameters, generation, quality control, quantification, and delivery followed by several methods for assessing genome editing efficiencies. As such the reader should be capable, by minor changes to the methods described here, to (co-) target rb1 or any one or multiple gene(s) within the Xenopus tropicalis genome by multiplex CRISPR/Cas9 methodology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naert</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Institute Ghent, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vleminckx</LastName><ForeName>Kris</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. Kris.Vleminckx@IRC.UGent.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Institute Ghent, Ghent, Belgium. Kris.Vleminckx@IRC.UGent.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, Ghent University, Ghent, Belgium. Kris.Vleminckx@IRC.UGent.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9, Rb1</Keyword><Keyword MajorTopicYN="N">Cancer model</Keyword><Keyword MajorTopicYN="N">Disease model</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">Retinoblastoma</Keyword><Keyword MajorTopicYN="N">Tumor model</Keyword><Keyword MajorTopicYN="N">Xenopus tropicalis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29468553</ArticleId><ArticleId IdType="doi">10.1007/978-1-4939-7565-5_16</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29468011</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2045-3701</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Cell &amp; bioscience</Title><ISOAbbreviation>Cell Biosci</ISOAbbreviation></Journal><ArticleTitle>Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells.</ArticleTitle><Pagination><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13578-018-0200-z</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">Precise genome editing is essential for both basic and translational research. The recently developed CRISPR/Cas9 system can specifically cleave a designated site of target gene to create a DNA double-strand break, which triggers cellular DNA repair mechanism of either inaccurate non-homologous end joining, or site-specific homologous recombination. Unfortunately, homology-directed repair (HDR) is challenging due to its very low efficiency. Herein, we focused on improving the efficiency of HDR using a combination of CRISPR/Cas9, eGFP, DNA ligase IV inhibitor SCR7, and single-stranded oligodeoxynucleotides (ssODN) in human cancer cells.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">When Cas9, gRNA and eGFP were assembled into a co-expression vector, the disruption rate more than doubled following GFP-positive cell sorting in transfected cells compared to those unsorted cells. Using ssODNs as templates, SCR7 treatment increased targeted insertion efficiency threefold in transfected cells compared to those without SCR7 treatment. Moreover, this combinatorial approach greatly improved the efficiency of HDR and targeted gene mutation correction at both the GFP-silent mutation and the β-catenin Ser45 deletion mutation cells.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The data of this study suggests that a combination of co-expression vector, ssODN, and ligase IV inhibitor can markedly improve the CRISPR/Cas9-directed gene editing, which should have significant application in targeted gene editing and genetic disease therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078 Hunan China.</Affiliation><Identifier Source="ISNI">0000 0004 1757 7615</Identifier><Identifier Source="GRID">grid.452223.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Translational Medicine Institute, National and Local Joint Engineering Laboratory for High-through Molecular Diagnosis Technology, The First People's Hospital of Chenzhou, Chenzhou, 432000 Hunan China.</Affiliation><Identifier Source="GRID">grid.459429.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Zhaoying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biology, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Southern University of Science and Technology, Shenzhen, 518055 Guangdong China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiaogang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>4Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 Guangdong China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Baishan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>5Institute of Chemical Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 Guangdong China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078 Hunan China.</Affiliation><Identifier Source="ISNI">0000 0004 1757 7615</Identifier><Identifier Source="GRID">grid.452223.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Dixian</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>2Translational Medicine Institute, National and Local Joint Engineering Laboratory for High-through Molecular Diagnosis Technology, The First People's Hospital of Chenzhou, Chenzhou, 432000 Hunan China.</Affiliation><Identifier Source="GRID">grid.459429.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yonglong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Southern University of Science and Technology, Shenzhen, 518055 Guangdong China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yuan-Shan</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078 Hunan China.</Affiliation><Identifier Source="ISNI">0000 0004 1757 7615</Identifier><Identifier Source="GRID">grid.452223.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6Department of Medicine, Weill Cornell Medical College, New York, NY 10065 USA.</Affiliation><Identifier Source="ISNI">000000041936877X</Identifier><Identifier Source="GRID">grid.5386.8</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Biosci</MedlineTA><NlmUniqueID>101561195</NlmUniqueID><ISSNLinking>2045-3701</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10330-4</RefSource><PMID Version="1">9294210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 May;23(5):720-3</RefSource><PMID Version="1">23545779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 Apr;23(4):465-72</RefSource><PMID Version="1">23528705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2013 Mar;23(3):539-46</RefSource><PMID Version="1">23152450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):403-7</RefSource><PMID Version="1">26721684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1995 Dec 25;23(24):5012-9</RefSource><PMID Version="1">8559659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Jul 22;146(2):318-31</RefSource><PMID Version="1">21757228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2014 Feb;141(3):707-14</RefSource><PMID Version="1">24401372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):99-113</RefSource><PMID Version="1">18166982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 28;6:20070</RefSource><PMID Version="1">26818188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Oct 07;6:34531</RefSource><PMID Version="1">27713537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Jul 3;109 (27):10915-20</RefSource><PMID Version="1">22711830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2017;1468:221-34</RefSource><PMID Version="1">27662879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):230-2</RefSource><PMID Version="1">23360966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):543-8</RefSource><PMID Version="1">25803306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Dec 21;151(7):1474-87</RefSource><PMID Version="1">23260137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 1997;38(2):91-6</RefSource><PMID Version="1">9339466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gene Med. 2012 Feb;14(2):109-19</RefSource><PMID Version="1">22228477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2010;79:181-211</RefSource><PMID Version="1">20192759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2005 Jun;6(6):507-12</RefSource><PMID Version="1">15931173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19821-6</RefSource><PMID Version="1">19064913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2015 Dec;29(12):4914-23</RefSource><PMID Version="1">26268927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):538-42</RefSource><PMID Version="1">25798939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2010 Sep;11(9):636-46</RefSource><PMID Version="1">20717154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2016 Jul;73(13):2543-63</RefSource><PMID Version="1">26755436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2004 Jan;5(1):5-6</RefSource><PMID Version="1">14749120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Oct 03;6:34524</RefSource><PMID Version="1">27694906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Oct 14;8(10):e77206</RefSource><PMID Version="1">24155929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Dec 5;13(6):659-62</RefSource><PMID Version="1">24315440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2010;649:247-56</RefSource><PMID Version="1">20680839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2015 Nov;282(22):4289-94</RefSource><PMID Version="1">26290158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):134-47</RefSource><PMID Version="1">18157161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(5):e20159</RefSource><PMID Version="1">21655278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 10;6:22847</RefSource><PMID Version="1">26961701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 Jul 17;8(9):753-5</RefSource><PMID Version="1">21765410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):400-3</RefSource><PMID Version="1">26721683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Dec 5;13(6):653-8</RefSource><PMID Version="1">24315439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2016 Jul 2;13(7):605-12</RefSource><PMID Version="1">27163284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2015 Jul 3;117(2):121-8</RefSource><PMID Version="1">25940550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6064-8</RefSource><PMID Version="1">8016116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1370-9</RefSource><PMID Version="1">23992847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Jun 8;149(6):1192-205</RefSource><PMID Version="1">22682243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Jul 16;4(7):e6257</RefSource><PMID Version="1">19606213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):407-411</RefSource><PMID Version="1">26721686</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">DNA ligase IV inhibitor</Keyword><Keyword MajorTopicYN="N">Homology-directed repair</Keyword><Keyword MajorTopicYN="N">Non-homologous DNA end joining</Keyword><Keyword MajorTopicYN="N">Single-stranded oligodeoxynucleotides (ssODN)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29468011</ArticleId><ArticleId IdType="doi">10.1186/s13578-018-0200-z</ArticleId><ArticleId IdType="pii">200</ArticleId><ArticleId IdType="pmc">PMC5819182</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29467464</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration.</ArticleTitle><Pagination><MedlinePgn>304</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-018-0365-8</ELocationID><Abstract><AbstractText>The progressive accumulation of dysfunctional mitochondria is implicated in aging and in common diseases of the elderly. To oppose this occurrence, organisms employ a variety of strategies, including the selective degradation of oxidatively damaged and misfolded mitochondrial proteins. Genetic studies in yeast indicate that the ATPase Associated with diverse cellular Activities (AAA<sup>+</sup>) family of mitochondrial proteases account for a substantial fraction of this protein degradation, but their metazoan counterparts have been little studied, despite the fact that mutations in the genes encoding these proteases cause a variety of human diseases. To begin to explore the biological roles of the metazoan mitochondrial AAA<sup>+</sup>protease family, we have created a CRISPR/Cas9 allele of the Drosophila homolog of SPG7, which encodes an inner membrane-localized AAA<sup>+</sup>protease known as paraplegin. Drosophila SPG7 mutants exhibited shortened lifespan, progressive locomotor defects, sensitivity to chemical and environmental stress, and muscular and neuronal degeneration. Ultrastructural examination of photoreceptor neurons indicated that the neurodegenerative phenotype of SPG7 mutants initiates at the synaptic terminal. A variety of mitochondrial defects accompanied the degenerative phenotypes of SPG7 mutants, including altered axonal transport of mitochondria, accumulation of electron-dense material in the matrix of flight muscle mitochondria, reduced activities of respiratory chain complexes I and II, and severely swollen and dysmorphic mitochondria in the synaptic terminals of photoreceptors. Drosophila SPG7 mutants recapitulate key features of human diseases caused by mutations in SPG7, and thus provide a foundation for the identification of Drosophila paraplegin substrates and strategies that could be used to ameliorate the symptoms of these diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pareek</LastName><ForeName>Gautam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, 3720 15th Avenue, NE, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, 3720 15th Avenue, NE, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallanck</LastName><ForeName>Leo J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, 3720 15th Avenue, NE, Seattle, WA, 98195, USA. pallanck@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS094901</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Brain. 2014 May;137(Pt 5):1323-36</RefSource><PMID Version="1">24727571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2003 Nov 24;163(4):777-87</RefSource><PMID Version="1">14623864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1638-43</RefSource><PMID Version="1">18230723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2017 Jun;44:47-53</RefSource><PMID Version="1">28213158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1999 Nov;23(3):296-303</RefSource><PMID Version="1">10610178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Cell Biol. 2015 Sep 01;68:3.27.1-33</RefSource><PMID Version="1">26331984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(6):e1002760</RefSource><PMID Version="1">22719267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2012 May 31;7(6):1235-46</RefSource><PMID Version="1">22653162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2009;457:319-33</RefSource><PMID Version="1">19426876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6400-5</RefSource><PMID Version="1">23509287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2002 Nov;71(5):1009-16</RefSource><PMID Version="1">12355399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4078-83</RefSource><PMID Version="1">12642658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 Aug;31(4):347-8</RefSource><PMID Version="1">12134148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Oct 6;64(1):148-162</RefSource><PMID Version="1">27642048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 May 29;10 (5):e1004279</RefSource><PMID Version="1">24874806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 1999 Sep;65(3):757-63</RefSource><PMID Version="1">10441583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2013 Apr 4;92(4):605-13</RefSource><PMID Version="1">23541340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2015 Mar 17;84(11):1174-6</RefSource><PMID Version="1">25681447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Apr 25;114(17 ):4388-4393</RefSource><PMID Version="1">28396416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2016 Apr;155:36-47</RefSource><PMID Version="1">26930296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2013 Jul;23(7):311-8</RefSource><PMID Version="1">23489877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2006 Jun;12(6):262-9</RefSource><PMID Version="1">16647881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2012;46:371-96</RefSource><PMID Version="1">22974305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2004 Jan;113(2):231-42</RefSource><PMID Version="1">14722615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2014;547:131-50</RefSource><PMID Version="1">25416356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 Jan 8;96(1):121-35</RefSource><PMID Version="1">25574826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Gerontol. 2005 May;40(5):386-95</RefSource><PMID Version="1">15919590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2010 Jan;1184:e1-20</RefSource><PMID Version="1">20329357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2015 Jun;16(6):345-59</RefSource><PMID Version="1">25970558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2006 Jan;116(1):202-8</RefSource><PMID Version="1">16357941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2016 Feb;23 (2):291-302</RefSource><PMID Version="1">26160069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2013 Mar 18;200(6):807-20</RefSource><PMID Version="1">23509070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2012 Apr;13(4):378-85</RefSource><PMID Version="1">22354088</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2014 Oct;7(10):1165-74</RefSource><PMID Version="1">25085991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2017 Apr;42(4):312-325</RefSource><PMID Version="1">28185716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurophysiol. 2005 Mar;93(3):1611-9</RefSource><PMID Version="1">15738275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2014 Feb 18;33(4):282-95</RefSource><PMID Version="1">24446486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2016 Jul;24(7):1016-21</RefSource><PMID Version="1">26626314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Mar 3;61(5):654-666</RefSource><PMID Version="1">26942670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2016 Mar 28;12(3):e1005944</RefSource><PMID Version="1">27019408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 16;148(6):1145-59</RefSource><PMID Version="1">22424226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2015 Aug 17;25(16):2130-6</RefSource><PMID Version="1">26234214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2014 Nov;21(11):1733-45</RefSource><PMID Version="1">24948011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Apr 5;119(14):3321-9</RefSource><PMID Version="1">22323447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Mouse Biol. 2016 Mar 01;6(1):1-14</RefSource><PMID Version="1">26928661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Aug 06;5:</RefSource><PMID Version="1">27495975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2017 May 3;94(3):595-610.e6</RefSource><PMID Version="1">28472658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Jun 29;441(7097):1162-6</RefSource><PMID Version="1">16672981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2008 Dec 1;183(5):795-803</RefSource><PMID Version="1">19029340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2015 Jan 21;85(2):257-73</RefSource><PMID Version="1">25611507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2014 Apr;196(4):961-71</RefSource><PMID Version="1">24478335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2009 Feb 04;(24):null</RefSource><PMID Version="1">19229190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2006 Nov;4(12):e416</RefSource><PMID Version="1">17132048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Jan;1797(1):1-10</RefSource><PMID Version="1">19664590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2013 Jul 15;22(14 ):2829-41</RefSource><PMID Version="1">23525905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1994 May 13;264(5161):891</RefSource><PMID Version="1">8178144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12093-8</RefSource><PMID Version="1">26362788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2014 Feb 13;(84):e51223</RefSource><PMID Version="1">24561810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2015 May 07;6:e1749</RefSource><PMID Version="1">25950479</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467464</ArticleId><ArticleId IdType="doi">10.1038/s41419-018-0365-8</ArticleId><ArticleId IdType="pii">10.1038/s41419-018-0365-8</ArticleId><ArticleId IdType="pmc">PMC5833341</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29467456</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0307</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Laboratory investigation; a journal of technical methods and pathology</Title><ISOAbbreviation>Lab. Invest.</ISOAbbreviation></Journal><ArticleTitle>Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41374-018-0027-6</ELocationID><Abstract><AbstractText>The genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screen is a powerful tool used to identify therapeutic targets that can be harnessed for cancer treatment. This study aimed to assess the efficacy of genome-wide CRISPR screening to identify druggable genes associated with sorafenib-treated hepatocellular carcinoma (HCC). A genome-scale CRISPR knockout (GeCKO v2) library containing 123,411 single guide RNAs (sgRNAs) was used to identify loss-of-function mutations conferring sorafenib resistance upon HCC cells. Resistance gene screens identified SGOL1 as an indicator of prognosis of patients treated with sorafenib. Of the 19,050 genes tested, the knockout screen identified inhibition of SGOL1 expression as the most-effective genetic suppressor of sorafenib activity. Analysis of the survival of 210 patients with HCC after hepatic resection revealed that high SGOL1 expression shortened overall survival (P = 0.021). Further, matched pairs analysis of the TCGA database revealed that SGOL1 is differentially expressed. When we used a lentivirus Cas9 vector to determine the effect of targeting SGOL1 with a specific sgRNA in HCC cells, we found that SGOL1 expression was efficiently inhibited and that loss of SGOL1 was associated with sorafenib resistance. Further, loss of SGOL1 from HCC cell decreased the cytotoxicity of sorafenib in vivo. We conclude that the CRISPR screen is a powerful tool for therapeutic target analysis of sorafenib treatment and that SGOL1 serves as a druggable target for HCC treated with sorafenib and an indicator of prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Weijian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Beng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Wendi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Shaobing</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhengjie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China. drwujian@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China. drwujian@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China. drwujian@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Shusen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China. shusenzheng@zju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province, Hangzhou, 310003, China. shusenzheng@zju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou, 310003, China. shusenzheng@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lab Invest</MedlineTA><NlmUniqueID>0376617</NlmUniqueID><ISSNLinking>0023-6837</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467456</ArticleId><ArticleId IdType="doi">10.1038/s41374-018-0027-6</ArticleId><ArticleId IdType="pii">10.1038/s41374-018-0027-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29467398</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-7370</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>The ISME journal</Title><ISOAbbreviation>ISME J</ISOAbbreviation></Journal><ArticleTitle>A virus or more in (nearly) every cell: ubiquitous networks of virus-host interactions in extreme environments.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41396-018-0071-7</ELocationID><Abstract><AbstractText>The application of viral and cellular metagenomics to natural environments has expanded our understanding of the structure, functioning, and diversity of microbial and viral communities. The high diversity of many communities, e.g., soils, surface ocean waters, and animal-associated microbiomes, make it difficult to establish virus-host associations at the single cell (rather than population) level, assign cellular hosts, or determine the extent of viral host range from metagenomics studies alone. Here, we combine single-cell sequencing with environmental metagenomics to characterize the structure of virus-host associations in a Yellowstone National Park (YNP) hot spring microbial community. Leveraging the relatively low diversity of the YNP environment, we are able to overlay evidence at the single-cell level with contextualized viral and cellular community structure. Combining evidence from hexanucelotide analysis, single cell read mapping, network-based analytics, and CRISPR-based inference, we conservatively estimate that &gt;60% of cells contain at least one virus type and a majority of these cells contain two or more virus types. Of the detected virus types, nearly 50% were found in more than 2 cellular clades, indicative of a broad host range. The new lens provided by the combination of metaviromics and single-cell genomics reveals a network of virus-host interactions in extreme environments, provides evidence that extensive virus-host associations are common, and further expands the unseen impact of viruses on cellular life.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munson-McGee</LastName><ForeName>Jacob H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Shengyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewerff</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepanauskas</LastName><ForeName>Ramunas</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4458-3108</Identifier><AffiliationInfo><Affiliation>Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Rachel J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weitz</LastName><ForeName>Joshua S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3433-8312</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physics, Georgia Institute of Technology, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA. Youngmyoung@montana.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Plant Sciences and Plant Pathology, Montana State University, Bozeman, Montana, USA. Youngmyoung@montana.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ISME J</MedlineTA><NlmUniqueID>101301086</NlmUniqueID><ISSNLinking>1751-7362</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467398</ArticleId><ArticleId IdType="doi">10.1038/s41396-018-0071-7</ArticleId><ArticleId IdType="pii">10.1038/s41396-018-0071-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29467380</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-8820</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>The Journal of antibiotics</Title><ISOAbbreviation>J. Antibiot.</ISOAbbreviation></Journal><ArticleTitle>Planctopirus hydrillae sp. nov., an antibiotic producing Planctomycete isolated from the aquatic plant Hydrilla and its whole genome shotgun sequence analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41429-018-0035-1</ELocationID><Abstract><AbstractText>An antibiotic producing novel Planctomycete strain, designated JC280<sup>T</sup>, was isolated from the surface of the plant Hydrilla verticillata collected from an alkaline lake (Buffalo lake), University of Hyderabad, Hyderabad, India. The morphological and chemotaxonomic properties of strain JC280<sup>T</sup>were in agreement with the characteristics of the genus Planctopirus. The cell shape was spherical to ovoid and some were tear drop shaped. The cells were Gram-stain-negative divided by budding presenting stalks and rosette formation and were non-sporulating. Crateriform structures with a sub-polar flagellum were observed. Characteristic polyamines were putrescine and spermidine. Diagnostic polar lipids were diphosphatidylglycerol, phosphatidylglycerol, phosphatidylcholine, an unidentified phospholipid (PL1), unidentified glycolipids (GL1-2), an unidentified aminophospholipid (APL), and an unidentified lipid (L3). Major (&gt;10%) fatty acids were C<sub>16:0</sub>, C<sub>17:1</sub>ω8c, C<sub>18:1</sub>ω9c, and summed feature-3. Major (88%) respiratory quinone was MK-6 with minor amount (12%) of MK-7. Strain JC280<sup>T</sup>showed 99.7% 16S rRNA gene sequence similarity with Planctopirus limnophila DSM 3776<sup>T</sup>. To resolve their full taxonomic position, the genome sequence was obtained and compared with the available P. limnophila DSM 3776<sup>T</sup>genome. The genome sequence of strain JC280<sup>T</sup>was 5,750,243 bp in size with a total of 4490 protein-coding genes, 66 RNA genes, and 2 CRISPR repeats. Based on whole-genome statistics, ANI value, in silico DDH, diversity of secondary metabolite biosynthetic gene clusters, distinct physiological, biochemical and chemotaxonomic differences, strain JC280<sup>T</sup>represents a new species in the genus Planctopirus, for which the name Planctopirus hydrillae sp. nov. is proposed. The type strain is JC280<sup>T</sup>(=KCTC 42880<sup>T</sup> <sup>=</sup> LMG 29153<sup>T</sup>).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Subhash</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal Netherlands Institute for Sea Research (NIOZ), Texel, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaddavalli</LastName><ForeName>Radha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siripuram</LastName><ForeName>Srinivas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eedara</LastName><ForeName>Ramaprasad Veera Venkata</ForeName><Initials>RVV</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Shivani</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bacterial Discovery Laboratory, Centre for Environment, Institute of Science and Technology, J. N. T. University, Kukatpally, Hyderabad, 500085, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabishankar</LastName><ForeName>Ojha</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodha</LastName><ForeName>Tushar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chintalapati</LastName><ForeName>Sasikala</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bacterial Discovery Laboratory, Centre for Environment, Institute of Science and Technology, J. N. T. University, Kukatpally, Hyderabad, 500085, India. sasi449@yahoo.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chintalapati</LastName><ForeName>VenkataRamana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, P.O. Central University, Hyderabad, 500046, India. cvr449@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Antibiot (Tokyo)</MedlineTA><NlmUniqueID>0151115</NlmUniqueID><ISSNLinking>0021-8820</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467380</ArticleId><ArticleId IdType="doi">10.1038/s41429-018-0035-1</ArticleId><ArticleId IdType="pii">10.1038/s41429-018-0035-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29467265</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-2954</ISSN><JournalIssue CitedMedium="Internet"><Volume>285</Volume><Issue>1873</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Proceedings. Biological sciences</Title><ISOAbbreviation>Proc. Biol. Sci.</ISOAbbreviation></Journal><ArticleTitle><i>apterous A</i>
specifies dorsal wing patterns and sexual traits in butterflies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">20172685</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rspb.2017.2685</ELocationID><Abstract><AbstractText>Butterflies have evolved different colour patterns on their dorsal and ventral wing surfaces to serve different signalling functions, yet the developmental mechanisms controlling surface-specific patterning are still unknown. Here, we mutate both copies of the transcription factor<i>apterous</i>in<i>Bicyclus anynana</i>butterflies using CRISPR/Cas9 and show that<i>apterous A,</i>expressed dorsally, functions both as a repressor and modifier of ventral wing colour patterns, as well as a promoter of dorsal sexual ornaments in males. We propose that the surface-specific diversification of wing patterns in butterflies proceeded via the co-option of<i>apterous A</i>or its downstream effectors into various gene regulatory networks involved in the differentiation of discrete wing traits. Further, interactions between<i>apterous</i>and sex-specific factors such as<i>doublesex</i>may have contributed to the origin of sexually dimorphic surface-specific patterns. Finally, we discuss the evolution of eyespot number diversity in the family Nymphalidae within the context of developmental constraints due to<i>apterous</i>regulation.</AbstractText><CopyrightInformation>© 2018 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prakash</LastName><ForeName>Anupama</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6922-2806</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, Republic of Singapore anupama@u.nus.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Antónia</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9696-459X</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, Republic of Singapore antonia.monteiro@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale-NUS College, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc Biol Sci</MedlineTA><NlmUniqueID>101245157</NlmUniqueID><ISSNLinking>0962-8452</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apterous</Keyword><Keyword MajorTopicYN="N">butterfly wing patterns</Keyword><Keyword MajorTopicYN="N">developmental constraints</Keyword><Keyword MajorTopicYN="N">dorsal–ventral differentiation</Keyword><Keyword MajorTopicYN="N">eyespot repression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467265</ArticleId><ArticleId IdType="pii">rspb.2017.2685</ArticleId><ArticleId IdType="doi">10.1098/rspb.2017.2685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29467179</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1744-4292</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecular systems biology</Title><ISOAbbreviation>Mol. Syst. Biol.</ISOAbbreviation></Journal><ArticleTitle>Toward an integrated map of genetic interactions in cancer cells.</ArticleTitle><Pagination><MedlinePgn>e7656</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15252/msb.20177656</ELocationID><Abstract><AbstractText>Cancer genomes often harbor hundreds of molecular aberrations. Such genetic variants can be drivers or passengers of tumorigenesis and create vulnerabilities for potential therapeutic exploitation. To identify genotype-dependent vulnerabilities, forward genetic screens in different genetic backgrounds have been conducted. We devised MINGLE, a computational framework to integrate CRISPR/Cas9 screens originating from different libraries building on approaches pioneered for genetic network discovery in model organisms. We applied this method to integrate and analyze data from 85 CRISPR/Cas9 screens in human cancer cells combining functional data with information on genetic variants to explore more than 2.1 million gene-background relationships. In addition to known dependencies, we identified new genotype-specific vulnerabilities of cancer cells. Experimental validation of predicted vulnerabilities identified GANAB and PRKCSH as new positive regulators of Wnt/β-catenin signaling. By clustering genes with similar genetic interaction profiles, we drew the largest genetic network in cancer cells to date. Our scalable approach highlights how diverse genetic screens can be integrated to systematically build informative maps of genetic interactions in cancer, which can grow dynamically as more data are included.</AbstractText><CopyrightInformation>© 2018 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rauscher</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heigwer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8230-1485</Identifier><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henkel</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hielscher</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voloshanenko</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutros</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9458-817X</Identifier><AffiliationInfo><Affiliation>Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany m.boutros@dkfz.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Syst Biol</MedlineTA><NlmUniqueID>101235389</NlmUniqueID><ISSNLinking>1744-4292</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 9;291(5506):1001-4</RefSource><PMID Version="1">11232561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2017 Jan;23 (1):60-68</RefSource><PMID Version="1">27869803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 May;16(5):299-311</RefSource><PMID Version="1">25854182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Sep 26;4(6):1224-34</RefSource><PMID Version="1">24035388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Jun;14 (6):577-580</RefSource><PMID Version="1">28481362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107</RefSource><PMID Version="1">20182618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2011 Oct 21;12(10):R104</RefSource><PMID Version="1">22018332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jul 27;170(3):577-592.e10</RefSource><PMID Version="1">28753431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2008 Nov;9(11):855-67</RefSource><PMID Version="1">18852697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D679-D686</RefSource><PMID Version="1">27789686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Dec 14;294(5550):2364-8</RefSource><PMID Version="1">11743205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Clin Pract Oncol. 2006 Aug;3(8):448-57</RefSource><PMID Version="1">16894390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2011 Jan 3;585(1):1-6</RefSource><PMID Version="1">21094158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol. 2007;6(3):8</RefSource><PMID Version="1">17897480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7</RefSource><PMID Version="1">27141961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 1995 Jun;9(9):726-35</RefSource><PMID Version="1">7601337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Dec;46(12):1264-6</RefSource><PMID Version="1">25344691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Aug 06;4(8):e6529</RefSource><PMID Version="1">19657394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Jul;13(7):577-80</RefSource><PMID Version="1">27240256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2003 Nov;13(11):2498-504</RefSource><PMID Version="1">14597658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2016 Nov;17 (11):1516-1531</RefSource><PMID Version="1">27702988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 May 16;344(6185):707-8</RefSource><PMID Version="1">24833384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Feb 23;168(5):890-903.e15</RefSource><PMID Version="1">28162770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2001 Aug;24(8):479-86</RefSource><PMID Version="1">11476888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 22;327(5964):425-31</RefSource><PMID Version="1">20093466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2008 Jul;9(7):554-66</RefSource><PMID Version="1">18521077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Sep 23;353(6306):</RefSource><PMID Version="1">27708008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):184-191</RefSource><PMID Version="1">26780180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 Mar 06;4:null</RefSource><PMID Version="1">25748138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subcell Biochem. 2014;85:187-97</RefSource><PMID Version="1">25201195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Biochem Mol Biol. 2016;51(2):74-85</RefSource><PMID Version="1">26627871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Jun;34(6):631-3</RefSource><PMID Version="1">27111720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2017 Mar;36(11):1461-1473</RefSource><PMID Version="1">27617575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 Oct 15;21(20):3940-1</RefSource><PMID Version="1">16096348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783</RefSource><PMID Version="1">27899578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Mar 21;275(5307):1787-90</RefSource><PMID Version="1">9065402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Mar 15;28(6):882-3</RefSource><PMID Version="1">22257669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D793-800</RefSource><PMID Version="1">23143270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 Apr;8(4):341-6</RefSource><PMID Version="1">21378980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2004;5(10):R80</RefSource><PMID Version="1">15461798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2012 Apr 1;364(1):32-41</RefSource><PMID Version="1">22285813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Jun;14 (6):573-576</RefSource><PMID Version="1">28319113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2011 Nov;3(11):623-36</RefSource><PMID Version="1">21953712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2005 Sep;5(9):689-98</RefSource><PMID Version="1">16110319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 Mar 24;17 :55</RefSource><PMID Version="1">27013184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jul 28;166(3):740-754</RefSource><PMID Version="1">27397505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2012 Jan 15;361(2):392-402</RefSource><PMID Version="1">22108505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2009 Jul;17(1):9-26</RefSource><PMID Version="1">19619488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protein Pept Sci. 2015;16(1):31-48</RefSource><PMID Version="1">25692846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 1993 Dec;4(12):1267-75</RefSource><PMID Version="1">8167409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Dec;7(12):1017-24</RefSource><PMID Version="1">21076421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Feb;1862(2):155-65</RefSource><PMID Version="1">26581171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Mar;16(3):1197-206</RefSource><PMID Version="1">9508208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2005 Nov 15;118(Pt 22):5171-80</RefSource><PMID Version="1">16280550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Jun 8;546(7657):307-311</RefSource><PMID Version="1">28562590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2317-26</RefSource><PMID Version="1">23739767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2011;12(4):R41</RefSource><PMID Version="1">21527027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 Jul 31;424(6948):549-52</RefSource><PMID Version="1">12891357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2006 Jun;13(6):941-50</RefSource><PMID Version="1">16601750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Aug 4;63(3):514-25</RefSource><PMID Version="1">27453043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2012 Sep;32(17):3372-81</RefSource><PMID Version="1">22733992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>G3 (Bethesda). 2017 Aug 7;7(8):2719-2727</RefSource><PMID Version="1">28655737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Mar 28;483(7391):570-5</RefSource><PMID Version="1">22460902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):965-71</RefSource><PMID Version="1">24161985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2016 Aug;6(8):900-13</RefSource><PMID Version="1">27260157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Apr 19;296(5567):550-3</RefSource><PMID Version="1">11910072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2016 Aug;6(8):914-29</RefSource><PMID Version="1">27260156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2014 Feb 15;28(4):305-16</RefSource><PMID Version="1">24532711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Syst. 2016 Jun 22;2(6):412-21</RefSource><PMID Version="1">27237738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 May 5;125(3):509-22</RefSource><PMID Version="1">16678095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Mar 6;136(5):823-37</RefSource><PMID Version="1">19269363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 May;10(5):427-31</RefSource><PMID Version="1">23563794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3461-6</RefSource><PMID Version="1">18305163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2012 Nov 16;7(11):1848-57</RefSource><PMID Version="1">22894855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Mar 28;483(7391):603-7</RefSource><PMID Version="1">22460905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Nov 27;350(6264):1096-101</RefSource><PMID Version="1">26472758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cancer. 2015 Nov 1;1(3):161-173</RefSource><PMID Version="1">26870836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Toxicol Methods. 2005 May-Jun;51(3):187-200</RefSource><PMID Version="1">15862464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(Database issue):D497-501</RefSource><PMID Version="1">19884131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Sep 23;5:</RefSource><PMID Version="1">27661255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2012 May 01;4(5):null</RefSource><PMID Version="1">22438566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Nov 7;278(5340):1064-8</RefSource><PMID Version="1">9353181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Mar;33(3):306-12</RefSource><PMID Version="1">25485619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Differentiation. 2012 Sep;84(2):203-13</RefSource><PMID Version="1">22784633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2008 Oct;9(10):977-82</RefSource><PMID Version="1">18787559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Jun;34(6):634-6</RefSource><PMID Version="1">27159373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2014 Dec;15(12):1254-67</RefSource><PMID Version="1">25391905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jul 27;170(3):564-576.e16</RefSource><PMID Version="1">28753430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 May 5;125(3):523-33</RefSource><PMID Version="1">16678096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2015 Dec;16(12):742-52</RefSource><PMID Version="1">26465718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Dec 3;163(6):1515-26</RefSource><PMID Version="1">26627737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2017 Nov;31(11):4832-4844</RefSource><PMID Version="1">28733458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2016 Jul 2;34(6):255-64</RefSource><PMID Version="1">27389087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Oct 18;17 (4):1193-1205</RefSource><PMID Version="1">27760321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Jun 8;149(6):1192-205</RefSource><PMID Version="1">22682243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12649-54</RefSource><PMID Version="1">23847203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1089-92</RefSource><PMID Version="1">24097268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2000 May;25(1):25-9</RefSource><PMID Version="1">10802651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Protoc. 2016 Jun 01;2016(6):pdb.prot077644</RefSource><PMID Version="1">26988373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Jul 11;20(2):427-438</RefSource><PMID Version="1">28700943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2016 Apr 16;17 :164</RefSource><PMID Version="1">27083490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2005 May;23(5):561-6</RefSource><PMID Version="1">15877074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2015 Jun 1;35(11):2007-23</RefSource><PMID Version="1">25825523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2014 May 30;5(10):2999-3011</RefSource><PMID Version="1">24930890</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2005 Oct;37(10):1147-52</RefSource><PMID Version="1">16155567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biostatistics. 2003 Apr;4(2):249-64</RefSource><PMID Version="1">12925520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2007 Apr;12(4):521-34</RefSource><PMID Version="1">17397399</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">epistasis</Keyword><Keyword MajorTopicYN="N">genetic interactions</Keyword><Keyword MajorTopicYN="N">networks</Keyword><Keyword MajorTopicYN="N">synthetic lethality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467179</ArticleId><ArticleId IdType="pmc">PMC5820685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29466914</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1551-4005</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cell cycle (Georgetown, Tex.)</Title><ISOAbbreviation>Cell Cycle</ISOAbbreviation></Journal><ArticleTitle>Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.</ArticleTitle><Pagination><MedlinePgn>0</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15384101.2018.1442621</ELocationID><Abstract><AbstractText>To easily edit the genome of naïve human embryonic stem cells (hESC), we introduced a dual cassette encoding an inducible Cas9 into the AAVS1 site of naïve hESC (iCas9). The iCas9 line retained karyotypic stability, expression of pluripotency markers, differentiation potential, and stability in 5iLA and EPS pluripotency conditions. The iCas9 line induced efficient homology-directed repair (HDR) and non-homologous end joining (NHEJ) based mutations through CRISPR-Cas9 system. We utilized the iCas9 line to study the epigenetic regulator, PRC2 in early human pluripotency. The PRC2 requirement distinguishes between early pluripotency stages, however, what regulates PRC2 activity in these stages is not understood. We show reduced H3K27me3 and pluripotency markers in JARID2 2iL-I-F hESC mutants, indicating JARID2 requirement in maintenance of hESC 2iL-I-F state. These data suggest that JARID2 regulates PRC2 in 2iL-I-F state and the lack of PRC2 function in 5iLA state may be due to lack of sufficient JARID2 protein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferreccio</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathieu</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Comparative Medicine , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Detraux</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logeshwaran</LastName><ForeName>Somasundaram</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1924-8156</Identifier><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavanaugh</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3230-0422</Identifier><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Comparative Medicine , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sopher</LastName><ForeName>Bryce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>d Department of Neurobiology , University of Washington , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3110-7938</Identifier><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>e Department of Molecular and Cellular Biology , University of Washington , Seattle , WA , 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Assis M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Shiri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Savannah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Comparative Medicine , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Sonia B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artoni</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3902-9217</Identifier><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palpant</LastName><ForeName>Nathan J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Department of Pathology , University of Washington , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>g The Institute for Molecular Bioscience , The University of Queensland , Brisbane , Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Department of Pathology , University of Washington , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuliang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>h Paul G. Allen School of Computer Science &amp; Engineering.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paddison</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>i Human Biology Division, Fred Hutchinson Cancer Research Center , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murry</LastName><ForeName>Charles</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3862-6773</Identifier><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Department of Pathology , University of Washington , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>j Center for Cardiovascular Biology , University of Washington School of Medicine , Seattle , Washington , 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>k Department of Bioengineering , University of Washington , Seattle , WA 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>l Department of Medicine/Cardiology , University of Washington , Seattle , WA 98195 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayadev</LastName><ForeName>Suman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>d Department of Neurobiology , University of Washington , Seattle , WA 98109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ware</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7171-6685</Identifier><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Comparative Medicine , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruohola-Baker</LastName><ForeName>Hannele</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5588-4531</Identifier><AffiliationInfo><Affiliation>a Department of Biochemistry , University of Washington , Seattle , Washington 98195 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute for Stem Cell and Regenerative Medicine , University of Washington , Seattle , Washington 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>e Department of Molecular and Cellular Biology , University of Washington , Seattle , WA , 98109 , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>k Department of Bioengineering , University of Washington , Seattle , WA 98195 , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Cycle</MedlineTA><NlmUniqueID>101137841</NlmUniqueID><ISSNLinking>1551-4005</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">JARID2</Keyword><Keyword MajorTopicYN="N">PRC2</Keyword><Keyword MajorTopicYN="N">PSEN2</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">human embryonic stem cells</Keyword><Keyword MajorTopicYN="N">naïve hESC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29466914</ArticleId><ArticleId IdType="doi">10.1080/15384101.2018.1442621</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29465426</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-6543</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Current opinion in nephrology and hypertension</Title><ISOAbbreviation>Curr. Opin. Nephrol. Hypertens.</ISOAbbreviation></Journal><ArticleTitle>Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/MNH.0000000000000408</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">The widespread adoption of next-generation sequencing by research and clinical laboratories has begun to uncover the previously unknown genetic basis of many diseases. In nephrology, one of the best examples of this is seen in focal and segmental glomerulosclerosis (FSGS) and nephrotic syndrome. We review advances made in 2017 as a result of human and molecular genetic studies as it relates to FSGS and nephrotic syndrome.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">There are more than 50 monogenic genes described in steroid-resistant nephrotic syndrome and FSGS, with seven reported in 2017. In individuals presenting with FSGS or nephrotic syndrome before or at the age of 18 years, the commonest genes in which a mutation is found continues to be limited to only a few including NPHS1 and NPHS2 based on multiple studies. For FSGS or nephrotic syndrome that presents after 18 years, a preponderance of mutations in COL4A3/4/5, traditionally reported in Alport syndrome, is reported. Despite the extensive genetic heterogeneity in FSGS, there is evidence that some of these genes converge onto common pathways. There are also reports of in-vivo models exploring apolipoprotein 1 biology, variants in which account for part of the increased risk of nondiabetic kidney disease in African-Americans. Finally, genetic testing has several clinical uses including clarification of diagnosis and treatment; identification of suitable young biologic relatives for kidney donation; and preimplantation genetic diagnosis. CRISPR gene editing is currently an experimental tool only, but the recent reports of excising mutations in embryos could be a therapeutic option for individuals with any monogenic disorder in the future.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Sequencing efforts are bringing novel variants into investigation and directing the efforts to understand how these lead to disease phenotypes. Expanding our understanding of the genetic basis of health and disease processes is the necessary first step to elaborate the repertoire of therapeutic agents available for patients with FSGS and nephrotic syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Bedra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Toronto General Research Institute, Toronto General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barua</LastName><ForeName>Moumita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Toronto General Research Institute, Toronto General Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, University Health Network.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Nephrol Hypertens</MedlineTA><NlmUniqueID>9303753</NlmUniqueID><ISSNLinking>1062-4821</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29465426</ArticleId><ArticleId IdType="doi">10.1097/MNH.0000000000000408</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29465287</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>The Exoribonuclease Xrn1 Is a Post-Transcriptional Negative Regulator of Autophagy.</ArticleTitle><Pagination><MedlinePgn>1-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2018.1441648</ELocationID><Abstract><AbstractText>Macroautophagy/autophagy is a conserved catabolic process that promotes survival during stress. Autophagic dysfunction is associated with pathologies such as cancer and neurodegenerative diseases. Thus, autophagy must be strictly modulated at multiple levels (transcriptional, post-transcriptional, translational and post-translational) to prevent deregulation. Relatively little is known about the post-transcriptional control of autophagy. Here we report that the exoribonuclease Xrn1/XRN1 functions as a negative autophagy factor in the yeast Saccharomyces cerevisiae and in mammalian cells. In yeast, chromosomal deletion of XRN1 enhances autophagy and the frequency of autophagosome formation. Loss of Xrn1 results in the upregulation of autophagy-related (ATG) transcripts under nutrient-replete conditions, and this effect is dependent on the ribonuclease activity of Xrn1. Xrn1 expression is regulated by the yeast transcription factor Ash1 in rich conditions. In mammalian cells, siRNA depletion of XRN1 enhances autophagy and the replication of 2 picornaviruses. This work provides insight into the role of the RNA decay factor Xrn1/XRN1 as a post-transcriptional regulator of autophagy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Delorme-Axford</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>a Life Sciences Institute , University of Michigan , Ann Arbor , MI 48109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abernathy</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>b Department of Genetics , Stanford University School of Medicine , Stanford , CA 94305 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lennemann</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>c Department of Pediatrics , University of Pittsburgh , Pittsburgh , PA 15224 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Amélie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Life Sciences Institute , University of Michigan , Ann Arbor , MI 48109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariosa</LastName><ForeName>Aileen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Life Sciences Institute , University of Michigan , Ann Arbor , MI 48109 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coyne</LastName><ForeName>Carolyn B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>c Department of Pediatrics , University of Pittsburgh , Pittsburgh , PA 15224 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkegaard</LastName><ForeName>Karla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>b Department of Genetics , Stanford University School of Medicine , Stanford , CA 94305 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klionsky</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>a Life Sciences Institute , University of Michigan , Ann Arbor , MI 48109 , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM053396</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ash1</Keyword><Keyword MajorTopicYN="N">Atg8</Keyword><Keyword MajorTopicYN="N">BECN1</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">CVB</Keyword><Keyword MajorTopicYN="N">Dcp2</Keyword><Keyword MajorTopicYN="N">LC3</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">RNA decay</Keyword><Keyword MajorTopicYN="N">autophagosome</Keyword><Keyword MajorTopicYN="N">autophagy-related</Keyword><Keyword MajorTopicYN="N">coxsackievirus B</Keyword><Keyword MajorTopicYN="N">mRNA</Keyword><Keyword MajorTopicYN="N">macroautophagy</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">stress</Keyword><Keyword MajorTopicYN="N">vacuole</Keyword><Keyword MajorTopicYN="N">yeast</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29465287</ArticleId><ArticleId IdType="doi">10.1080/15548627.2018.1441648</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29464088</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Deciphering microRNA targets in pancreatic cancer using miRComb R package.</ArticleTitle><Pagination><MedlinePgn>6499-6517</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.24034</ELocationID><Abstract><AbstractText>MiRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression. They play important roles in cancer but little is known about the specific functions that each miRNA exerts in each type of cancer. More knowledge about their specific targets is needed to better understand the complexity of molecular networks taking part in cancer. In this study we report the miRNA-mRNA interactome occurring in pancreatic cancer by using a bioinformatic approach called miRComb, which combines tissue expression data with miRNA-target prediction databases (TargetScan, miRSVR and miRDB). MiRNome and transcriptome of 12 human pancreatic tissues (9 pancreatic ductal adenocarcinomas and 3 controls) were analyzed by next-generation sequencing and microarray, respectively. Analysis confirmed differential expression of both miRNAs and mRNAs in cancerous tissue versus control, and unveiled 17401 relevant miRNA-mRNA interactions likely to occur in pancreatic cancer. They were sorted according to the degree of negative correlation between miRNA and mRNA expression. Results highlighted the importance of miR-148a and miR-21 interactions among others. Two components of the Notch signaling pathway, ADAM17 and EP300, were confirmed as miR-148a targets in MiaPaca-2 pancreatic cancer cells overexpressing miR-148a. Moreover, a CRISPR-Cas9 cellular model was generated to knock-out the expression of miR-21 in PANC-1 cells. As expected, the expression of two miRComb miR-21 predicted targets, PDCD4 and BTG2, was significantly upregulated in these cells in comparison to control PANC-1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vila-Casadesús</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastrointestinal &amp; Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Platform, CIBEREHD, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila-Navarro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Gastrointestinal &amp; Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raimondi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gene Therapy and Cancer, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universitat de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fillat</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Gene Therapy and Cancer, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universitat de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castells</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gastrointestinal &amp; Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano</LastName><ForeName>Juan José</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Gastrointestinal &amp; Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Platform, CIBEREHD, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gironella</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastrointestinal &amp; Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2010 Jul;56(7):1107-18</RefSource><PMID Version="1">20431052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Dec;21 Suppl 4:S564-74</RefSource><PMID Version="1">24748127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2003 Apr;9(4):818-23</RefSource><PMID Version="1">12679940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Jun 1;70(11):4528-38</RefSource><PMID Version="1">20460539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2005 Nov 7;11(41):6543-8</RefSource><PMID Version="1">16425432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2017 Jun;265(6):1226-1234</RefSource><PMID Version="1">27232245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 27;44(13):6019-35</RefSource><PMID Version="1">27317695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Jan 14;120(1):15-20</RefSource><PMID Version="1">15652477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2010;11(10):R106</RefSource><PMID Version="1">20979621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2007 Jul 6;27(1):91-105</RefSource><PMID Version="1">17612493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014 Feb 03;15(2):R29</RefSource><PMID Version="1">24485249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 31;8(12 ):e85502</RefSource><PMID Version="1">24392017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2007 Nov;13(11):1894-910</RefSource><PMID Version="1">17872505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 2011 Oct;91(10 ):1472-9</RefSource><PMID Version="1">21709669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2011 May;11(5):338-51</RefSource><PMID Version="1">21508972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pathol. 2014;9:287-314</RefSource><PMID Version="1">24079833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Jan 15;18(2):534-45</RefSource><PMID Version="1">22114136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Oct 13;9(10):e110267</RefSource><PMID Version="1">25310697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708</RefSource><PMID Version="1">19806144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2011 Nov 18;12(12):861-74</RefSource><PMID Version="1">22094949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2010;11(8):R90</RefSource><PMID Version="1">20799968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Sep 1;39(16):6845-53</RefSource><PMID Version="1">21652644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2003 Dec;4(6):437-50</RefSource><PMID Version="1">14706336</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Haematol. 2013;130(2):87-94</RefSource><PMID Version="1">23548551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Apr;6(4):259-69</RefSource><PMID Version="1">16557279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2392-403</RefSource><PMID Version="1">26036346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mamm Genome. 2006 Mar;17(3):189-202</RefSource><PMID Version="1">16518686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2014 Sep;22(9):1665-77</RefSource><PMID Version="1">24895996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(1):37-52</RefSource><PMID Version="1">21911355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jan;35(1):837-44</RefSource><PMID Version="1">23975374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2010 Mar;7(3):163-72</RefSource><PMID Version="1">20101258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Oct 10;24(29):4677-84</RefSource><PMID Version="1">16966691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2012 Mar;58(3):610-8</RefSource><PMID Version="1">22194634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2009 May;8(5):1067-74</RefSource><PMID Version="1">19435867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2006 Nov 15;20(22):3161-73</RefSource><PMID Version="1">17114586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52</RefSource><PMID Version="1">25378301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2003 Jun;3(6):565-76</RefSource><PMID Version="1">12842085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2005 Sep;8(3):185-95</RefSource><PMID Version="1">16169464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2013 Apr 4;32(14):1843-53</RefSource><PMID Version="1">22614007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2013 Jul 03;14:438</RefSource><PMID Version="1">23819653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2015 Oct;12(4):4917-24</RefSource><PMID Version="1">26151427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Dev Res. 2015 Sep;76(6):270-7</RefSource><PMID Version="1">26082192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8</RefSource><PMID Version="1">17991681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Apr 3;27(15):2128-36</RefSource><PMID Version="1">17968323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastrointest Surg. 2008 Dec;12(12):2171-6</RefSource><PMID Version="1">18642050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2016 Mar;63(3):864-79</RefSource><PMID Version="1">26599259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Jan 23;136(2):215-33</RefSource><PMID Version="1">19167326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mod Pathol. 2012 Jan;25(1):112-21</RefSource><PMID Version="1">21983937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2013 Apr 15;19(8):2096-106</RefSource><PMID Version="1">23446999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cancer Res. 2017 Feb 01;7(2):173-186</RefSource><PMID Version="1">28337369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Mar 11;11(3):e0151127</RefSource><PMID Version="1">26967326</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">pancreatic cancer</Keyword><Keyword MajorTopicYN="N">target prediction</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST There are no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29464088</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.24034</ArticleId><ArticleId IdType="pii">24034</ArticleId><ArticleId IdType="pmc">PMC5814228</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29464070</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>2-Amino-3-methylcarboxy-5-heptyl-thiophene (TJ191) is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.</ArticleTitle><Pagination><MedlinePgn>6259-6269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23501</ELocationID><Abstract><AbstractText>Current chemotherapy regimens often include non-specific cytostatic/cytotoxic drugs, which do not distinguish between normal and tumor cells, therefore causing considerable systemic toxicity. We previously reported the synthesis and anti-proliferative activity of a novel synthetic 2-aminothiophene-3-carboxylic acid ester derivative TJ191 that selectively targets certain cancer cells without affecting the proliferation of other cancer cells or normal fibroblasts or immune cells (over 600-fold selectivity). In a panel of ten human T-cell leukemia/lymphoma cell lines and peripheral blood mononuclear cells (PBMCs), we now found that transforming growth factor β type III receptor (TβRIII) expression correlates inversely with TJ191 sensitivity, but not with sensitivity against classical chemotherapeutic drugs, thus serving as a predictive marker for TJ191 sensitivity. Accordingly, CRISPR/Cas9-mediated knock-out of TβRIII partially restored the susceptibility of TJ191-resistant cells to this novel compound. Our findings highlight TJ191 as a potent and selective anti-cancer molecule with pronounced activity against human malignant T-cells expressing low levels of TβRIII.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Gazzar</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noppen</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Joice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehaen</LastName><ForeName>Wim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chemistry, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balzarini</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liekens</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Eur J Med Chem. 2017 May 26;132:219-235</RefSource><PMID Version="1">28365318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2012 Oct;11(10):790-811</RefSource><PMID Version="1">23000686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2003 Jun 13;113(6):685-700</RefSource><PMID Version="1">12809600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Nov 1;68(21):8643-53</RefSource><PMID Version="1">18974103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Mar;29(3):528-35</RefSource><PMID Version="1">18174241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2002 Oct 24;21(49):7514-23</RefSource><PMID Version="1">12386814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Jul;6(7):506-20</RefSource><PMID Version="1">16794634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource><PMID Version="1">21376230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2006 Aug 24;49(17):5339-51</RefSource><PMID Version="1">16913724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest New Drugs. 2014 Feb;32(1):200-10</RefSource><PMID Version="1">23733228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2013 Oct;13(10):714-26</RefSource><PMID Version="1">24060863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Aug 15;62(16):4690-5</RefSource><PMID Version="1">12183427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Oct;6(10 ):813-23</RefSource><PMID Version="1">16990858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2007 Jan;117(1):206-17</RefSource><PMID Version="1">17160136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Feb 26;160(5):963-76</RefSource><PMID Version="1">25723170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2011 Mar 24;54(6):1927-42</RefSource><PMID Version="1">21332170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Feb 28;8(9):14325-14342</RefSource><PMID Version="1">27224920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Feb 1;67(3):1090-8</RefSource><PMID Version="1">17283142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1991 Nov 15;67(4):797-805</RefSource><PMID Version="1">1657407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2014 Nov;11(11):649-62</RefSource><PMID Version="1">25286976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ChemMedChem. 2014 Dec;9(12):2744-53</RefSource><PMID Version="1">25234111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Mar 20;23(9):2078-93</RefSource><PMID Version="1">15774796</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T-cell leukemia/lymphoma</Keyword><Keyword MajorTopicYN="N">TβRIII</Keyword><Keyword MajorTopicYN="N">cytostatic/cytotoxic anti-cancer molecule</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST J.B., W.D., J.T., S.L. are co-inventors on a patent application entitled “Novel antiproliferative agents” related to the TJ191 compound.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29464070</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23501</ArticleId><ArticleId IdType="pii">23501</ArticleId><ArticleId IdType="pmc">PMC5814210</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29463822</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>True gene-targeting events by CRISPR/Cas-induced DSB repair of the PPO locus with an ectopically integrated repair template.</ArticleTitle><Pagination><MedlinePgn>3338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-21697-z</ELocationID><Abstract><AbstractText>In recent years, several tools have become available for improved gene-targeting (GT) in plants. DNA breaks at specific sites activate local DNA repair and recombination, including recombination with ectopic sequences leading to GT. Large-scale transformation with the repair template can be avoided by pre-insertion of the repair template in the genome and liberation by sequence-specific nucleases (in planta GT procedure). Here, we tested whether release of the repair template was required for GT. Plants were transformed with constructs encoding a CRISPR/Cas nuclease with a recognition site in the endogenous PPO gene and a repair template harboring a 5' truncated PPO gene with two amino acid substitutions rendering the enzyme insensitive to the herbicide butafenacil. Selection resulted in so-called true GT events, repaired via homologous recombination at both ends of the gene and transmitted to the next generation. As the template was surrounded by geminiviral LIR sequences, we also tested whether replication of the template could be induced by crossing-in an integrated geminivirus REP gene. However, we could not find evidence for repair template replication by REP and we obtained similar numbers of GT events in these plants. Thus, GT is possible without any further processing of the pre-inserted repair template.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Pater</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2626-3661</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Developmental Genetics, Institute of Biology, Leiden University, Leiden, 2333 BE, The Netherlands. b.s.de.pater@biology.leidenuniv.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klemann</LastName><ForeName>Bart J P M</ForeName><Initials>BJPM</Initials><AffiliationInfo><Affiliation>Department of Molecular and Developmental Genetics, Institute of Biology, Leiden University, Leiden, 2333 BE, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dümmen Orange, De Lier, 2678 PS, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooykaas</LastName><ForeName>Paul J J</ForeName><Initials>PJJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9736-6927</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Developmental Genetics, Institute of Biology, Leiden University, Leiden, 2333 BE, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 May 21;459(7245):442-5</RefSource><PMID Version="1">19404258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell. 2014 Jan;26(1):151-63</RefSource><PMID Version="1">24443519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2016 Feb;170(2):667-77</RefSource><PMID Version="1">26668334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2016 Feb;14 (2):519-32</RefSource><PMID Version="1">26360626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 1999 Jul;152(3):1173-81</RefSource><PMID Version="1">10388832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2014 Jul;79(2):348-59</RefSource><PMID Version="1">24836556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell Physiol. 2015 Mar;56(3):389-400</RefSource><PMID Version="1">25416289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2009 Oct;7(8):821-35</RefSource><PMID Version="1">19754840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2013 Apr;11(3):305-14</RefSource><PMID Version="1">23094946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>G3 (Bethesda). 2017 Jan 5;7(1):193-202</RefSource><PMID Version="1">27866150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 1998 Dec;16(6):735-43</RefSource><PMID Version="1">10069079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Plant Biol. 2017 Apr;36:1-8</RefSource><PMID Version="1">27914284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Nov 06;16:232</RefSource><PMID Version="1">26541286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Mol Biol. 2015 Jan;87(1-2):99-110</RefSource><PMID Version="1">25344637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Biotechnol. 2015 Mar 12;15:16</RefSource><PMID Version="1">25879861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Methods. 2013 Oct 11;9(1):39</RefSource><PMID Version="1">24112467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2015 Jan-Feb;33(1):41-52</RefSource><PMID Version="1">25536441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2003 Oct;133(2):736-47</RefSource><PMID Version="1">12972658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2017 Mar;89(6):1251-1262</RefSource><PMID Version="1">27943461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Vaccin. 2011 Mar;7(3):331-8</RefSource><PMID Version="1">21358270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2013 Jan;161(1):20-7</RefSource><PMID Version="1">23124327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2015 Apr;199(4):959-71</RefSource><PMID Version="1">25695951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2015 Apr;32:76-84</RefSource><PMID Version="1">25437637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnology (N Y). 1991 Oct;9(10):963-7</RefSource><PMID Version="1">1368724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2001 Dec;28(6):671-7</RefSource><PMID Version="1">11851913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2014 Dec;80(6):1139-50</RefSource><PMID Version="1">25327456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2015 Feb;33(2):120-31</RefSource><PMID Version="1">25496918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Plant Biol. 2013;64:327-50</RefSource><PMID Version="1">23451779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 May 14;93(10):5055-60</RefSource><PMID Version="1">8643528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2013 May;11(4):510-5</RefSource><PMID Version="1">23279135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Dev Biol. 2013;57(6-8):629-37</RefSource><PMID Version="1">24166445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1990 Oct;9(10):3077-84</RefSource><PMID Version="1">2209538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2017;149:65-80</RefSource><PMID Version="1">28712501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 May 8;109(19):7535-40</RefSource><PMID Version="1">22529367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2015 Aug;8(8):1274-84</RefSource><PMID Version="1">25917172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 May 21;459(7245):437-41</RefSource><PMID Version="1">19404259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2017 Aug;174(4):2023-2037</RefSource><PMID Version="1">28646085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29463822</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-21697-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-21697-z</ArticleId><ArticleId IdType="pmc">PMC5820285</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29463653</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>MBio</ISOAbbreviation></Journal><ArticleTitle>Efficient and Scalable Precision Genome Editing in<i>Staphylococcus aureus</i>through Conditional Recombineering and CRISPR/Cas9-Mediated Counterselection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00067-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.00067-18</ELocationID><Abstract><AbstractText><i>Staphylococcus aureus</i>
is an important human pathogen, but studies of the organism have suffered from the lack of a robust tool set for its genetic and genomic manipulation. Here we report the development of a system for the facile and high-throughput genomic engineering of<i>S. aureus</i>using single-stranded DNA (ssDNA) oligonucleotide recombineering coupled with clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-mediated counterselection. We identify recombinase<i>EF2132</i>, derived from<i>Enterococcus faecalis</i>, as being capable of integrating single-stranded DNA oligonucleotides into the<i>S. aureus</i>genome. We found that<i>EF2132</i>can readily mediate recombineering across multiple characterized strains (3 of 3 tested) and primary clinical isolates (6 of 6 tested), typically yielding thousands of recombinants per transformation. Surprisingly, we also found that some<i>S. aureus</i>strains are naturally recombinogenic at measurable frequencies when oligonucleotides are introduced by electroporation, even without exogenous recombinase expression. We construct a temperature-sensitive, two-vector system which enables conditional recombineering and CRISPR/Cas9-mediated counterselection in<i>S. aureus</i>without permanently introducing exogenous genetic material or unintended genetic lesions. We demonstrate the ability of this system to efficiently and precisely engineer point mutations and large single-gene deletions in the<i>S. aureus</i>genome and to yield highly enriched populations of engineered recombinants even in the absence of an externally selectable phenotype. By virtue of utilizing inexpensive, commercially synthesized synthetic DNA oligonucleotides as substrates for recombineering and counterselection, this system provides a scalable, versatile, precise, inexpensive, and generally useful tool for producing isogenic strains in<i>S. aureus</i>which will enable the high-throughput functional assessment of genome variation and gene function across multiple strain backgrounds.<b>IMPORTANCE</b>Engineering genetic changes in bacteria is critical to understanding the function of particular genes or mutations but is currently a laborious and technically challenging process to perform for the important human pathogen<i>Staphylococcus aureus</i>In an effort to develop methods which are rapid, easy, scalable, versatile, and inexpensive, here we describe a system for incorporating synthetic, mutagenic DNA molecules into the<i>S. aureus</i>genome and for eliminating cells that lack the engineered mutation. This method allows efficient, precise, and high-throughput genetic engineering of<i>S. aureus</i>strains and will facilitate studies seeking to address a variety of issues about the function of particular genes and specific mutations.</AbstractText><CopyrightInformation>Copyright © 2018 Penewit et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penewit</LastName><ForeName>Kelsi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLean</LastName><ForeName>Kathyrn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Mingxin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waalkes</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salipante</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA stevesal@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2011 Dec;157(Pt 12):3314-23</RefSource><PMID Version="1">21921101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2014 Feb 13;10(2):e1003871</RefSource><PMID Version="1">24550724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(9):e24301</RefSource><PMID Version="1">21912685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 May 26;6(3):e00308-15</RefSource><PMID Version="1">26015493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2015 Apr;53(4):1072-9</RefSource><PMID Version="1">25631811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 1995;47:209-16</RefSource><PMID Version="1">7550737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Microbiol. 1954 Feb;10(1):174-6</RefSource><PMID Version="1">13130839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathogens. 2015 Mar 02;4(1):66-89</RefSource><PMID Version="1">25738646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1987 Oct;53(10):2452-7</RefSource><PMID Version="1">2447829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Oct 14;5:15096</RefSource><PMID Version="1">26463009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2011 Mar 18;407(1):45-59</RefSource><PMID Version="1">21256136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioengineered. 2012 Jul-Aug;3(4):209-17</RefSource><PMID Version="1">22750793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2012;8(11):e1003003</RefSource><PMID Version="1">23133387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Microbiol. 2014 Feb 06;32:Unit 9C.3.</RefSource><PMID Version="1">24510849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2003 Jan;185(2):610-9</RefSource><PMID Version="1">12511508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 2014 Oct;36(10):991-6</RefSource><PMID Version="1">25100240</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Feb;14 (2):153-159</RefSource><PMID Version="1">27992409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2011 Feb 1;52(3):285-92</RefSource><PMID Version="1">21217178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2502-7</RefSource><PMID Version="1">26884157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2016 Jul;34(7):575-587</RefSource><PMID Version="1">26944793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1626-31</RefSource><PMID Version="1">18230724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Sep 1;39(16):7336-47</RefSource><PMID Version="1">21609953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Jul;81(13):4423-31</RefSource><PMID Version="1">25911483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1972 Feb;109(2):844-7</RefSource><PMID Version="1">5058455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Jan;190(1):300-10</RefSource><PMID Version="1">17951380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Aug 13;460(7257):894-898</RefSource><PMID Version="1">19633652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2007 Oct 17;298(15):1763-71</RefSource><PMID Version="1">17940231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15748-53</RefSource><PMID Version="1">14673109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 1999 Dec;14 (6):1340-4</RefSource><PMID Version="1">10624764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Oct 19;550(7676):407-410</RefSource><PMID Version="1">28931002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2017 Mar 15;139(10 ):3790-3795</RefSource><PMID Version="1">28218837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Biochim Biophys Sin (Shanghai). 2017 Sep 1;49(9):764-770</RefSource><PMID Version="1">28910979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Announc. 2015 Sep 24;3(5):null</RefSource><PMID Version="1">26404610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2012 Apr;50(4):1355-61</RefSource><PMID Version="1">22238442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(9):e44638</RefSource><PMID Version="1">22957093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 2006 Jan;55(1):58-63</RefSource><PMID Version="1">16051359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Microbiol. 2012 Dec 05;12:288</RefSource><PMID Version="1">23216979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2016 Mar 22;3:CD011581</RefSource><PMID Version="1">27003247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2013 Feb 28;56(4):1389-404</RefSource><PMID Version="1">23294220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2014 Dec;196(23):4140-51</RefSource><PMID Version="1">25225270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2011 Jul;49(7):2680-4</RefSource><PMID Version="1">21525224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2016 Sep 13;7(5):</RefSource><PMID Version="1">27624131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2016 Feb;37:61-68</RefSource><PMID Version="1">26629846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 2009 Mar;61(2):126-9</RefSource><PMID Version="1">18996145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2004 Mar;186(5):1518-30</RefSource><PMID Version="1">14973027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Aug 15;82(17 ):5421-7</RefSource><PMID Version="1">27342565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6742-6</RefSource><PMID Version="1">11381128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2013 Mar;159(Pt 3):421-35</RefSource><PMID Version="1">23378573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1997 Mar;179(5):1614-21</RefSource><PMID Version="1">9045821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Oct;12(10):982-8</RefSource><PMID Version="1">26322839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 1997 Jun 1;151(1):1-8</RefSource><PMID Version="1">9198277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2006 May;60(4):820-7</RefSource><PMID Version="1">16677295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 May;6(5):343-5</RefSource><PMID Version="1">19363495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2011 Nov;77(22):8097-105</RefSource><PMID Version="1">21926198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Biochim Biophys Sin (Shanghai). 2015 Apr;47(4):231-43</RefSource><PMID Version="1">25739462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 1996 Dec;40(12):2680-5</RefSource><PMID Version="1">9124822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Microbiol. 1952 Feb;6(1-2):95-107</RefSource><PMID Version="1">14927856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Lett. 2013 Feb;150(1-2):12-22</RefSource><PMID Version="1">23376548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2004 Aug 21-27;364(9435):703-5</RefSource><PMID Version="1">15325835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2004 Oct;70(10):6076-85</RefSource><PMID Version="1">15466553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2015 Apr;23(4):225-32</RefSource><PMID Version="1">25698413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2012 Mar 20;3(2):null</RefSource><PMID Version="1">22434850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Aug 20;339(8):520-32</RefSource><PMID Version="1">9709046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2015 Jun;99(12):5151-62</RefSource><PMID Version="1">25750031</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">genetic engineering</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">mutS</Keyword><Keyword MajorTopicYN="N">recombineering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29463653</ArticleId><ArticleId IdType="pii">mBio.00067-18</ArticleId><ArticleId IdType="doi">10.1128/mBio.00067-18</ArticleId><ArticleId IdType="pmc">PMC5821094</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29463564</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-0020</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Blood</Title><ISOAbbreviation>Blood</ISOAbbreviation></Journal><ArticleTitle>Glutaminolysis is a metabolic dependency in FLT3<sup>ITD</sup>acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">blood-2017-12-820035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1182/blood-2017-12-820035</ELocationID><Abstract><AbstractText>FLT3 internal tandem duplication (FLT3<sup>ITD</sup>) are common mutations in acute myeloid leukemia (AML) associated with poor patient prognosis. Although new generation FLT3 tyrosine kinase inhibitors (TKI) have shown promising results, the outcome of FLT3<sup>ITD</sup>AML patients remains poor and demands the identification of novel, specific and validated therapeutic targets for this highly aggressive AML subtype. Utilizing an unbiased genome-wide CRISPR/Cas9 screen, we identify GLS, the first enzyme in glutamine metabolism, as synthetically lethal with FLT3-TKI treatment. Using complementary metabolomic and gene-expression analysis, we demonstrate that glutamine metabolism, through its ability to support both mitochondrial function and cellular redox metabolism, becomes a metabolic dependency of FLT3<sup>ITD</sup>AML, specifically unmasked by FLT3-TKI treatment. We extend these findings to AML subtypes driven by other tyrosine kinase (TK) activating mutations, and validate the role of GLS as a clinically actionable therapeutic target in both primary AML and<i>in vivo</i>models. Our work highlights the role of metabolic adaptations as a resistance mechanism to several TKI, and suggests glutaminolysis as a therapeutically targetable vulnerability when combined with specific TKI in FLT3<sup>ITD</sup>and other TK activating mutation driven leukemias.</AbstractText><CopyrightInformation>Copyright © 2018 American Society of Hematology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gallipoli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giotopoulos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Haematology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzelepis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ana S H</ForeName><Initials>ASH</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vohra</LastName><ForeName>Shabana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Perez</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basheer</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marando</LastName><ForeName>Ludovica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lisio</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Haematology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Joao M L</ForeName><Initials>JML</Initials><AffiliationInfo><Affiliation>Department of Haematology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Haematology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasca</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliou</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frezza</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huntly</LastName><ForeName>Brian J P</ForeName><Initials>BJP</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, United Kingdom; bjph2@cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Blood</MedlineTA><NlmUniqueID>7603509</NlmUniqueID><ISSNLinking>0006-4971</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29463564</ArticleId><ArticleId IdType="pii">blood-2017-12-820035</ArticleId><ArticleId IdType="doi">10.1182/blood-2017-12-820035</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29463318</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8161</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Parasitology</Title><ISOAbbreviation>Parasitology</ISOAbbreviation></Journal><ArticleTitle>New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S003118201800001X</ELocationID><Abstract><AbstractText>Although the application of CRISPR/Cas9 genome engineering approaches was first reported in apicomplexan parasites only 3 years ago, this technology has rapidly become an essential component of research on apicomplexan parasites. This review briefly describes the history of CRISPR/Cas9 and the principles behind its use along with documenting its implementation in apicomplexan parasites, especially Plasmodium spp. and Toxoplasma gondii. We also discuss the recent use of CRISPR/Cas9 for whole genome screening of gene knockout mutants in T. gondii and highlight its use for seminal genetic manipulations of Cryptosporidium spp. Finally, we consider new variations of CRISPR/Cas9 that have yet to be implemented in apicomplexans. Whereas CRISPR/Cas9 has already accelerated rapid interrogation of gene function in apicomplexans, the full potential of this technology is yet to be realized as new variations and innovations are integrated into the field.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Cristina</LastName><ForeName>Manlio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry,Biology and Biotechnology,University of Perugia,Perugia 06122,Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carruthers</LastName><ForeName>Vern B</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology,University of Michigan Medical School,Ann Arbor,Michigan 48109,USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI046675</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI120607</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parasitology</MedlineTA><NlmUniqueID>0401121</NlmUniqueID><ISSNLinking>0031-1820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apicomplexans</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">genetic manipulation</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">recombination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29463318</ArticleId><ArticleId IdType="pii">S003118201800001X</ArticleId><ArticleId IdType="doi">10.1017/S003118201800001X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29463237</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.</ArticleTitle><Pagination><MedlinePgn>210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4126-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Accumulating evidence suggest that autophagy plays a pivotal role in various anticancer therapies, including photodynamic therapy (PDT), acting as a pro-death or pro-survival mechanism in a context-dependent manner. Therefore, we aimed to determine the role of autophagy in Photofrin-based PDT.</AbstractText><AbstractText Label="METHODS">In vitro cytotoxic/cytostatic effects of PDT were evaluated with crystal violet cell viability assay. Autophagy induction was analyzed by immunoblotting and immunofluorescence using anti-LC3 antibody. Autophagy was inhibited by shRNA-mediated ATG5 knockdown or CRISPR/Cas9-mediated ATG5 knockout. Apoptosis was assessed by flow cytometry analysis of propidium iodide and anexin V-positive cells as well as by detection of cleaved PARP and caspase 3 proteins using immunoblotting. Protein carbonylation was evaluated by the 2,4-dinitrophenylhydrazine (DNPH) method.</AbstractText><AbstractText Label="RESULTS">Photofrin-PDT leads to robust autophagy induction in two cancer cell lines, Hela and MCF-7. shRNA-mediated knockdown of ATG5 only partially blocks autophagic response and only marginally affects the sensitivity of Hela and MCF-7 cells to PDT. ATG5 knockout in HeLa cell line utilizing CRISPR/Cas9 genome editing results in increased PDT-mediated cytotoxicity, which is accompanied by an enhanced apoptotic response and increased accumulation of carbonylated proteins.</AbstractText><AbstractText Label="CONCLUSIONS">Altogether, these observations imply that autophagy contributes to Photofrin-PDT resistance by enabling clearance of carbonylated and other damaged proteins. Therefore, autophagy inhibition may serve as a strategy to improve PDT efficacy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Domagala</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stachura</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate School of Molecular Medicine, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabrysiak</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunity&amp;Cancer Laboratory, The Francis Crick Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muchowicz</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zagozdzon</LastName><ForeName>Radoslaw</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioinformatics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golab</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firczuk</LastName><ForeName>Malgorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Medical University of Warsaw, 1A Banacha Str., F building, 02-097, Warsaw, Poland. mfirczuk@wum.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DI2013006643</GrantID><Agency>Ministerstwo Nauki i Szkolnictwa Wyższego</Agency><Country>International</Country></Grant><Grant><GrantID>STREAM 692190</GrantID><Agency>European Commission</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2003 Mar;194(3):363-75</RefSource><PMID Version="1">12548556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Photochem Photobiol Sci. 2015 Aug;14(8):1410-24</RefSource><PMID Version="1">25666525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Photodiagnosis Photodyn Ther. 2016 Jun;14 :57-65</RefSource><PMID Version="1">26868051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2010 Feb;6(2):248-55</RefSource><PMID Version="1">20083906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Photochem Photobiol. 2007 Sep-Oct;83(5):1024-8</RefSource><PMID Version="1">17880495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Feb 5;140(3):313-26</RefSource><PMID Version="1">20144757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2006 Jul-Sep;2(3):238-40</RefSource><PMID Version="1">16874066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 Dec;7(12 ):961-7</RefSource><PMID Version="1">17972889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2016 Oct 1;76(19):5610-5614</RefSource><PMID Version="1">27634767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2009 Jan;1792(1):3-13</RefSource><PMID Version="1">19022377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81</RefSource><PMID Version="1">21617154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2010 Jan;6(1):7-18</RefSource><PMID Version="1">19855190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2009 Jul;10 (7):458-67</RefSource><PMID Version="1">19491929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2008 May;19(5):2092-100</RefSource><PMID Version="1">18321988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1976 Jul;36(7 PT 1):2326-9</RefSource><PMID Version="1">1277137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2012 Nov;19(11):1880-91</RefSource><PMID Version="1">22705852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 2015 Jan;93(1):35-42</RefSource><PMID Version="1">25331550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Biochim Pol. 2005;52(2):339-52</RefSource><PMID Version="1">15990919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2013 Oct;9(10):1449-50</RefSource><PMID Version="1">23800703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2012 Sep;8(9):1312-24</RefSource><PMID Version="1">22889744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Manag Res. 2015 Sep 11;7:291-9</RefSource><PMID Version="1">26392787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2016;12 (1):1-222</RefSource><PMID Version="1">26799652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Dec 28;282(52):37298-302</RefSource><PMID Version="1">17986448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Apoptosis. 2016 Jun;21(6):749-60</RefSource><PMID Version="1">27108344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Apr 26;12(6):401-10</RefSource><PMID Version="1">22534666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 May 15;69(10 ):4235-43</RefSource><PMID Version="1">19435917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Mol Med. 2011 Jun;15(6):1402-14</RefSource><PMID Version="1">20626525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2015 Mar;22(3):377-88</RefSource><PMID Version="1">25257172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Environ Pathol Toxicol Oncol. 2006;25(1-2):29-50</RefSource><PMID Version="1">16566709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 May 27;280(21):20722-9</RefSource><PMID Version="1">15778222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Dec 18;273(51):33889-92</RefSource><PMID Version="1">9852036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2010 Aug;224(2):414-22</RefSource><PMID Version="1">20432438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2014 Jul;10 (7):1179-92</RefSource><PMID Version="1">24905352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Oct 22;40(2):280-93</RefSource><PMID Version="1">20965422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2010 Apr 2;584(7):1393-8</RefSource><PMID Version="1">20040365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2012 Sep;8(9):1333-41</RefSource><PMID Version="1">22889762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2000 Dec 1;290(5497):1717-21</RefSource><PMID Version="1">11099404</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">ATG5</Keyword><Keyword MajorTopicYN="Y">Autophagy</Keyword><Keyword MajorTopicYN="Y">CRISR/Cas-9</Keyword><Keyword MajorTopicYN="Y">Photodynamic therapy</Keyword><Keyword MajorTopicYN="Y">Photofrin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29463237</ArticleId><ArticleId IdType="doi">10.1186/s12885-018-4126-y</ArticleId><ArticleId IdType="pii">10.1186/s12885-018-4126-y</ArticleId><ArticleId IdType="pmc">PMC5819678</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29462894</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2073-4425</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Modeling the Role of Wnt Signaling in Human and Drosophila Stem Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E101</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes9020101</ELocationID><Abstract><AbstractText>The discovery of induced pluripotent stem (iPS) cells, barely more than a decade ago, dramatically transformed the study of stem cells and introduced a completely new way to approach many human health concerns. Although advances have pushed the field forward, human application remains some years away, in part due to the need for an in-depth mechanistic understanding. The role of Wnts in stem cells predates the discovery of iPS cells with Wnts established as major pluripotency promoting factors. Most work to date has been done using mouse and tissue culture models and few attempts have been made in other model organisms, but the recent combination of clustered regularly interspaced short palindromic repeats (CRISPR) gene editing with iPS cell technology provides a perfect avenue for exploring iPS cells in model organisms.<i>Drosophila</i>is an ideal organism for such studies, but fly iPS cells have not yet been made. In this opinion article, we draw parallels between Wnt signaling in human and<i>Drosophila</i>stem cell systems, propose ways to obtain<i>Drosophila</i>iPS cells, and suggest ways to exploit the versatility of the<i>Drosophila</i>system for future stem cell studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Prameet</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Yale-NUS College Research Labs @ E6, E6, 5 Engineering Drive 1, #04-02, Singapore 117608, Singapore. prameet.kaur@yale-nus.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Helen Jingshu</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Yale-NUS College Research Labs @ E6, E6, 5 Engineering Drive 1, #04-02, Singapore 117608, Singapore. jingshu.jin@u.yale-nus.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lusk</LastName><ForeName>Jay B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-5728-8872</Identifier><AffiliationInfo><Affiliation>Yale-NUS College Research Labs @ E6, E6, 5 Engineering Drive 1, #04-02, Singapore 117608, Singapore. jay.lusk@u.yale-nus.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolwinski</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0002-8507-2737</Identifier><AffiliationInfo><Affiliation>Yale-NUS College Research Labs @ E6, E6, 5 Engineering Drive 1, #04-02, Singapore 117608, Singapore. nicholas.tolwinski@yale-nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore. nicholas.tolwinski@yale-nus.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">Wnt</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29462894</ArticleId><ArticleId IdType="pii">genes9020101</ArticleId><ArticleId IdType="doi">10.3390/genes9020101</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29462720</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-9867</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>Molecular plant</Title><ISOAbbreviation>Mol Plant</ISOAbbreviation></Journal><ArticleTitle>Engineering introns to express RNA guides for Cas9- and Cpf1-mediated multiplex genome editing.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1674-2052(18)30055-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molp.2018.02.005</ELocationID><Abstract><AbstractText>The Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) system has emerged as the revolutionary platform for DNA targeting. This system uses a site-specific RNA guide to direct a CRISPR effector (e.g., Cas9 and Cpf1) to a DNA target. Here, we elaborate a general strategy to simultaneously express multiple guide RNAs (gRNA) and CRISPR RNAs (crRNA) from introns of Cas9 and Cpf1. This method utilizes the endogenous tRNA processing system or crRNA processing activity of Cpf1 to cleave the spliced intron which contains tRNA-gRNA polycistron or crRNA-crRNA array. We demonstrated that the tRNA-gRNA intron is able to fuse with Cas9 as one gene. Such hybrid gene could be expressed using one polymerase II promoter and exhibited high efficiency and robustness to simultaneously targeting multiple sites. We also implemented this strategy in Cpf1-mediated genome editing using intronic tRNA-crRNA and crRNA-crRNA array. Interestingly, hybrid genes containing Cpf1 and intronic crRNA array exhibited remarkably increased efficiency than the conventional Cpf1 vectors. Taken together, this study presents a method to express CRISPR reagents from one hybrid gene to increase genome editing efficiency and capacity. Owing to its simplicity and versatility, this method could be broadly used to develop sophisticated CRISPR tools in eukaryotes.</AbstractText><CopyrightInformation>Copyright © 2018 The Author. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement and National Centre of Plant Gene Research (Wuhan), Huazhong Agricultural University, Wuhan 430070, China; Hubei Key Laboratory of Plant Pathology, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kaiyuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement and National Centre of Plant Gene Research (Wuhan), Huazhong Agricultural University, Wuhan 430070, China; Hubei Key Laboratory of Plant Pathology, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuedan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement and National Centre of Plant Gene Research (Wuhan), Huazhong Agricultural University, Wuhan 430070, China; Hubei Key Laboratory of Plant Pathology, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement and National Centre of Plant Gene Research (Wuhan), Huazhong Agricultural University, Wuhan 430070, China; Hubei Key Laboratory of Plant Pathology, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Kabin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Crop Genetic Improvement and National Centre of Plant Gene Research (Wuhan), Huazhong Agricultural University, Wuhan 430070, China; Hubei Key Laboratory of Plant Pathology, Huazhong Agricultural University, Wuhan 430070, China. Electronic address: kabinxie@mail.hzau.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Plant</MedlineTA><NlmUniqueID>101465514</NlmUniqueID><ISSNLinking>1674-2052</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Cpf1</Keyword><Keyword MajorTopicYN="N">intron</Keyword><Keyword MajorTopicYN="N">multiplex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29462720</ArticleId><ArticleId IdType="pii">S1674-2052(18)30055-8</ArticleId><ArticleId IdType="doi">10.1016/j.molp.2018.02.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29461055</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5126</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of the American Chemical Society</Title><ISOAbbreviation>J. Am. Chem. Soc.</ISOAbbreviation></Journal><ArticleTitle>Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/jacs.7b13050</ELocationID><Abstract><AbstractText>Since the initial characterization of Streptococcus pyogenes CRISPR/Cas9 as a powerful gene-editing tool, it has been widely accepted that Cas9 generates blunt-ended DNA products by concerted cleavage of the target (tDNA) and non-target (ntDNA) strands three nucleotides away from the protospacer adjacent motif (PAM) by HNH and RuvC nuclease active sites, respectively. Following initial DNA cleavage, RuvC catalyzes 3'→5' degradation of the ntDNA resulting in DNA products of various lengths. Here, we found that Cas9 selects multiple sites for initial ntDNA cleavage and preferentially generates staggered-ended DNA products containing single-nucleotide 5'-overhangs. We also quantitatively evaluated 3'→5' post-cleavage trimming (PCT) activity of RuvC to find that ntDNA degradation continues up to the -10 position on the PAM distal DNA product and is kinetically significant when compared to extremely slow DNA product release. We also discovered a previously unidentified 5'→3' PCT activity of RuvC which can shorten the PAM proximal ntDNA product by precisely one nucleotide with a comparable rate as the 3'→5' PCT activity. Taken together, our results demonstrate that RuvC-catalyzed PCT ultimately generates DNA fragments with heterogeneous ends following initial DNA cleavage including a PAM proximal fragment with a blunt end and a PAM distal fragment with a staggered-end, 3'-recessed on the ntDNA strand. These kinetic and biochemical findings underline the importance of temporal control of Cas9 during gene-editing experiments and help explain the patterns of nucleotide insertions at sites of Cas9-catalyzed gene modification in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Anthony A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raper</LastName><ForeName>Austin T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suo</LastName><ForeName>Zucai</ForeName><Initials>Z</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3871-3420</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Chem Soc</MedlineTA><NlmUniqueID>7503056</NlmUniqueID><ISSNLinking>0002-7863</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29461055</ArticleId><ArticleId IdType="doi">10.1021/jacs.7b13050</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29460422</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0290</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Biotechnology and bioengineering</Title><ISOAbbreviation>Biotechnol. Bioeng.</ISOAbbreviation></Journal><ArticleTitle>Engineered CRISPR/Cas9 system for multiplex genome engineering of polyploid industrial yeast strains.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/bit.26569</ELocationID><Abstract><AbstractText>The CRISPR/Cas9 system has been widely used for multiplex genome engineering of Saccharomyces cerevisiae. However, its application in manipulating industrial yeast strains is less successful, probably due to the genome complexity and low copy numbers of gRNA expression plasmids. Here we developed an efficient CRISPR/Cas9 system for industrial yeast strain engineering by using our previously engineered plasmids with increased copy numbers. Four genes in both a diploid strain (Ethanol Red, 8 alleles in total) and a triploid strain (ATCC 4124, 12 alleles in total) were knocked out in a single step with 100% efficiency. This system was used to construct xylose-fermenting, lactate-producing industrial yeast strains, in which ALD6, PHO13, LEU2, and URA3 were disrupted in a single step followed by the introduction of a xylose utilization pathway and a lactate biosynthetic pathway on auxotrophic marker plasmids. The optimized CRISPR/Cas9 system provides a powerful tool for the development of industrial yeast based microbial cell factories.</AbstractText><CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Jiazhang</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9784-9876</Identifier><AffiliationInfo><Affiliation>Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Zehua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Sumeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9069-6739</Identifier><AffiliationInfo><Affiliation>Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Chemical and Biomolecular Engineering, Chemistry, Biochemistry, and Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IllinoisIllinois.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biotechnol Bioeng</MedlineTA><NlmUniqueID>7502021</NlmUniqueID><ISSNLinking>0006-3592</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">multiplex genome editing</Keyword><Keyword MajorTopicYN="N">polyploid industrial yeast</Keyword><Keyword MajorTopicYN="N">xylose utilization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29460422</ArticleId><ArticleId IdType="doi">10.1002/bit.26569</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29459713</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5594</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Oncogene</Title><ISOAbbreviation>Oncogene</ISOAbbreviation></Journal><ArticleTitle>Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41388-018-0139-x</ELocationID><Abstract><AbstractText>Warburg effect has been recognized as a hallmark of cancer cells for many years, but its modulation mechanism remains a great focus. Our current study found a member of solute carrier family 25 (SLC25A29), the main arginine transporter on mitochondria, significantly elevated in various cancer cells. Knockout of SLC25A29 by CRISPR/Cas9 inhibited proliferation and migration of cancer cells both in vitro and in vivo. SLC25A29-knockout cells also showed an altered metabolic status with enhanced mitochondrial respiration and reduced glycolysis. All of above impacts could be reversed after rescuing SLC25A29 expression in SLC25A29-knockout cells. Arginine is transported into mitochondria partly for nitric oxide (NO) synthesis. Deletion of SLC25A29 resulted in severe decrease of NO production, indicating that the mitochondria is a significant source of NO. SLC25A29-knockout cells dramatically altered the variation of metabolic processes, whereas addition of arginine failed to reverse the effect, highlighting the necessity of transporting arginine into mitochondria by SLC25A29. In conclusion, aberrant elevated SLC25A29 in cancer functioned to transport more arginine into mitochondria, improved mitochondria-derived NO levels, thus modulated metabolic status to facilitate increased cancer progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huiyuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qinyi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Junzhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shenghui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lida</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, WT-MRC Cambridge Stem Cell Institute, Cambridge University, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yuchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Institute of Molecular Medicine, Peking University, Beijing, China. ycgu@pku.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational and Regenerative Medicine Center, Aston Medical Research Institute, Aston University, Birmingham, UK. ycgu@pku.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oncogene</MedlineTA><NlmUniqueID>8711562</NlmUniqueID><ISSNLinking>0950-9232</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29459713</ArticleId><ArticleId IdType="doi">10.1038/s41388-018-0139-x</ArticleId><ArticleId IdType="pii">10.1038/s41388-018-0139-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29459677</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1718</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat. Genet.</ISOAbbreviation></Journal><ArticleTitle>A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41588-018-0054-7</ELocationID><Abstract><AbstractText>Primary cilia organize Hedgehog signaling and shape embryonic development, and their dysregulation is the unifying cause of ciliopathies. We conducted a functional genomic screen for Hedgehog signaling by engineering antibiotic-based selection of Hedgehog-responsive cells and applying genome-wide CRISPR-mediated gene disruption. The screen can robustly identify factors required for ciliary signaling with few false positives or false negatives. Characterization of hit genes uncovered novel components of several ciliary structures, including a protein complex that contains δ-tubulin and ε-tubulin and is required for centriole maintenance. The screen also provides an unbiased tool for classifying ciliopathies and showed that many congenital heart disorders are caused by loss of ciliary signaling. Collectively, our study enables a systematic analysis of ciliary function and of ciliopathies, and also defines a versatile platform for dissecting signaling pathways through CRISPR-based screening.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Breslow</LastName><ForeName>David K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0245-3348</Identifier><AffiliationInfo><Affiliation>Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA. david.breslow@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. david.breslow@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogendoorn</LastName><ForeName>Sascha</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1155-8697</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopp</LastName><ForeName>Adam R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgens</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Brandon K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Margaret C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Kyuho</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Gaelen T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassik</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>James K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9220-8436</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA. jameschen@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA. jameschen@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nachury</LastName><ForeName>Maxence V</ForeName><Initials>MV</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4918-1562</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. maxence.nachury@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, UCSF, San Francisco, CA, USA. maxence.nachury@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 HD082280</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 HD082280</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM089933</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29459677</ArticleId><ArticleId IdType="doi">10.1038/s41588-018-0054-7</ArticleId><ArticleId IdType="pii">10.1038/s41588-018-0054-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29459263</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1484</ISSN><JournalIssue CitedMedium="Internet"><Volume>271</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Atherosclerosis</Title><ISOAbbreviation>Atherosclerosis</ISOAbbreviation></Journal><ArticleTitle>Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.</ArticleTitle><Pagination><MedlinePgn>26-35</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0021-9150(18)30078-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.atherosclerosis.2018.02.015</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Low-density lipoprotein receptor (Ldlr) and apolipoprotein E (Apoe) knockout (KO) mice have been widely used as animal models of atherosclerosis. However, data suggested that it is difficult to develop typical atherosclerosis in rats. To this end, Ldlr and Apoe KO rats were generated and the potential to develop novel atherosclerosis models was evaluated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We established Apoe/Ldlr single and double KO (DKO) rats via the CRISPR/Cas9 system in the same background. Phenotypes of dyslipidemia and atherosclerosis in these KO rats were systematically characterized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Knockout of either gene led to severe dyslipidemia and liver steatosis. Significant atherosclerotic plaques were observed in the abdominal aorta of all mutant rats fed a normal diet for 48 weeks. Western diet greatly aggravated atherosclerosis and fatty liver. In addition, we found mononuclear cell infiltration in early lesions. Increased expression of inflammatory cytokines, as well as macrophage accumulation in lesions of mutants, was observed, indicating that mononuclear cell trafficking and endothelial inflammation affected atherogenesis. Moreover, mutant rats displayed a sex difference profile more similar to humans in which males had heavier plaque burdens than females.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Deficiency of either Ldlr or Apoe genes induced hyperlipidemia, which promoted endothelial inflammation and led to typical atherosclerosis in rats on normal or Western diets. These models display certain advantages, which will benefit future investigations of atherosclerotic pathology and antiatherosclerotic therapeutics.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yongliang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yiqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Roumei</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yufang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Panpan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tongtong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bioray Laboratories Inc., Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dali</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: dlli@bio.ecnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huaqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: hqchen@bio.ecnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingyao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China; Institute of Biosciences and Technology, Department of Molecular and Cellular Medicine, Texas A&amp;M University Health Science Center, Houston, TX, USA. Electronic address: myliu@bio.ecnu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Atherosclerosis</MedlineTA><NlmUniqueID>0242543</NlmUniqueID><ISSNLinking>0021-9150</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apoe</Keyword><Keyword MajorTopicYN="N">Atherosclerosis</Keyword><Keyword MajorTopicYN="N">Gene knockout</Keyword><Keyword MajorTopicYN="N">Ldl receptor</Keyword><Keyword MajorTopicYN="N">Rat</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29459263</ArticleId><ArticleId IdType="pii">S0021-9150(18)30078-9</ArticleId><ArticleId IdType="doi">10.1016/j.atherosclerosis.2018.02.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29458767</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-7988</ISSN><JournalIssue CitedMedium="Internet"><Volume>600</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Methods in enzymology</Title><ISOAbbreviation>Meth. Enzymol.</ISOAbbreviation></Journal><ArticleTitle>Single-Molecule Dynamics and Localization of DNA Repair Proteins in Cells.</ArticleTitle><Pagination><MedlinePgn>375-406</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0076-6879(17)30353-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/bs.mie.2017.11.015</ELocationID><Abstract><AbstractText>Direct observation of individual protein molecules in their native environment, at nanometer resolution, in a living cell, in motion is not only fascinating but also uniquely informative. Several recent major technological advances in genomic engineering, protein and synthetic fluorophore development, and light microscopy have dramatically increased the accessibility of this approach. This chapter describes the procedures for modifying endogenous genomic loci to producing fluorescently tagged proteins, their high-resolution visualization, and analysis of their dynamics in mammalian cells, using DNA repair proteins BRCA2 and RAD51 as an example.</AbstractText><CopyrightInformation>© 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Maarten W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelensky</LastName><ForeName>Alex N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyman</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Radiation Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaar</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: r.kanaar@erasmusmc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Enzymol</MedlineTA><NlmUniqueID>0212271</NlmUniqueID><ISSNLinking>0076-6879</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BRCA2</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Genetic engineering</Keyword><Keyword MajorTopicYN="N">Homologous recombination</Keyword><Keyword MajorTopicYN="N">Live-cell imaging</Keyword><Keyword MajorTopicYN="N">RAD51</Keyword><Keyword MajorTopicYN="N">Single-particle tracking</Keyword><Keyword MajorTopicYN="N">Super-resolution microscopy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29458767</ArticleId><ArticleId IdType="pii">S0076-6879(17)30353-1</ArticleId><ArticleId IdType="doi">10.1016/bs.mie.2017.11.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29458735</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1977</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Hematology/oncology clinics of North America</Title><ISOAbbreviation>Hematol. Oncol. Clin. North Am.</ISOAbbreviation></Journal><ArticleTitle>Gene Therapy and Genome Editing.</ArticleTitle><Pagination><MedlinePgn>329-342</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0889-8588(17)30209-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hoc.2017.11.007</ELocationID><Abstract><AbstractText>The β-thalassemias are inherited blood disorders that result from insufficient production of the β-chain of hemoglobin. More than 200 different mutations have been identified. β-Thalassemia major requires life-long transfusions. The only cure for severe β-thalassemia is to provide patients with hematopoietic stem cells. Globin gene therapy promises a curative autologous stem cell transplantation without the immunologic complications of allogeneic transplantation. The future directions of gene therapy include enhancement of lentiviral vector-based approaches, fine tuning of the conditioning regimen, and the design of safer vectors. Progress in genetic engineering bodes well for finding a cure for severe globin disorders.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boulad</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: bouladf@mskcc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansilla-Soto</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabriolu</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivière</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadelain</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hematol Oncol Clin North Am</MedlineTA><NlmUniqueID>8709473</NlmUniqueID><ISSNLinking>0889-8588</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Gene editing</Keyword><Keyword MajorTopicYN="N">Gene transfer</Keyword><Keyword MajorTopicYN="N">Lentivirus</Keyword><Keyword MajorTopicYN="N">Thalassemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29458735</ArticleId><ArticleId IdType="pii">S0889-8588(17)30209-5</ArticleId><ArticleId IdType="doi">10.1016/j.hoc.2017.11.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29458716</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1878-6146</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>2-3</Issue><PubDate><MedlineDate>2018 Feb - Mar</MedlineDate></PubDate></JournalIssue><Title>Fungal biology</Title><ISOAbbreviation>Fungal Biol</ISOAbbreviation></Journal><ArticleTitle>Selection is required for efficient Cas9-mediated genome editing in Fusarium graminearum.</ArticleTitle><Pagination><MedlinePgn>131-137</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1878-6146(17)30164-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.funbio.2017.11.006</ELocationID><Abstract><AbstractText>Genome engineering using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated nucleases, such as Cas9 (CRISPR-associated protein 9), are revolutionising molecular biology. In this study, we established a Cas9-based genome editing system in Fusarium graminearum, a highly destructive fungal pathogen of cereal crops. Although the molecular toolkit of F. graminearum is well developed compared to other fungi, Cas9-mediated engineering offers a number of potential benefits, such as the ability to create marker free mutants in this species. Here we have used a codon-optimised Cas9 nuclease and dual ribozyme-based expression of a single guide RNA (sgRNA) to induce mutations. Cas9-mediated mutations were identified through a fungicide resistance-based phenotypic screen, which selects for null mutations in the FgOs1 gene encoding an osmosensor histidine kinase. In the absence of selection, however, mutations were identified at very low frequency. Examination of the mutant alleles identified suggests that, a microhomology-mediated end joining (MMEJ) DNA repair pathway is likely to be the predominant process involved in erroneous repairing of Cas9-induced double-stranded breaks in F. graminearum.</AbstractText><CopyrightInformation>Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gardiner</LastName><ForeName>Donald M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>CSIRO Agriculture and Food, Queensland Bioscience Precinct, St. Lucia, Qld, 4067, Australia. Electronic address: Donald.Gardiner@csiro.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazan</LastName><ForeName>Kemal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CSIRO Agriculture and Food, Queensland Bioscience Precinct, St. Lucia, Qld, 4067, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Fungal Biol</MedlineTA><NlmUniqueID>101524465</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Fusarium head blight</Keyword><Keyword MajorTopicYN="N">MMEJ</Keyword><Keyword MajorTopicYN="N">Os1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29458716</ArticleId><ArticleId IdType="pii">S1878-6146(17)30164-2</ArticleId><ArticleId IdType="doi">10.1016/j.funbio.2017.11.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29458391</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Molecular brain</Title><ISOAbbreviation>Mol Brain</ISOAbbreviation></Journal><ArticleTitle>Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.</ArticleTitle><Pagination><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13041-018-0349-8</ELocationID><Abstract><AbstractText>Ghrelin exerts a wide range of physiological actions throughout the body and appears to be a promising target for disease therapy. Endogenous ghrelin receptors (GHSRs) are present in extrahypothalamic sites including the substantia nigra pars compacta (SNc), which is related to phenotypic dysregulation or frank degeneration in Parkinson's disease (PD). Here we found a dramatic decrease in the expression of GHSR in PD-specific induced pluripotent stem cell (iPSC)-derived dopaminergic (DAnergic) neurons generated from patients carrying parkin gene (PARK2) mutations compared to those from healthy controls. Consistently, a significant decrease in the expression of GHSR was found in DAnergic neurons of isogenic PARK2-iPSC lines that mimicked loss of function of the PARK2 gene through CRISPR Cas9 technology. Furthermore, either intracerebroventricular injection or microinjection into the SNc of the selective GHSR1a antagonist [D-Lys3]-GHRP6 in normal mice produced cataleptic behaviors related to dysfunction of motor coordination. These findings suggest that the down-regulation of GHSRs in SNc-DA neurons induced the initial dysfunction of DA neurons, leading to extrapyramidal disorder under PD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>Yukari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuzumaki</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. n-kuzumaki@hoshi.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. n-kuzumaki@hoshi.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sone</LastName><ForeName>Takefumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narita</LastName><ForeName>Michiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamada</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasawa</LastName><ForeName>Chizuru</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibasaki</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maekawa</LastName><ForeName>Aya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Genetics, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Miri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akamatsu</LastName><ForeName>Wado</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic and Regenerative Medicine, Juntendo University, School of Medicine, Bunkyo-ku, Tokyo, 113-8431, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Nobutaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okano</LastName><ForeName>Hideyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. hidokano@a2.keio.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. hidokano@a2.keio.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narita</LastName><ForeName>Minoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. narita@hoshi.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. narita@hoshi.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP16K08280</GrantID><Agency>Japan Society for the Promotion of Science (JP)</Agency><Country/></Grant><Grant><GrantID>JP25830055</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Brain</MedlineTA><NlmUniqueID>101468876</NlmUniqueID><ISSNLinking>1756-6606</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2008 Aug;212(2):532-7</RefSource><PMID Version="1">18577498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Mar 8;6(3):422-35</RefSource><PMID Version="1">26905201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1999 Dec 9;402(6762):656-60</RefSource><PMID Version="1">10604470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):689-702</RefSource><PMID Version="1">21376232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Brain Res. 2012 Jun 15;232(1):13-9</RefSource><PMID Version="1">22484009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2015 Dec 8;5(6):1010-1022</RefSource><PMID Version="1">26549851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2006 Dec;116(12):3229-39</RefSource><PMID Version="1">17060947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2007 May;30(5):244-50</RefSource><PMID Version="1">17418429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol Chemother. 1957 Mar;12(1):12-5</RefSource><PMID Version="1">13413144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2017 Nov 14;9(5):1675-1691</RefSource><PMID Version="1">29107593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotox Res. 2009 May;15(4):332-47</RefSource><PMID Version="1">19384567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1998 Apr 9;392(6676):605-8</RefSource><PMID Version="1">9560156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>eNeuro. 2016 Sep 02;3(4):</RefSource><PMID Version="1">27622213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Brain. 2014 Mar 31;7:22</RefSource><PMID Version="1">24685317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Feb 11;5(2):e9159</RefSource><PMID Version="1">20161791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1999 Apr;8(4):567-74</RefSource><PMID Version="1">10072423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1996 Aug 16;273(5277):974-7</RefSource><PMID Version="1">8688086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Brain. 2012 Oct 06;5:35</RefSource><PMID Version="1">23039195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2004 Nov 29;1695(1-3):235-47</RefSource><PMID Version="1">15571819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Suppl. 2006;(70):209-13</RefSource><PMID Version="1">17017531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2009 Nov 11;29(45):14057-65</RefSource><PMID Version="1">19906954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2003 Feb 20;37(4):649-61</RefSource><PMID Version="1">12597862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2017 Jan 29;483(1):88-93</RefSource><PMID Version="1">28057485</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Nov 30;131(5):861-72</RefSource><PMID Version="1">18035408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:1435</RefSource><PMID Version="1">23385580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2006 Mar;9(3):381-8</RefSource><PMID Version="1">16491079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Jan 11;409(6817):194-8</RefSource><PMID Version="1">11196643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 2006 Jan 20;494(3):528-48</RefSource><PMID Version="1">16320257</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dopamine neuron</Keyword><Keyword MajorTopicYN="N">GHSR</Keyword><Keyword MajorTopicYN="N">Ghrelin</Keyword><Keyword MajorTopicYN="N">Parkinson’s disease</Keyword><Keyword MajorTopicYN="N">iPS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29458391</ArticleId><ArticleId IdType="doi">10.1186/s13041-018-0349-8</ArticleId><ArticleId IdType="pii">10.1186/s13041-018-0349-8</ArticleId><ArticleId IdType="pmc">PMC5819262</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29458131</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Antiviral research</Title><ISOAbbreviation>Antiviral Res.</ISOAbbreviation></Journal><ArticleTitle>Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus.</ArticleTitle><Pagination><MedlinePgn>58-67</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0166-3542(17)30675-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2018.02.011</ELocationID><Abstract><AbstractText>Chronic hepatitis B virus (HBV) infection is difficult to cure due to the presence of covalently closed circular DNA (cccDNA). Accumulating evidence indicates that the CRISPR/Cas9 system effectively disrupts HBV genome, including cccDNA, in vitro and in vivo. However, efficient delivery of CRISPR/Cas9 system to the liver or hepatocytes using an adeno-associated virus (AAV) vector remains challenging due to the large size of Cas9 from Streptococcus pyogenes (Sp). The recently identified Cas9 protein from Staphylococcus aureus (Sa) is smaller than SpCas9 and thus is able to be packaged into the AAV vector. To examine the efficacy of SaCas9 system on HBV genome destruction, we designed 5 guide RNAs (gRNAs) that targeted different HBV genotypes, 3 of which were shown to be effective. The SaCas9 system significantly reduced HBV antigen expression, as well as pgRNA and cccDNA levels, in Huh7, HepG2.2.15 and HepAD38 cells. The dual expression of gRNAs/SaCas9 in these cell lines resulted in more efficient HBV genome cleavage. In the mouse model, hydrodynamic injection of gRNA/SaCas9 plasmids resulted in significantly lower levels of HBV protein expression. We also delivered the SaCas9 system into mice with persistent HBV replication using an AAV vector. Both the AAV vector and the mRNA of Cas9 could be detected in the C3H mouse liver cells. Decreased hepatitis B surface antigen (HBsAg), HBV DNA and pgRNA levels were observed when a higher titer of AAV was injected, although this decrease was not significantly different from the control. In summary, the SaCas9 system accurately and efficiently targeted the HBV genome and inhibited HBV replication both in vitro and in vivo. The system was delivered by an AAV vector and maybe used as a novel therapeutic strategy against chronic HBV infection.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Miaoxian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mingxing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Cantao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Haohui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xueying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hongkai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhanhui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: wangzhh@smu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Antiviral Res</MedlineTA><NlmUniqueID>8109699</NlmUniqueID><ISSNLinking>0166-3542</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA targeting</Keyword><Keyword MajorTopicYN="N">Gene therapy</Keyword><Keyword MajorTopicYN="N">Hepatitis B virus</Keyword><Keyword MajorTopicYN="N">SaCas9 system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29458131</ArticleId><ArticleId IdType="pii">S0166-3542(17)30675-7</ArticleId><ArticleId IdType="doi">10.1016/j.antiviral.2018.02.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29457956</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-7732</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Pathogens and global health</Title><ISOAbbreviation>Pathog Glob Health</ISOAbbreviation></Journal><ArticleTitle>Gene drives to fight malaria: current state and future directions.</ArticleTitle><Pagination><MedlinePgn>1-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/20477724.2018.1438880</ELocationID><Abstract><AbstractText>Self-propagating gene drive technologies have a number of desirable characteristics that warrant their development for the control of insect pest and vector populations, such as the malaria-transmitting mosquitoes. Theoretically easy to deploy and self-sustaining, these tools may be used to generate cost-effective interventions that benefit society without obvious bias related to wealth, age or education. Their species-specific design offers the potential to reduce environmental risks and aim to be compatible and complementary with other control strategies, potentially expediting the elimination and eradication of malaria. A number of strategies have been proposed for gene-drive based control of the malaria mosquito and recent demonstrations have shown proof-of-principle in the laboratory. Though several technical, ethical and regulatory challenges remain, none appear insurmountable if research continues in a step-wise and open manner.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1757-5009</Identifier><AffiliationInfo><Affiliation>a Department of Life Sciences , Imperial College London , London , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galizi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3134-7480</Identifier><AffiliationInfo><Affiliation>a Department of Life Sciences , Imperial College London , London , UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pathog Glob Health</MedlineTA><NlmUniqueID>101583421</NlmUniqueID><ISSNLinking>2047-7724</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Gene drive</Keyword><Keyword MajorTopicYN="N">genetic vector control</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">malaria</Keyword><Keyword MajorTopicYN="N">mosquito</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457956</ArticleId><ArticleId IdType="doi">10.1080/20477724.2018.1438880</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29457907</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-3907</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of proteome research</Title><ISOAbbreviation>J. Proteome Res.</ISOAbbreviation></Journal><ArticleTitle>Deletion of Adipose Triglyceride Lipase Links Triacylglycerol Accumulation to a More-Aggressive Phenotype in A549 Lung Carcinoma Cells.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jproteome.7b00782</ELocationID><Abstract><AbstractText>Adipose triglyceride lipase (ATGL) catalyzes the rate limiting step in triacylglycerol breakdown in adipocytes but is expressed in most tissues. The enzyme was shown to be lost in many human tumors, and its loss may play a role in early stages of cancer development. Here, we report that loss of ATGL supports a more-aggressive cancer phenotype in a model system in which ATGL was deleted in A549 lung cancer cells by CRISPR/Cas9. We observed that loss of ATGL led to triacylglycerol accumulation in lipid droplets and higher levels of cellular phospholipid and bioactive lipid species (lyso- and ether-phospholipids). Label-free quantitative proteomics revealed elevated expression of the pro-oncogene SRC kinase in ATGL depleted cells, which was also found on mRNA level and confirmed on protein level by Western blot. Consistently, higher expression of phosphorylated (active) SRC (Y416 phospho-SRC) was observed in ATGL-KO cells. Cells depleted of ATGL migrated faster, which was dependent on SRC kinase activity. We propose that loss of ATGL may thus increase cancer aggressiveness by activation of pro-oncogenic signaling via SRC kinase and increased levels of bioactive lipids.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomin</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritz</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gindlhuber</LastName><ForeName>Juergen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldherr</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pucher</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Computational Biotechnology, Graz University of Technology , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thallinger</LastName><ForeName>Gerhard G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Computational Biotechnology, Graz University of Technology , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Daniel K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1614-8360</Identifier></Author><Author ValidYN="Y"><LastName>Schittmayer</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3249-655X</Identifier><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birner-Gruenberger</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3950-0312</Identifier><AffiliationInfo><Affiliation>Research Unit Functional Proteomics and Metabolic Pathways , Institute of Pathology, Medical University of Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Omics Center Graz, BioTechMed-Graz , 8010 Graz , Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Proteome Res</MedlineTA><NlmUniqueID>101128775</NlmUniqueID><ISSNLinking>1535-3893</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A549 lung carcinoma cells</Keyword><Keyword MajorTopicYN="N">ATGL</Keyword><Keyword MajorTopicYN="N">SRC</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">lipid droplet</Keyword><Keyword MajorTopicYN="N">migration</Keyword><Keyword MajorTopicYN="N">triacylglycerol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457907</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.7b00782</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29457792</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1548-7105</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Nature methods</Title><ISOAbbreviation>Nat. Methods</ISOAbbreviation></Journal><ArticleTitle>On the design of CRISPR-based single-cell molecular screens.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/nmeth.4604</ELocationID><Abstract><AbstractText>Several groups recently coupled CRISPR perturbations and single-cell RNA-seq for pooled genetic screens. We demonstrate that vector designs of these studies are susceptible to ∼50% swapping of guide RNA-barcode associations because of lentiviral template switching. We optimized a published alternative, CROP-seq, in which the guide RNA also serves as the barcode, and here confirm that this strategy performs robustly and doubled the rate at which guides are assigned to cells to 94%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1503-5014</Identifier><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McFaline-Figueroa</LastName><ForeName>José L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starita</LastName><ForeName>Lea M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasperini</LastName><ForeName>Molly J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matreyek</LastName><ForeName>Kenneth A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Packer</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shendure</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trapnell</LastName><ForeName>Cole</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8105-4347</Identifier><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP1 HG007811</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 HD088158</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 HG009408</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Methods</MedlineTA><NlmUniqueID>101215604</NlmUniqueID><ISSNLinking>1548-7091</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457792</ArticleId><ArticleId IdType="pii">nmeth.4604</ArticleId><ArticleId IdType="doi">10.1038/nmeth.4604</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29457665</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8355</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Cell biology international</Title><ISOAbbreviation>Cell Biol. Int.</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis of Lipid-Mediated CRISPR-Cas9 Genome Editing Techniques.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/cbin.10952</ELocationID><Abstract><AbstractText>CRISPR-Cas technology has revolutionized genome engineering. While Cas9 was not the first programmable endonuclease identified, its simplicity of use has driven widespread adoption in a short period of time. While CRISPR-Cas genome editing holds enormous potential for clinical applications, its use in laboratory settings for genotype-phenotype studies and genome-wide screens has led to breakthroughs in the understanding of many molecular pathways. Numerous protocols have been described for introducing CRISPR-Cas components into cells, and here we sought to simplify and optimize a protocol for genome editing using readily available and inexpensive tools. We compared plasmid, ribonucleoprotein (RNP), and RNA transfection to determine which was method was most optimal for editing cells in a laboratory setting. We limited our comparison to lipofection-mediated introduction because the reagents are widely available. To facilitate optimization, we developed a novel reporter assay to measure gene disruption and the introduction of a variety of exogenous DNA tags. Each method efficiently disrupted endogenous genes and was able to stimulate the introduction of foreign DNA at specific sites, albeit to varying efficiencies. RNP transfection produced the highest level of gene disruption and was the most rapid and efficient method overall. Finally, we show that very short homology arms of 30 base pairs can mediate site-specific editing. The methods described here should broaden the accessibility of RNP-mediated lipofection for laboratory genome-editing experiments.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ringer</LastName><ForeName>Kelsey P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Mark G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garey</LastName><ForeName>Mitchell S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piorczynski</LastName><ForeName>Ted B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suli</LastName><ForeName>Arminda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alder</LastName><ForeName>Jonathan K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Physiology &amp; Developmental Biology, Brigham Young University, Provo, UT 84602.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Biol Int</MedlineTA><NlmUniqueID>9307129</NlmUniqueID><ISSNLinking>1065-6995</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">cloning Oxidative Stress</Keyword><Keyword MajorTopicYN="N">repair Molecular genetics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457665</ArticleId><ArticleId IdType="doi">10.1002/cbin.10952</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29457566</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1544-2217</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Veterinary pathology</Title><ISOAbbreviation>Vet. Pathol.</ISOAbbreviation></Journal><ArticleTitle>Using Genetically Modified Rodent Models in Drug Development to Explore Target Physiology and Potential Drug Effects.</ArticleTitle><Pagination><MedlinePgn>193-194</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0300985817747328</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1 Safety Assessment, Genentech, Inc., South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dambach</LastName><ForeName>Donna M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>1 Safety Assessment, Genentech, Inc., South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maher</LastName><ForeName>Jonathan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>1 Safety Assessment, Genentech, Inc., South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Vet Pathol</MedlineTA><NlmUniqueID>0312020</NlmUniqueID><ISSNLinking>0300-9858</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-terminal Src kinase</Keyword><Keyword MajorTopicYN="N">CreLoxP</Keyword><Keyword MajorTopicYN="N">CrispR</Keyword><Keyword MajorTopicYN="N">drug development</Keyword><Keyword MajorTopicYN="N">gene editing</Keyword><Keyword MajorTopicYN="N">gene excision</Keyword><Keyword MajorTopicYN="N">transgenic models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457566</ArticleId><ArticleId IdType="doi">10.1177/0300985817747328</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29457136</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.</ArticleTitle><Pagination><MedlinePgn>eaar4134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.aar4134</ELocationID><Abstract><AbstractText>Bacteria and bacteriophages arm themselves with various defensive and counterdefensive mechanisms to protect their own genome and degrade the other's. CRISPR (clustered regularly interspaced short palindromic repeat)-Cas (CRISPR-associated) is an adaptive bacterial defense mechanism that recognizes short stretches of invading phage genome and destroys it by nuclease attack. Unexpectedly, we discovered that the CRISPR-Cas system might also accelerate phage evolution. When<i>Escherichia coli</i>bacteria containing CRISPR-Cas9 were infected with phage T4, its cytosine hydroxymethylated and glucosylated genome was cleaved poorly by Cas9 nuclease, but the continuing CRISPR-Cas9 pressure led to rapid evolution of mutants that accumulated even by the time a single plaque was formed. The mutation frequencies are, remarkably, approximately six orders of magnitude higher than the spontaneous mutation frequency in the absence of CRISPR pressure. Our findings lead to the hypothesis that the CRISPR-Cas might be a double-edged sword, providing survival advantages to both bacteria and phages, leading to their coevolution and abundance on Earth.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Pan</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0082-2229</Identifier><AffiliationInfo><Affiliation>Department of Biology, The Catholic University of America, Washington, DC 20064, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-3237-2805</Identifier><AffiliationInfo><Affiliation>Department of Biology, The Catholic University of America, Washington, DC 20064, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Venigalla</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0777-6587</Identifier><AffiliationInfo><Affiliation>Department of Biology, The Catholic University of America, Washington, DC 20064, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI081726</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI111538</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI081726</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Virol J. 2010 Dec 03;7:356</RefSource><PMID Version="1">21129201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):2984-9</RefSource><PMID Version="1">25713377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jul 06;6:7548</RefSource><PMID Version="1">26144253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2014;11(1):42-4</RefSource><PMID Version="1">24457913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5846-51</RefSource><PMID Version="1">23530211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virol J. 2006 May 23;3:30</RefSource><PMID Version="1">16716236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2017;1581:255-267</RefSource><PMID Version="1">28374254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Aug;42(14):9504-13</RefSource><PMID Version="1">25063295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 Jun 16;6(3):e00648</RefSource><PMID Version="1">26081634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Virus Res. 2012;82:119-53</RefSource><PMID Version="1">22420853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013;9(7):e1003495</RefSource><PMID Version="1">23853602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 Oct 20;6(10 ):1952-1961</RefSource><PMID Version="1">28657724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jan 17;493(7432):429-32</RefSource><PMID Version="1">23242138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 1986 Nov;114(3):669-85</RefSource><PMID Version="1">2431959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 Apr 21;6(2):null</RefSource><PMID Version="1">25900652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1403:499-518</RefSource><PMID Version="1">27076150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2008;42:647-81</RefSource><PMID Version="1">18687036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 Jul 21;6(7):1351-1358</RefSource><PMID Version="1">28324650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Jun 11;11(6):e1004847</RefSource><PMID Version="1">26066799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Dec 26;135(7):1251-62</RefSource><PMID Version="1">19109896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2003 Oct;6(5):506-11</RefSource><PMID Version="1">14572544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1998;32:379-413</RefSource><PMID Version="1">9928485</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Sep 29;357(6358):1420-1424</RefSource><PMID Version="1">28963258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8290-7</RefSource><PMID Version="1">11459966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 1994 Nov;138(3):553-64</RefSource><PMID Version="1">7851754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virol J. 2010 Oct 28;7:292</RefSource><PMID Version="1">21029436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Aug 5;353(6299):aad5147</RefSource><PMID Version="1">27493190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource><PMID Version="1">24076990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Dec 15;167(7):1829-1838.e9</RefSource><PMID Version="1">27984730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Rev. 2014 Sep;38(5):916-31</RefSource><PMID Version="1">24617569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2013 Mar;11(3):194-204</RefSource><PMID Version="1">23385786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8184-E8193</RefSource><PMID Version="1">28893988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virol J. 2010 Dec 03;7:358</RefSource><PMID Version="1">21129203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7160-4</RefSource><PMID Version="1">1831267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Microbiol. 2016 Jun 13;1(8):16085</RefSource><PMID Version="1">27573108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2015 Dec;13(12 ):777-86</RefSource><PMID Version="1">26548913</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29457136</ArticleId><ArticleId IdType="doi">10.1126/sciadv.aar4134</ArticleId><ArticleId IdType="pii">aar4134</ArticleId><ArticleId IdType="pmc">PMC5812732</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29456867</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2054-3085</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Fungal biology and biotechnology</Title><ISOAbbreviation>Fungal Biol Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Heterologous and endogenous<i>U6</i>snRNA promoters enable CRISPR/Cas9 mediated genome editing in<i>Aspergillus niger</i>.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40694-018-0047-4</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED"><i>U6</i>
promoters have been used for single guide RNA (sgRNA) transcription in the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas9) genome editing system. However, no available<i>U6</i>promoters have been identified in<i>Aspergillus niger,</i>which is an important industrial platform for organic acid and protein production. Two CRISPR/Cas9 systems established in<i>A. niger</i>have recourse to the RNA polymerase II promoter or in vitro transcription for sgRNA synthesis, but these approaches generally increase cloning efforts and genetic manipulation. The validation of functional RNA polymerase II promoters is therefore an urgent need for<i>A. niger</i>.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">Here, we developed a novel CRISPR/Cas9 system in<i>A. niger</i>for sgRNA expression, based on one endogenous<i>U6</i>promoter and two heterologous<i>U6</i>promoters. The three tested<i>U6</i>promoters enabled sgRNA transcription and the disruption of the polyketide synthase<i>albA</i>gene in<i>A. niger</i>. Furthermore, this system enabled highly efficient gene insertion at the targeted genome loci in<i>A. niger</i>using donor DNAs with homologous arms as short as 40-bp.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">This study demonstrated that both heterologous and endogenous<i>U6</i>promoters were functional for sgRNA expression in<i>A. niger</i>. Based on this result, a novel and simple CRISPR/Cas9 toolbox was established in<i>A. niger,</i>that will benefit future gene functional analysis and genome editing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9136-0666</Identifier><AffiliationInfo><Affiliation>1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Xiqidao 32, Tianjin Airport Economic Area, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Xiqidao 32, Tianjin Airport Economic Area, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jibin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0208-504X</Identifier><AffiliationInfo><Affiliation>1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Xiqidao 32, Tianjin Airport Economic Area, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kun</LastName><ForeName>Zhang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Xiqidao 32, Tianjin Airport Economic Area, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, Beijing, 100049 China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yanhe</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Xiqidao 32, Tianjin Airport Economic Area, Tianjin, 300308 China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Fungal Biol Biotechnol</MedlineTA><NlmUniqueID>101655873</NlmUniqueID><ISSNLinking>2054-3085</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Nov 20;5:5560</RefSource><PMID Version="1">25410609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fungal Genet Biol. 2016 Jan;86:47-57</RefSource><PMID Version="1">26701308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fungal Genet Biol. 2016 Apr;89:72-83</RefSource><PMID Version="1">26555930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Lett. 2011 Mar;33(3):469-76</RefSource><PMID Version="1">21088867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2016 Dec 12;15(1):210</RefSource><PMID Version="1">27955649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 15;10(7):e0133085</RefSource><PMID Version="1">26177455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2015 Nov;14(11):1073-80</RefSource><PMID Version="1">26318395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioresour Technol. 2017 Dec;245(Pt B):1327-1333</RefSource><PMID Version="1">28533066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fungal Genet Biol. 2016 Apr;89:3-9</RefSource><PMID Version="1">26365384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2010 Jul;87(4):1463-73</RefSource><PMID Version="1">20422182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2007 Mar 10;128(4):770-5</RefSource><PMID Version="1">17275117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2015 Dec;112(12):2543-9</RefSource><PMID Version="1">26039904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Jul 15;5(7):754-64</RefSource><PMID Version="1">27072635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1988 Jul 21;334(6179):213-8</RefSource><PMID Version="1">3041282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2017 Jan 3;10 :1</RefSource><PMID Version="1">28053662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Discov. 2015 May 12;1:15007</RefSource><PMID Version="1">27462408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2017 Feb 14;8:225</RefSource><PMID Version="1">28261181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2007 May-Jun;25(3):244-63</RefSource><PMID Version="1">17337335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Lett. 2016 Apr;38(4):637-42</RefSource><PMID Version="1">26687199</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aspergillus niger</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9 system</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">U6 snRNA promoters</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29456867</ArticleId><ArticleId IdType="doi">10.1186/s40694-018-0047-4</ArticleId><ArticleId IdType="pii">47</ArticleId><ArticleId IdType="pmc">PMC5806293</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29456815</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2008-3866</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Iranian journal of basic medical sciences</Title><ISOAbbreviation>Iran J Basic Med Sci</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.</ArticleTitle><Pagination><MedlinePgn>181-187</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22038/IJBMS.2017.25145.6230</ELocationID><Abstract><AbstractText Label="Objectives" NlmCategory="UNASSIGNED">Multidrug resistance (MDR) is a major obstacle in the successful chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP-binding cassette (ABC) transporters, is a well-known strategy to overcome MDR in cancer. The aim of this study was to investigate the efficiency and ability of CRISPR/Cas9 genome editing technology to knockdown ABCB1 gene expression in adriamycin resistant (A2780/ADR) ovarian cancer cell line and evaluate the sensitivity changes to doxorubicin.</AbstractText><AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">Three single-guide RNAs (sgRNAs) targeting the fourth and fifth exons of human ABCB1 gene were designed in this study. Expression level of ABCB1 was detected using quantitative real time PCR (qRT-PCR) after co-transfection of all three sgRNAs into A2780/ADR cell line and subsequent antibiotic selection. Drug sensitivity to doxorubicin was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">The results showed that CRISPR/Cas9 system could significantly reduce the expression of P-gp. The dramatic decline in ABCB1 gene expression was associated with increased sensitivity of cells transfected with sgRNAs to doxorubicin.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Based on the results of this study, it is concluded that the CRISPR-based systems, used in the present study, effectively down-regulated the target gene and acted as an ideal and cost-effective tool for gene editing of A2780/ADR cell line resulting in restoration of nonmalignant phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Norouzi-Barough</LastName><ForeName>Leyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarookhani</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salehi</LastName><ForeName>Rasoul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharifi</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghbelinejad</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetic, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Iran J Basic Med Sci</MedlineTA><NlmUniqueID>101517966</NlmUniqueID><ISSNLinking>2008-3866</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2006 Feb 13;580(4):998-1009</RefSource><PMID Version="1">16405967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 May;16(5):299-311</RefSource><PMID Version="1">25854182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2013 Oct;131(1):241-5</RefSource><PMID Version="1">23726888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2013 Jul;31(7):397-405</RefSource><PMID Version="1">23664777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Feb 29;6:22312</RefSource><PMID Version="1">26924382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 17;9(9):e103988</RefSource><PMID Version="1">25230021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Jul;18(14):2685-94</RefSource><PMID Version="1">10894867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2016 Sep 15;8(9):3986-3994</RefSource><PMID Version="1">27725879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biotechnol. 2010 Nov;46(3):308-16</RefSource><PMID Version="1">20717753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Res Perspect. 2015 Oct;3(5):e00170</RefSource><PMID Version="1">26516582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 May 23;17 (1):108</RefSource><PMID Version="1">27215396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Metab Dispos. 2014 Apr;42(4):623-31</RefSource><PMID Version="1">24492893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cancer Drug Targets. 2013 Mar;13(3):326-46</RefSource><PMID Version="1">23369096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pathol. 2009;4:287-313</RefSource><PMID Version="1">18842102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2010;649:247-56</RefSource><PMID Version="1">20680839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Int Med Res. 2012;40(2):426-35</RefSource><PMID Version="1">22613403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2013 Mar 1;19(5):961-8</RefSource><PMID Version="1">23307860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2015 Sep 14;16(9):22151-68</RefSource><PMID Version="1">26389881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Prime Rep. 2013 Nov 01;5:47</RefSource><PMID Version="1">24273648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Dec 22;16:286</RefSource><PMID Version="1">26694713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 10;6:22847</RefSource><PMID Version="1">26961701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharm Sci. 2016 Feb;105(2):1017-1021</RefSource><PMID Version="1">26869442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e59180</RefSource><PMID Version="1">23554992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Gene Ther. 2016 Jan;23 (1):24-8</RefSource><PMID Version="1">26584532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Dec 13;7(50):83502-83513</RefSource><PMID Version="1">27835872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Ther. 2012 Apr-Jun;8(2):226-31</RefSource><PMID Version="1">22842366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):207-25</RefSource><PMID Version="1">16359925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1995 Nov 23;333(21):1380-5</RefSource><PMID Version="1">7477118</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Lett. 2013 Sep;6(3):795-800</RefSource><PMID Version="1">24137413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Jul 15;119(2):414-22</RefSource><PMID Version="1">16646006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(1):e55509</RefSource><PMID Version="1">23383209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 2009 Nov 1;394(1):110-6</RefSource><PMID Version="1">19622337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2008 Jun;1(2):93-105</RefSource><PMID Version="1">19079736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Res. 2016 Feb;168:15-21</RefSource><PMID Version="1">26470680</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Doxorubicin</Keyword><Keyword MajorTopicYN="N">Drug resistance</Keyword><Keyword MajorTopicYN="N">Ovarian cancer</Keyword><Keyword MajorTopicYN="N">P-glycoprotein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29456815</ArticleId><ArticleId IdType="doi">10.22038/IJBMS.2017.25145.6230</ArticleId><ArticleId IdType="pii">IJBMS-21-181</ArticleId><ArticleId IdType="pmc">PMC5811757</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29456189</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4164</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol. Cell</ISOAbbreviation></Journal><ArticleTitle>Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.</ArticleTitle><Pagination><MedlinePgn>906-914.e4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1097-2765(18)30054-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2018.01.025</ELocationID><Abstract><AbstractText>The microbial CRISPR systems enable adaptive defense against mobile elements and also provide formidable tools for genome engineering. The Cas9 proteins are type II CRISPR-associated, RNA-guided DNA endonucleases that identify double-stranded DNA targets by sequence complementarity and protospacer adjacent motif (PAM) recognition. Here we report that the type II-C CRISPR-Cas9 from Neisseria meningitidis (Nme) is capable of programmable, RNA-guided, site-specific cleavage and recognition of single-stranded RNA targets and that this ribonuclease activity is independent of the PAM sequence. We define the mechanistic feature and specificity constraint for RNA cleavage by NmeCas9 and also show that nuclease null dNmeCas9 binds to RNA target complementary to CRISPR RNA. Finally, we demonstrate that NmeCas9-catalyzed RNA cleavage can be blocked by three families of type II-C anti-CRISPR proteins. These results fundamentally expand the targeting capacities of CRISPR-Cas9 and highlight the potential utility of NmeCas9 as a single platform to target both RNA and DNA.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Beth A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Zhonggang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gramelspacher</LastName><ForeName>Max J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: yzhangbc@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Neisseria</Keyword><Keyword MajorTopicYN="N">PAM</Keyword><Keyword MajorTopicYN="N">RNA cleavage</Keyword><Keyword MajorTopicYN="N">RNA targeting</Keyword><Keyword MajorTopicYN="N">RNA-guided</Keyword><Keyword MajorTopicYN="N">programmable</Keyword><Keyword MajorTopicYN="N">ribonuclease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29456189</ArticleId><ArticleId IdType="pii">S1097-2765(18)30054-6</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2018.01.025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29456084</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>172</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.</ArticleTitle><Pagination><MedlinePgn>979-992.e6</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(18)30049-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2018.01.012</ELocationID><Abstract><AbstractText>Fragile X syndrome (FXS), the most common genetic form of intellectual disability in males, is caused by silencing of the FMR1 gene associated with hypermethylation of the CGG expansion mutation in the 5' UTR of FMR1 in FXS patients. Here, we applied recently developed DNA methylation editing tools to reverse this hypermethylation event. Targeted demethylation of the CGG expansion by dCas9-Tet1/single guide RNA (sgRNA) switched the heterochromatin status of the upstream FMR1 promoter to an active chromatin state, restoring a persistent expression of FMR1 in FXS iPSCs. Neurons derived from methylation-edited FXS iPSCs rescued the electrophysiological abnormalities and restored a wild-type phenotype upon the mutant neurons. FMR1 expression in edited neurons was maintained in vivo after engrafting into the mouse brain. Finally, demethylation of the CGG repeats in post-mitotic FXS neurons also reactivated FMR1. Our data establish that demethylation of the CGG expansion is sufficient for FMR1 reactivation, suggesting potential therapeutic strategies for FXS.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>X Shawn</ForeName><Initials>XS</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Fulcrum Therapeutics, One Kendall Square, Binney Street b7102, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krzisch</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xuebing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graef</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fulcrum Therapeutics, One Kendall Square, Binney Street b7102, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muffat</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hnisz</LastName><ForeName>Denes</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Charles H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Bingbing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Chuanyun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vershkov</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, Jerusalem 91904, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacace</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fulcrum Therapeutics, One Kendall Square, Binney Street b7102, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaenisch</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: jaenisch@wi.mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CGG repeats</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">DNA methylation editing</Keyword><Keyword MajorTopicYN="N">FMR1 reactivation</Keyword><Keyword MajorTopicYN="N">fragile X syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29456084</ArticleId><ArticleId IdType="pii">S0092-8674(18)30049-7</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.01.012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29453460</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5497</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of obesity (2005)</Title><ISOAbbreviation>Int J Obes (Lond)</ISOAbbreviation></Journal><ArticleTitle>Development and initial characterization of a novel ghrelin receptor CRISPR/Cas9 knockout wistar rat model.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41366-018-0013-5</ELocationID><Abstract><AbstractText Label="BACKGROUND/OBJECTIVES" NlmCategory="OBJECTIVE">Ghrelin, a stomach-derived hormone implicated in numerous behaviors including feeding, reward, stress, and addictive behaviors, acts by binding to the growth hormone secretagogue receptor (GHSR). Here, we present the development, verification, and initial characterization of a novel GHSR knockout (KO) Wistar rat model created with CRISPR genome editing.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using CRISPR/Cas9, we developed a GHSR KO in a Wistar background. Loss of GHSR mRNA expression was histologically verified using RNAscope in wild-type (WT; n = 2) and KO (n = 2) rats. We tested the effects of intraperitoneal acyl-ghrelin administration on food consumption and plasma growth hormone (GH) concentrations in WT (n = 8) and KO (n = 8) rats. We also analyzed locomotion, food consumption, and body fat composition in these animals. Body weight was monitored from early development to adulthood.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The RNAscope analysis revealed an abundance of GHSR mRNA expression in the hypothalamus, midbrain, and hippocampus in WTs, and no observed probe binding in KOs. Ghrelin administration increased plasma GH levels (p = 0.0067) and food consumption (p = 0.0448) in WT rats but not KOs. KO rats consumed less food overall at basal conditions and weighed significantly less compared with WTs throughout development (p = 0.0001). Compared with WTs, KOs presented higher concentrations of brown adipose tissue (BAT; p = 0.0322).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We have verified GHSR deletion in our KO model using histological, physiological, neuroendocrinological, and behavioral measures. Our findings indicate that GHSR deletion in rats is not only associated with a lack of response to ghrelin, but also associated with decreases in daily food consumption and body growth, and increases in BAT. This GHSR KO Wistar rat model provides a novel tool for studying the role of the ghrelin system in obesity and in a wide range of medical and neuropsychiatric disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zallar</LastName><ForeName>L J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunstall</LastName><ForeName>B J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richie</LastName><ForeName>C T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Genetic Engineering and Viral Vector Core, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Genetic Engineering and Viral Vector Core, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Z B</ForeName><Initials>ZB</Initials><AffiliationInfo><Affiliation>Neuropsychopharmacology Section, Molecular Targets and Medications Discover Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>E L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Neuropsychopharmacology Section, Molecular Targets and Medications Discover Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heilig</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Social and Affective Neuroscience, IKE, Linköping University, Linköping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickel</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Transgenic Core Facility, National Institute of Mental Health Intramural Research Program, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koob</LastName><ForeName>G F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vendruscolo</LastName><ForeName>L F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>B K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Molecular Mechanisms of Cellular Stress and Inflammation Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leggio</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7284-8754</Identifier><AffiliationInfo><Affiliation>Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Bethesda, MD, USA. lorenzo.leggio@nih.gov.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA. lorenzo.leggio@nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Obes (Lond)</MedlineTA><NlmUniqueID>101256108</NlmUniqueID><ISSNLinking>0307-0565</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453460</ArticleId><ArticleId IdType="doi">10.1038/s41366-018-0013-5</ArticleId><ArticleId IdType="pii">10.1038/s41366-018-0013-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29453406</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses.</ArticleTitle><Pagination><MedlinePgn>3154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-21575-8</ELocationID><Abstract><AbstractText>African swine fever virus (ASFV) causes a highly contagious disease called African swine fever. This disease is often lethal for domestic pigs, causing extensive losses for the swine industry. ASFV is a large and complex double stranded DNA virus. Currently there is no commercially available treatment or vaccine to prevent this devastating disease. Development of recombinant ASFV for producing live-attenuated vaccines or studying the involvement of specific genes in virus virulence has relied on the relatively rare event of homologous recombination in primary swine macrophages, causing difficulty to purify the recombinant virus from the wild-type parental ASFV. Here we present the use of the CRISPR-Cas9 gene editing system as a more robust and efficient system to produce recombinant ASFVs. Using CRISPR-Cas9 a recombinant virus was efficiently developed by deleting the non-essential gene 8-DR from the genome of the highly virulent field strain Georgia07 using swine macrophages as cell substrate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borca</LastName><ForeName>Manuel V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Agricultural Research Service (ARS), Plum Island Animal Disease Center, Greenport, NY, 11944, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holinka</LastName><ForeName>Lauren G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Agricultural Research Service (ARS), Plum Island Animal Disease Center, Greenport, NY, 11944, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berggren</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, 37831, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gladue</LastName><ForeName>Douglas P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7894-0233</Identifier><AffiliationInfo><Affiliation>Agricultural Research Service (ARS), Plum Island Animal Disease Center, Greenport, NY, 11944, USA. Douglas.Gladue@ars.usda.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Virus Res. 2016 Sep 2;223:181-9</RefSource><PMID Version="1">27497620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2002 Mar;43(6):1565-75</RefSource><PMID Version="1">11952905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2009 Aug;34(8):401-7</RefSource><PMID Version="1">19646880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 24;7:46747</RefSource><PMID Version="1">28436458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Jun;89(11):6048-56</RefSource><PMID Version="1">25810553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virus Res. 2016 Aug 2;221:8-14</RefSource><PMID Version="1">27182007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 1997 Apr 14;230(2):252-64</RefSource><PMID Version="1">9143281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1998 Apr;72(4):2881-9</RefSource><PMID Version="1">9525608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Feb;74(3):1275-85</RefSource><PMID Version="1">10627538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol Methods. 2015 Mar;213:18-25</RefSource><PMID Version="1">25479355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 1999 Oct;80 ( Pt 10):2693-7</RefSource><PMID Version="1">10573162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2016 Dec 23;7:2110</RefSource><PMID Version="1">28066407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Infect Dis. 2011 Apr;17(4):599-605</RefSource><PMID Version="1">21470447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Feb;89(4):2324-32</RefSource><PMID Version="1">25505073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 1994 Mar;199(2):463-8</RefSource><PMID Version="1">7907198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1996 Dec;70(12):8865-71</RefSource><PMID Version="1">8971015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 May;89(9):5176-9</RefSource><PMID Version="1">25741005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 1997 Sep 1;235(2):377-85</RefSource><PMID Version="1">9281518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2015 Mar;96(Pt 3):626-36</RefSource><PMID Version="1">25502645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Philos Trans R Soc Lond B Biol Sci. 2009 Sep 27;364(1530):2683-96</RefSource><PMID Version="1">19687038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):62-7</RefSource><PMID Version="1">24476820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Aug;89(16):8556-66</RefSource><PMID Version="1">26063424</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453406</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-21575-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-21575-8</ArticleId><ArticleId IdType="pmc">PMC5816594</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29453285</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>The distal upstream region of insulin-like growth factor-binding protein-1 enhances its expression in endometrial stromal cells during decidualization.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA117.000234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA117.000234</ELocationID><Abstract><AbstractText>We have previously shown that decidualization of human endometrial stromal cells (ESCs) causes a genome-wide increase in the levels of acetylation of histone-H3 Lys-27 (H3K27ac). We also reported that the distal gene regions, more than 3 kb up or downstream of gene transcription start sites have increased H3K27ac levels. Insulin-like growth factor-binding protein-1 (IGFBP-1) is a specific decidualization marker and has increased H3K27ac levels in its distal upstream region (-4701 bp to -7501 bp). Here, using a luciferase reporter gene construct containing this IGFBP-1 upstream region, we tested the hypothesis that it is an IGFBP-1 enhancer. To induce decidualization, we incubated ESCs with cAMP and found that cAMP increased luciferase expression, indicating that decidualization increased the transcriptional activity from the IGFBP-1 upstream region. Furthermore, CRISPR/Cas9-mediated deletion of this region in HepG2 cells significantly reduced IGFBP-1 expression, confirming its role as an IGFBP-1 enhancer. A ChIP assay revealed that cAMP increased the recruitment of the transcriptional regulators CCAAT enhancer-binding protein β (C/EBPβ), forkhead box O1 (FOXO1), and p300 to the IGFBP-1 enhancer in ESCs. Of note, C/EBPβ knockdown inhibited the stimulatory effects of cAMP on the levels of H3K27ac, chromatin opening, and p300 recruitment at the IGFBP-1 enhancer. These results indicate that the region -4701 to -7501 bp upstream of IGFBP-1 functions as an enhancer for IGFBP-1 expression in ESCs undergoing decidualization, that C/EBPβ and FOXO1 bind to the enhancer region to up-regulate IGFBP-1 expression, and that C/EBPβ induces H3K27ac by recruiting p300 to the IGFBP-1 enhancer.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tamura</LastName><ForeName>Isao</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jozaki</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Shun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirafuta</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinagawa</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maekawa</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taketani</LastName><ForeName>Toshiaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asada</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamura</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugino</LastName><ForeName>Norihiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CCAAT-enhancer-binding protein (C/EBP)</Keyword><Keyword MajorTopicYN="N">cyclic AMP (cAMP)</Keyword><Keyword MajorTopicYN="N">endocrinology</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">histone acetylation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453285</ArticleId><ArticleId IdType="pii">RA117.000234</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA117.000234</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29453277</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Editing out five<i>Serpina1</i>paralogs to create a mouse model of genetic emphysema.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">201713689</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1713689115</ELocationID><Abstract><AbstractText>Chronic obstructive pulmonary disease affects 10% of the worldwide population, and the leading genetic cause is α-1 antitrypsin (AAT) deficiency. Due to the complexity of the murine locus, which includes up to six<i>Serpina1</i>paralogs, no genetic animal model of the disease has been successfully generated until now. Here we create a quintuple<i>Serpina1a-e</i>knockout using CRISPR/Cas9-mediated genome editing. The phenotype recapitulates the human disease phenotype, i.e., absence of hepatic and circulating AAT translates functionally to a reduced capacity to inhibit neutrophil elastase. With age,<i>Serpina1</i>null mice develop emphysema spontaneously, which can be induced in younger mice by a lipopolysaccharide challenge. This mouse models not only AAT deficiency but also emphysema and is a relevant genetic model and not one based on developmental impairment of alveolarization or elastase administration. We anticipate that this unique model will be highly relevant not only to the preclinical development of therapeutics for AAT deficiency, but also to emphysema and smoking research.</AbstractText><CopyrightInformation>Copyright © 2018 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borel</LastName><ForeName>Florie</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8171-6195</Identifier><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Huaming</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zieger</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardozo</LastName><ForeName>Brynn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Weiying</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Airiel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cummings School of Veterinary Medicine, Tufts University, Grafton, MA 01536.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruntman</LastName><ForeName>Alisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cummings School of Veterinary Medicine, Tufts University, Grafton, MA 01536.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flotte</LastName><ForeName>Terence R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodsky</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cummings School of Veterinary Medicine, Tufts University, Grafton, MA 01536.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmallah</LastName><ForeName>Mai K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605; chris.mueller@umassmed.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Serpina1</Keyword><Keyword MajorTopicYN="N">alpha-1 antitrypsin</Keyword><Keyword MajorTopicYN="N">emphysema</Keyword><Keyword MajorTopicYN="N">mouse model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453277</ArticleId><ArticleId IdType="pii">1713689115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1713689115</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29453254</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5336</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Applied and environmental microbiology</Title><ISOAbbreviation>Appl. Environ. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Development of a versatile Cas9-driven subpopulation-selection toolbox in<i>Lactococcus lactis</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">AEM.02752-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/AEM.02752-17</ELocationID><Abstract><AbstractText>CRISPR-Cas9 technology has been exploited for the removal or replacement of genetic elements in a wide range of prokaryotes and eukaryotes. Here we describe the extension of the Cas9 application toolbox to the industrially important dairy species<i>Lactococcus lactis</i>The Cas9 expression vector pLABTarget was constructed, encoding the<i>Streptocccus pyogenes</i>Cas9 under control of a constitutive promoter, and allowing plug and play introduction of sgRNA sequences to target specific genetic loci. Introduction of a<i>pepN</i>-targeting derivative of pLABTarget into<i>L. lactis</i>MG1363 led to a strong reduction in the number of transformants obtained, which did not occur in a<i>pepN</i>deletion derivative of the same strain, demonstrating the specificity and lethality of the Cas9 mediated double strand breaks in the lactococcal chromosome. Moreover, the same pLABTarget derivative allowed the selection of a<i>pepN</i>deletion subpopulation from its corresponding single crossover plasmid integrant precursor, accelerating the construction and selection of gene-specific deletion derivatives in<i>L. lactis</i>Finally, pLABTarget containing sgRNAs designed to target mobile genetic elements, allowed the effective curing of plasmids, prophages and integrative conjugative elements (ICE). These results establish that pLABTarget enables the effective exploitation of Cas9 targeting in<i>L. lactis</i>, while the broad host range vector used suggests that this toolbox could be readily expanded to other Gram-positive bacteria.<b>Significance statement</b>Mobile genetic elements in<i>Lactococcus lactis</i>and other lactic acid bacteria play an important role in dairy fermentation, having both positive and detrimental effects during the production of fermented dairy products. The pLABTarget vector offers an efficient cloning platform for Cas9 application in lactic acid bacteria. Targeting Cas9 towards mobile genetic elements enabled their effective curing, which is of particular interest in the context of potentially problematic prophages present in a strain. Moreover, Cas9 targeting to other mobile genetic elements enables the deciphering of their contribution to dairy fermentation processes and further establishing their importance for product characteristics.</AbstractText><CopyrightInformation>Copyright © 2018 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Els</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Host-Microbe Interactomics Group, Animal Sciences, Wageningen University &amp; Research, De Elst 1, 6708 WD, Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIZO B.V., Kernhemseweg 2, 6718 ZB, Ede, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BE-Basic Foundation, Mijnbouwstraat 120, 2628 RX, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Jennelle K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>NIZO B.V., Kernhemseweg 2, 6718 ZB, Ede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleerebezem</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Host-Microbe Interactomics Group, Animal Sciences, Wageningen University &amp; Research, De Elst 1, 6708 WD, Wageningen, The Netherlands. michiel.kleerebezem@wur.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BE-Basic Foundation, Mijnbouwstraat 120, 2628 RX, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bron</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>NIZO B.V., Kernhemseweg 2, 6718 ZB, Ede, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BE-Basic Foundation, Mijnbouwstraat 120, 2628 RX, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Appl Environ Microbiol</MedlineTA><NlmUniqueID>7605801</NlmUniqueID><ISSNLinking>0099-2240</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453254</ArticleId><ArticleId IdType="pii">AEM.02752-17</ArticleId><ArticleId IdType="doi">10.1128/AEM.02752-17</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29453099</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-6265</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Current opinion in virology</Title><ISOAbbreviation>Curr Opin Virol</ISOAbbreviation></Journal><ArticleTitle>Impact of integrated viral DNA on the goal to clear hepatitis B surface antigen with different therapeutic strategies.</ArticleTitle><Pagination><MedlinePgn>24-31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1879-6257(17)30155-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.coviro.2018.01.011</ELocationID><Abstract><AbstractText>A hallmark of hepatitis B virus (HBV) infection is the presence of hepatitis B surface antigen (HBsAg) in the serum of patients. Sustained loss of HBV DNA and HBsAg from the blood are main goals for treatment, and considered as functional cure. It is rarely achieved with long-term nucleoside analogue treatment though, both because cccDNA, the template for viral replication, is not completely cleared, and probably also because hepatocytes with HBV DNA integrated into their chromosomes persist and continue to produce large amounts of HBsAg. Therefore, loss of HBsAg requires that both cccDNA and integrated DNA are cleared or their expression blocked. Recent data indicate that this may be achieved in some patients by stopping nucleoside analogue treatment, and that HBsAg-levels can be reduced by using specific interfering RNA. In the future, targeted degradation or disruption of HBV DNA might be possible using genome editing techniques such as CRISPR/Cas9.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lindh</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, 413 46 Gothenburg, Sweden. Electronic address: magnus.lindh@microbio.gu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rydell</LastName><ForeName>Gustaf E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, 413 46 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Simon B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, 413 46 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Opin Virol</MedlineTA><NlmUniqueID>101560941</NlmUniqueID><ISSNLinking>1879-6257</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29453099</ArticleId><ArticleId IdType="pii">S1879-6257(17)30155-4</ArticleId><ArticleId IdType="doi">10.1016/j.coviro.2018.01.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29452643</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4164</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol. Cell</ISOAbbreviation></Journal><ArticleTitle>Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis.</ArticleTitle><Pagination><MedlinePgn>699-708.e7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1097-2765(18)30046-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2018.01.017</ELocationID><Abstract><AbstractText>The metabolic pathways fueling tumor growth have been well characterized, but the specific impact of transforming events on network topology and enzyme essentiality remains poorly understood. To this end, we performed combinatorial CRISPR-Cas9 screens on a set of 51 carbohydrate metabolism genes that represent glycolysis and the pentose phosphate pathway (PPP). This high-throughput methodology enabled systems-level interrogation of metabolic gene dispensability, interactions, and compensation across multiple cell types. The metabolic impact of specific combinatorial knockouts was validated using<sup>13</sup>C and<sup>2</sup>H isotope tracing, and these assays together revealed key nodes controlling redox homeostasis along the KEAP-NRF2 signaling axis. Specifically, targeting KEAP1 in combination with oxidative PPP genes mitigated the deleterious effects of these knockouts on growth rates. These results demonstrate how our integrated framework, combining genetic, transcriptomic, and flux measurements, can improve elucidation of metabolic network alterations and guide precision targeting of metabolic vulnerabilities based on tumor genetics.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dongxin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badur</LastName><ForeName>Mehmet G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luebeck</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magaña</LastName><ForeName>Jose H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birmingham</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Computational Biology and Bioinformatics, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasik</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Computational Biology and Bioinformatics, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ideker</LastName><ForeName>Trey</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Genetics, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metallo</LastName><ForeName>Christian M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. Electronic address: cmetallo@ucsd.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mali</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA. Electronic address: pmali@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA188652</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA222826</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009285</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 May 1;30(9):1333-5</RefSource><PMID Version="1">24413674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Oct 31;6:</RefSource><PMID Version="1">29087937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Aug 6;59(3):359-71</RefSource><PMID Version="1">26190262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Aug 16;488(7411):337-42</RefSource><PMID Version="1">22895339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2013 Aug 12;24(2):213-228</RefSource><PMID Version="1">23911236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9</RefSource><PMID Version="1">16381927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Mar 13;452(7184):230-3</RefSource><PMID Version="1">18337823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):184-191</RefSource><PMID Version="1">26780180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2006 Oct;3(10 ):e420</RefSource><PMID Version="1">17020408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2017 Nov;23 (11):1362-1368</RefSource><PMID Version="1">28967920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Nov;23 (22):8137-51</RefSource><PMID Version="1">14585973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2011 Aug 31;10(9):671-84</RefSource><PMID Version="1">21878982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Jul 20;67(2):348-354.e4</RefSource><PMID Version="1">28732207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Sep;12(9):823-6</RefSource><PMID Version="1">26167643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 May 26;275(21):16023-9</RefSource><PMID Version="1">10821856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Feb 11;164(4):681-94</RefSource><PMID Version="1">26853473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Jun;14 (6):573-576</RefSource><PMID Version="1">28319113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol. 1998 May;274(5 Pt 1):E843-51</RefSource><PMID Version="1">9612242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Nov 15;491(7424):458-462</RefSource><PMID Version="1">23064226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Jul 30;162(3):540-51</RefSource><PMID Version="1">26232224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2016 Jan 12;23 (1):27-47</RefSource><PMID Version="1">26771115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2016 Dec 13;24(6):875-885</RefSource><PMID Version="1">27667664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2015 Dec;47(12):1475-81</RefSource><PMID Version="1">26482881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Sep 15;62(18):5196-203</RefSource><PMID Version="1">12234984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2000 Jul;46(7):901-6</RefSource><PMID Version="1">10894831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2016 Oct;16(10 ):635-49</RefSource><PMID Version="1">27634447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Aug 15;6:null</RefSource><PMID Version="1">28826492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2012 Jul 10;22(1):66-79</RefSource><PMID Version="1">22789539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Jul 17;55(2):253-63</RefSource><PMID Version="1">24882210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Sep 5;134(5):703-7</RefSource><PMID Version="1">18775299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Jul 06;475(7354):106-9</RefSource><PMID Version="1">21734707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 May 22;324(5930):1029-33</RefSource><PMID Version="1">19460998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Nov 27;350(6264):1096-101</RefSource><PMID Version="1">26472758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(Database issue):D1144-9</RefSource><PMID Version="1">22086960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2006 Apr;116(4):984-95</RefSource><PMID Version="1">16585964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Feb 2;542(7639):119-123</RefSource><PMID Version="1">28099419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2544-9</RefSource><PMID Version="1">26864203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Dec 3;163(6):1515-26</RefSource><PMID Version="1">26627737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2017 Oct 18;139(41):14368-14371</RefSource><PMID Version="1">28911221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 May;35(5):463-474</RefSource><PMID Version="1">28319085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2010 Apr;10(4):267-77</RefSource><PMID Version="1">20300106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis Sci. 2015 Feb;60(2):420-6</RefSource><PMID Version="1">25381201</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">KEAP1</Keyword><Keyword MajorTopicYN="N">NADPH</Keyword><Keyword MajorTopicYN="N">NRF2</Keyword><Keyword MajorTopicYN="N">combinatorial CRISPR screening</Keyword><Keyword MajorTopicYN="N">genetic interactions</Keyword><Keyword MajorTopicYN="N">glycolysis</Keyword><Keyword MajorTopicYN="N">metabolic enzyme compensation</Keyword><Keyword MajorTopicYN="N">metabolic enzyme essentiality</Keyword><Keyword MajorTopicYN="N">metabolic flux analysis</Keyword><Keyword MajorTopicYN="N">redox metabolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29452643</ArticleId><ArticleId IdType="pii">S1097-2765(18)30046-7</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2018.01.017</ArticleId><ArticleId IdType="pmc">PMC5819357</ArticleId><ArticleId IdType="mid">NIHMS937020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29452418</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-4685</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of molecular cell biology</Title><ISOAbbreviation>J Mol Cell Biol</ISOAbbreviation></Journal><ArticleTitle>PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/jmcb/mjy007</ELocationID><Abstract><AbstractText>The differentiation status of neuroblastoma (NB) strongly correlates with its clinical outcomes; however, the molecular mechanisms driving maintenance of stemness and differentiation remain poorly understood. Here, we show that plant homeodomain finger-containing protein 20 (PHF20) functions as a critical epigenetic regulator in sustaining stem cell-like phenotype of NB by using CRISPR/Cas9-based targeted knockout (KO) for high-throughput screening of gene function in NB cell differentiation. Expression of PHF20 in NB was significantly associated with high aggressiveness of the tumor and poor outcomes for NB patients. Deletion of PHF20 inhibited NB cell proliferation, invasive migration, and stem cell-like traits. Mechanistically, PHF20 interacts with poly (ADP-ribose) polymerase 1 (PARP1) and directly binds to promoter regions of octamer-binding transcription factor 4 (OCT4) and sex determining region Y-box 2 (SOX2) to modulate a histone mark associated with active transcription, trimethylation of lysine 4 on histone H3 protein subunit (H3K4me3). Overexpression of OCT4 and SOX2 restored growth and progression of PHF20 KO tumor cells. Consistently, OCT4 and SOX2 protein levels in NB clinical specimens were positively correlated with PHF20 expression. Our results establish PHF20 as a key driver of NB stem cell-like properties and aggressive behaviors, with implications for prognosis and therapy.</AbstractText><CopyrightInformation>© The Author(s) (2018). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Wenyong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery in Xiangya Hospital, Central South University, Changsha 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute Center for Molecular Design and Biomimetics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Junjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Linfeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qianquan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery in Xiangya Hospital, Central South University, Changsha 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Changsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Helen Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery in Xiangya Hospital, Central South University, Changsha 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Rong-Fu</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biosciences and Technology, Texas A&amp;M University Health Science Center, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Cell Biol</MedlineTA><NlmUniqueID>101503669</NlmUniqueID><ISSNLinking>1759-4685</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PARP1</Keyword><Keyword MajorTopicYN="N">PHF20</Keyword><Keyword MajorTopicYN="N">cancer stem cell-like traits</Keyword><Keyword MajorTopicYN="N">epigenetic regulation</Keyword><Keyword MajorTopicYN="N">neuroblastoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29452418</ArticleId><ArticleId IdType="pii">4857401</ArticleId><ArticleId IdType="doi">10.1093/jmcb/mjy007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29452156</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8584</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of molecular and cellular cardiology</Title><ISOAbbreviation>J. Mol. Cell. Cardiol.</ISOAbbreviation></Journal><ArticleTitle>Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.</ArticleTitle><Pagination><MedlinePgn>49-61</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0022-2828(18)30041-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yjmcc.2018.02.007</ELocationID><Abstract><AbstractText>PRKAG2 cardiac syndrome is a distinct form of human cardiomyopathy characterized by cardiac hypertrophy, ventricular pre-excitation and progressive cardiac conduction disorder. However, it remains unclear how mutations in the PRKAG2 gene give rise to such a complicated disease. To investigate the underlying molecular mechanisms, we generated disease-specific hiPSC-derived cardiomyocytes from two brothers both carrying a heterozygous missense mutation c.905G&gt;A (R302Q) in the PRKAG2 gene and further corrected the R302Q mutation with CRISPR-Cas9 mediated genome editing. Disease-specific hiPSC-cardiomyocytes recapitulated many phenotypes of PRKAG2 cardiac syndrome including cellular enlargement, electrophysiological irregularities and glycogen storage. In addition, we found that the PRKAG2-R302Q mutation led to increased AMPK activities, resulting in extensive glycogen deposition and cardiomyocyte hypertrophy. Finally we confirmed that disrupted phenotypes of PRKAG2 cardiac syndrome caused by the specific PRKAG2-R302Q mutation can be alleviated by small molecules inhibiting AMPK activity and be rescued with CRISPR-Cas9 mediated genome correction. Our results showed that disease-specific hiPSC-CMs and genetically-corrected hiPSC-cardiomyocytes would be a very useful platform for understanding the pathogenesis of, and testing autologous cell-based therapies for, PRKAG2 cardiac syndrome.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Yongkun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Cardiovascular Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Huanhuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Ruizhe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Sifeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Lianhua</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Shanghai Key Lab of Birth Defect, Children's Hospital of Fudan University, Shanghai 201102, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Guoying</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shanghai Key Lab of Birth Defect, Children's Hospital of Fudan University, Shanghai 201102, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Aijun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Shanghai Cardiovascular Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: sun.aijun@zs-hospital.sh.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Junbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shanghai Cardiovascular Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: ge.junbo@zs-hospital.sh.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Shanghai Key Lab of Birth Defect, Children's Hospital of Fudan University, Shanghai 201102, China; Institute of Integrative Medicine, Fudan University, Shanghai 200032, China; Shanghai Key Laboratory of Clinical Geriatric Medicine, Fudan University, Shanghai 200032, China. Electronic address: sunning@fudan.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Mol Cell Cardiol</MedlineTA><NlmUniqueID>0262322</NlmUniqueID><ISSNLinking>0022-2828</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AMPK activity</Keyword><Keyword MajorTopicYN="N">Cardiac hypertrophy</Keyword><Keyword MajorTopicYN="N">Cardiomyocytes</Keyword><Keyword MajorTopicYN="N">Glycogen storage</Keyword><Keyword MajorTopicYN="N">Human induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">PRKAG2 cardiac syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29452156</ArticleId><ArticleId IdType="pii">S0022-2828(18)30041-5</ArticleId><ArticleId IdType="doi">10.1016/j.yjmcc.2018.02.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29451908</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Cas9-mediated excision of proximal DNaseI/H3K4me3 signatures confers robust silencing of microRNA and long non-coding RNA genes.</ArticleTitle><Pagination><MedlinePgn>e0193066</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193066</ELocationID><Abstract><AbstractText>CRISPR/Cas9-based approaches have greatly facilitated targeted genomic deletions. Contrary to coding genes however, which can be functionally knocked out by frame-shift mutagenesis, non-coding RNA (ncRNA) gene knockouts have remained challenging. Here we present a universal ncRNA knockout approach guided by epigenetic hallmarks, which enables robust gene silencing even in provisionally annotated gene loci. We build on previous work reporting the presence of overlapping histone H3 lysine 4 tri-methylation (H3K4me3) and DNaseI hypersensitivity sites around the transcriptional start sites of most genes. We demonstrate that excision of this gene-proximal signature leads to loss of microRNA and lincRNA transcription and reveals ncRNA phenotypes. Exemplarily we demonstrate silencing of the constitutively transcribed MALAT1 lincRNA gene as well as of the inducible miR-146a and miR-155 genes in human monocytes. Our results validate a role of miR-146a and miR-155 in negative feedback control of the activity of inflammation master-regulator NFκB and suggest that cell-cycle control is a unique feature of miR-155. We suggest that our epigenetically guided CRISPR approach may improve existing ncRNA knockout strategies and contribute to the development of high-confidence ncRNA phenotyping applications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Janga</LastName><ForeName>Harshavardhan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Lung Research, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aznaourova</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Lung Research, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldt</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Lung Research, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damm</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Pharmaceutical Chemistry, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grünweller</LastName><ForeName>Arnold</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Pharmaceutical Chemistry, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Leon N</ForeName><Initials>LN</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6814-9344</Identifier><AffiliationInfo><Affiliation>Institute for Lung Research, Philipps University, Marburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6</RefSource><PMID Version="1">16885212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Feb 18;43(3):e17</RefSource><PMID Version="1">25414344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 27;507(7493):462-70</RefSource><PMID Version="1">24670764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2016 Apr 28;16(5):279-94</RefSource><PMID Version="1">27121651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2012 Sep;22(9):1775-89</RefSource><PMID Version="1">22955988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Nov 17;539(7629):452-455</RefSource><PMID Version="1">27783602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2012 Aug;18(8):1487-99</RefSource><PMID Version="1">22718948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2735-40</RefSource><PMID Version="1">19193853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Sep 6;489(7414):75-82</RefSource><PMID Version="1">22955617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 Jul;16(7):421-33</RefSource><PMID Version="1">26077373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2014;11(7):829-35</RefSource><PMID Version="1">25137067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Feb 17;45(3):e12</RefSource><PMID Version="1">28180319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2012 Jul 26;2(1):111-23</RefSource><PMID Version="1">22840402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2016 Jan 1;30(1):34-51</RefSource><PMID Version="1">26701265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2015 Oct 23;16:846</RefSource><PMID Version="1">26493208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2013 May;253(1):146-57</RefSource><PMID Version="1">23550644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Jan;1859(1):192-9</RefSource><PMID Version="1">26434412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan 7;41(1):542-53</RefSource><PMID Version="1">23143100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013 Mar;9(3):e1003368</RefSource><PMID Version="1">23555285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2011 Nov;21(11):1944-54</RefSource><PMID Version="1">21844124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Apr 28;106(17 ):7113-8</RefSource><PMID Version="1">19359473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2011 May 18;30(10):1977-89</RefSource><PMID Version="1">21468030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Jan;29(1):24-6</RefSource><PMID Version="1">21221095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2010 Apr 16;584(8):1481-6</RefSource><PMID Version="1">20219467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Sep 26;419(6905):407-11</RefSource><PMID Version="1">12353038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Sep 24;39(6):925-38</RefSource><PMID Version="1">20797886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Dec;34(12 ):1279-1286</RefSource><PMID Version="1">27798563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2012;81:145-66</RefSource><PMID Version="1">22663078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2017 Mar 2;13(3):e1005341</RefSource><PMID Version="1">28253259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2016 Apr;17(4):207-23</RefSource><PMID Version="1">26948815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2012 Aug;9(8):1076-87</RefSource><PMID Version="1">22858678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2014;2014:945169</RefSource><PMID Version="1">24772440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jan;37(Database issue):D623-8</RefSource><PMID Version="1">18940869</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29451908</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193066</ArticleId><ArticleId IdType="pii">PONE-D-17-39903</ArticleId><ArticleId IdType="pmc">PMC5815609</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29451876</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3.</ArticleTitle><Pagination><MedlinePgn>e0192452</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192452</ELocationID><Abstract><AbstractText>Several probiotic-marketed formulations available for the consumers contain live lactic acid bacteria and/or bifidobacteria. The multispecies product commercialized as VSL#3 has been used for treating various gastro-intestinal disorders. However, like many other products, the bacterial strains present in VSL#3 have only been characterized to a limited extent and their efficacy as well as their predicted mode of action remain unclear, preventing further applications or comparative studies. In this work, the genomes of all eight bacterial strains present in VSL#3 were sequenced and characterized, to advance insights into the possible mode of action of this product and also to serve as a basis for future work and trials. Phylogenetic and genomic data analysis allowed us to identify the 7 species present in the VSL#3 product as specified by the manufacturer. The 8 strains present belong to the species Streptococcus thermophilus, Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus helveticus, Bifidobacterium breve and B. animalis subsp. lactis (two distinct strains). Comparative genomics revealed that the draft genomes of the S. thermophilus and L. helveticus strains were predicted to encode most of the defence systems such as restriction modification and CRISPR-Cas systems. Genes associated with a variety of potential probiotic functions were also identified. Thus, in the three Bifidobacterium spp., gene clusters were predicted to encode tight adherence pili, known to promote bacteria-host interaction and intestinal barrier integrity, and to impact host cell development. Various repertoires of putative signalling proteins were predicted to be encoded by the genomes of the Lactobacillus spp., i.e. surface layer proteins, LPXTG-containing proteins, or sortase-dependent pili that may interact with the intestinal mucosa and dendritic cells. Taken altogether, the individual genomic characterization of the strains present in the VSL#3 product confirmed the product specifications, determined its coding capacity as well as identified potential probiotic functions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Douillard</LastName><ForeName>François P</ForeName><Initials>FP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7201-6907</Identifier><AffiliationInfo><Affiliation>Research Program Unit Immunobiology, Medicum, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Food, Environmental, and Nutritional Sciences (DeFENS), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eijlander</LastName><ForeName>Robyn T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>NIZO, Ede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wels</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NIZO, Ede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vos</LastName><ForeName>Willem M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Research Program Unit Immunobiology, Medicum, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Jun 13;82(13):3783-92</RefSource><PMID Version="1">27084020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2005 Jul;187(14):4928-34</RefSource><PMID Version="1">15995208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jul;41(12):e121</RefSource><PMID Version="1">23598997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1261-3</RefSource><PMID Version="1">18560907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2006 Jul;72(7):5069-72</RefSource><PMID Version="1">16820507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2014 Dec;147(6):1327-37.e3</RefSource><PMID Version="1">25450083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Biotechnol. 2013 Sep;6(5):576-87</RefSource><PMID Version="1">23815335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glycobiology. 2013 Dec;23(12):1439-51</RefSource><PMID Version="1">24000282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Syst Appl Microbiol. 2003 Jun;26(2):269-76</RefSource><PMID Version="1">12866854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Mar 17;11(3):e0151824</RefSource><PMID Version="1">26985831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1998 Jan;64(1):21-6</RefSource><PMID Version="1">9435057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Res. 2016 Mar;79(3):445-52</RefSource><PMID Version="1">26571226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bacteriophage. 2012 Jul 1;2(3):149-158</RefSource><PMID Version="1">23275866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2009 Jul;191(13):4144-51</RefSource><PMID Version="1">19376856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14</RefSource><PMID Version="1">24912386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Jul 15;30(14):2068-9</RefSource><PMID Version="1">24642063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2012 Jun 25;13(6):R56</RefSource><PMID Version="1">22731987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Nutr. 2000 May;83(5):505-12</RefSource><PMID Version="1">10953675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Microbiol. 2004;96(4):777-86</RefSource><PMID Version="1">15012816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2012 Jan;78(1):185-93</RefSource><PMID Version="1">22020518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2003 Aug;6(4):417-24</RefSource><PMID Version="1">12941415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antonie Van Leeuwenhoek. 2014 Jul;106(1):57-65</RefSource><PMID Version="1">24633913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2014 Jun 05;13:82</RefSource><PMID Version="1">24902482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2003 Sep;13(9):2178-89</RefSource><PMID Version="1">12952885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Sep 29;6:8322</RefSource><PMID Version="1">26415554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:2087</RefSource><PMID Version="1">23820428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 May 11;12 (5):e0176739</RefSource><PMID Version="1">28493885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2014 Aug 29;13 Suppl 1:S8</RefSource><PMID Version="1">25186768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSystems. 2017 Aug 22;2(4):null</RefSource><PMID Version="1">28845461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Nov 19;9(11):e112963</RefSource><PMID Version="1">25409509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2016 Nov;24(11):853-861</RefSource><PMID Version="1">27374775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19474-9</RefSource><PMID Version="1">19047644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G315-22</RefSource><PMID Version="1">16973917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 Sep 29;8(10):785-6</RefSource><PMID Version="1">21959131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Jan 02;32(1):11-6</RefSource><PMID Version="1">14704338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2010 May;192(9):2467-8</RefSource><PMID Version="1">20190051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2015 Jan;9(1):207-16</RefSource><PMID Version="1">25003965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Gastroenterol Hepatol. 2009 Nov;7(11):1202-9, 1209.e1</RefSource><PMID Version="1">19631292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(8):e1003683</RefSource><PMID Version="1">23966868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11151-6</RefSource><PMID Version="1">23776216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 19;8(7):e68731</RefSource><PMID Version="1">23894338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2013 Jun;97(12):5225-43</RefSource><PMID Version="1">23677442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSphere. 2016 Jun 01;1(3):null</RefSource><PMID Version="1">27303749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2010 Mar 08;11:119</RefSource><PMID Version="1">20211023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Biotechnol. 2016 Jul;9(4):452-65</RefSource><PMID Version="1">27231133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aliment Pharmacol Ther. 2014 Jun;39(11):1276-85</RefSource><PMID Version="1">24738701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mediators Inflamm. 2014;2014:348959</RefSource><PMID Version="1">24795503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunopharmacol. 2014 Jul;21(1):186-92</RefSource><PMID Version="1">24815859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2013 May;10(5):817-27</RefSource><PMID Version="1">23492433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Dec 29;9(12):e115676</RefSource><PMID Version="1">25546330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2013 Nov;159(Pt 11):2269-82</RefSource><PMID Version="1">24002751</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 Oct;193(19):5581-2</RefSource><PMID Version="1">21914889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):454-9</RefSource><PMID Version="1">20018654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1990 Oct 5;215(3):403-10</RefSource><PMID Version="1">2231712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2014 Dec 11;10(12):e1004472</RefSource><PMID Version="1">25501953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2003 Aug;52(2):145-8</RefSource><PMID Version="1">12837738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2017 Jun 30;8:1185</RefSource><PMID Version="1">28713337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Dec 30;83(2):</RefSource><PMID Version="1">27815279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W52-7</RefSource><PMID Version="1">17537822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mediators Inflamm. 2013;2013:237921</RefSource><PMID Version="1">23576850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2009;532:13-27</RefSource><PMID Version="1">19271177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2012 Dec;194(23):6638</RefSource><PMID Version="1">23144392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3906-12</RefSource><PMID Version="1">15671160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bioinform Comput Biol. 2008 Apr;6(2):387-401</RefSource><PMID Version="1">18464329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 Jun;193(12):3160-1</RefSource><PMID Version="1">21478345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurogastroenterol Motil. 2005 Oct;17(5):687-96</RefSource><PMID Version="1">16185307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2017 Sep 15;83(19):</RefSource><PMID Version="1">28754709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11217-22</RefSource><PMID Version="1">21690406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2013 Feb;79(4):1221-31</RefSource><PMID Version="1">23220964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2014 Jan;80(1):9-18</RefSource><PMID Version="1">24123746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ecol. 2015 May;24(9):2241-52</RefSource><PMID Version="1">25611725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1990-5</RefSource><PMID Version="1">12566566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut Microbes. 2012 Sep-Oct;3(5):420-5</RefSource><PMID Version="1">22713271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Nutr. 2011 Aug;6(3):205-7</RefSource><PMID Version="1">21484155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Sep 16;82(19):5756-62</RefSource><PMID Version="1">27422834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2371-6</RefSource><PMID Version="1">19190178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 Jul;193(13):3419-20</RefSource><PMID Version="1">21515769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2013 Nov;79(22):6903-10</RefSource><PMID Version="1">23995933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2004 Nov;53(11):1602-9</RefSource><PMID Version="1">15479680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ecol. 2013 Mar;22(6):1503-17</RefSource><PMID Version="1">23293987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mob Genet Elements. 2015 Jul 24;5(5):63-66</RefSource><PMID Version="1">26904375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 May;76(10):3364-9</RefSource><PMID Version="1">20348299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Jun 22;11(6):e0157958</RefSource><PMID Version="1">27333286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17193-8</RefSource><PMID Version="1">19805152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2009 Jan;7(1):61-71</RefSource><PMID Version="1">19029955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2010 Oct;105(10):2218-27</RefSource><PMID Version="1">20517305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2011 Feb 15;27(4):578-9</RefSource><PMID Version="1">21149342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Jan 03;7:40128</RefSource><PMID Version="1">28045137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2004 Jan;53(1):108-14</RefSource><PMID Version="1">14684584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2008 Jan;16(1):33-40</RefSource><PMID Version="1">18083568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2011 Aug 30;10 Suppl 1:S20</RefSource><PMID Version="1">21995802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2014 Oct;80(19):6104-13</RefSource><PMID Version="1">25063664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jan 1;33(Database issue):D325-8</RefSource><PMID Version="1">15608208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2010 Jul;192(13):3243-5</RefSource><PMID Version="1">20418394</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29451876</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192452</ArticleId><ArticleId IdType="pii">PONE-D-17-32442</ArticleId><ArticleId IdType="pmc">PMC5815585</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29451200</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1673-5374</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neural regeneration research</Title><ISOAbbreviation>Neural Regen Res</ISOAbbreviation></Journal><ArticleTitle>Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease.</ArticleTitle><Pagination><MedlinePgn>19-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1673-5374.224362</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is an increasingly pressing worldwide public-health, social, political and economic concern. Despite significant investment in multiple traditional therapeutic strategies that have achieved success in preclinical models addressing the pathological hallmarks of the disease, these efforts have not translated into any effective disease-modifying therapies. This could be because interventions are being tested too late in the disease process. While existing therapies provide symptomatic and clinical benefit, they do not fully address the molecular abnormalities that occur in AD neurons. The pathophysiology of AD is complex; mitochondrial bioenergetic deficits and brain hypometabolism coupled with increased mitochondrial oxidative stress are antecedent and potentially play a causal role in the disease pathogenesis. Dysfunctional mitochondria accumulate from the combination of impaired mitophagy, which can also induce injurious inflammatory responses, and inadequate neuronal mitochondrial biogenesis. Altering the metabolic capacity of the brain by modulating/potentiating its mitochondrial bioenergetics may be a strategy for disease prevention and treatment. We present insights into the mechanisms of mitochondrial dysfunction in AD brain as well as an overview of emerging treatments with the potential to prevent, delay or reverse the neurodegenerative process by targeting mitochondria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Onyango</LastName><ForeName>Isaac G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Gencia Biotechnology, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Neural Regen Res</MedlineTA><NlmUniqueID>101316351</NlmUniqueID><ISSNLinking>1673-5374</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">antioxidants</Keyword><Keyword MajorTopicYN="N">bioenergetics</Keyword><Keyword MajorTopicYN="N">caloric restriction</Keyword><Keyword MajorTopicYN="N">clustered regularly interspaced short palindromic repeats/associated protein 9 (CRISPR/ Cas9)</Keyword><Keyword MajorTopicYN="N">hypometabolism</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitochondrial DNA</Keyword><Keyword MajorTopicYN="N">mitochondrial biogenesis</Keyword><Keyword MajorTopicYN="N">mitochondrial transcription activator-like effector nucleases</Keyword><Keyword MajorTopicYN="N">mitohormesis</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword><Keyword MajorTopicYN="N">recombinant-human mitochondrial transcription factor A</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29451200</ArticleId><ArticleId IdType="pii">NeuralRegenRes_2018_13_1_19_224362</ArticleId><ArticleId IdType="doi">10.4103/1673-5374.224362</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29450543</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-5783</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Investigative ophthalmology &amp; visual science</Title><ISOAbbreviation>Invest. Ophthalmol. Vis. Sci.</ISOAbbreviation></Journal><ArticleTitle>Mutation in the Zebrafish cct2 Gene Leads to Abnormalities of Cell Cycle and Cell Death in the Retina: A Model of CCT2-Related Leber Congenital Amaurosis.</ArticleTitle><Pagination><MedlinePgn>995-1004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1167/iovs.17-22919</ELocationID><Abstract><AbstractText Label="Purpose" NlmCategory="UNASSIGNED">The compound heterozygous mutations in the β subunit of chaperonin containing TCP-1 (CCT), encoded by CCT2, lead to the Leber congenital amaurosis (LCA). In this study, a cct2 mutant line of zebrafish was established to investigate the role of CCT2 mutations in LCA in vertebrates.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">A cct2 mutant zebrafish line was produced using the CRISPR-Cas9 system. Changes in the eyes of developing wild-type and mutant larvae were monitored using microscopy, immunostaining, TUNEL, and EdU assays. Phenotypic rescue of mutant phenotype was investigated by injection of CCT2 RNA into zebrafish embryos.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">The cct2 mutation (L394H-7del) led to the synthesis of a mutated cctβ protein with the L394H replacement and deletion of 7 amino acid residues (positions 395-401). The homozygous cct2-L394H-7del mutant exhibited a small eye phenotype at 2 days post fertilization (dpf) and was embryonically lethal after 5 dpf. In homozygous cct2-L394H-7del mutants, the retinal ganglion cell differentiation was attenuated, retinal cell cycle was affected, and the neural retinal cell death was significantly increased at 2 dpf compared with wild-type. Injection of RNA encoding wild-type human CCTβ rescued the small eye phenotype, reduced retinal cell death, and restored the levels of CCTβ protein and the major client protein Gβ1 that were significantly reduced in the homozygous cct2-L394H-7del mutant compared with wild-type. These results indicate that cct2 plays an essential role in retinal development by regulating the cell cycle.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">The retinal pathology observed in the homozygous cct2-L394H-7del mutants resembles the retinal pathology of human LCA patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Minegishi</LastName><ForeName>Yuriko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Section of Retinal Ganglion Cell Biology, Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakaya</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Retinal Ganglion Cell Biology, Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomarev</LastName><ForeName>Stanislav I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Section of Retinal Ganglion Cell Biology, Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Invest Ophthalmol Vis Sci</MedlineTA><NlmUniqueID>7703701</NlmUniqueID><ISSNLinking>0146-0404</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>World J Clin Cases. 2015 Feb 16;3(2):112-24</RefSource><PMID Version="1">25685757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2010 Aug 20;401(3):532-43</RefSource><PMID Version="1">20600117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1488-93</RefSource><PMID Version="1">20080638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2015 Sep 14;589(19 Pt A):2522-32</RefSource><PMID Version="1">26140986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2000 May 15;20(10):3552-62</RefSource><PMID Version="1">10804196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2012 Mar 1;363(1):106-14</RefSource><PMID Version="1">22226979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Sep 1;69(17):6879-88</RefSource><PMID Version="1">19690144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Sep 20;6:33742</RefSource><PMID Version="1">27645772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1999 Oct 15;13(20):2713-24</RefSource><PMID Version="1">10541557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2004 May;131(9):1913-25</RefSource><PMID Version="1">15056614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 Jun;31(2):135-40</RefSource><PMID Version="1">12006978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2008 Oct;14(10):1067-76</RefSource><PMID Version="1">18836459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 1997 Feb;18(2):223-30</RefSource><PMID Version="1">9052793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Dec 08;7:13821</RefSource><PMID Version="1">27929117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2008 Sep 4;1228:27-42</RefSource><PMID Version="1">18625210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2003 Jul;22(4):483-543</RefSource><PMID Version="1">12742393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):12792-7</RefSource><PMID Version="1">15256591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glia. 2017 Oct;65(10 ):1697-1716</RefSource><PMID Version="1">28722174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2006 Jul 15;312(12):2309-24</RefSource><PMID Version="1">16765944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3077-82</RefSource><PMID Version="1">23365139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2000 Nov;219(3):391-401</RefSource><PMID Version="1">11066095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surv Ophthalmol. 2004 Jul-Aug;49(4):379-98</RefSource><PMID Version="1">15231395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angiogenesis. 2007;10(2):77-88</RefSource><PMID Version="1">17322966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2015 Sep 11;427(18):2919-30</RefSource><PMID Version="1">25936650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1998 Apr 3;93(1):125-38</RefSource><PMID Version="1">9546398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2012 Mar;96(1):147-56</RefSource><PMID Version="1">22200487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2012 Nov 29;3:e434</RefSource><PMID Version="1">23190606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 1994 Nov;4(11):389-94</RefSource><PMID Version="1">14731814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 1996 Dec;17(6):1117-31</RefSource><PMID Version="1">8982160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Jan 10;275(5297):203-6</RefSource><PMID Version="1">8985012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2006 May;25(3):277-95</RefSource><PMID Version="1">16515881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2014 Dec;98(12):1724-8</RefSource><PMID Version="1">24997176</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29450543</ArticleId><ArticleId IdType="pii">2672938</ArticleId><ArticleId IdType="doi">10.1167/iovs.17-22919</ArticleId><ArticleId IdType="pmc">PMC5815422</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29450416</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-548X</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>19</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Chemical communications (Cambridge, England)</Title><ISOAbbreviation>Chem. Commun. (Camb.)</ISOAbbreviation></Journal><ArticleTitle>A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.</ArticleTitle><Pagination><MedlinePgn>2377-2380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c7cc08893k</ELocationID><Abstract><AbstractText>Originating as a component of prokaryotic adaptive immunity, the type II CRISPR/Cas9 system has been repurposed for targeted genome editing in various organisms. Although Cas9 can bind and cleave DNA efficiently under in vitro conditions, its activity inside a cell can vary dramatically between targets owing to the differences between genomic loci and the availability of enough Cas9/sgRNA (single guide RNA) complex molecules for cleavage. Most methods have so far relied on Cas9 protein engineering or base modifications in the sgRNA sequence to improve CRISPR/Cas9 activity. Here we demonstrate that a structure based rational design of sgRNAs can enhance the efficiency of Cas9 cleavage in vivo. By appending a naturally forming RNA G-quadruplex motif to the 3' end of sgRNAs we can improve its stability and target cleavage efficiency in zebrafish embryos without inducing off-target activity, thereby underscoring its value in the design of better and optimized genome editing triggers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nahar</LastName><ForeName>Smita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sehgal</LastName><ForeName>Paras</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azhar</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Amrita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivasubbu</LastName><ForeName>Sridhar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Debojyoti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiti</LastName><ForeName>Souvik</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9897-1419</Identifier><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research, Anusandhan Bhawan, New Delhi, 110001, India and CSIR-Institute of Genomics &amp; Integrative Biology, Mathura Road, Delhi 110025, India and CSIR-National Chemical Laboratory, Dr Homi Bhabha Road, Pune 411008, India. souvik@igib.res.in debojyoti.chakraborty@igib.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Commun (Camb)</MedlineTA><NlmUniqueID>9610838</NlmUniqueID><ISSNLinking>1359-7345</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29450416</ArticleId><ArticleId IdType="doi">10.1039/c7cc08893k</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29449939</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1674-9782</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of animal science and biotechnology</Title><ISOAbbreviation>J Anim Sci Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Innovative approaches to genome editing in avian species.</ArticleTitle><Pagination><MedlinePgn>15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40104-018-0231-7</ELocationID><Abstract><AbstractText>The tools available for genome engineering have significantly improved over the last 5 years, allowing scientist to make precise edits to the genome. Along with the development of these new genome editing tools has come advancements in technologies used to deliver them. In mammals genome engineering tools are typically delivered into in vitro fertilized single cell embryos which are subsequently cultured and then implanted into a recipient animal. In avian species this is not possible, so other methods have been developed for genome engineering in birds. The most common involves in vitro culturing of primordial germ cells (PGCs), which are cells that migrate through the embryonic circulatory system to the developing gonad and colonize the gonad, eventually differentiating into the gonadocytes which produce either sperm or ova. While in culture the PGCs can be modified to carry novel transgenes or gene edits, the population can be screened and enriched, and then transferred into a recipient embryo. The largest drawback of PGC culture is that culture methods do not transfer well across avian species, thus there are reliable culture methods for only a few species including the chicken. Two newer technologies that appear to be more easily adapted in a wider range of avian species are direct injection and sperm transfection assisted gene editing (STAGE). The direct injection method involves injecting genome engineering tools into the circulatory system of the developing embryo just prior to the developmental time point when the PGCs are migrating to the gonads. The genome engineering tools are complexed with transfection reagents, allowing for in vivo transfection of the PGCs. STAGE utilizes sperm transfection to deliver genome engineering tools directly to the newly fertilized embryo. Preliminary evidence indicates that both methodologies have the potential to be adapted for use in birds species other than the chicken, however further work is needed in this area.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Caitlin A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Private Bag 24, Geelong, VIC 3220 Australia.</Affiliation><Identifier Source="ISNI">0000 0001 2188 8254</Identifier><Identifier Source="GRID">grid.413322.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doran</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Private Bag 24, Geelong, VIC 3220 Australia.</Affiliation><Identifier Source="ISNI">0000 0001 2188 8254</Identifier><Identifier Source="GRID">grid.413322.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challagulla</LastName><ForeName>Arjun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Private Bag 24, Geelong, VIC 3220 Australia.</Affiliation><Identifier Source="ISNI">0000 0001 2188 8254</Identifier><Identifier Source="GRID">grid.413322.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tizard</LastName><ForeName>Mark L V</ForeName><Initials>MLV</Initials><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Private Bag 24, Geelong, VIC 3220 Australia.</Affiliation><Identifier Source="ISNI">0000 0001 2188 8254</Identifier><Identifier Source="GRID">grid.413322.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Kristie A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Private Bag 24, Geelong, VIC 3220 Australia.</Affiliation><Identifier Source="ISNI">0000 0001 2188 8254</Identifier><Identifier Source="GRID">grid.413322.5</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anim Sci Biotechnol</MedlineTA><NlmUniqueID>101581293</NlmUniqueID><ISSNLinking>1674-9782</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2009;4(10):1471-501</RefSource><PMID Version="1">19798082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jul;39(12):e82</RefSource><PMID Version="1">21493687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Oct 26;318(5850):648-51</RefSource><PMID Version="1">17962565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome. 2016 Mar;59(3):185-96</RefSource><PMID Version="1">26868024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12716-21</RefSource><PMID Version="1">25139993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2013 Dec;22(6):1257-64</RefSource><PMID Version="1">23807321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Apr 21;11(4):e0154303</RefSource><PMID Version="1">27099923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Jul;26(7):808-16</RefSource><PMID Version="1">18587387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zygote. 1998 Aug;6(3):227-31</RefSource><PMID Version="1">9854794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Apr 06;6:23980</RefSource><PMID Version="1">27050479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20170-5</RefSource><PMID Version="1">24282302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2017 Mar 1;144(5):928-934</RefSource><PMID Version="1">28174243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2012 Jun;9(6):588-90</RefSource><PMID Version="1">22543349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2008 May;5(5):374-5</RefSource><PMID Version="1">18446154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biosci. 2011 Sep;36(4):613-20</RefSource><PMID Version="1">21857108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nutrients. 2017 Feb 21;9(2):null</RefSource><PMID Version="1">28230769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-60</RefSource><PMID Version="1">8577732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2017 Jun;26(3):331-347</RefSource><PMID Version="1">27896535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Equine Vet J. 2008 Jan;40(1):76-82</RefSource><PMID Version="1">18083664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2002 Jul;161(3):1169-75</RefSource><PMID Version="1">12136019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2015 Nov 1;407(1):68-74</RefSource><PMID Version="1">26277216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zygote. 1999 Feb;7(1):51-9</RefSource><PMID Version="1">10216917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1994 Dec;14(12):8096-106</RefSource><PMID Version="1">7969147</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Avian</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Genome engineering</Keyword><Keyword MajorTopicYN="N">PGCs</Keyword><Keyword MajorTopicYN="N">Sperm</Keyword><Keyword MajorTopicYN="N">TALEN</Keyword></KeywordList><CoiStatement>Not applicableNot applicableThe authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449939</ArticleId><ArticleId IdType="doi">10.1186/s40104-018-0231-7</ArticleId><ArticleId IdType="pii">231</ArticleId><ArticleId IdType="pmc">PMC5806378</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29449584</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing.</ArticleTitle><Pagination><MedlinePgn>261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-018-0301-y</ELocationID><Abstract><AbstractText>The necroptotic cell death pathway is a key component of human pathogen defense that can become aberrantly derepressed during tissue homeostasis to contribute to multiple types of tissue damage and disease. While formation of the necrosome kinase signaling complex containing RIPK1, RIPK3, and MLKL has been extensively characterized, additional mechanisms of its regulation and effector functions likely remain to be discovered. We screened 19,883 mouse protein-coding genes by CRISPR/Cas9-mediated gene knockout for resistance to cytokine-induced necroptosis and identified 112 regulators and mediators of necroptosis, including 59 new candidate pathway components with minimal or no effect on cell growth in the absence of necroptosis induction. Among these, we further characterized the function of PTBP1, an RNA binding protein whose activity is required to maintain RIPK1 protein abundance by regulating alternative splice-site selection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callow</LastName><ForeName>Marinella G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics and Computational Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wickliffe</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bainer</LastName><ForeName>Russell</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics and Computational Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kummerfield</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics and Computational Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuellar</LastName><ForeName>Trinna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Washington Road, Princeton, NJ, 08544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janakiraman</LastName><ForeName>Vasantharajan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chih</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haley</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Physiological Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. mcosta@gene.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11280-5</RefSource><PMID Version="1">17592138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 May 27;111(21):7753-8</RefSource><PMID Version="1">24821786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2011 Jan;18(1):26-37</RefSource><PMID Version="1">20539307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 May 22;157(5):1189-202</RefSource><PMID Version="1">24813850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Dec 7;287(50):42129-37</RefSource><PMID Version="1">23091056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biotechnol. 2016 Jul;58(7):450-9</RefSource><PMID Version="1">27179969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):554</RefSource><PMID Version="1">25476604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 22;327(5964):459-63</RefSource><PMID Version="1">20093472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2017 May;277(1):128-149</RefSource><PMID Version="1">28462528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2013 Sep 19;39(3):443-53</RefSource><PMID Version="1">24012422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 15;517(7534):311-20</RefSource><PMID Version="1">25592536</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Dec 11;36(5):831-44</RefSource><PMID Version="1">20005846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</RefSource><PMID Version="1">27458237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Dec 28;11(12 ):e0168968</RefSource><PMID Version="1">28030641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Nov 24;5:</RefSource><PMID Version="1">27882870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Dec 26;135(7):1311-23</RefSource><PMID Version="1">19109899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2011 Nov 06;12 (12 ):1176-83</RefSource><PMID Version="1">22057290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2009 Mar 13;380(3):431-6</RefSource><PMID Version="1">19284986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Dec 6;17 (10 ):2766-2775</RefSource><PMID Version="1">27926877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2011 Aug 8;194(3):459-72</RefSource><PMID Version="1">21807881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2010 Jan;17 (1):35-45</RefSource><PMID Version="1">19680262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1988 Jul 25;263(21):10262-6</RefSource><PMID Version="1">2839482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2015 Jun;25(6):347-53</RefSource><PMID Version="1">25662614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2017 Jul;24(7):1172-1183</RefSource><PMID Version="1">28362430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Dec 15;13(10 ):2258-72</RefSource><PMID Version="1">26670046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 2017 Feb;95(2):131-136</RefSource><PMID Version="1">27909314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2008 Mar;9(3):254-62</RefSource><PMID Version="1">18246070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2014 Jan;16(1):55-65</RefSource><PMID Version="1">24316671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2005 Jun 24;332(1):181-7</RefSource><PMID Version="1">15896315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2006 Aug;7(8):568-79</RefSource><PMID Version="1">16936697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 2015 May-Jun;93(5):452-60</RefSource><PMID Version="1">25582340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2016 Sep 1;23 (9):1565-76</RefSource><PMID Version="1">27177019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 May 1;21(9):1859-75</RefSource><PMID Version="1">15728110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</RefSource><PMID Version="1">22037414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2017 Jul;24(7):1184-1195</RefSource><PMID Version="1">28498367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2011 Nov 16;12 (12 ):1133-5</RefSource><PMID Version="1">22089210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Cell Dev Biol. 2014 Jul;31:30-9</RefSource><PMID Version="1">24769370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protein Pept Sci. 2012 Mar;13(2):124-33</RefSource><PMID Version="1">22044156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Sep 15;63(6):990-1005</RefSource><PMID Version="1">27591049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Jan 30;370(5):455-65</RefSource><PMID Version="1">24476434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2017 Oct;74(19):3509-3531</RefSource><PMID Version="1">28503708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2014 Sep 15;127(Pt 18):3970-82</RefSource><PMID Version="1">25074807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2016 Sep 1;35(17 ):1868-84</RefSource><PMID Version="1">27307491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 May 22;157(5):1175-88</RefSource><PMID Version="1">24813849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2004 Sep;21(3):415-28</RefSource><PMID Version="1">15357952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Aug 30;16(9):2271-80</RefSource><PMID Version="1">27545878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2014 Mar 15;458(3):559-73</RefSource><PMID Version="1">24393035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Aug 25;166(5):1147-1162.e15</RefSource><PMID Version="1">27565344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2016 Jun;73(11-12):2177-81</RefSource><PMID Version="1">27066893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Nov 11;147(4):742-58</RefSource><PMID Version="1">22078876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Sep 27;17 (1):104-113</RefSource><PMID Version="1">27681424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2014 Nov;14 (11):759-67</RefSource><PMID Version="1">25324125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pathol. 2017 Jan 24;12 :103-130</RefSource><PMID Version="1">27959630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2017 Feb 7;25(2):285-299</RefSource><PMID Version="1">28178566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Direct. 2008 May 21;3:20</RefSource><PMID Version="1">18495041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Dec 30;280(52):42685-93</RefSource><PMID Version="1">16263722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Apr 10;54(1):133-146</RefSource><PMID Version="1">24703947</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449584</ArticleId><ArticleId IdType="doi">10.1038/s41419-018-0301-y</ArticleId><ArticleId IdType="pii">10.1038/s41419-018-0301-y</ArticleId><ArticleId IdType="pmc">PMC5833675</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29449560</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment.</ArticleTitle><Pagination><MedlinePgn>273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-018-0337-z</ELocationID><Abstract><AbstractText>Interleukin 7 receptor (il7r), a transmembrane receptor, belongs to the type I cytokine receptor family. Il7r is involved in the pathogenesis of neurodegenerative disorders, such as multiple sclerosis. Targeted knockdown of il7r leads to delayed myelination, highlighting the potential role of il7r in the development of the nervous system. Zebrafish is an ideal model for the study of neurogenesis; moreover, the il7r gene is highly conserved between zebrafish and human. The aim of the present study was to investigate the novel function of il7r in neurogenesis. First, an il7r<sup>-/-</sup>homozygous mutant line was generated by clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 (CRISPR/Cas9) technology. Second, the gross development of il7r<sup>-/-</sup>mutants revealed remarkably smaller eyes and delayed retinal neurodifferentiation. Third, microarray analysis revealed that genes associated with the phototransduction signalling pathway were strongly down-regulated in il7r<sup>-/-</sup>mutants. Finally, the results from behavioural tests indicated that visual function was impaired in il7r<sup>-/-</sup>mutant larvae. Overall, our data demonstrate that a lack of il7r retards the development of the retina. Thus, il7r is an essential molecule for maintaining normal retinal development in zebrafish.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Shijiao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, 300350, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Jianlin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical International Collaborative Innovation Center, Nankai University, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zongjin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4603-3743</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2022-9526</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University School of Medicine, Tianjin, 300071, China. liyuhao@nankai.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical International Collaborative Innovation Center, Nankai University, Tianjin, 300071, China. liyuhao@nankai.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 1987 Jun 15;260(3):461-71</RefSource><PMID Version="1">3597842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2016 Oct;32(10 ):638-659</RefSource><PMID Version="1">27615122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 Apr;23(4):465-72</RefSource><PMID Version="1">23528705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2013 Oct 19;(80):e50644</RefSource><PMID Version="1">24192694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2011 May;14(5):578-86</RefSource><PMID Version="1">21441919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Jun 15;186(12):7060-6</RefSource><PMID Version="1">21562163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1451:65-79</RefSource><PMID Version="1">27464801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2001 Jul 19;31(1):87-101</RefSource><PMID Version="1">11498053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Apr 25;8(17 ):28395-28407</RefSource><PMID Version="1">28415697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Theor Biol. 2016 Nov 7;408:75-87</RefSource><PMID Version="1">27519951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Quant Biol. 2014 Jun;2(2):59-70</RefSource><PMID Version="1">25722925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(5):2448-51</RefSource><PMID Version="1">17406490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychopharmacology (Berl). 2015 Jan;232(1):197-208</RefSource><PMID Version="1">24958231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2011 Mar;41(3):845-53</RefSource><PMID Version="1">21287555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2010 Oct;186(2):757-61</RefSource><PMID Version="1">20660643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2013 Aug;84(2):132-41</RefSource><PMID Version="1">23701314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Biol Regul. 2013 May;53(2):211-22</RefSource><PMID Version="1">23234870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicol Teratol. 2011 Nov-Dec;33(6):658-67</RefSource><PMID Version="1">21683787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neuroimmunol. 2010 May;222(1-2):82-6</RefSource><PMID Version="1">20226540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Immunol. 2014 Jul;75(7):662-6</RefSource><PMID Version="1">24759676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Endocrinol. 2016 Mar 15;424:81-93</RefSource><PMID Version="1">26802877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Top Microbiol Immunol. 2012;360:47-73</RefSource><PMID Version="1">22695916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2015 Sep 1;195(5):1974-83</RefSource><PMID Version="1">26223651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 8;327(5962):167-70</RefSource><PMID Version="1">20056882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):513-33</RefSource><PMID Version="1">15996891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e32472</RefSource><PMID Version="1">22485131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 1999 Feb 22;404(4):515-36</RefSource><PMID Version="1">9987995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Genomics. 2011 Jun;12(4):238-49</RefSource><PMID Version="1">22131869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1992 Jun;1(3):209-13</RefSource><PMID Version="1">1303237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Electrophoresis. 2012 Mar;33(5):788-96</RefSource><PMID Version="1">22437793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2007 Sep;39(9):1083-91</RefSource><PMID Version="1">17660817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2011 Jun;9(6):467-77</RefSource><PMID Version="1">21552286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2009 Apr 1;328(1):24-39</RefSource><PMID Version="1">19210961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1997 Feb 15;182(2):331-41</RefSource><PMID Version="1">9070331</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2001 Aug;221(4):365-72</RefSource><PMID Version="1">11500973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2002 Jul;161(3):1169-75</RefSource><PMID Version="1">12136019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Cell Biol. 2016;134:257-334</RefSource><PMID Version="1">27312496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Immunol. 2012 Jun;24(3):198-208</RefSource><PMID Version="1">22421572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurol. 2013 Jan;9(1):44-53</RefSource><PMID Version="1">23165340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449560</ArticleId><ArticleId IdType="doi">10.1038/s41419-018-0337-z</ArticleId><ArticleId IdType="pii">10.1038/s41419-018-0337-z</ArticleId><ArticleId IdType="pmc">PMC5833684</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29449551</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Mutations in CFAP43 and CFAP44 cause male infertility and flagellum defects in Trypanosoma and human.</ArticleTitle><Pagination><MedlinePgn>686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-02792-7</ELocationID><Abstract><AbstractText>Spermatogenesis defects concern millions of men worldwide, yet the vast majority remains undiagnosed. Here we report men with primary infertility due to multiple morphological abnormalities of the sperm flagella with severe disorganization of the sperm axoneme, a microtubule-based structure highly conserved throughout evolution. Whole-exome sequencing was performed on 78 patients allowing the identification of 22 men with bi-allelic mutations in DNAH1 (n = 6), CFAP43 (n = 10), and CFAP44 (n = 6). CRISPR/Cas9 created homozygous CFAP43/44 male mice that were infertile and presented severe flagellar defects confirming the human genetic results. Immunoelectron and stimulated-emission-depletion microscopy performed on CFAP43 and CFAP44 orthologs in Trypanosoma brucei evidenced that both proteins are located between the doublet microtubules 5 and 6 and the paraflagellar rod. Overall, we demonstrate that CFAP43 and CFAP44 have a similar structure with a unique axonemal localization and are necessary to produce functional flagella in species ranging from Trypanosoma to human.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coutton</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM de Génétique Chromosomique, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Alexandra S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9826-0526</Identifier><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amiri-Yekta</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8099-7984</Identifier><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM GI-DPI, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACER, Tehran, 16635-148, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kherraf</LastName><ForeName>Zine-Eddine</ForeName><Initials>ZE</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM GI-DPI, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Mustapha</LastName><ForeName>Selima Fourati</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Tanno</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM de Génétique Chromosomique, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wambergue-Legrand</LastName><ForeName>Clémentine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM GI-DPI, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karaouzène</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM GI-DPI, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM de Génétique Chromosomique, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crouzy</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie et Biologie des Métaux, Institut de Recherche en Technologie et Sciences pour le Vivant, CEA iRTSV/LCBM/GMCT, CNRS UMR 5249, Université Grenoble Alpes, 38054, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daneshipour</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACER, Tehran, 16635-148, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini</LastName><ForeName>Seyedeh Hanieh</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, 16635-148, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Valérie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>EA 4308, Department of Reproductive Biology and Spermiology-CECOS Lille, University Medical Center, Lille, 59037, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halouani</LastName><ForeName>Lazhar</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrakchi</LastName><ForeName>Ouafi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makni</LastName><ForeName>Mounir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latrous</LastName><ForeName>Habib</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharouf</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deleuze</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Centre National de Génotypage, Institut de Génomique, CEA, 91000, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre National de Génotypage, Institut de Génomique, CEA, 91000, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennebicq</LastName><ForeName>Sylviane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UF de Biologie de la procréation, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satre</LastName><ForeName>Véronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM de Génétique Chromosomique, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jouk</LastName><ForeName>Pierre-Simon</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>CHU de Grenoble, UF de Génétique Médicale, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thierry-Mieg</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Univ. Grenoble Alpes/CNRS TIMC-IMAG, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conne</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetic Medicine and Development, University of Geneva Medical School, 1211, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dacheux</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Microbiologie Fondamentale et Pathogénicité CNRS UMR 5234, University Bordeaux, 33000, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bordeaux-INP, Microbiologie Fondamentale et Pathogénicité, UMR-CNRS 5234, 33000, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landrein</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Microbiologie Fondamentale et Pathogénicité CNRS UMR 5234, University Bordeaux, 33000, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale, INSERM U1016, Institut Cochin, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, CNRS UMR8104, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stouvenel</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale, INSERM U1016, Institut Cochin, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, CNRS UMR8104, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorès</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale, INSERM U1016, Institut Cochin, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, CNRS UMR8104, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Khouri</LastName><ForeName>Elma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale, INSERM U1016, Institut Cochin, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, CNRS UMR8104, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bottari</LastName><ForeName>Serge P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fauré</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU de Grenoble UF de Biochimie Génétique et Moléculaire, 38000, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grenoble Neuroscience Institute, INSERM 1216, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire d'Histologie Embryologie - Biologie de la Reproduction, GH Cochin Broca Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernet-Gallay</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Grenoble Neuroscience Institute, INSERM 1216, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escoffier</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gourabi</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACER, Tehran, 16635-148, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Derrick R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Microbiologie Fondamentale et Pathogénicité CNRS UMR 5234, University Bordeaux, 33000, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nef</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetic Medicine and Development, University of Geneva Medical School, 1211, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dulioust</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire d'Histologie Embryologie - Biologie de la Reproduction, GH Cochin Broca Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zouari</LastName><ForeName>Raoudha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonhivers</LastName><ForeName>Mélanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9179-8473</Identifier><AffiliationInfo><Affiliation>Microbiologie Fondamentale et Pathogénicité CNRS UMR 5234, University Bordeaux, 33000, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touré</LastName><ForeName>Aminata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale, INSERM U1016, Institut Cochin, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, CNRS UMR8104, 75014, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnoult</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Pierre F</ForeName><Initials>PF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1544-7449</Identifier><AffiliationInfo><Affiliation>Genetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000, Grenoble, France. pray@chu-grenoble.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Grenoble, UM GI-DPI, 38000, Grenoble, France. pray@chu-grenoble.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Syst Biol. 2011 Oct 11;7:539</RefSource><PMID Version="1">21988835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Apr 24;3:e02419</RefSource><PMID Version="1">24843028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2017 Feb;91(2):313-321</RefSource><PMID Version="1">27573432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1998 Feb 5;391(6667):548</RefSource><PMID Version="1">9468133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subcell Biochem. 2008;48:20-30</RefSource><PMID Version="1">18925368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Nov 1;491(7422):56-65</RefSource><PMID Version="1">23128226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 Jun 06;17 (1):122</RefSource><PMID Version="1">27268795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2016 Nov 17;10 (11):e0005125</RefSource><PMID Version="1">27855164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 1992 Jun;102 ( Pt 2):249-60</RefSource><PMID Version="1">1400632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 2017 Jun;107(6):1312-1318.e2</RefSource><PMID Version="1">28577616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 1999 Mar 15;99(1):89-101</RefSource><PMID Version="1">10215027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Cell. 2011 Mar;103(3):109-30</RefSource><PMID Version="1">21275904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2010 Jul;172(1):52-5</RefSource><PMID Version="1">20302889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Sep;32(9):903-14</RefSource><PMID Version="1">25150838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2013 Aug 15;29(16):2056-8</RefSource><PMID Version="1">23772049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2001 May 15;10(11):1117-28</RefSource><PMID Version="1">11371505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e46494</RefSource><PMID Version="1">23071579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e35618</RefSource><PMID Version="1">22558177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Biol. 2015 Jan;5(1):140197</RefSource><PMID Version="1">25567099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Aug 5;291(32):16448-61</RefSource><PMID Version="1">27317664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2011 Jul;10(7):884-94</RefSource><PMID Version="1">21378260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Endocrinol. 2009 Jul 10;306(1-2):24-32</RefSource><PMID Version="1">19481682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 May 17;277(20):17580-8</RefSource><PMID Version="1">11877446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cilia. 2013 Nov 29;2(1):16</RefSource><PMID Version="1">24289478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2016;2016:7372362</RefSource><PMID Version="1">26942199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2014 Jul;13(7):1769-86</RefSource><PMID Version="1">24741115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1975 Jun;44(2):394-436</RefSource><PMID Version="1">805734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Prime Rep. 2015 Mar 10;7:36</RefSource><PMID Version="1">25926987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 1997 Dec 1;90(1):95-109</RefSource><PMID Version="1">9497035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2014 Jul;12(7):505-18</RefSource><PMID Version="1">24931043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jan;37(Database issue):D380-6</RefSource><PMID Version="1">19036790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Apr;7(4):248-9</RefSource><PMID Version="1">20354512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Am Thorac Soc. 2011 Sep;8(5):423-9</RefSource><PMID Version="1">21926393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biophys Biochem Cytol. 1959 Mar 25;5(2):269-78</RefSource><PMID Version="1">13654448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Hum Reprod. 2015 Feb;21(2):157-68</RefSource><PMID Version="1">25354701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Aug 17;536(7616):285-91</RefSource><PMID Version="1">27535533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 1989 Jul;93 ( Pt 3):491-500</RefSource><PMID Version="1">2606940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11105-8</RefSource><PMID Version="1">21690369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2001 Nov 2;313(4):903-19</RefSource><PMID Version="1">11697912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2007 Feb 1;120(Pt 3):478-91</RefSource><PMID Version="1">17227795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2014 Jan 2;94(1):95-104</RefSource><PMID Version="1">24360805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(Database issue):D457-62</RefSource><PMID Version="1">19843604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Parasitol. 1980 Apr;66(2):229-36</RefSource><PMID Version="1">6993640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2006 Jan;145(1):117-20</RefSource><PMID Version="1">16269191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2017 Nov 1;13(11):e1006710</RefSource><PMID Version="1">29091964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 1996 May;77(2):235-9</RefSource><PMID Version="1">8813669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1995 Apr 7;247(4):536-40</RefSource><PMID Version="1">7723011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod. 2016 Jun;31(6):1164-72</RefSource><PMID Version="1">27094479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1218):573-88</RefSource><PMID Version="1">2568647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2009;4(7):1073-81</RefSource><PMID Version="1">19561590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Mar 9;440(7081):224-7</RefSource><PMID Version="1">16525475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod. 2016 Dec;31(12 ):2872-2880</RefSource><PMID Version="1">27798045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2007 Feb;23(2):71-7</RefSource><PMID Version="1">17174157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2001 Dec;127(4):1500-7</RefSource><PMID Version="1">11743094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2017 Feb;91(2):217-232</RefSource><PMID Version="1">27779748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2000 Jul;109(2):195-201</RefSource><PMID Version="1">10960180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2004 Jul;15(7):3257-65</RefSource><PMID Version="1">15146060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2017 Aug;9(8):1132-1149</RefSource><PMID Version="1">28554943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod Update. 2015 Jul-Aug;21(4):455-85</RefSource><PMID Version="1">25888788</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449551</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-02792-7</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-02792-7</ArticleId><ArticleId IdType="pmc">PMC5814398</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29449511</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaar6245</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aar6245</ELocationID><Abstract><AbstractText>CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems. Like CRISPR-Cas9, Cas12a has been harnessed for genome editing based on its ability to generate targeted, double-stranded DNA (dsDNA) breaks. Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules. We find that target-activated, non-specific ssDNase cleavage is also a property of other type V CRISPR-Cas12 enzymes. By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA Endonuclease Targeted CRISPR<i>Trans</i>Reporter (DETECTR), which achieves attomolar sensitivity for DNA detection. DETECTR enables rapid and specific detection of human papillomavirus in patient samples, thereby providing a simple platform for molecular diagnostics.</AbstractText><CopyrightInformation>Copyright © 2018, American Association for the Advancement of Science.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Janice S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4797-3056</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Enbo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Lucas B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Costa</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7268-1912</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xinran</ForeName><Initials>X</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9484-7856</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palefsky</LastName><ForeName>Joel M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5097-3818</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doudna</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9161-999X</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. doudna@berkeley.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94704, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449511</ArticleId><ArticleId IdType="pii">science.aar6245</ArticleId><ArticleId IdType="doi">10.1126/science.aar6245</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29449508</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaaq0179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aaq0179</ELocationID><Abstract><AbstractText>Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications. We recently developed a platform termed SHERLOCK (<u>S</u>pecific<u>H</u>igh Sensitivity<u>E</u>nzymatic<u>R</u>eporter Un<u>LOCK</u>ing) that combines isothermal pre-amplification with Cas13 to detect single molecules of RNA or DNA. Through characterization of CRISPR enzymology and application development, we report here four advances integrated into SHERLOCKv2: 1) 4-channel single reaction multiplexing using orthogonal CRISPR enzymes; 2) quantitative measurement of input down to 2 aM; 3) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxilary CRISPR-associated enzyme; and 4) lateral flow read-out. SHERLOCKv2 can detect Dengue or Zika virus ssRNA as well as mutations in patient liquid biopsy samples via lateral flow, highlighting its potential as a multiplexable, portable, rapid, and quantitative detection platform of nucleic acids.</AbstractText><CopyrightInformation>Copyright © 2018, American Association for the Advancement of Science.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gootenberg</LastName><ForeName>Jonathan S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2757-2175</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Harvard University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abudayyeh</LastName><ForeName>Omar O</ForeName><Initials>OO</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7979-3220</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellner</LastName><ForeName>Max J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5404-0628</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joung</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0178-7995</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard Cambridge, MA 02142, USA. zhang@broadinstitute.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449508</ArticleId><ArticleId IdType="pii">science.aaq0179</ArticleId><ArticleId IdType="doi">10.1126/science.aaq0179</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29449507</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Rewritable multi-event analog recording in bacterial and mammalian cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaap8992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aap8992</ELocationID><Abstract><AbstractText>We present two CRISPR-mediated analog multi-event recording apparatus (CAMERA) systems that use base editors and Cas9 nucleases to record cellular events in bacteria and mammalian cells. The devices record signal amplitude or duration as changes in the ratio of mutually exclusive DNA sequences (CAMERA 1), or as single-base modifications (CAMERA 2). We achieved recording of multiple stimuli in bacteria or mammalian cells, including exposure to antibiotics, nutrients, viruses, light, and changes in Wnt signaling. When recording to multi-copy plasmids, reliable readout requires as few as 10-100 cells. The order of stimuli can be recorded through an overlapping guide RNA design and memories can be erased and re-recorded over multiple cycles. CAMERA systems serve as "cell data recorders" that write a history of endogenous or exogenous signaling events into permanent DNA sequence modifications in living cells.</AbstractText><CopyrightInformation>Copyright © 2018, American Association for the Advancement of Science.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Weixin</ForeName><Initials>W</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5739-5416</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA, and Department of Chemistry and Chemical Biology and Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9943-7557</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA, and Department of Chemistry and Chemical Biology and Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA. drliu@fas.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM118062</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449507</ArticleId><ArticleId IdType="pii">science.aap8992</ArticleId><ArticleId IdType="doi">10.1126/science.aap8992</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29449471</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>359</Volume><Issue>6377</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>'CAMERA' records cell action with new CRISPR tricks.</ArticleTitle><Pagination><MedlinePgn>728</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.359.6377.728</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449471</ArticleId><ArticleId IdType="pii">359/6377/728</ArticleId><ArticleId IdType="doi">10.1126/science.359.6377.728</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29449428</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur. Respir. J.</ISOAbbreviation></Journal><ArticleTitle>A novel piperidine identified by stem cell based screening attenuates pulmonary arterial hypertension<i>via</i>regulating BMP2 and PTGS2 levels.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1702229</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.02229-2017</ELocationID><Abstract><AbstractText>Genetic defects in bone morphogenetic protein type-II receptor (BMPRII) signalling and inflammation contribute to the pathogenesis of pulmonary arterial hypertension (PAH). The receptor is activated by BMP ligands, which also enhance<i>BMPR2</i>transcription. A small molecule BMP upregulator with selectivity on vascular endothelium would represent a desirable therapeutic intervention for PAH.We assayed compounds identified in the screening of BMP2 upregulators for their ability to increase expression of Inhibitor of DNA binding 1 (Id1), using a dual reporter driven specifically in human embryonic stem cell (hESC)-derived endothelial cells (ECs). These assays identified a novel piperidine (BMP upregulator 1, BUR1) with half-maximal effective concentration (EC<sub>50</sub>) of 0.098 μmol/L to increase endothelial Id1 expression. Microarray analyses and immunoblotting showed that BUR1 induced BMP2 and PTGS2 expression. BUR1 effectively rescued deficient angiogenesis in autologous<i>BMPR2</i><sup>+/R899X</sup>ECs generated by CRISPR/Cas9 and patient cells.BUR1 prevented and reversed PAH in monocrotaline (MCT) rats, it also restored BMPRII downstream signalling and modulated arachidonic acid pathway in the pulmonary arterial endothelium in Sugen 5416/hypoxia PAH model.In conclusion, using stem cell technology we provide a novel small molecule compound that regulates BMP2 and PTGS2 levels which might be useful for the treatment of PAH.</AbstractText><CopyrightInformation>Copyright ©ERS 2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Yanjiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Qingxia</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Shiqiang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ai-Lamki</LastName><ForeName>Rafia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge School of Clinical Medicine, Level 5, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortmann</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Anne McLaren Laboratory for Regenerative Medicine, Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Mingxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Anne McLaren Laboratory for Regenerative Medicine, Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Guangdong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, College of Life Sciences, Nanjing Normal University, 1 Wenyuan Rd, Nanjing, Jiangsu Province 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Shuyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, 1 Tiantanxili, Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrell</LastName><ForeName>Nicholas W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge School of Clinical Medicine, Level 5, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Molecular Biology, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dongdan San Tiao, Beijing 100005, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449428</ArticleId><ArticleId IdType="pii">13993003.02229-2017</ArticleId><ArticleId IdType="doi">10.1183/13993003.02229-2017</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29449377</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Haploid embryonic stem cells can be enriched and maintained by simple filtration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA118.002029</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA118.002029</ELocationID><Abstract><AbstractText>Haploid mammalian embryonic stem cells (haESCs) serve as a powerful tool for genetic analyses at both cellular and organismal levels. However, spontaneous diploidization of haESCs limits their use in these analyses. Addition of small molecules to culture medium to control the cell cycle can slow down diploidization, but cell-sorting methods such as FACS are still required to enrich haploid cells for long-term maintenance in vitro. Here, acting on our observation that haploid and diploidized cells differ in diameter, we developed a simplified filtration method to enrich haploid cells from cultured haESCs. We found that regular cell filtration with this system reliably maintained haploidy of mouse haESCs for over 30 passages. Importantly, CRISPR/Cas9-mediated knockout and knockin were successfully achieved in the filtrated cells, leading to stable haploid cell lines carrying the desired gene modifications. Of note, by injecting the haESCs into metaphase II oocytes, we efficiently obtained live mice with the expected genetic traits, indicating that the regular filtration maintained the functional integrity of the haESCs. Moreover, this filtration system was also feasible for derivation of mouse haESCs from parthenogenetic haploid blastocysts and for human haESCs maintenance. In conclusion, we have identified a reliable, efficient and easy-to-handle technique for countering diploidization of haploid cells, a major obstacle in haESC applications.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Suming</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lingbo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tsinghua University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yeguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tsinghua University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinsong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Biochemistry and Cell Biology, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">FACS</Keyword><Keyword MajorTopicYN="N">cell biology</Keyword><Keyword MajorTopicYN="N">cell sorting</Keyword><Keyword MajorTopicYN="N">diploidization</Keyword><Keyword MajorTopicYN="N">embryo</Keyword><Keyword MajorTopicYN="N">embryonic stem cell</Keyword><Keyword MajorTopicYN="N">filtration</Keyword><Keyword MajorTopicYN="N">haploid embryonic stem cells</Keyword><Keyword MajorTopicYN="N">haploidy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29449377</ArticleId><ArticleId IdType="pii">RA118.002029</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA118.002029</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29448764</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Frontiers in CRISPR.</ArticleTitle><Pagination><MedlinePgn>296-304</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.8b00135</ELocationID><Abstract><AbstractText>CRISPR-based approaches to genetic engineering are progressing at a rapid pace and present exciting new avenues for science, medicine, and technology. Many of the most cutting-edge advances in genome engineering are encompassed in the Research Articles, Reviews, and Perspectives in this special issue, often with an eye toward future directions for the field. Yet, many questions remain at this new frontier. We asked over 100 CRISPR researchers, including our contributing authors, for their perspectives on some of the most pressing questions surrounding the future of genome engineering and the CRISPR-Cas platform, the challenges that lie ahead, and opportunities for chemists and chemical biologists to drive creative molecular solutions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weidmann</LastName><ForeName>Alyson G</ForeName><Initials>AG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29448764</ArticleId><ArticleId IdType="doi">10.1021/acschembio.8b00135</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29448763</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Special Issue on the Chemical Biology of CRISPR.</ArticleTitle><Pagination><MedlinePgn>283-284</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.8b00134</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weidmann</LastName><ForeName>Alyson G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3876-2847</Identifier><AffiliationInfo><Affiliation>Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard , 415 Main Street, Rm 3012, Cambridge, Massachusetts 02142, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhary</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard , 415 Main Street, Rm 3012, Cambridge, Massachusetts 02142, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29448763</ArticleId><ArticleId IdType="doi">10.1021/acschembio.8b00134</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29448761</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Spotlight: A Conversation with Laura Kiessling and Jennifer Doudna.</ArticleTitle><Pagination><MedlinePgn>290-295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.8b00108</ELocationID><Abstract><AbstractText>ACS Chemical Biology recorded a special podcast, in which Editor-in-Chief Laura Kiessling (Massachusetts Institute of Technology) interviews CRISPR investigator and former Associate Editor Jennifer Doudna (University of California, Berkeley). Listen to the podcast here . A transcript of the interview, which has been lightly edited, is published here as part of our Special Issue on the Chemical Biology of CRISPR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiessling</LastName><ForeName>Laura L</ForeName><Initials>LL</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6829-1500</Identifier></Author><Author ValidYN="Y"><LastName>Doudna</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29448761</ArticleId><ArticleId IdType="doi">10.1021/acschembio.8b00108</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29448634</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1533-4880</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of nanoscience and nanotechnology</Title><ISOAbbreviation>J Nanosci Nanotechnol</ISOAbbreviation></Journal><ArticleTitle>Comparison of the Off-Target Effects Among One-Base to Three-Base Mismatched Targets of gRNA Using a Blue to White Assay.</ArticleTitle><Pagination><MedlinePgn>1594-1598</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1166/jnn.2018.13813</ELocationID><Abstract><AbstractText>The present study was designed to test a new strategy for comparing the off-target effects of CRISPR/cas9 employing a blue/white colony based assay. Eight types of AmpR plasmids with matched, one base mismatched, two bases mismatched and three bases mismatched targets were constructed. The wild typed alpha peptide of the beta-glactosidase gene and some with mutations, chosen as the targets, were successfully subcloned into the plasmids in an inframe pattern. The relevant gRNA and cas9 were subcloned into the ChloR plasmid. Transformation of the plasmid harboring the target gene yielded blue colonies, while white colonies formed in the plates following the co-transformation of target gene plasmid and the CRISPR/cas9 plasmid. Colonies in different levels of blue color were formed from the plasmids having completely matched target and mismatched targets. The appearance of different blue levels following the co-transformation of the different target plasmid and CRISPR/cas9 plasmid qualitatively indicated the effectiveness of the gRNA, while the ratio of the AMP/CL colonies can be used for relatively quantitative evaluation. The target and off-target effects among different targets of gRNA were differentially identifiable and these effects in turn demonstrated the effectiveness of the blue to white assay. Either the qualitative or the quantitative analysis of the blue to white depends on the final interactions among the target, the cas9 and the gRNA. Clearly, when co-transformation is replaced by single transformation using a specialized nanoparticle containing these three components, the target and off-target effect will be more accurately evaluated. Thus, this study provided a model for application of nanoparticle in gene editing studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Medicine, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wanping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Chungen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Medicine, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Nongyue</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Nanosci Nanotechnol</MedlineTA><NlmUniqueID>101088195</NlmUniqueID><ISSNLinking>1533-4880</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29448634</ArticleId><ArticleId IdType="doi">10.1166/jnn.2018.13813</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29447858</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7544</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Neuroscience</Title><ISOAbbreviation>Neuroscience</ISOAbbreviation></Journal><ArticleTitle>Intrathecal Injection of scAAV9-hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0306-4522(18)30112-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroscience.2018.02.004</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a chronic, fatal neurodegenerative disorder characterized by the progressive loss of upper and lower motor neurons. Currently, there is no effective drug for ALS. Recent studies in ALS model mice have shown that insulin-like growth factor-1 (IGF1) may be a promising therapeutic drug. We demonstrate that self-complementary adeno-associated virus serum type 9 encoding the human IGF1 (scAAV9-hIGF1) could significantly postpone the onset and slow down the progression of the disease owning to inhibiting the NF-κB signaling pathway. Furthermore, the results were supported by experiments in which the CRISPR/Cas9 system was used to knock-down IGF1 in ALS mice (mIGF1). Our data indicate that IGF1-mediated suppression of NF-κB activation in microglia is a novel molecular mechanism underlying MN death in ALS. It provides new insight into IGF1 and points toward novel therapeutic targets of IGF1 in ALS.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>HaoJie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China; Department of Neurology, The First People's Hospital of Guiyang, Guiyang City, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>HuiQian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China; Department of Neurology, The First Hospital of Shijiazhuang City, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>WeiSong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>ZhongYao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>YaKun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>ChunYan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, China; Department of Neurology, The Second Hospital of Hebei Medical University, Heping West Road 215, Shijiazhuang, Hebei Province, China. Electronic address: hblicy5@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroscience</MedlineTA><NlmUniqueID>7605074</NlmUniqueID><ISSNLinking>0306-4522</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">NF-κB</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">insulin-like growth factor-1</Keyword><Keyword MajorTopicYN="N">intrathecal injection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447858</ArticleId><ArticleId IdType="pii">S0306-4522(18)30112-X</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2018.02.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29447841</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7905</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of immunological methods</Title><ISOAbbreviation>J. Immunol. Methods</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0022-1759(17)30500-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jim.2018.02.004</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To prevent unwanted complement activation and subsequent damage, complement activation must be tightly regulated on healthy host cells. Dysregulation of the complement system contributes to the pathology of diseases like Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome. To investigate complement regulator deficiencies, primary patient cells may be used, but access to patient cells may be limited and cells are heterogeneous between different patients. To inhibit regulator function on healthy host cells, blocking antibodies can be used, though it may be difficult to exclude antibody-mediated effects. To circumvent these issues, we created single and combined complement regulator human knockout cells to be able to in vitro investigate complement activation and regulation on human cells.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">CRISPR/Cas9 was used to knockout (KO) complement regulatory proteins CD46, CD55 and/or CD59 in human HAP1 cells. Single cell derived cell lines were profiled by Sanger sequencing and flow cytometry. To confirm the lack of complement regulatory function, the cells were exposed to complement in normal human serum and subsequently C3 and C4 deposition on the cell surface were detected by using flow cytometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We created single KO cell lines that completely lacked CD46, CD55 or CD59. We additionally generated double CD46/CD55, CD46/CD59 and CD55/CD59 KOs and triple CD46/CD55/CD59 KOs. Upon classical pathway activation, deletion of CD46 resulted in increased C3 and C4 deposition, while deleting CD55 mainly resulted to increased C3 deposition, confirming their reported function in complement regulation. Upon alternative pathway activation, C3 deposition was only observed on the triple CD46/CD55/CD59 KO cells and not on any of the other cell lines, suggesting that human cells are resistant to spontaneous complement activation and suggesting a role for CD59 in C3 regulation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The generation of complement regulator KO cell lines provides a relevant tool for future in vitro investigations of complement activation and regulation on human cells. Furthermore, these cell lines may also be helpful to evaluate therapeutic complement inhibitors and may shed light on novel roles of complement regulatory proteins as we here observed for CD59.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thielen</LastName><ForeName>Astrid J F</ForeName><Initials>AJF</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Baarsen</LastName><ForeName>Iris M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jongsma</LastName><ForeName>Marlieke L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeerleder</LastName><ForeName>Sacha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Meibegdreef 9, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spaapen</LastName><ForeName>Robbert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wouters</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: d.wouters@sanquin.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Immunol Methods</MedlineTA><NlmUniqueID>1305440</NlmUniqueID><ISSNLinking>0022-1759</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Complement</Keyword><Keyword MajorTopicYN="N">Knock outs</Keyword><Keyword MajorTopicYN="N">Regulatory proteins</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447841</ArticleId><ArticleId IdType="pii">S0022-1759(17)30500-8</ArticleId><ArticleId IdType="doi">10.1016/j.jim.2018.02.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29447390</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>Pold3 is required for genomic stability and telomere integrity in embryonic stem cells and meiosis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gky098</ELocationID><Abstract><AbstractText>Embryonic stem cells (ESCs) and meiosis are featured by relatively higher frequent homologous recombination associated with DNA double strand breaks (DSB) repair. Here, we show that Pold3 plays important roles in DSB repair, telomere maintenance and genomic stability of both ESCs and spermatocytes in mice. By attempting to generate Pold3 deficient mice using CRISPR/Cas9 or transcription activator-like effector nucleases, we show that complete loss of Pold3 (Pold3-/-) resulted in early embryonic lethality at E6.5. Rapid DNA damage response and massive apoptosis occurred in both outgrowths of Pold3-null (Pold3-/-) blastocysts and Pold3 inducible knockout (iKO) ESCs. While Pold3-/- ESCs were not achievable, Pold3 iKO led to increased DNA damage response, telomere loss and chromosome breaks accompanied by extended S phase. Meanwhile, loss of Pold3 resulted in replicative stress, micronucleation and aneuploidy. Also, DNA repair was impaired in Pold3+/- or Pold3 knockdown ESCs. Moreover, Pold3 mediates DNA replication and repair by regulating 53BP1, RIF1, ATR and ATM pathways. Furthermore, spermatocytes of Pold3 haploinsufficient (Pold3+/-) mice with increasing age displayed impaired DSB repair, telomere shortening and loss, and chromosome breaks, like Pold3 iKO ESCs. These data suggest that Pold3 maintains telomere integrity and genomic stability of both ESCs and meiosis by suppressing replicative stress.</AbstractText><CopyrightInformation>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhongcheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lingling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Feixiang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Genetics, School of basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lingyi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Genetics, The Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447390</ArticleId><ArticleId IdType="pii">4852812</ArticleId><ArticleId IdType="doi">10.1093/nar/gky098</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29447381</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gky076</ELocationID><Abstract><AbstractText>Single-stranded oligodeoxyribonucleotide (ssODN)-mediated repair of CRISPR/Cas9-induced DNA double-strand breaks (DSB) can effectively be used to introduce small genomic alterations in a defined locus. Here, we reveal DNA mismatch repair (MMR) activity is crucial for efficient nucleotide substitution distal from the Cas9-induced DNA break when the substitution is instructed by the 3' half of the ssODN. Furthermore, protecting the ssODN 3' end with phosphorothioate linkages enhances MMR-dependent gene editing events. Our findings can be exploited to optimize efficiencies of nucleotide substitutions distal from the DSB and imply that oligonucleotide-mediated gene editing is effectuated by templated break repair.</AbstractText><CopyrightInformation>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harmsen</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaasen</LastName><ForeName>Sjoerd</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Vrugt</LastName><ForeName>Henri</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Genetics, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Riele</LastName><ForeName>Hein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447381</ArticleId><ArticleId IdType="pii">4852809</ArticleId><ArticleId IdType="doi">10.1093/nar/gky076</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
